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FACULTY OF ENGINEERING AND THE ENVIRONMENT 
 
Loss of upper-limb function is a problem following stroke. Recent research has led to the 
emergence of new treatments but progress is hampered by lack of reliable objective 
measures of impairment, and understanding of the underlying impairment mechanisms 
associated with loss and recovery of functional activity. The aim of this research was to 
identify, using neuromechanical measurement methods, inter-relationships between motor 
impairments, and correlates of motor impairments with functional activity limitation in the 
upper limb of acute and chronic stroke survivors.  
  An instrumented rig has been developed to measure impairments: muscle weakness, active 
range of movement, motor control accuracy in rhythmic and discrete tracking tasks, 
spasticity, coactivation, contracture and non-neural stiffness. In pilot studies, signal 
processing and data analysis techniques have been used to generate novel, clinically and 
physiologically relevant indices to quantify impairments. In a Main Study, 13 older impaired 
participants in the acute phase post-stroke, 13 in the chronic phase 14 age-matched 
unimpaired participants underwent rig assessments and performed a test of upper limb 
activity. A sub-group of impaired participants were tested on two days for test-retest reliability 
evaluation. 
  Statistical tests have confirmed the validity of the impairments to distinguish between acute 
and chronic patients and unimpaired individuals, except coactivation during discrete 
movements and non-neural stiffness.  Repeatability coefficients for the active test indices 
have been presented as benchmark values for use in future trials. The muscle activation 
indices showed lower repeatability which highlights the challenge of using these to measure 
change over time. The impairments that contributed to lower motor control accuracy were 
reduced extensor weakness, delayed extensor onset timing, coactivation and smaller 
extension AROM and PROM; coactivation was more strongly associated with motor control 
accuracy than with spasticity or stiffness.  
  The most important contributors to functional activity in the acute group was extensor 
weakness, and in the chronic group was motor control accuracy and coactivation (rhythmic 
task). Contracture was important contributor in both groups, and was associated with 
weakness and loss of active range of movement rather than spasticity. The findings support 
the notion that rehabilitation strategies should focus on increasing muscle strength and 
prevention of contracture. However, assessment of more complex impairments like motor 
control accuracy and coactivation may be crucial to better target therapy, especially in the 
later phases post-stroke.     ii     iii 
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Glossary of Terms 
Active ROM    Range of movement capable without assistance 
Anterior     Toward the front of the body 
Coactivation  The simultaneous activity of agonist and antagonist muscles crossing 
the same joint that activate in phase and increase the stiffness of the 
joint 
Coactivation index  Correlation of flexor and extensor EMG based on time-points when 
extensor EMG was increasing 
Distal       Away from the centre of the body 
Extension     Increasing inner angle of the joint 
Flexion     Decreasing inner angle of the joint 
Isometric Force  Force measured during muscle contraction with no movement taking 
place 
Lateral     Away from the midline of the body 
Posterior     Toward the back of the body 
Mean torque index  Non-neural torque measured during passive stretch 
Medial       Toward the centre, or midline of the body 
Sample     A group of people, especially regarded as a class or 
subset within a larger group (OED, 1989) 
Path length    Extent of corrective sub-movements at target end-point 
Passive ROM   Range of movement capable with assistance 
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the tonic stretch reflex (muscle tone) with exaggerated tendon jerks, 
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of the upper motor neurone syndrome.’ (Lance 1980) 
Stretch reflex / index  Neural response of flexor EMG to passive stretch 
Torque     Rotational force around an axis 
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1. Introduction 
This thesis presents interdisciplinary research carried out at the Institute of Sound and 
Vibration Research and Faculty of Health Sciences, University of Southampton and forms the 
requirement for Doctor of Philosophy.  
 
This chapter presents a justification for the research, introduces the specific aims and 
objectives of the research, outlines the original contributions made and summarises the 
programme of studies.  
1.1.  Justification for this research 
1.1.1.  The impact of stroke 
Stroke is defined as a clinical syndrome, of presumed vascular origin, typified by rapidly 
developing signs of focal or global disturbance of cerebral functions, lasting more than 24 
hours or leading to death (World Health Organisation 1978). Stroke is one of the top three 
causes of death in England (National Audit Office 2005) and is the most common cause of 
complex disability in older adults (Adamson et al. 2004). Approximately 110,000 strokes occur 
in England each year (National Audit Office 2005). Stroke care costs the NHS about £2.8 
billion a year in direct care costs, and the total annual direct cost of stroke is about £4 billion 
or approximately 5.5% of the total UK expenditure on health care (Saka et al. 2009).  
Although the incidence of stroke in the UK over the past 20 years has fallen by approximately 
40%, which has been  associated with increased use of preventive treatments and major 
reductions in premorbid risk factors (Rothwell et al. 2004), there is a predicted increase in the 
percentage of people in England who are over 65 (from 16% in 2003 to 23% in 2031).  It is 
therefore expected that stroke-related disability will have increased impact on healthcare 
resources with the largest cost being rehabilitation and community care (National Audit Office 
2005). 
1.1.2.  Loss of upper limb function after stroke 
Loss of arm/hand function is a common problem following stroke. It affects 85% of survivors 
(Nakayama et al. 1994) and has an impact on quality of life (Nichols-Larsen et al. 2005). 
Current therapy has limited effectiveness – less than half of those affected have regained 
upper limb function on discharge from hospital (Nakayama et al. 1994) and a longitudinal 
study of 102 patients with flaccid paralysis found that only 38% had regained ‘some dexterity’ 
at 6 months (Kwakkel et al. 2003).  The inability to move effectively with associated limited 
functional activity is caused by a combination of impairments. The primary motor impairments 
following stroke are: weakness, fatigue and loss of dexterity (negative features), and Introduction    Chapter 1 
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abnormal involuntary activity (positive features) such as spasticity, increased tendon reflexes, 
clonus and co-activation during movement (Barnes 2001).  Later onset impairments, due to 
non-neural mechanical changes, are shortening and increased stiffness of muscles and soft 
tissue around joints, resulting in reduced range of movement and abnormal postures. 
1.1.3.  The need for better outcome measurement 
1.1.3.1.  Classification of Impairments, Activity and Participation 
The WHO International Classification of Functioning, Disability and Health (ICF) (World 
Health Organisation 2001) is a classification framework which provides a unified and standard 
language to enable the impact of health and disability to be understood and measured in 
terms that are useful for the patient, carer, clinician and researcher (McPherson et al. 2005). 
The domains are classified into three areas: impairments (problems in body function or 
structure such as a significant deviation or loss), activity limitations (difficulties in execution of 
a task or action) and participation restrictions (problems an individual may experience in their 
life roles).The ICF framework is now commonly used both by clinical therapists in neurological 
rehabilitation and by rehabilitation researchers to classify and understand individual patient 
disability  and evaluate interventions (an example is given in Figure ‎ 1-1 for spasticity). The 
terms impairment, activity limitation and participation restriction and the framework in which 
they are used are the basis for this research and are used throughout this report. 
 
Figure ‎ 1-1: An example of the ICF framework and how it can be used to classify the problem 
of spasticity, adapted from WHO International Classification of Functioning, Disability and 
Health (ICF) (World Health Organisation 2001)  Introduction    Chapter 1 
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1.1.3.2.  The need for impairment measures 
The aim of physical rehabilitation after stroke is to achieve maximum recovery of function by 
reducing impairment, increasing activity and enabling people to participate as fully as possible 
in society (Kwakkel et al. 1999). The basis for the rehabilitation process is the assessment 
and prioritisation of patient’s individual problems and goals in all these domains in order to 
target therapy. There is some two-way connection (see Figure ‎ 1-1) between the three 
domains, for example, therapists realise that targeting treatment at the impairment level will 
contribute to increasing functional activity. In my experience as a physiotherapist, patients 
often present with a complex mix of interrelated motor impairments, and, although skilled 
observation, handling and clinical judgement is used, it is still difficult to prioritise which 
impairments are important to target. Therapy is therefore often based on subjective 
assessment and a process of trial and error. Better objective quantitative measurement and 
understanding of the underlying impairment mechanisms would, one might expect, lead to 
better targeted therapy and improved outcomes for patients. 
   
Similarly, in the field of upper limb rehabilitation research, although considerable advances in 
identifying the potential for recovery with intensive practice has led to the emergence of new 
treatments, progress in the development of rehabilitation therapies has been hampered by 
lack of reliable objective measures of impairment (Pomeroy and Tallis 2000). Commonly used 
standardised tests of upper limb activity are useful to determine functional change, but do not 
inform the underlying mechanisms of functional limitations. More recently, researchers have 
identified the importance of the understanding of the underlying mechanisms associated with 
loss and recovery of function (Kwakkel et al. 2008). Better identification and measurement of 
impairments is key to a greater understanding of a) movement dysfunction of the upper limb 
post-stroke and how it compares to normal movement, and of b) the underlying reasons for 
improvement or deterioration in function. This is expected to provide the foundation for better 
clinical diagnosis of specific individual impairments leading to better targeted treatments, as 
well as better measurement of “natural” recovery and the effectiveness of rehabilitation 
therapies.  
  
1.2.  Aims and Objectives 
The primary aim of this research was to advance understanding of the physiological and 
biomechanical mechanisms associated with normal and impaired function and recovery and 
the relationship between motor impairments and loss of activity in the upper limb of older 
adults, early and late post-stroke. The findings of the research were then used to make 
recommendations on measurement of impairments related to upper limb activity.   Introduction    Chapter 1 
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The objectives were: 
1.  Development of a system of measuring and characterising motor impairments using the 
instrumented wrist rig; including the development of appropriate signal processing and 
data analysis techniques. 
2.  a) Characterisation and derivation of indices for key elements of motor impairments at the 
wrist early and late after stroke;  
b) Evaluation of the validity impairment indices i.e. their ability to distinguish impaired from 
unimpaired and repeatability. 
3.  Evaluate relationships between motor impairments and with functional activity early and 
late after stroke (using a standardised assessment of upper limb activity). 
Further detailed objectives can be found at the end of Chapter 2 following the Literature 
Review. 
1.3.  Development of the wrist rig at Southampton 
This interdisciplinary PhD research work was conducted within the Rehabilitation and Health 
Technologies (RHT) Research Group at the Faculty of Health Sciences (FHS), and the Signal 
Processing and Control Group at the Institute of Sound and Vibration Research (ISVR). The 
RHT group research is into the development, validation and evaluation of rehabilitation and 
health technologies. More specifically, this research is focussed in the ARM (Activity 
Rehabilitation and Measurement of the upper limb) research programme  
 
To achieve the first objective required the development of a system of measuring and 
characterising motor impairments in the upper limb. I have used an instrumented wrist rig (a 
picture of a previous version of the wrist rig can be seen in Chapter 2 Literature Review 
Section ‎ 2.10 and the version used in this study in Chapter 4 Methodology Figure 4.2 and 
Chapter 6 Main Study Figure   6-2). In previous work, the wrist rig, modified from an original 
design, the Strathclyde wrist rig (Pandyan et al. 1997), was developed at the FHS in 
collaboration with the ISVR to objectively measure motor impairments in neurological 
conditions such as stroke, using a combined biomechanical and neurophysiological 
(neuromechanical) approach (Burridge et al. 2008; Notley et al. 2007; Turk et al. 2008a; Turk 
et al. 2008b). The wrist rig was instrumented to measure torque about the wrist joint and wrist 
angle in a horizontal plane combined with surface Electromyography (sEMG) of wrist flexors 
and extensors. In a small preliminary validation study, we used the wrist rig to develop 
neuromechanical measures of motor control, muscle activation patterns, weakness, 
spasticity, and non-neural stiffness (Turk et al. 2008b). This was in preparation for the rig 
being used as tool to measure impairment changes in a clinical study, testing the feasibility of 
implanted microstimulators to improve upper limb functional activity post-stroke (Turk et al. 
2008a). The impairment measures were evaluated for reliability, sensitivity to distinguish Introduction    Chapter 1 
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between people with and without stroke induced hemiplegia (Turk et al. 2008b), and 
relationship with upper limb activity (Burridge et al. 2008). Following this work, I identified 
ways in which the rig could be improved in terms of usability and ability to generate data that 
was more relevant to functional activity. Further details of the results of these studies and the 
research questions raised which led to the formation of this PhD research are outlined in 
Chapter 2 Section ‎ 2.10.  
 
1.4.  List of main original contributions 
The following is a summary of original contributions from this research which extend the 
knowledge in the field: 
1.  Evaluation of the underlying impairment mechanisms associated with upper limb activity 
loss post-stroke through quantifying a wide range of negative, positive and secondary 
motor impairments using one neuromechanical measurement tool  
2.  Evaluation of upper limb motor impairments and functional activity in an older stroke 
population compared to an older unimpaired population 
3.  Evaluation of how a wide range of negative, positive and secondary upper limb motor 
impairments and functional activity relationships differ in the acute and chronic stages 
post-stroke 
4.  Evaluation of motor control during both rhythmic and discrete active tracking tasks. In 
particular, a novel step tracking task has been developed for the purpose of evaluating 
discrete movements 
5.  Evaluation of muscle activation patterns as a method of measuring spasticity in activity. In 
particular, a novel method of measuring abnormal coactivation has been developed. 
 
1.5.  Summary of thesis chapters and overview of studies  
Chapter one has outlined the research problem, rationale for the research, and summarised 
the aim and objectives, as well as the original contributions. The programme of studies used 
to fulfil these aims and objectives is illustrated in the flowchart below (Figure ‎ 1-2).   
 
Chapter 2 gives a review to date of the relevant background literature. The neurophysiology 
of normal motor control is considered, followed by a section on motor impairments of the 
upper limb post-stroke and, specifically, methods of measurement are reviewed and critiqued.  
The wrist rig, used in previous work as a measurement method, is detailed. Lastly, a 
discussion on standardised upper limb activity measures is followed by a summary of that 
literature which is found to date on the relationship between motor impairments and upper Introduction    Chapter 1 
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limb functional activity. This is then followed by the research questions and hypotheses, and 
more detailed aims and objectives are presented.  
 
Chapter 3 details a development phase during which the wrist rig hardware was re-designed 
and re-built including modified arm positioning. A new signal acquisition system, new human 
computer interface software and novel tracking tests were designed and implemented.   
 
Chapter 4 describes the methodology. The study design, participant samples, confounding 
factors, clinical assessments, wrist rig testing protocol, modified Wolf motor function test 
protocol, impairment measure indices, and statistical analyses are discussed and justified. 
 
Chapter 5 reports the pilot studies that were undertaken to optimise the design of the rig and 
to test the methodology of data collection and analysis used in the Main Study. A series of 
four studies are described through which the final protocol was defined. Firstly, new methods 
of measuring coactivation were developed and evaluated. Secondly, usability of active 
tracking tests and four hand positions with younger unimpaired participants was assessed. 
Thirdly all wrist rig tests and two hand positions were assessed with older unimpaired 
participants and participants with chronic post-stroke hemiplegia of all ages.  From these data 
indices of function/impairment were developed and evaluated.  Lastly, the stretch test was 
reassessed with younger and older unimpaired and chronic stroke participants. The study 
findings are discussed in the light of current evidence and lastly, a summary of the final wrist 
rig testing protocol and impairment indices to be used for the Main Study, is given.  
 
Chapter 6 reports the Main Study where the wrist rig tests and an upper limb activity measure 
were conducted with three groups of older participants: those in the acute phase post-stroke, 
those in the chronic phase post-stroke and a control group of age-matched unimpaired 
participants. Results are reported and discussed.  
 
Chapter 7 pulls the discussion sections from Chapters five and six together.  The clinical 
implications of the findings are addressed as well as limitations of the study and plans for 
future research 
 
Chapter 8 contains the final conclusions and recommendations on important functionally-
related upper limb impairment measures which are relevant to clinical practice and 
rehabilitation research. 
 Introduction    Chapter 1 
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Figure ‎ 1-2 Flowchart of the interrelated studies and objectives of this research showing the 
iterative development of the wrist rig and impairment measurement methods in the pilot 
phase that feed into the Main Study data collection method, analysis and conclusions 
Development of wrist rig:  
Hardware; hand positioning; software; tracking tests 
Conclusions and recommendations  
on important functionally-related impairment measures  
Main Study 
 Evaluate differences between impaired and 
unimpaired groups, test-retest and within test 
repeatability and contribution of impairments to 
functional activity  
 
Acute patient group              Chronic patient group  
  (N=13)       (N=13) 
Unimpaired control group 
(N=14) 
Literature Review 
Pilot Studies 
 
Pilot Study 1 – Evaluate preliminary method to derive 
a coactivation index  
 
Pilot Study 2 – Evaluate usability of active tracking 
tests and four hand positions 
 
Pilot Study 3 – Evaluate all wrist rig tests, two hand 
positions, and methods to derive impairment indices 
 
Pilot Study 4 – Evaluate passive stretch response test 
 
 
Development of 
the wrist rig 
measurement 
system 
Characterise and 
derive indices to 
measure key 
motor 
impairments   
Evaluate 
relationships 
between motor 
impairments and 
functional activity  
Studies or Phases of Research Programme  Objectives 
 
Evaluate ability to 
distinguish 
impaired from 
unimpaired and 
repeatability  Literature Review    Chapter 2 
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2. Literature Review 
2.1.  Introduction 
This literature review informs the selection of appropriate tests and methods of analysis for 
the main study with the following objectives: 
  Increase understanding of the neurophysiology of motor control 
  Identify key motor impairments of the upper limb after stroke  
  Identify and critically appraise the biomechanical and neurophysiological methods used to 
measure motor impairments of the upper limb after stroke  
  Identify and critically appraise the standardised measures of upper limb functional activity 
to select the most appropriate measure for the study 
  Identify what is known so far about important relationships between motor impairments 
and functional activity.   
The motor impairments include negative, positive and the secondary features of the upper 
motor neurone syndrome.  The review of research on which impairments relate to functional 
activity suggests that the negative features are more important than spasticity measured 
during passive movements, but a debate exists in the importance of positive features having 
an effect during movement, particularly coactivation.  A more detailed review has therefore 
been made on methods of measurement and analysis of coactivation. 
 
2.2.  Control of voluntary movement 
2.2.1.  Neurophysiology of motor control 
Movement arises through the interaction of sensory / perceptual and motor systems, with 
cognition affecting both systems at many different levels.  The focus of this literature review is 
on motor systems, however sensory systems will be included as they play a strong role in 
control of movement especially peripheral receptors such as muscle spindles and their 
afferent pathways, which will be discussed in reference to their primary role in spasticity.  
 
Movement control is thought to be achieved through the cooperative effort of brain structures 
organised both hierarchically and in parallel (Shumway-Cook and Woollacott 2001).  This 
means that a signal may be processed within ascending levels of the central nervous system 
(CNS) and the same signal may be processed simultaneously among many brain structures 
(Shumway-Cook & Woollacott 2001).  Voluntary motor command has been divided into 
higher, middle and lower levels that can be seen in Figure   2-1 (Gracies 2005a).  The higher 
level can be subdivided into two units, and the first generates the kinematic parameters of the Literature Review    Chapter 2 
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movement required through spatial and temporal representation and the second provides the 
motivation to move.  The middle level corresponds to the planning and preparation of 
movement, i.e. the programming in time and space of the muscle contractions needed to 
achieve the higher level’s movement representation.   The anterior part of the supplementary 
cortex which has connections with the prefrontal cortex and basal ganglia, and the cerebellum 
are thought to be involved in this pre-programming.  The execution of movement itself 
happens centrally at the lower level of command by the primary motor area, centrum 
semiovale, internal capsule and corticospinal tract, and peripherally by the lower motor 
neurone, neuromuscular junction and muscle (Gracies 2005a). 
 
Figure ‎ 2-1 Movement generation (Gracies 2005a): the classically opposed types of 
movement command, voluntary and reflex, are schematised, and the components of each 
level of voluntary command are indicated with the location of the underlying pathways. The 
higher level is the generation of kinematic parameters of the movement required and the 
motivation to move, the middle level corresponds to the planning and preparation of 
movement, and the lower level is the execution of movement. CAR - cutaneous abdominal 
responses; CPR - cutaneous plantar responses; DTR - deep tendon reflexes 
 
2.2.2.  The neurophysiology of discrete and rhythmic upper limb 
movements 
Normal upper limb activity involves reaching, grasping and manipulating objects as the basis 
for important functional activities such as feeding or dressing (Shumway-Cook & Woollacott Literature Review    Chapter 2 
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2001).  These upper limb movements can be described as discrete i.e. they involve a distinct 
start and end point, and sometimes, in complex movements, with intermediary via points.  On 
the other hand, some movements in the body can be described as rhythmic, most commonly 
in the lower limb during locomotion, but also the mouth while chewing, and the upper limb 
when scratching (Schaal et al. 2004).  Animal neurophysiological studies have shown that 
rhythmic movements are associated with central pattern generators and there is some 
indirect evidence for these in human locomotion studies (Shumway-Cook & Woollacott 2001).  
Neurophysiological and computational research on human arm motor control has focused 
almost exclusively on discrete movements, essentially assuming similar neural circuitry for 
rhythmic tasks. In contrast, many behavioural studies have focused on rhythmic models, 
subsuming discrete movement as a special case. Recent research using functional magnetic 
resonance imaging (MRI), whilst performing rhythmic and discrete single-joint wrist flexion-
extension movements, similar to those proposed for this study, found that in addition to areas 
activated in rhythmic movement, discrete movement involves several higher cortical planning 
areas (Schaal et al. 2004).  This suggests that discrete and rhythmic movements use different 
neuronal circuits for control, and therefore should be considered separately in terms of 
neurophysiological and clinical research (Schaal et al. 2004). The study proposed in this 
research will involve investigating motor control accuracy of both rhythmic (sinusoidal 
tracking) and discrete (random step tracking) wrist movements of unimpaired subjects and 
those impaired by stroke.   
 
2.3.  Motor impairments of the upper limb post-stroke 
Motor impairments of the upper limb post-stroke will be defined and grouped using a concept 
used regularly in the literature, the upper motor neuron (UMN) syndrome.  
2.3.1.  Features of the Upper Motor Neurone Syndrome 
The UMN syndrome occurs following any lesion affecting some or all of the descending motor 
pathways of the brain and spinal cord and is a complex group of impairments that often has a 
considerable impact on a person’s activity and participation (Barnes 2001).  Hughlings 
Jackson, a neurologist in the 19
th century, categorized the features of upper motor neuron 
lesions  into two broad groups – positive features and negative features (Walshe 1961). 
The negative features of the UMN syndrome are characterised by a reduction in motor activity 
and include: muscle weakness, loss of dexterity and fatigueability (Barnes 2001).  The 
positive features of the UMN syndrome are characterised by excessive and inappropriate 
motor activity and include: spasticity (exaggerated tonic stretch reflexes), dyssynergic 
patterns of coactivation during movement, associated reactions and other dyssynergic and 
stereotypical spastic dystonias, clonus, extensor and/or flexor spasms, increased tendon Literature Review    Chapter 2 
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reflexes with radiation and positive Babinski sign (Barnes 2001).  In addition to the primary 
positive and negative features which are a direct result of the lesion, there are also secondary 
features that develop over time as a result of the primary impairments.  These include 
stiffness, loss of active range of movement and contracture due to biomechanical changes of 
soft tissue including muscles, tendons, ligaments and joints (Barnes 2001; Thilmann et al. 
1991b). There are also alterations in the histology of muscle tissue such as increased atrophy 
of type II muscle fibres, a predominance of type II fibres (though this may depend on the initial 
fibre type), structural changes mainly in type I fibres, and the presence of target fibres (Dietz 
et al. 1986; Gracies 2005a). 
 
This review will focus on the features that can be measured in the wrist rig: muscle weakness, 
loss of motor control accuracy/ dexterity, spasticity, coactivation and stiffness. The next 
sections describe each impairment, their definition and underlying pathophysiology, and lastly 
how they have been measured in the literature using neuromechanical methods. 
 
2.4.  Weakness  
Weakness of one side of the body, or hemiparesis, is the most immediate effect of a central 
lesion.  Weakness is defined as an inability to generate normal levels of force or tension in a 
muscle for the purposes of posture and movement (Shumway-Cook & Woollacott 2001).  
After a stroke, the problem of reduced muscle force production may be compounded by a 
decreased rate of force production and relaxation (Canning et al. 1999) 
2.4.1.  Pathophysiology of weakness after stroke 
Normal muscle force is generated when either the absolute number of active motor units is 
increased or the firing rates of already-active motor units are increased, and usually both 
processes occur simultaneously.  Normal recruitment of motor units occurs according to their 
size and force-producing characteristics, so that small low-force motor units are the first to be 
recruited, and as force requirements increase, larger and higher force producing motor units 
are recruited (Henneman size principle), resulting in a smooth increase in muscle strength 
(Henneman et al. 1965).  After a stroke there are changes at the motoneurone and muscle 
levels which can decrease the ability to produce force.  These are loss of motor units, 
changes in the properties of motor units, disrupted recruitment order of motor units and 
decreased motor unit firing rates (Bourbonnais and Vanden 1989). A lesion in the higher 
centres of the CNS, discussed in section one, disrupts the access of volitional command and 
excitatory drive to the lower motor neurone. Only lesions involving the pathways of the lower 
level of motor command cause paresis, though lesions affecting higher levels may affect 
motivation and conception of movement, planning and monitoring (Gracies 2005a).  The loss Literature Review    Chapter 2 
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of excitatory drive results in an inability to recruit and / or modulate the motor neurones 
leading to a loss of movement (Shumway-Cook & Woollacott 2001).  This has been shown as 
impersistent motor unit recruitment with gaps in the interference pattern (Bourbonnais & 
Vanden 1989; Fitts et al. 1989), with low-threshold motor units (MUs) firing within the lower 
end of their normal range, high-threshold MUs firing below their normal range or are not 
recruited (Frontera et al. 1997), and a reduced integrated electromyogram (Frontera et al. 
1997; Sahrmann and Norton 1977). 
2.4.2.  Measurement of Weakness 
After stroke weakness is typically measured as the torque or force produced by a maximum 
voluntary contraction (MVC), and methods include handheld (Bohannon 2004) and isokinetic 
dynamometers (Kim and Eng 2003) and grip strength (Boissy et al. 1999; Wetter et al. 2005).  
These measures have been shown to be prognostic indicators (Bohannon and Smith 1987; 
Sunderland et al. 1989). There is another method of quantifying weakness by calculating the 
amplitude of electromyography (EMG) signals i.e. measuring the amount of EMG activation 
during a maximal voluntary contraction (Chae et al. 2002b). However this can be problematic 
because surface EMG (sEMG) signal amplitudes are not directly comparable so 
normalisation must be undertaken using maximum voluntary contraction or other methods. 
The method chosen for this study is measurement of torque during a MVC. 
 
2.5.  Loss of Motor Control Accuracy 
2.5.1.  Definition 
Although loss of dexterity is within the list of negative features of the UMN syndrome, it is 
usually considered to be related only to the skilled use of the hands (manual dexterity). 
However loss of skilled control of movements in single joints or in the upper limb as a whole 
after stroke is of interest. Some researchers investigated motor control in the upper limb 
(elbow joint) and used the term dexterity but with a much broader definition (Ada et al. 1996; 
Canning et al. 2000; Canning et al. 2004).  The task that they used in their studies that tested 
precise muscular coordination involved tracking a visual target by horizontal flexion-extension 
movements of the elbow joint and the definition they used was adroitness and competency in 
use of the limbs by coordinating muscle activity to adequately solve a task to meet 
environmental demands.  This is the definition that will be used in this research programme 
and the term for this will be motor control accuracy.  
2.5.2.  Measurement of Motor Control Accuracy 
The use of tracking tasks is a useful and established approach to the measurement of motor 
control accuracy. Various forms of tracking tasks have been used in the laboratory to provide Literature Review    Chapter 2 
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insight into sensory-motor behaviour such as patterns of muscle activation in unimpaired 
people (Fagg et al. 2002; Hoffman and Strick 1999), perceptual-motor performance of older 
adults (Jagacinski et al. 1995) and muscle activation patterns and motor control accuracy in 
people with post-stroke hemiplegia at the ankle (Burridge and McLellan 2000; Wirth et al. 
2008); elbow (Ada et al. 1996; Canning et al. 2000; Canning et al. 2004; Patten et al. 2003), 
wrist (Burridge et al. 2008; Notley SV et al. 2007; Turk et al. 2008b; Yarosh et al. 2004) and 
finger joints (Carey et al. 1998; Carey et al. 2002; Halaney and Carey 1989).  Through using 
a biomechanical approach coupled with sEMG, both accuracy of tracking and muscle 
activation patterns can be measured and related.  
 
 Tracking is mostly visual commonly using a target on a computer screen (Canning et al. 
2000; Turk et al. 2008b) which tests not just motor control but also visuo-perceptual abilities 
(Jagacinski et al. 1995). An advantage to having a tracking target close to the line of sight of 
the moving joint is that it may reduce some of the visuo-perceptual demand of the task.   
 
Upper limb tracking research has used sinusoidal waveforms (Patten et al. 2003; Turk et al. 
2008b) or repeated random patterns (Canning et al. 2000) which can be described as 
rhythmic movements. Others have used step tracking (Hoffman & Strick 1999; Yarosh et al. 
2004), moving to different points of displacement with variable rest periods in between, which 
are discrete movements.  It is possible that step tracking may relate to more to normal 
functional use of the arm where functional movements are generally discrete. Although there 
are some functional rhythmic upper limb movements (e.g. brushing teeth or brushing hair), 
rhythmic sinusoidal tracking may be more associated to functional use of the lower limb in 
walking. 
 
Accuracy of tracking is calculated using the signal from the target itself and the angle signal 
due to movement of the joint.  Researchers use different methods to calculate the difference 
between the two signals including root mean square (RMS) error (Patten et al. 2003), cross-
correlational and spectral analysis to assess coherence between the signals (Canning et al. 
2000), and cross-correlation (Notley et al. 2007; Turk et al. 2008b).  The RMS and cross 
correlation methods were investigated and it was found that cross correlation method most 
related to functional ability and therefore is arguably more clinically relevant. 
2.5.3.  Impairments that contribute to loss of motor control accuracy 
Loss of control in movement performance may be due to any number of positive, negative or 
secondary features.  A relationship has been shown between wrist tracking ability and wrist 
extensor strength (Burridge et al. 2008) however others suggest that weakness (Ada et al. 
1996; Canning et al. 2000; Wirth et al. 2008) is not associated with loss of tracking Literature Review    Chapter 2 
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performance in the elbow and ankle. Spasticity was not considered to be associated with loss 
of motor control accuracy in two studies as the patients had low spasticity scores on the 
modified Ashworth score (MAS) yet still demonstrated poor tracking performance (Canning et 
al. 2000; Wirth et al. 2008).  Another study showed a relationship between tracking motor 
control and the MAS but not the stretch reflex (Burridge et al. 2008). Neither slowness of 
muscle activation (Canning et al. 2000) nor excessive coactivation (Burridge et al. 2008; 
Canning et al. 2000) seem to be related to dexterity, yet Canning et al found that decreased 
coupling of muscle activation with respect to the target and excessive biceps activation 
distinguished those with low dexterity from those with high dexterity (Canning et al. 2000).  It 
seems therefore that rather than slowness of activation, a lack of consistency of timing of 
muscle activation is more responsible.  It has been hypothesized that a lack of precise 
modulation of the firing rate of motor units as well as their impaired synchronization, which 
has been reported in stroke patients (Farmer et al. 1993; Gemperline et al. 1995) might be 
the underlying factors (Canning et al. 2000).  It is further suggested that this lack of precise 
modulation may be due to reduced corticospinal tract conductivity (Canning et al. 2000; Wirth 
et al. 2008). 
2.6.  Spasticity 
2.6.1.  Definitions 
Spasticity is a well-known but complex phenomenon that remains difficult to define and 
terminology used to describe it can be confusing.  It is easily recognisable by clinicians 
working in neurology as an increase in muscle tone (tension in a muscle experienced as 
resistance to passive movement), often with associated spasms and/or clonus (Stevenson 
and Marsden 2006).  Spasticity is commonly used by clinicians and researchers alike as a 
generic term which encompasses a variety of the positive (e.g. exaggerated stretch reflexes, 
associated reactions, clonus and spasms) and secondary (e.g. stiffness) features of the UMN 
syndrome.  However, the most commonly used and accepted definition in the literature is 
much more precise: ‘…motor disorder characterized by a velocity dependent increase in the 
tonic stretch reflex (muscle tone) with exaggerated tendon jerks, resulting from hyper 
excitability of the stretch reflex, as one component of the upper motor neurone syndrome.’ 
(Lance 1980). More recently a European working group (EU-SPASM) of researchers have 
attempted to update this definition, suggesting that it did not reflect accurately recent research 
findings and current clinical interpretations (Pandyan et al. 2005).  From their literature 
reviews of approaches to measurement of spasticity, they suggest that spasticity cannot be 
considered a pure motor disorder, as afferent activity is also involved. It does not exclusively 
result from hyper excitability of the stretch reflex, activity in other pathways (afferent, 
supraspinal, and changes in the α motor neurone) are also important. The velocity-dependent 
changes in resistance to passive movement are not solely due to neural changes  but are Literature Review    Chapter 2 
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contributed to by the viscoelastic properties of soft tissues (Pandyan et al. 2005). Furthermore 
Lance’s definition relates purely to passive movement of a limb and makes no reference to 
spasticity during active movement (Burridge et al. 2005).  The EU-SPASM group therefore 
redefined spasticity as ‘disordered sensory-motor control, resulting from an upper motor 
neurone lesion, presenting as intermittent or sustained involuntary activation of muscle’ 
(Burridge et al. 2005; Pandyan et al. 2005).   
A specific aspect of spasticity (altered stretch reflexes), muscle activation patterns associated 
with spasticity (coactivation) and secondary biomechanical changes that are associated with 
or influence increased muscle tone in the upper limb post-stroke, and that will be measured 
as part of this research, will be further defined in the following sections. 
2.6.2.  Stretch Reflexes 
In response to muscle stretch, sensory axons (group Ia and II afferents) arising from muscle 
spindles are activated and relay information to the spinal cord and brain about length changes 
(amplitude and speed of stretch) of the muscle (Figure ‎ 2-2).  The Ia afferents wrap around the 
equatorial (middle) region of the muscle spindle, are sensitive to rate of change of muscle 
stretch and have a low threshold to stretch.  The Type II afferents wrap around the juxta-
equatorial (end) region of the spindle, are sensitive to changes in the length of the muscle 
and have a higher threshold to stretch (Shumway-Cook & Woollacott 2001; Vander et al. 
2000). These afferents make monosynaptic (Type Ia) and disynaptic (Type II) connections 
with the α motor neurones leading to contraction of the same muscle (Figure ‎ 2-2).  This is 
clinically seen as a tendon reflex caused by a very brief stretch of muscle (tendon tap) and is 
known as a phasic stretch reflex.  The Ia afferents also excite the Ia inhibitory interneurone 
which connects to the α motor neurones of the antagonist muscles, thus causing 
simultaneous relaxation of the antagonist muscle (reciprocal inhibition) (Stevenson & 
Marsden 2006).   
 Literature Review    Chapter 2 
    16 
 
 
 
 
Figure ‎ 2-2: Muscle spindle and the stretch reflex 
(Vander et al. 2000) 
 
 
 
In the UMN syndrome the clinical signs of hyperexcitability of phasic stretch reflexes include 
exaggerated tendon jerks, as per Lance’s definition above (Lance 1980), irradiation of tendon 
reflexes and clonus (Sheean 2002).  Another stretch reflex is detected in response to muscle 
stretch at the rate used clinically to measure for muscle tone, and that is the tonic stretch 
reflex. In patients with spasticity, long duration responses (tonic stretch reflexes) can be seen 
using EMG even at low stretch velocities (35˚/s in the elbow), which increase linearly with 
increasing velocity (Sheean 2001; Thilmann et al. 1991a). When stretching the muscles of 
unimpaired subjects at rest, however, a stretch reflex is not seen on EMG until a very fast 
stretch velocity (greater than 240˚/s in the elbow) is applied and the short burst of activity then 
may be analogous to a phasic tendon jerk reflex (Thilmann et al. 1991a).  Long duration tonic 
reflexes are not present, even in elderly unimpaired subjects (Yeo et al. 1998), which 
suggests that spasticity is not an exaggeration of a normal reflex (Sheean 2002).    
 
Another aspect of the tonic stretch reflex seen in the UMN syndrome is that although it is 
considered to be dynamic (responds to passive movement) often when the muscle is 
stretched and then maintained in a stretched position, the stretch reflex continues at least for 
a time  and therefore there may be a static component (Sheean 2002).  A further aspect is Literature Review    Chapter 2 
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that the excitability of the tonic stretch reflex depends on the length of the muscle at which it 
is stretched (Sheean 2002) 
2.6.3.  Pathophysiology of spasticity 
2.6.3.1. Spinal reflex pathways 
Given that hyperexcitability of the stretch reflex has a central contribution to spasticity, 
research on the pathophysiology of spasticity over the last 30-40 years has investigated 
which spinal reflex circuits may be involved in the development of spasticity.  Excitation of the 
monosynaptic 1a afferents has a major role in the stretch reflex, but other spinal reflex 
pathways may increase or decrease the effect of this monosynaptic excitation: excitation of 
type II afferents; presynaptic inhibition of Ia afferent terminals; autogenetic inhibition; 
recurrent inhibition; and reciprocal inhibition from muscle spindle Ia afferents from antagonist 
muscles (Nielsen et al. 2007).   
 
Increased excitatory postsynaptic potentials (EPSPs) of muscle spindle afferent information 
caused by presynaptic inhibition of Ia afferents has been demonstrated in patients with 
spasticity due to multiple sclerosis (Nielsen et al. 1995) and spinal cord injury (Faist et al. 
1994) but not for hemiplegic stroke patients (Faist et al. 1994).  
 
Autogenic inhibition is caused by activation of Golgi tendon organs via Ib afferents and is 
mediated by inhibitory interneurones connected to α motor neurones of the same muscle. A 
lack of autogenic inhibition has been shown in patients with hemiplegia (Delwaide and Oliver 
1988), and as it has been argued that reciprocal inhibition at the wrist is mediated by Ib 
inhibitory pathways (Wargon et al. 2006) then the observation of reduced reciprocal inhibition 
at the hemiplegic wrist (Nakashima et al. 1989) provides further evidence that alteration of Ib 
inhibition may play an important role in the pathophysiology of spasticity.  Two other inhibitory 
pathways that are thought to contribute to spasticity are disynaptic reciprocal 1a inhibition 
(this is discussed further in the pathophysiology of coactivation section) and recurrent 
inhibition.  This is mediated by Renshaw cells which are located in the ventral horn of the 
spinal cord and receive excitatory connections from the motor axons and project back to 
motor neurones as well as Ia inhibitory neurones (Nielsen et al. 2007).  Recurrent inhibition 
has been demonstrated to be normal at rest but impaired during voluntary movement in 
patients with hemiplegia (Katz and Pierrot-Deseilligny 1999).  This implies that it does not 
contribute to spasticity when tested passively, but may play a role in often unexplained 
disordered motor control seen during activity. Literature Review    Chapter 2 
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2.6.3.2. Supraspinal descending pathways 
The changes in reflex transmission in spinal pathways depend on the supraspinal drive via 
descending pyramidal (corticospinal) or parapyramidal pathways, which are altered due to the 
stroke lesion.  Both the positive and negative features of the UMN syndrome are largely due 
to dysfunction of parapyramidal tracts and, less so, due to a lesion of the pyramidal tract 
(Sheean 2002).  The modulatory parapyramidal pathways, particularly the dorsal 
reticulospinal tract, are important in inhibiting spinal reflex activity and in controlling the 
threshold and rate of α motor neurone activation (Brown 1994).   
2.6.3.3. Plateau Potentials 
If it were only a case of loss of inhibitory control on spinal reflexes then these would become 
hyperactive very quickly.  More recent studies, however, have suggested other contributing 
factors to the onset of spasticity which fit better with the common clinical picture: one of slow 
development of spasticity.  These include the possibility of new pathways or connections 
(collateral sprouting) or changes in receptor sensitivity (denervation hypersensitivity) that 
arise at cellular level in the spinal cord (Gracies 2005b; Sheean 2002), though the latter have 
been investigated only in animal models not patients with spasticity (Nielsen et al. 2007).  
Another concept is that of the discharge properties of motoneurones undergoing intrinsic 
changes that develop over time.  These result in prolonged depolarized states called plateau 
potentials.  The mechanism for this is thought to involve active membrane properties 
including voltage-dependent, persistent inward calcium and sodium currents that amplify and 
prolong the response of motor neurones to synaptic excitation (Gracies 2005b; Nielsen et al. 
2007).  Plateau potentials have been demonstrated in the chronic state following spinal 
lesions in animal studies (Bennett et al. 2001; Hultborn et al. 2004) and may contribute to the 
presence of spasms in chronic spinal cord injured patients (Gorassini et al. 2004), but to what 
extent they are involved in the development of spasticity following stroke remains unclear.  
2.6.1.  Measurement of spasticity  
2.6.1.1. Clinical measures of spasticity 
The most commonly used clinical scales for the measurement of spasticity have been the 
Ashworth and Modified Ashworth Scales (Van Wijck et al. 2001). However, recently their 
validity has been increasingly questioned, as they do not address the velocity-dependent 
neural aspect of the phenomenon as described by Lance (Lance 1980), and they have poor 
inter-rater reliability (Fleuren et al. 2010; Pandyan et al. 2003b). The Tardieu Scale, which 
was adapted from Tardieu’s original research (Tardieu et al.) by Held and Pierrot-Deseilligny 
(Held and Pierrot-Deseilligny 1969) and translated by Gracies et al. (Gracies et al. 2000), 
demonstrates several advantages in the measurement of spasticity as it uses both a fast and 
slow speed of movement and incorporates an interval level measure (range of movement) as Literature Review    Chapter 2 
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well as a subjective rating scale.  A recent study has demonstrated its validity in that it had 
statistically significant greater agreement with laboratory measures of spasticity (stretch-
induced EMG) and contracture (passive range of movement) than the Ashworth scale (Patrick 
and Ada 2006). 
2.6.1.2. Neurophysiological Measurement of the Stretch Reflex Response 
Neurophysiological measurement methods of spasticity use sEMG to measure responses to 
movement (active and passive), mechanical tap of a tendon and electrical stimulation. 
Methods include the tendon reflex, Hoffmann reflex (H-reflex), and stretch reflex (SR) 
(Voerman et al. 2005).  The tendon jerk is a commonly used method to illustrate a spinal 
reflex.  Tapping a tendon and measuring the resultant muscle activation (latency and 
amplitude) using sEMG was thought to be evidence of the monosynaptic reflex but 
oligosynaptic pathways could also be involved (Rothwell 1994).  The H-reflex is obtained by 
electrically stimulating Ia afferents by submaximal electrical stimulation of a mixed peripheral 
nerve.  This activates the α motor neurones from the same muscle and the subsequent 
muscle activation is measured using sEMG.   
 
The stretch reflex (SR) evoked by passive movement can be elicited by short muscle 
contraction, or displacement of a limb by rotation of a joint either by sinusoidal (Rothwell 
1994; Turk et al. 2008b) or constant velocity movements (Kamper and Rymer 2000).  Three 
peaks (M1, M2, M3) in the response correspond to the short latency reflex due to Ia afferents 
(M1), second due to group II afferents (M2) and the third peak the long-latency tonic reflex 
(M3) (Voerman et al. 2005).  The SR can be quantified in terms of latency (in time (Cody et al. 
1987) or joint angle (Levin and Hui-Chan 1993) of a threshold, amplitude (Cody et al. 1987) 
and duration (Levin & Hui-Chan 1993).  
 
Factors that affect changes in SR are velocity of stretch (as velocity increases the amplitude 
of the EMG recording increases); limb position (this determines the length of the muscle 
which affects the SR); background muscle activity (evoking the SR when a muscle is 
contracted increases the size of the SR) (Voerman et al. 2005); and frequency of SR 
evocation (habituation and fatigue of M2 and M3 responses (Rothwell et al. 1986), and 
reduced joint torque (Schmit et al. 2000) occur after repeated joint movements.  It is therefore 
important that velocity and displacement and limb position are controlled and standardised, 
that background activity is taken into account for normalisation, and that there are 10 second 
rest periods between repeated stretches to minimize habituation and fatigue (Voerman et al. 
2005).  
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Often neurophysiological measures of SR are presented with biomechanical parameters 
which describe the relation between the occurrence of the reflex and the angle and / or 
velocity of displacement. In a study of spasticity measurement at the wrist the SR was 
quantified using a wrist rig instrumented with a potentiometer, tachometer and sEMG.  The 
measurement method involved 10 passive 50˚ constant velocity displacements of the wrist 
joint at 500˚/s using a torque motor.  This speed allowed comparison with unimpaired stretch 
reflex data.  The SR latency and amplitude (area of flexor EMG) were quantified, as well as 
SR threshold speed (the minimum velocity able to evoke the SR).  Others have used 
sinusoidal displacements at varying velocities and range of displacement. One research 
group found that speeds of at least 3 Hz with 10º sinusoidal displacement needed to be used 
to prevent voluntary tracking activity (Ada et al. 2006; Neilson 1972; O'Dwyer et al. 1996).  In 
a preliminary study with the wrist rig (Turk et al. 2008b), our method involved manual passive 
sinusoidal displacements of +/- 30˚ around the subject’s midpoint of their active range of 
movement and at 1.5Hz frequency.  The SR was quantified by calculating the RMS value of 
the flexor EMG envelope above the baseline EMG for the first quadrant of the sinusoidal 
movement curve (from zero degrees to maximum extension) (Turk et al. 2008b).  This 
method was found to be reliable between testing sessions however, because it used repeated 
movements without rest, and as such the resulting SRs were likely to be subject to 
habituation and fatigue. 
 
Biomechanical methods focus on resistance to passive stretch (Wood et al. 2005).  
Resistance to stretch depends on tension generated by SR activity (neural component), 
voluntary activity which the individual might not be able to suppress, and the secondary 
biomechanical stiffness within the soft tissues (non-neural component) (Gracies 2005a).  
Burridge et al concluded that one of the purposes of an appropriate measurement tool is the 
ability to characterize and distinguish between these different components (Burridge et al. 
2005). 
 
2.7.  Coactivation 
2.7.1.  Muscle activation patterns in normal movement 
Normal movement is brought about by the synergic activation of muscles around joints which 
occurs through co-activation, reciprocal inhibition and reciprocal activation.  Reciprocal 
inhibition and activation both involve alternating activity of the agonist and antagonist. For 
reciprocal inhibition, as the agonist contracts, the antagonist is simultaneously inhibited 
(Sherrington 1906), whereas reciprocal activation occurs through passive relaxation of the 
antagonist rather than inhibition (Damiano 1993). The pattern of alternating muscle interaction 
depends on the movement task. Step tracking, which involves rapid movement of a limb to a Literature Review    Chapter 2 
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target, is brought about by a characteristic tri-phasic muscle activation. Here a burst of 
agonist activity (AG1) which initiates the movement is followed sequentially by a burst of 
antagonist activity (ANT1) which breaks the movement, and another burst of agonist activity 
(AG2) which moderates the antagonist braking forces and redirects the movement to the 
target (Cooke and Brown 1990; Wierzbicka et al. 1986). In many instances additional bursts 
of activity alternate between agonists and antagonists until the limb is stabilised at the target 
(Hoffman and Strick 1990).  Muscle interaction during rhythmic cyclic or sinusoidal 
movements has been less well researched, but a study of reversal movements shows ANT1 
acting to decelerate and reverse movement direction and accelerate limb in reverse direction 
(Almeida et al. 2006).  
2.7.2.  Definition of Coactivation 
Coactivation is defined as the simultaneous activity of agonist and antagonist muscles 
crossing the same joint (Sheean 2001; Shumway-Cook & Woollacott 2001) that activate in 
phase and increase the stiffness of the joint (Damiano 1993). Extensive coactivation is a 
normal feature in motor system development during the first four years of life (O'Sullivan et al. 
1998).Controlled coactivation is used thereafter to stabilise joints and modulates in response 
to changing task requirements such as perturbing effects of external loads (De Serres and 
Milner 1991; Milner 2002), movement velocity (Suzuki et al. 2001) and accuracy requirements 
(Gribble et al. 2003), and reduces during motor learning (Gribble et al. 2003; Osu et al. 2002). 
Coactivation becomes abnormal at the point where the mechanical stiffness it creates impairs 
movement (Damiano 1993). This can occur as a result of neurological pathology and 
coactivation is seen in adult CNS lesions, though more commonly in cerebral palsy 
(O'Sullivan et al. 1998), and is associated with spasticity (Gracies 2005b; Gracies 2004; 
Sheean 2001). The extent to which coactivation is present and impairs function after stroke is 
debated with some authors finding it is (Burridge & McLellan 2000; Chae et al. 2002b; 
Hammond et al. 1988a; Hu et al. 2006; Kamper and Rymer 2001; Leonard et al. 2006; Neckel 
et al. 2006) and others not (Canning et al. 2000; Davies et al. 1996; Fellows et al. 1994; 
Gowland et al. 1992; Wagner et al. 2007). This debate is not surprising because coactivation 
is often seen as part of normal movement patterns (Damiano 1993) and this varies across 
movement tasks, and thus the point at which coactivation becomes abnormal may be difficult 
to define.   
2.7.3.  Pathophysiology of coactivation 
When needed to control and stabilise a joint in normal movement, coactivation results from 
controlling reciprocal inhibition (Sheean 2002).  It is suggested that a possible 
pathophysiological cause of coactivation is impairment of 1a reciprocal inhibition (Sheean 
2001; Sheean 2002).  In unimpaired motor control, the 1a afferents of an agonist muscle Literature Review    Chapter 2 
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inhibit, via 1a interneurones, the alpha moto-neurones of its antagonist.  The interneurones 
have some control from higher centres, at a segmental level (including Renshaw cells) and at 
a supraspinal level (including corticospinal fibres) (Sheean 2001).  If the 1a reciprocal 
inhibition is impaired (reduced) following a stroke then it follows that there will be greater 
activation of an antagonist muscle when it should be inhibited.  1a reciprocal inhibition can be 
studied by applying threshold conditioning electrical stimuli to a nerve supplying an antagonist 
and observing the effect on the H reflex obtained from the agonist.  Two main inhibitory 
phases are seen, distinguished by timing: early, short duration disynaptic inhibition and later, 
long lasting presynaptic inhibition.  Using this method, altered reciprocal inhibition has been 
observed in the lower limb (Okuma and Lee 1996) and upper limb (Artieda et al. 1991; 
Nakashima et al. 1989; Panizza et al. 1995) of patients with hemiplegia from stroke.  In upper 
limb studies, reduced reciprocal inhibition was found in the forearm flexors and extensors in 
both the disynaptic and presynaptic phases.  Although abnormal inhibition has been 
implicated in abnormal coactivation of the UMN syndrome (Crone et al. 1994) none of the 
studies have measured coactivation in order to test the correlation.  However, a correlation 
has been shown in the post-stroke upper limb between impaired reciprocal inhibition and the 
presence of increased tone (specifically disynaptic inhibition) (Nakashima et al. 1989) and the 
severity of increased tone (Panizza et al. 1995).  
2.7.4.  Measurement of Coactivation 
An extensive review of studies which measured coactivation in both unimpaired and impaired 
subjects with neurological lesions was conducted. The aim was to better understand the 
definition of coactivation used by researchers, and the methods of measurement and analysis 
used.  Electronic databases were searched, including: Medline, CINAHL, AMED and 
EMBASE. The search strategy used the following keywords in various combinations: Stroke / 
CVA; hemiparesis / hemiplegia; measure$; coactivation / co-activation / cocontraction / co-
contraction; muscle activation. Other sources were: reference lists from papers identified, 
conference proceedings, books and book chapters.    
 
The summary table below (Table ‎ 2-1) reports the results of the studies found that measured 
coactivation with patients with stroke; both upper limb and lower limb studies are included.   
 
The following conclusions have been reached: 
  Study sizes were small with sample populations with varied levels of impairments.   
  Studies testing coactivation during contraction without movement (isometric) mostly find 
coactivation to be present, whereas of the nine studies of coactivation during movement, 
five did not find coactivation to be significantly present. Literature Review    Chapter 2 
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  A number of studies which did not find significant presence of coactivation in the paretic 
limb did report that the presence of coactivation varied in the group, suggesting that 
coactivation may be a problem for some individuals but not for others and may therefore 
still be worth measuring. 
  Results from one study suggested that patients with abnormal coactivation patterns also 
had more severe impairments and disabilities (Lamontagne et al. 2000), whereas another 
found abnormal coactivation minimally present in both low and high functioning groups 
(Canning et al. 2000).     
  The methods of analysis used in stroke studies are varied; six main methods have been 
identified: 
1.  Mean EMG activity of flexors during extension movement of the affected limb, 
compared with the unimpaired limb or unimpaired controls (Davies et al. 1996; 
Gowland et al. 1992; Kamper & Rymer 2001). There is a need to normalise the EMG 
data using this method (using % maximal voluntary contraction (MVC) or % of 
maximum activity).  
2.  Ratio of flexor EMG during 0˚ - maximum flexion (when acting as agonist) to flexor 
EMG during 0˚ – maximum extension (when acting as antagonist) (modulation index) 
(Burridge et al. 2001; Turk et al. 2008b). 
Neither of these two methods evaluates the co-activation relationship of the antagonist with 
the agonist, as defined in the literature. 
3.  Ratio of normalised agonist to normalised antagonist EMG (Chae et al. 2002b) 
4.  Ratio of antagonist activity to total (agonist + antagonist) activity (Hammond et al. 
1988a; Yan et al. 2005) 
These two methods included both muscles in their analysis but these were measured during 
isometric contraction not movement  
5.  The area of overlap between the agonist and antagonist muscles during activity (Hu et 
al. 2007; Lamontagne et al. 2000). 
Although changes were observed over time using this method, validity in distinguishing 
impaired and unimpaired subjects was not demonstrated. It was thought that this method 
would be unsuitable to distinguish normal from abnormal coactivation in our study because in 
our tracking tasks, especially step tracking, the agonist and antagonist would often overlap to 
act as a ‘break’ at the end of the movement (normal co-activation).   
6.  Correlation coefficient of agonist and antagonist EMG (Canning et al. 2000; Dewald et 
al. 1995; Hu et al. 2006) 
This method selectively analyses abnormal simultaneous activation of the flexor (antagonist) 
when the extensor (agonist) is activated. The similarity in timing and shape of the agonist and 
antagonist activation curves are measured providing a meaningful index, a correlation 
coefficient ranging between +1 and -1, with positive values indicating simultaneous activation Literature Review    Chapter 2 
    24 
(coactivation) and negative values alternating activation (reciprocal inhibition/activation). For 
these reasons, this method was chosen to be evaluated further in this programme of 
research. 
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Table ‎ 2-1: Summary of upper and lower limb stroke studies which measure coactivation. The methods used have been divided into measurement of 
coactivation during isometric contraction, during isokinetic contraction and during both. 
During isometric contraction 
 
Authors  Sample  Joints   Measurement 
Tool 
Description of method  Method of analysis  Outcome 
Chae et al. 2002b  Stroke; N=26; 
6 mth+ 
Wrist  Wrist rig; sEMG  MVC of wrist extensors and 
flexors for 3s and 5s 
Ratio of RMS of the antagonist 
EMG : agonist EMG 
Significantly greater 
coactivation in paretic 
than non-paretic limb 
Dewald et al. 1995  Stroke N=10 
1yr+ normal 
controls N=2 
elbow, 
sh , 
forearm  
load cell 3º of 
freedom; sEMG, 
fine wire EMG 
1.5s MVC shoulder and 
elbow muscles against 5 to 8 
different loads in 8 directions  
Agonist EMG / antagonist EMG 
scatter plots and correlation 
analysis 
Elbow agonist and 
antagonist coactivation 
in 3 of 10 subjects  
Hammond et al. 
1988a 
Stroke N=9 
1yr+; normal 
controls N=5 
Wrist  Wrist rig; needle 
EMG 
MVC of wrist flexion and 
extension at 3, 6, or 9 
second duration 
Ratio of antagonist activity to total 
(agonist + antagonist) activity. 
Compared stroke with normal 
group 
Significantly greater 
coactivation in stroke 
than controls 
Hu et al. 2006  Stroke N=116 
mth+;  
Wrist 
and 
elbow 
Wrist rig; sEMG  5s MVC of wrist flexion and 
extension at 8 angles 
between   -45º to 60º, 
hemiplegic and non-
hemiplegic sides 
Normalised EMG to maximum – 
resting baseline. Agonist EMG / 
antagonist EMG scatter plots and 
correlation analysis 
Significant wrist 
extensor flexor  
coactivation found in 
affected limb at all 
angles 
Neckel et al. 2006  Stroke N=16 
1yr+; normal 
controls N=16 
Hip, 
knee, 
ankle 
load cell 6 
degrees of 
freedom; sEMG 
3s MVC of hip, knee and 
ankle muscles in 8 directions 
Normalised EMG to % maximum. 
Agonist EMG x physiological cross 
sectional area (PSCA) / antagonist 
EMG x PCSA. Compared stroke 
with normal group 
Significantly greater 
coactivation during 
ankle dorsiflexion and 
plantarflexion and 
knee extension  
Yan et al. 2005  Stroke N=46 
acute 
Ankle  sEMG  MVC of dorsiflexors and 
plantarflexors for 3s 
Ratio of antagonist activity to total 
(agonist + antagonist) activity 
normalised by MVC. Compared 
FES treatment group with non-FES 
control groups 
Significant reduction in 
coactivation with FES 
treatment compared to 
control  
Yan and Hui-Chan 
2009 
Stroke N=62 
acute 
Ankle  sEMG  MVC of dorsiflexors and 
plantarflexors for 3s 
Ratio of antagonist activity to total 
(agonist + antagonist) activity 
normalised by MVC. Compared 
FES treatment group with standard 
rehabilitation and placebo 
stimulation control groups 
Significant reduction in 
coactivation with FES 
treatment compared to 
control groups Literature Review    Chapter 2 
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During isokinetic contraction  
 
Authors  Sample  Joints   Measurement 
Tool 
Description of method  Method of analysis  Outcome 
Burridge & 
McLellan 2000 
Stroke N=18; 
Normal 
controls N=12 
Ankle  Ankle rig; sEMG  30˚sinusoidal  tracking tasks 
at 1Hz and 2Hz  
Calf Modulation Index - ratio of calf 
EMG relaxed (mid to dorsiflexion) 
to active (mid to plantarflexion).  
Compared stroke to normal controls 
Calf coactivation in 10 
of 15 subjects. Those 
with coactivation were 
more likely to respond 
to FES 
Canning et al. 2000  Stroke N=16 
1yr+ Normal 
controls N=10 
Elbow  Elbow rig; 
sEMG 
Semi-random tracking with 
50˚ elbow flexion and 
extension  
Cross Correlation and spectral 
analysis  
Only 2 of 16 subjects 
had coactivation in 
both slow and fast 
tracking 
Fellows et al. 1994  Stroke N=25 
9m+ Normal 
controls N=15 
Elbow  Elbow rig with 
pulley and 
weight system, 
sEMG 
Tracking with 90˚ flexion 
extension at 100º/s, 200º/s, 
300º/s, without resistance 
and resisted at 1.27 and 3.2 
Nm.  MVC at 90˚ 
Biceps /triceps IEMG for total 
activation, and activation prior to 
peak velocity as % of total.  
Compared stroke group with normal 
group. 
Increased antagonist 
EMG during extension 
in one group of 
subjects (n=7), without 
load at low speeds.  
Hu et al. 2007  Stroke N=7 
1yr+ 
Elbow 
and Sh 
Elbow rig 
(robot), sEMG 
Robot-assisted tracking 
training of 90˚ elbow flexion / 
extension at 10˚/second. 
Overlapping activity of normalised 
biceps /triceps, anterior / posterior 
deltoid IEMG 
Coactivation increased 
during early training 
and significantly 
decreased by end of 
training 
Lamontagne et al. 
2000 
Stroke N=30 
<6m Normal 
controls N=17 
Ankle  sEMG   Walking at preferred speed 
for stroke and slow speed for 
control participants 
Overlapping activity of tibialis 
anterior and gastrocnemius (above 
20 µV threshold) divided by 
duration of gait phase 
Less coactivation on 
paretic side in single 
support, more 
coactivation on non-
paretic side in double-
support 
Gowland et al. 
1992 
 
Stroke N=44 
subacute; 
normal  
controls N=10 
Sh and 
elbow 
 
sEMG + 
movement 
analysis  
 
6 Chedoke-McMaster stroke 
assessment tasks 
undertaken 
 
Mean amplitude EMG of agonist 
and antagonist, compared those 
who could and couldn’t achieve 
tasks with control group 
No significant 
difference in 
antagonist activity 
between groups 
Turk et al. 2008b 
 
 
Stroke N=10 
1yr+; Normal 
Controls N=12 
Wrist  Wrist rig; sEMG 
 
60˚ sinusoidal  tracking task 
at 0.5Hz 
 
Flexor Modulation Index - ratio of 
wrist flexor EMG relaxed (mid to full 
extension) to active (mid to full 
flexion).  Compared stroke to 
unimpaired 
No significant different 
between groups Literature Review    Chapter 2 
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During both isometric and isokinetic contractions 
 
Authors  Sample  Joints   Measurement 
Tool 
Description of method  Method of analysis  Outcome 
Davies et al. 1996  Stroke N=12 
Normal 
controls N=12 
Knee  Isokinetic 
dynamometer 
Isometric and isokinetic MVC 
flexion and extension 
RMS EMG activity of biceps and 
rectus femoris normalised by 
MVCmax. Compared stroke to 
normal controls 
Coactivation was low 
or absent and similar 
between groups 
Kamper & Rymer 
2001 
Stroke N=11 
2yr+; Normal 
controls  N=6 
Fingers 
MCP 
joints 
MCP Rig; sEMG  MVC; resisted flexion + 
extension, extensors - 
eccentric contraction during 
flexion, concentric 
contraction during extension;  
Non-resisted extension 
Mean EMG of agonist and 
antagonist in flexion and extension, 
and compared stroke and normal 
control groups 
Significantly greater 
normalised flexor and 
1
st dorsal interosseous 
EMG activity in stroke 
than control group  Literature Review    Chapter 2 
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2.8.  Muscle onset timing 
Altered timing of muscle activation, such as delayed onset has been shown to relate to 
functional activity of the hemiparetic upper limb (Chae et al. 2002a; Hughes et al. 2010a; 
Wagner et al. 2007). 
2.8.1.  Pathophysiology of delayed muscle onset timing in stroke 
Onset of muscle activation in stroke can be attributed to lesions causing specific impairments 
in three components of a simple motor task: signal detection, motor processing and selection 
of motor strategy, and task execution. Motor processing is mediated by the posterior parietal 
cortex and premotor areas, whereas selection of motor strategy and motor execution are 
mediated by the primary motor and premotor areas (Ghez 1991). However, the final motor 
output among stroke survivors can be modulated by changes in descending and propriospinal 
excitatory and inhibitory inputs into the spinal interneurons and alpha motoneurones (Cohen 
1999) as well as neuroplastic changes consequent to brain injury (Nudo and Friel 1999). 
2.8.2.  Methods of determining muscle onset 
Onset of muscle activation is commonly evaluated in both impaired and unimpaired 
movement and posture, though no standard method of determination of muscle activation 
onset is used in the literature. Furthermore, due to the random characteristics of the EMG 
signal, onset determination is prone to false detection, especially when the signal-to-noise 
ratio (SNR) is very low i.e. conditions where the surface EMG response is weak, subjects 
themselves have little EMG activity or there is high level background noise.  Visual 
determination may be used; however this is subjective, dependent on the assessors 
experience and skill, and has shown to have poor inter-rater reliability (Di Fabio 1987).  One 
study, however, suggested that using an experienced assessor, visual determination was 
highly repeatable between assessments(Hodges and Bui 1996), and this method has been 
used to determine EMG onset in the stroke literature (Chae et al. 2002a). 
 
Computer analysis may increase the objectivity of onset determination, reduce observer bias 
and be less time consuming(Di Fabio 1987), though there is little agreement regarding the 
most appropriate method. Techniques referred to as single-threshold methods are based on 
the comparison of the rectified raw signals and an amplitude threshold whose value depends 
on the mean power of the background noise (Di Fabio 1987; Hedman et al. 1997).  To 
improve detection accuracy more advanced techniques have been proposed such as 
generalised-likelihood ratios (Micera et al. 1998), statistical methods based on double-
threshold detection (Bonato et al. 1998), wavelet template matching (Merlo et al. 2003), and 
more recently a Teager–Kaiser energy operation method (Li et al. 2007). These methods, 
however, are computationally intense and thus beyond the scope of this project.  Furthermore Literature Review    Chapter 2 
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using these methods good detection analysis is often possible only when a priori knowledge 
of the processed signal is known or correctly estimated, which is limited for this application. A 
further advance of the techniques proposed to detect EMG activity is in the direction of a local 
analysis of the signal (Khalil and Duchene 2000).  Global properties are replaced by local 
properties, whose degree of change is measured on the basis of their recent values. This 
approach leads to an increase of accuracy, since the threshold level can be more precisely 
and adaptively set.   
 
Other methods compare a low-pass filtered version of the rectified signal (the signal 
envelope) with a threshold based on the noise related (baseline) envelope(Hodges & Bui 
1996). This method has an advantage in that it requires relatively uncomplicated processing 
algorithms, but is criticized for not being based directly on the raw (i.e. physiological origin) of 
the signal. Furthermore if the time delay introduced by the filtering is not taken into account a 
methodological bias will result. Differing criteria for the algorithms have been used in the 
literature to determine onset, such as the degree of smoothing the EMG signal (the frequency 
of the low pass filter (LPF)), the width of the sample window (in ms) for a moving average 
filter (MAF), and the magnitude of the deviation from the baseline required to indicate a 
threshold (number of standard deviations (SD)). An EMG study of unimpaired subjects 
performing arm movements compared the relative accuracy of a variety of these criteria for 
the computer determination of EMG onset against visually determined EMG onsets from the 
rectified raw signal (Hodges & Bui 1996).  They showed that the LPF/SD/MAF parameter 
combinations of 50Hz/3 SD/25ms and 50 Hz/1 SD/50 ms respectively did not significantly 
vary from visually derived data for both subject groups divided by low background activity 
(high SNR) and high (low SNR). This method is therefore proposed for the current research, 
and different parameter combinations, as well as the use of global versus local baseline, will 
be evaluated against visual determination of EMG onset. 
 
2.9.  Non-neural stiffness and contracture 
2.9.1.  Pathophysiology of stiffness 
The resulting hemiparesis and emerging spasticity from a CNS lesion causes limbs to be 
immobilised with muscles in a shortened position, which leads to stiffness and contracture.  
The increased stiffness experienced when stretching a limb of patients with spasticity can be 
attributable to 1) an increase in the stiffness mediated by the stretch reflex (neural response), 
2) an increase in the intrinsic stiffness (muscle fibres contracting prior to stretch), and 3) an 
increase in the passive stiffness of tendons joints or muscles (Sinkjaer and Magnussen 
1994).  The non-neural (or non-reflex) stiffness in response to passive stretch is the sum of 
the intrinsic and passive components.  The biomechanical changes that contribute to stiffness Literature Review    Chapter 2 
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are loss of sarcomeres and accumulation of intramuscular connective tissue and fat (Gracies 
2005a).  Another possible cause of muscle stiffness is thixotrophy.  This term has been 
applied to substances which can be changed from gel to solution after being stirred.  Muscles 
behave as a thixotrophic substance which is thought to be due to the formation of titin 
filaments in the relaxed muscle (Vattanasilp et al. 2000). This can be seen clinically with 
stroke patients when resistance to passive movement is initially increased when a paralysed 
limb has been sustained for some time in a shortened position, but decreases after stretch.  
When tested at the ankle joint, however, patients with spasticity after a stroke did not exhibit 
any higher thixotrophic response than neurologically normal subjects, suggesting that 
although thixotrophy may produce enough immediate resistance to impede movement in 
those who are very weak, it is not a substantial contributor to long-term muscle stiffness 
(Vattanasilp et al. 2000). 
2.9.2.  Measurement of non-neural stiffness 
When measuring spasticity it is important to distinguish the reflex (neural) contribution to 
resistance to passive movement from the non-neural contribution due to biomechanical 
changes in muscles tendons and joints. Researchers have used different methods to make 
this distinction. Sinkjaer and colleagues measured total torque (sum of neural and non-neural 
torque) around the ankle joint during a voluntary contraction and non-neural torque during a 
contraction elicited by electrical stimulation of the tibial nerve which eliminates the stretch 
reflex (Sinkjaer et al. 1988; Sinkjaer et al. 1993; Sinkjaer & Magnussen 1994). Other 
researchers have investigated stiffness by measuring perturbations at various joints and used 
a complex model, described as a parallel-cascade, non-linear system identification technique, 
to separate overall stiffness into neural and non-neural components (Kearney et al. 1997; 
Mirbagheri et al. 2001; Mirbagheri et al. 2007).   Another study (Kamper et al. 2003) 
measured stiffness at the metacarpophalangeal (MCP) joints of the fingers before and after 
administration of a local anaesthetic, blocking the median and ulnar nerves at the elbow. The 
anaesthetic was administered to reduce the activity of the muscles flexing the MCP joints, in 
order to distinguish mechanical from neuronal resistance to imposed MCP rotation. These 
methods measure and distinguish between neural and non-neural components in the same or 
matched conditions, however, they are complex and difficult to replicate in terms of 
practicality in a clinical setting. 
 
Other researchers have distinguished non-neural torque from total torque using different 
speed conditions as the stretch reflex is not apparent at very slow speeds.  Non-neural 
stiffness during extension was measured at the wrist joint (Pisano et al. 2000), with the 
fingers strapped in flexion around a handle, by ten repeated 50˚ passive range displacements 
in a torque motor controlled rig using constant velocity movements at 10˚/second. Only19 of Literature Review    Chapter 2 
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the 48 subjects were included for analysis as they exhibited no flexor EMG activity during the 
test. An intrinsic stiffness index was derived by calculating the slope of a torque angle 
regression curve, and statistically significant differences were found between unimpaired and 
impaired groups. 
 
In our preliminary testing with the Southampton wrist rig, we measured non-neural stiffness 
during extension using manual slow passive displacements with range and speed controlled 
by tracking a target with a 0.04Hz sinusoidal waveform.  The force angle index (FAI) was 
derived as the slope of an average force-angle curve calculated over the angles of 0˚ to 30˚ 
wrist extension. Unexpectedly, however, there was considerable overlap of FAI values 
between the impaired and unimpaired groups with no statistically significant difference.  
Although samples were examined during the test to ensure that there was no EMG activity, 
more detailed inspection of the EMG showed that in spite of clear instructions and 
encouragement, some subjects appeared to be unable to entirely avoid any flexor and 
extensor muscle activation in phase with passive wrist movement, which may have 
contributed to the large overlap in FAI between unimpaired and hemiplegic subjects.  
 
To account for thixotrophy when measuring stiffness, using a ramp and hold method may be 
better than a constantly moving sinusoidal movement. It may be important to perform more 
than one displacement and calculate an average stiffness value. Prior to the test being 
carried out it may be important to control the number and range of stretches applied to the 
wrist for each subject. 
 
This literature review has so far identified key motor impairments and identified and critically 
appraised methods of measuring these.  The section that follows describes the tool that has 
been used in Southampton to neuromechanically measure motor impairments in the 
hemiplegic upper limb.  
 
2.10. Tool used to measure upper limb motor impairments 
There are a variety of different ways to measure motor control and other impairments of the 
upper limb after stroke. The choice of measurement method may include: the use of 
kinematics (movement analysis), accelerometers or other movement sensors, EMG, angle 
and torque sensors; measurement of multi-joint movement that is free and un-supported 
(Zackowski et al. 2004), or supported in a rotatory jig or robot (Hughes et al. 2010a); or 
measurement of single-joint movement in a rig designed for that joint (Kamper & Rymer 2001; 
Turk et al. 2008b). In this research, measurement of single-joint movement through the use of 
EMG and angle and torque sensors was used. This was because we thought that Literature Review    Chapter 2 
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neuromechanical methods would provide a better understanding of the underlying neural and 
biomechanical mechanisms that affect people post-stroke. Multi-joint movements were not 
chosen because, although they are closer to functional activity, the variability in movement is 
more than in uni-joint movement which adds to the already considerable variation in EMG. 
 
It was therefore decided to use a wrist rig that had been previously researched by our group. 
In a small preliminary validation study, we used the wrist rig and active and passive sinusoidal 
tracking tasks to develop neuromechanical measures of motor control (sinusoidal tracking 
accuracy), muscle activation patterns (modulation of the flexors during active sinusoidal 
tracking), weakness (maximal voluntary isometric force), spasticity (reflex response to fast 
passive stretch), and non-neural stiffness (force angle relationship to slow passive stretch) 
(Turk et al. 2008b).  
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 2-3: The version of the wrist rig that was used in the previous validity and FES studies 
(Turk et al. 2008a; Turk et al. 2008b) 
 
The impairment measures were evaluated for reliability, sensitivity to distinguish between 
people with and without stroke induced hemiplegia (Turk et al. 2008b), and relationship with 
upper limb activity (Burridge et al. 2008). The within session test-retest reliability was 
excellent for these measures in the impaired group (ICC = 0.88-0.98) and Bland-Altman 
statistics showed no bias between two assessors for interrater reliability. Of all the measures, 
the sinusoidal tracking index was found to relate most closely with upper limb activity 
(r=0.710, p=0.003, and 56% of the variance in the Action Research Arm Test (ARAT) score). 
The wrist rig was then used as tool to measure impairment changes in a clinical study testing 
the feasibility of implanted microstimulators to improve upper limb functional activity post-
stroke (Turk et al. 2008a). It was found that the sinusoidal tracking index and extensor muscle 
weakness were more sensitive measures of change than the ARAT. 
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2.11. Assessment of upper limb activity limitations 
An extensive review of standardised upper limb functional activity measures was undertaken 
the aim of which was to choose the measure for this research according to set criteria.  The 
search strategy was undertaken in two stages: firstly standardised upper limb functional 
activity measures were identified from a literature search and secondly each measure was 
assessed according to set criteria that were important to this study.  Electronic databases 
were searched, including: Medline, CINAHL, AMED and EMBASE. The search strategy used 
the following keywords in combination: outcome measure$; upper limb / arm; function / 
activity; and with and without: Stroke / CVA; hemiparesis / hemiplegia. Other sources were 
reference lists from papers identified, books and book chapters. Table   2-2 shows the results 
of this review with the criteria listed on the left hand.  The criteria that were thought to be most 
important for this research were: 
  the measure is at the activity level and includes everyday tasks using whole arm reaching 
and hand manipulation of real life objects;  
  there is both a scale of functional ability and a timing score;  
  the measure has been used in stroke studies and is appropriate for elderly patients i.e. 
can be completed within 30 minutes;  
  the measure is sensitive to differences in patients especially at the higher and lower levels 
of activity;  
  construct validity and test-retest reliability have been tested and there is a correlation with 
an impairment measure.   
 
Five measures which show the greatest fit with the criteria were short listed for the final 
decision: Action research arm test (ARAT), the arm motor ability test AMAT; the Wolf motor 
function test (WMFT); the CAHAI Chedoke Arm and Hand Inventory (CAHAI) and the Test 
d'Evaluation des Membres supérieurs des Personnes Agées (TEMPA).   
 
The ARAT is quick to perform, the researcher of this thesis has been trained and is 
experienced in conducting this test, and the equipment is already available at the University 
of Southampton.  However, the test contains some tasks more at the impairment level and 
does not have any everyday tasks using real life objects.  The AMAT, CAHAI and TEMPA 
include tasks solely at the activity level. The CAHAI and TEMPA tasks however involve 
bilateral tasks and therefore do not focus on the ability of the impaired limb and therefore 
were not considered appropriate for this research.  The AMAT is not appropriate as it takes 
too long to complete especially for older more frail patients.  The WMFT, although it includes 
some tasks that could be considered more at the impairment level, it also has everyday tasks 
using real life objects that specifically test different grips and includes reaching at high and 
low levels, in sitting and standing positions.  The modified WMFT (Whitall et al. 2006) is more Literature Review    Chapter 2 
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valid for use with moderately affected patients than the original and is more sensitive than the 
ARAT in that it includes easy and more difficult tasks with the same object. The functional 
scoring is more sensitive because there is 1 more point on the scale. The tasks are timed, 
with a set time if a task is not completed. Overall it was decided that the Modified WMFT 
should be chosen for the study. Literature Review    Chapter 2 
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Table ‎ 2-2: Review of upper limb functional activity measures 
Criteria  ARAT 
(Lyle 
1981; 
Platz et 
al. 2005) 
Box and 
Block 
(Mathiowet
z et al. 
1985a; 
Platz et al. 
2005) 
AMAT 
(Chae et al. 
2003; Kopp 
et al. 1997) 
WMFT 
(Modified) 
(Morris et al. 
2001; Whitall et 
al. 2006; Wolf 
et al. 1989) 
CAHAI 
(Barreca 
et al. 
2005) 
SHAP 
(Light et 
al. 2002) 
Jebsen 
(Hackel 
et al. 
1992; 
Jebsen 
et al. 
1969) 
TEMPA 
(Desrosiers 
et al. 1995; 
Feys et al. 
2002; Platz 
et al. 2001) 
Frenchay 
Arm Test 
(Heller et 
al. 1987) 
Motor 
Assessment 
Scale (Carr et 
al. 1985) 
Nine Hole 
Peg 
Test(Mathi
owetz et al. 
1985b) 
Impairment / 
Activity 
Imp-> 
Activity 
Activity  Activity  Imp-> Activity  Activity  Imp-> 
Activity 
Activity  Activity  Activity  Imp-> Activity  Activity 
Whole arm 
activity 
                   also LL and 
trunk 
 
Hand 
manipulation 
                   also LL and 
trunk 
 
Real life 
objects/tasks 
                     
Timed 
 
                     
Functional 
scoring Scale 
(not Y/N) 
                     
Complete in <30 
mins 
                     
Used with stroke                        
Construct 
Validity 
         ARAT       ARAT    FMA   
Test re-test 
reliability 
                     
Standardised 
protocol 
     not 
published 
 not published               
Normal data 
 
     not 
published 
(unaffected 
side) 
        N/A     
Correlation with 
impairment 
measure 
FMA / 
MAS / MI 
N/A   FMA  FMA   CMSA  not 
published 
?  N/A   
Motricity 
Index 
  ? 
Sensitivity at  
upper and lower 
limits 
  N/A        ?  ?   lower 
limits 
 lower 
limits 
 lower limits  ? 
ARAT Action Research Arm Test; AMAT Arm motor ability test; WMFT Wolf motor function test; CAHAI Chedoke Arm and Hand Inventory; CMSA Chedoke-McMaster Stroke 
Assessment; SHAP Southampton hand assessment procedure; TEMPATest d'Evaluation des Membressuperieurs des Personnes AgeeLiterature Review    Chapter 2 
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2.12. The relationship between impairments and function – what we know so far 
Historically it was assumed that spasticity was the major cause of activity limitations, and 
some therapeutic treatment approaches were based on the importance of reduction of 
spasticity. Recent studies, however, suggest that there is a poor relationship between 
spasticity and motor performance of the upper limb after stroke.  Katz et al found a correlation 
between the upper limb Fugl Meyer assessment (FMA) score and elbow stiffness measured 
by ramp and hold tests (Katz et al. 1992), though the neural component was not distinguished 
from non-neural components, whereas no correlation was found between the FMA and 
stretch reflex measure using the H-reflex test.  Others have also investigated spasticity at the 
elbow joint and found that although it contributed to contracture in the first four months after 
stroke, there was no significant contribution to motor performance measured using the upper 
limb tests of the motor assessment scale (Ada et al. 2006).  This latter finding was 
corroborated in our preliminary study investigating impairments at the wrist, which found that 
both spasticity (stretch response) and non-neural stiffness did not relate to activity limitations 
measured using the ARAT (Burridge et al. 2008). As has been mentioned already (see 
coactivation section) there is a debate whether coactivation is related to spasticity and 
whether it is an important contributor to activity limitations, though it is clear that inconsistent 
timing of agonist and antagonist activation as well as delay in activation and termination may 
well be related to poor motor performance (Canning et al. 2000; Chae et al. 2002a). 
 
Recent studies are suggesting that negative impairments may be more responsible for poor 
motor performance. Weakness, whether measured as torque (Ada et al. 2006; Burridge et al. 
2008), or EMG activation (Chae et al. 2002b; Leonard et al. 2006), in particular has been 
found to be a major contributor to poor motor performance measured using the FMA (Chae et 
al. 2002b; Leonard et al. 2006) Arm motor ability test (AMAT) (Chae et al. 2002b), motor 
assessment scale (Ada et al. 2006) and ARAT (Burridge et al. 2008).  Weakness has also 
been shown to contribute to reaching deficits, but more to velocity of upper limb reaching, 
whereas joint individuation (the ability to isolate flexion and extension movements at the wrist, 
elbow and shoulder) strongly contributes to variance in reach path and accuracy of end-point 
(Zackowski et al. 2004).  Loss of dexterity measured using tracking tasks may also have a 
major contribution (Burridge et al. 2008), but less so than weakness (Canning et al. 2004).  
These studies included participants of wide age range but the mean age was 63 years or 
less.  It is important to evaluate impairments in the older age group as patients with stroke are 
predominantly over 65 and it has been found that motor impairments may be affected by 
increasing age (Jagacinski et al. 1995). 
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2.13. Research questions 
Through conducting the previous studies with the wrist rig as described in Section ‎ 2.10, 
further questions were raised related to the tests used, the indices derived from the tests, and 
the relationship between the impairment indices and functional activity, specifically: 
  Would different forms of tracking tasks, such as those with more random waveforms, 
those using discrete rather than rhythmic sinusoidal movements, and those with some 
resistance applied, better characterise motor control dysfunction in post-stroke 
hemiplegia? 
  Would different methods of measuring muscle activation patterns, in particular 
coactivation, provide more understanding of how spasticity affects active movement? 
  What are the differences in the relationship of motor impairments to functional activity 
between the acute phase and chronic phase after a stroke? 
It was these questions that informed the aims and objectives for this current research. 
 
2.14. Aims and Objectives 
The primary aim of this research was to advance understanding of the physiological and 
biomechanical mechanisms associated with normal and impaired function and recovery and 
the relationship between motor impairments and loss of activity in the upper limb of older 
adults, early and late post-stroke. The findings of the research were then used to make 
recommendations on measurement of impairments related to upper limb activity.   
The objectives were: 
1.  Development of a system of measuring and characterising motor impairments using the 
instrumented wrist rig; including the development of appropriate signal processing and 
data analysis techniques. 
2.  a) Characterisation and derivation of indices for key elements of motor impairments at the 
wrist early and late after stroke; 
b) Evaluation of the validity impairment indices i.e. their ability to distinguish impaired from 
unimpaired and repeatability. 
3.  a) Evaluation of relationships between motor impairments grouped into negative, positive 
and secondary impairments early and late after stroke; 
b) Evaluation of the associations between motor impairments and motor control accuracy 
early and late after stroke; 
c) Evaluation of relationships between motor impairments and functional activity (using a 
standardised assessment of upper limb activity) early and late after stroke. 
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2.15. Hypotheses 
2.15.1.  Null hypotheses (H0): 
1.  Negative impairments will not relate more to loss of functional activity than positive and 
secondary impairments, especially in acute participants.  
2.  Positive and secondary impairments will not relate to loss of functional activity in some 
individuals, especially in the chronic group. 
3.  Motor control accuracy and coactivation measures from step tracking (discrete 
movements) will not relate more to upper limb functional activity than the same measures 
from sinusoidal (rhythmic) tracking. 
4.  Negative impairments will not relate more with each other rather than with positive and 
secondary impairments 
5.  Positive impairments will not relate more with each other and with secondary impairments  
2.15.2.  Alternative hypotheses (H1): 
1.  Negative impairments will relate more to loss of functional activity than positive and 
secondary impairments, especially in acute participants.  
2.  Positive and secondary impairments will relate to loss of functional activity in some 
individuals, especially in the chronic group. 
3.  Motor control accuracy and coactivation measures from step tracking (discrete 
movements) will relate more to upper limb functional activity than the same measures 
from sinusoidal (rhythmic) tracking. 
4.  Negative impairments will relate more with each other rather than with positive and 
secondary impairments 
5.  Positive impairments will relate more with each other and with secondary impairments  
 
2.16. Summary 
This Chapter has given a review to date of the relevant background literature related to this 
doctoral research. The neurophysiology of normal motor control has been considered, 
followed by a section on motor impairments of the upper limb post-stroke.  Specifically, 
methods of measurement have been reviewed and critiqued, in order to inform the tests and 
impairment indices used for this research.  The wrist rig, used in previous work as a 
measurement method, has been detailed. A review of standardised upper limb activity 
measures has been discussed, and has informed a decision regarding the most appropriate 
functional activity measure for this research. Lastly, a summary has been given of the 
literature which is found to date on the relationship between motor impairments and upper 
limb functional activity. The research questions and hypotheses, and more detailed aims and Literature Review    Chapter 2 
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objectives have been presented, which lead on to the methodology used in this research, 
which can be found in the following Chapter 3. Development Phase    Chapter 3 
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3. Development of the wrist rig  
3.1.  Introduction 
This chapter describes the development of the wrist rig measurement system prior to trialling 
in the Pilot Studies Figure ‎ 3-1. The wrist rig was re-designed and re-built incorporating a new 
pivot joint system with the ability to add resistance, a new tracking target display and a new 
system for signal acquisition. Bench testing and calibration were carried out and safety tests 
passed. Using MatLab a novel human-computer interface software programme was 
developed; then new tracking tests were designed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 3-1: Flowchart to illustrate the initial development work undertaken on the wrist rig 
measurement system in preparation for testing with participants in the Pilot Studies. 
 
3.2.  Redesign and build of the wrist rig 
The original wrist rig consisted of an instrumented arm rest attached to a chair, with a 
potentiometer (angle sensor) and strain gauges (force sensors) combined with 
electromyography (EMG) as described previously in the Literature Review Chapter 2, 
Section   2.10 and shown in Figure ‎ 2-3. The redesign described above was undertaken by 
collaboration between Ruth Turk (PhD researcher) and Dr David Simpson (ISVR Engineer 
and Supervisor) with advice from Prof Jane Burridge (Supervisor). Following extensive 
preliminary considerations of a) former designs, b) experience from previous related work, and 
c) cost and time constraints, a new design based around previous components was devised.  
The build was undertaken by ISVR technicians: a Mechanical Engineer Technician plus three 
Redesign and 
build of the 
wrist rig hard- 
ware 
Development of the 
wrist rig system 
Development of 
human computer 
interface software 
programme 
Development of 
tracking test 
protocols 
Bench testing 
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calibration 
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Electronics Engineer Technicians.  This process involved a number of iterations of designs 
and test mock-ups, bench testing of new components and modifications to arrive at the final 
design.  The main innovations included: 
  An LED array display designed for the tracking tests:  Previously the target was 
displayed as an ellipse on a computer screen placed at eye height and during the tracking 
test participants’ wrist movement was represented on the screen as a cross (similar to the 
movement of a mouse on a computer screen). Thus, the previous tracking tests involved 
not only control of movement, but also, considerable visuo-perceptual demands and hand-
eye coordination; all of which may be problematic for participants with stroke. In order to 
reduce the visuo-perceptual demands of the tracking tests, an LED display was fixed to 
the front the armrest; purposely placed so that participants could simultaneously watch the 
tracking target and see their hand moving. The LED array consisted of 80 LEDs placed on 
eight vertically mounted circuit boards, located on an arc from 80˚ flexion to 80˚ extension, 
one LED for every 2˚, as shown in Figure ‎ 3-2. 
 
 
Figure ‎ 3-2: The LED display fixed to the front of the rig shown from above. The LED display 
consists of 80 LEDs (red when lit) placed on eight vertically mounted circuit boards, located on 
an arc from 80˚ flexion to 80˚ extension, one LED for every 2˚. 
 
  Development of four methods of hand positioning for pilot testing: In our previous 
work, the wrist rig was designed with the hand supported by an air splint – an inflatable 
cuff within a U-shaped thermoplastic splint.  Previous wrist rig designs in the literature 
have used a variety of finger positions from being held in flexion (Chae et al. 2002b; 
Yarosh et al. 2004), extension (Pandyan et al. 1997), or allowed to move freely (Kamper et 
al. 2006a; Pisano et al. 2000). Due to the close biomechanical relationship between the 
wrist and fingers, finger position was thought to be crucial when measuring a combination 
of motor impairments at the wrist.  An adjustable foam covered handle, and a 
Target LED’s (lit in 
red) on the 
vertically mounted 
circuit boards 
Pointer at the 
end of the 
lever arm  
Participant’s wrist 
aligned with the 
lever arm pivot 
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thermoplastic full hand splint and palm splint, both of which were fixed to the handle, were 
developed to be compared with the air splint (see Chapter 4, Pilot Studies 2 and 3 for 
further details). 
  Development of a system to apply resistance to movement of the lever arm when 
required:  A commercially available slip clutch (Vari-Tork adjustable friction clutch, Huco 
Dynatork, Hertford, UK) was incorporated in the pivot joint, which, when turned ‘off’, 
allowed the pivot joint to be virtually friction-free, and which, when tightened, applied 
increasing resistance to the pivot joint. 
  Redesign of the pivot joint: A new configuration for within the pivot joint mechanism was 
designed which allowed the slip clutch to be positioned at the bottom and the 
potentiometer for measuring angle at the top (Figure ‎ 3-3); rather than being located at the 
bottom, as previously designed. A new strain gauge arrangement was designed and built 
on a new pivot joint axle, in order to monitor changes in resistance applied by the slip 
clutch.  
 
 
 
 
 
 
 
 
 
 
Figure ‎ 3-3: Configuration of the pivot joint mechanism 
 
  Development of electronics and connections for signal acquisition: The EMG, strain 
gauges, potentiometer and LED display were connected to newly designed electronic 
circuits and housed in a box also containing A/D and D/A convertors (USB-1408FS and 
USB-1608FS, respectively, Measurement Computing, Norton, MA, USA) and a power 
supply (OFM100, Powerbox, Gnesta, Sweden). An optical USB link (Rover 200, Amplicon, 
Brighton, UK) provided an electrically isolated interface between the electronics box and 
the laptop computer (XPS M1330, Dell, Bracknell, UK) where the data is recorded and 
stored (see Wrist rig block diagram in Appendix A) 
  Development of a new elbow restraint, forearm support and strapping: These 
restraints and support were designed to prevent movement of the elbow, upper arm and 
forearm during tests, so that movement and muscular effort was restricted to the wrist. 
 
Potentiometer 
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3.3.  Bench testing and Calibration  
In order to test the system and its outputs and calibrate the measurements, bench tests on the 
rig components were carried out by the researcher and Dr Simpson with the assistance of 
ISVR technicians.  This process involved iterative testing, (modification and retesting) to 
ensure that the rig system and output data were valid and reliable.  For details on the bench 
testing and calibration see Appendix B. The calibration coefficients for each output (angle, 
torque, EMG) were calculated and inserted into a customised Excel spread sheet (Appendix 
B, Table B1). This Excel spread sheet was read by the specially designed Matlab® wrist rig 
software when processing signals and representing signals on graphs in appropriate units of 
measurement (degrees/ Nm/ mV).  
 
The calibration coefficients for most outputs remained stable throughout the duration of the 
project. However, the lever torque calibration coefficients were found to have changed 
following the pilot study.  As these had remained stable through repeated assessments during 
the bench testing and calibration process, and changes to the pivot joint and electronics were 
also made following the pilot study, the source of the change in lever joint calibration was not 
clear.  Because the accuracy of the calibration of this sensor was very important, it was 
decided to recalibrate before and after each testing session in the main study. As it became 
clear that the calibration coefficients were remaining stable, recalibration then occurred after 
every second testing session. 
 
3.4.  Safety testing 
To ensure the wrist rig complied with medical safety standards, testing was carried out by an 
independent assessor at the Medical Physics and Bioengineering Department at the 
Southampton General Hospital.  This initial test raised issues that could be partly corrected by 
ISVR technicians, but further specific advice was sought from Clinical Engineers at the 
Hospital to ensure compliance with the standard BS EN 60601-1.  A final test was carried out 
and passed (30/3/2009). 
 
3.5.  Design and development of rig software programmes 
3.5.1.  Development of the human computer interface software 
programme 
A new Matlab® software programme (Figure   3-4), easily adjustable for the needs of the 
system and application of new test protocols, was developed by Dr Oliver Baumann, a signal 
processing Engineer at ISVR, in close collaboration with the researcher (RT) and Dr Simpson.  Development Phase    Chapter 3 
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The software was written in accordance with the testing protocol (Appendix C) developed by 
the researcher, informed by past experience and the literature review. This specified the tests 
to be included, and the parameters associated with, and signal outputs needed from, each 
test. The software was tested and modified iteratively until it was ready to be used for data 
collection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 3-4: Software user interface showing the test programmes on the left and online signal 
display (in this case AROM test with flexion / extension ranges and mid-point)  on the right 
3.5.2.  Development of the tracking tests 
The tracking tests were either active, to measure motor control accuracy and muscle 
activation patterns, or passive, to measure spasticity or non-neural stiffness. The active 
tracking tests involved the participant pointing the lever arm, by flexing or extending their wrist, 
at a moving LED target (Figure ‎ 3-2), using a sinusoidal waveform for rhythmic movements and 
a random square waveform for discrete movements. In the passive tests, the assessor flexed 
and extended the participant’s wrist in the rig to track the LED target. A range of possible 
tracking tests, with different specifications based on the intended measurement objective, 
were designed during this development phase and later evaluated during the Pilot Study 
phase (see Chapter 5, Section   5.3):  
3.5.2.1. Active sinusoidal tracking (rhythmic movements):  
Sinusoidal tracking, used in the previous studies with the wrist rig, was used, and employed a 
sinusoidal waveform (Figure   3-5) of ﾱ20˚ displacement around the participant’s midpoint of 
their active range of movement (AROM). The reason for using each individual’s midpoint was 
because muscle function is maximal around the mid-range (Saladin 2004), and as each Development Phase    Chapter 3 
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participant’s mid-range will vary (stroke participants are likely to be in more flexion than 
unimpaired participants), it is important that the tracking tasks are standardised to each 
individual. The frequency was set at 0.5Hz (both impaired and unimpaired participants in 
previous research have found this a moderately easy tracking speed) and 0.25Hz (a slower 
speed for training purposes). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 3-5 Example of unimpaired sinusoidal tracking at 0.5Hz frequency ﾱ20˚ around the 
participant’s midpoint (approximately 13º flexion) showing the target (black dotted) and 
unimpaired wrist movement (blue) signals. 
 
3.5.2.2. Active step tracking (discrete movements):  
The newly developed step tracking test used a square waveform (Figure   3-6). The target was 
visible as an individual LED lighting up at different positions on the LED array representing 
varied angles of displacement around a participant’s midpoint of their active ROM and the 
target does not move during the plateau phase.  The intention was that this would be a task 
demanding a higher level of voluntary engagement than sinusoidal tracking, where subjects 
may follow the rhythm and anticipate the target movement. Therefore both the time the LED 
stayed on (duration of the plateaus) e.g. between one and four seconds, and the displacement 
(step-size) changed randomly. The displacement was purposefully designed, starting with 
small ranges e.g. between 0˚ and 5˚ around the subject’s midpoint, increasing in a series of 15 
second blocks, up to ﾱ40˚ (Figure   3-6) in order that stroke participants with low movement 
ability could at least perform the first part of the test, but that the last part of the test would be 
more challenging for those with higher ability.  Different tests were designed with a variety of 
plateau phase times, ranges of displacement, and lengths of time blocks in order to determine 
the most appropriate combination of parameters. In the final protocol, all tests were carried out 
with an identical (random) sequence.  
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Figure ‎ 3-6 Example of square wave step tracking showing both target (black dotted) and 
unimpaired wrist movement signals (blue) with varying time intervals between steps and 
increasing displacement around the participant’s midpoint. This is an unimpaired subject and 
the short delay in tracking is clearly evident. 
 
3.5.2.3. Fast passive tracking (stretch response test) 
A passive tracking test was developed using the same sinusoidal waveform of the active test 
at ﾱ20˚ displacement around the participant’s midpoint of active ROM but at a higher 
frequency (1.5Hz) to measure stretch response; the same frequency used in our previous 
studies (Turk et al. 2008a; Turk et al. 2008b). 
 
3.5.2.4. Slow passive tracking (torque angle test) 
A second passive test was developed to measure non-neural biomechanical stiffness around 
the wrist joint. This used a saw-tooth waveform (Figure   3-7), with ramps in angles from full 
passive flexion to full extension (taken from the passive range of movement test) at a constant 
velocity of 5˚/second, a hold of ten seconds at full extension and five seconds rest between 
repetitions. Full passive extension range was defined as the pain-free end-block reached at 
the end of a passive extension stretch. This protocol was based on previous research (Pisano 
et al. 2000). It should be emphasized again that, in the passive tasks, the experimenter guided 
the hand of the participant in accordance with the target.  
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Figure ‎ 3-7 An example of slow passive tracking (torque angle test) using a saw-tooth 
waveform with ramps at 5˚/second over the full passive range of movement with a hold of five 
seconds at full extension and ten seconds rest between repetitions. 
 
3.6.  Summary and conclusions 
This Chapter has detailed the development work undertaken prior to the start of wrist rig and 
functional activity tests with participants in the Pilot Study.  
1.  The wrist rig redesign and build involved much iteration before bench testing was 
completed and safety tests were passed. It involved a number of new innovations, was 
more extensive and complex than originally expected and took up the first year of the 
research project (from April 2008 to March 2009). However it was critical that the wrist rig 
was ‘fit-for-purpose’ to ensure the validity of the data generated and therefore the 
usefulness of the research.    
2.  The new software user interface using Matlab software was more flexible, and enabled 
easier adjustment as new tools facilities were required, and for the application of new 
tests.  
3.  New tracking tests requiring a higher level of voluntary engagement were designed and 
written in MatLab code. 
4.  At the end of this phase the system was ready to be piloted with participants in the Pilot 
Studies which follow in Chapter 4.  The aim of the pilot work was to optimise the design of 
the rig, to test the methodology of data collection proposed for the Main Study, and to 
develop and evaluate methods for deriving the impairment indices. 
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4. Methodology 
This chapter presents the methodologies used in the Pilot and Main Studies.  The study 
design, participant samples, confounding factors, clinical assessments, wrist rig testing 
protocol, modified Wolf motor function test protocol, impairment measure indices, and 
statistical analyses are described and justified. 
4.1.  Study design 
An observational measurement design was used in both the Pilot and Main Studies. The Pilot 
Studies, with impaired participants in the chronic stroke phase and unimpaired participants, 
involved one testing session comprising wrist rig tests (see Section ‎ 4.8) and the modified 
Wolf Motor Function Test (mWMFT) (Section ‎ 4.10). Repeated measures were taken in the rig 
to trial tests with different parameters (such as frequency of target tracking movements and 
range of displacement), and to test the effect of different hand supports (see Pilot Studies 
Chapter 5 for further details).  
The Main Study was a cross-sectional observational study, with impaired participants in the 
acute and chronic phases post-stroke (see Section ‎ 4.4.2, selection criteria). It involved two 
testing sessions for most participants. The first session comprised practice runs with the 
active wrist rig tests, followed by an assessment with these tests and also the mWMFT, and 
in the second session both the full wrist rig protocol (active and passive tests) and the 
mWMFT was completed. For the convenience of participants who were able to complete the 
full-testing protocol in a single session, testing was only conducted on one day.  
4.2.  Study sites 
4.2.1.  Pilot Studies 
The Pilot Studies were predominantly conducted at the University of Southampton and, for 
some unimpaired participants, at a Farnham University of the Third Age (U3A) site in Surrey. 
Unimpaired participants were recruited from the Faculty of Health Sciences staff working 
within the ARM (Activity Rehabilitation and Measurement of the upper limb) research 
programme (age under 60), and from a local Southampton Church and the Farnham U3A 
group (age over 60). Impaired participants were recruited from the Faculty of Health 
Sciences’ Participant Register. 
4.2.2.  Main Study 
Testing for the Main Study took place at four sites: in the Therapy departments of the 
Western Community Hospital in Southampton, Milford and Farnham Community Hospitals in 
Surrey and at the ARM research laboratory at the University of Southampton. Recruitment of Methodology    Chapter 4 
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acute and chronic impaired participants was from two NHS centres: a community-based 
stroke service in Southampton (Solent NHS Trust) with a 25-bedded stroke unit, community 
and outpatient neurological therapy services; and community stroke services in South-West 
Surrey (Surrey Community Health) which comprises two inpatient stroke units, community 
and outpatient stroke therapy services and two day hospitals. For the chronic group, 
participants were also recruited from the Faculty of Health Sciences’ Participant Register. 
4.3.  Ethics and Research Governance approval 
Ethical approval for the Pilot Studies was given by the Faculty of Health Sciences Ethics 
Committee (SoHS-ETHICS 08-002), and sponsorship and insurance approval from the 
University of Southampton Research Governance Office. The Main Study was granted ethics 
approval by the Southampton and South West Hampshire Research Ethics Committee 
(Reference number: 09/H0504/21).  This study gained research governance approval from 
the two NHS sites: Solent NHS Trust and Surrey Community Health; and sponsorship and 
insurance approval from the University of Southampton Research Governance Office (see 
Appendix D). 
4.4.  Study Sample 
4.4.1.  Sample size 
This exploratory study examined a large number of impairment variables, relationships 
between them and a functional activity measure; we did not therefore have a primary 
outcome measure on which to estimate sample size.  However, using data from the previous 
wrist rig development study (Turk et al. 2008b) with 10 unimpaired participants and 10 
participants with hemiplegia following stroke, a power calculation was made based on the 
between group difference for one impairment measure.  Taking motor control, measured by 
the sinusoidal tracking index, as the example impairment measure, (unimpaired mean = 
192.6, impaired mean = 120.4) and the larger standard deviation (66.3), it was calculated 
that, to detect a difference between groups, fourteen participants per group were required to 
achieve an 80% power in a 2-sided 5% test. To allow for drop-out, non-compliance and 
anticipated smaller between group differences for other impairment measures, it was planned 
that 20 acute stroke participants, 20 chronic stroke participants and 20 age-matched 
unimpaired older adults would be recruited for the Main Study.  
4.4.2.  Recruitment and selection criteria – impaired and 
unimpaired participants 
For recruitment of the Pilot Studies participants, convenience sampling was used, the 
advantage being that participants were easy to recruit, near at hand and likely to respond 
(Bowling 2002).  For recruitment of impaired participants to the Main Study, a pragmatic, Methodology    Chapter 4 
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clinically-based approach was used.  Impaired participants were recruited into two groups: i) 
acute – stroke was between 2 and 17 weeks prior to recruitment (as most recovery occurs up 
to 4 months post-stroke in 95% of even the most severe strokes (Jorgensen et al. 1995)) and 
ii) chronic – stroke was more than one year prior to recruitment, as used in other studies 
(Canning et al. 2000; Kamper et al. 2003). For the acute group, consecutive sampling was 
used over a period of eight months for the three NHS centres, the advantage of this being 
ease of recruitment and retention of sample participants (Bowling 2002). Participants were 
identified by therapy staff as being suitable for the study, invited by their therapist to take part 
and given a participation information sheet (see Appendix I).  For the chronic group, all 
discharged patients from the three centres over the previous two year period (2008 – 2009), 
who fit the selection criteria were identified by therapy staff through their patient records, and 
were sent an invitation and information sheet by letter from the lead therapist of the stroke 
service. invited to take part. A further convenience sample was recruited from the Faculty of 
Health Sciences participant database. These participants were identified by the database 
Manager and invited by letter or e-mail to participate. Those who expressed an interest in 
participating to their therapist or the researcher were recruited following an interview with the 
researcher (either in person or over the phone) with an explanation of the study and the 
opportunity to ask questions. Informed consent was obtained and documented by the 
researcher. 
 The validity and reliability of the findings is enhanced by the fact that the recruitment of 
patients was from two sites – Southampton and Surrey. Expanding the recruitment to further 
sites was not feasible within the scope of this project.  
The selection criteria for the impaired group for both studies were as follows: 
Inclusion criteria  
1.  Diagnosis (MRI/CT scan) of first stroke 
2.  Between 2 and 17 weeks (four months) post-stroke (acute group) or over one year post-
stroke (chronic group)  
3.  Aged 60 or over (for the main study)   
4.  Upper limb movement deficit: with a minimum of some perceivable activity in the wrist (at 
least 5˚ active flexion/extension movement in the rig), with a maximum of some remaining 
gross movement deficit i.e. those with only hand dexterity problems were excluded   
5.  Able to transfer to a chair either independently or with the assistance of one person 
6.  Informed written consent.  
7.  Participants with all levels of spasticity, including those on antispasticity medication 
Exclusion criteria  
1.  Upper limb sensory, perceptual or movement deficits attributable to non-stroke pathology;  Methodology    Chapter 4 
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2.  Unilateral visuo-spatial neglect (star cancellation test score less than 51 (Wilson et al. 
1987)) or other, non-corrected, visual deficits likely to compromise ability to attend to the 
tracking target;  
3.  Skin allergy to alcohol wipes and sticky tape;  
4.  Medical, psychological, language or cognitive impairment that, in the opinion of the 
treating therapist and/or researcher would compromise ability to undertake the testing 
protocol. 
 
Unimpaired participants were selected if they were age 60 or over (for inclusion into Pilot 
Study 3 and 4 and the Main Study) and without any neuromusculoskeletal condition that 
impaired movement of their dominant arm, and visual deficiencies that were not corrected by 
contact lenses or glasses. 
  
4.5.  Confounding factors 
A confounding factor can be defined as an extraneous factor (a factor other than the variables 
under study), not controlled for, which distorts the results (Bowling 2002). Possible 
confounding factors that were identified in this research were: 
  Age 
  Gender 
  Hand dominance  
  Side of cortical stroke 
  Current and previous use of anti-spasmodic medication 
  Sensory deficit (loss of proprioception) 
The data for all these factors was collected at baseline and recorded. These characteristics 
are detailed in the Results Chapter Main Study Chapter 6, Table ‎ 6-1, and will be considered 
further in the Discussion Chapter 7. In the Main Study, age was controlled for to a degree by 
the inclusion of participants only over 60 for both the impaired and unimpaired groups. It was 
recognised that gender may have an effect on impairment measures such as muscle strength 
between the impaired and unimpaired groups but was more difficult to match due to the 
practicalities of the study.  
 
4.6.  Clinical assessments undertaken at baseline 
Two clinical assessments were undertaken with impaired participants prior to data collection 
with the wrist rig and the functional activity test. Methodology    Chapter 4 
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4.6.1.  Neglect 
Cancellation tests are paper and pencil tests that measure neglect in peri-personal space.  
Participants with a history of unilateral neglect were tested using the star cancellation test 
(Wilson et al. 1987). If a participant scored less than 51 stars cancelled during the test (which 
indicates presence of unilateral neglect) they were excluded from the study.  
4.6.2.  Spasticity 
The Tardieu scale was used in this study to clinically assess the level of spasticity at the wrist 
joint because it is the most valid and reliable scale available (see Literature Review Chapter 
2, Section ‎ 2.6.1.1. The specific protocol used for this study was based on that described by 
Morris (Morris 2002) and is shown in Appendix E, Table E-1. 
4.6.3.  Proprioception 
Although the focus of this research is motor impairments, the prevalence of somatosensory 
deficits after stroke is as high as 35-60% (Carey 1995) and the somatosensory system has an 
important role in motor control, and could be considered a confounding factor. Proprioception 
sensation was tested at the wrist joint using a protocol described in a recently revised version 
of the Nottingham Sensory Assessment (Stolk-Hornsveld et al. 2006) and is described in 
Appendix E, Table E-2. 
 
4.7.  Protocol for data acquisition in the wrist rig 
The following protocol was common to the Pilot and Main Studies.   
 
EMG protocol: 
Participants were seated comfortably in the chair and the skin of the forearm was rubbed with 
an alcohol wipe. Two pairs of active surface EMG electrodes (Biologic snap electrodes, 
Biosense Med Ltd) were applied with skin preparation according to standard guidelines 
(Hermans et al. 1999) with an inter-electrode distance of 1.5 cm.  The flexor (flexor carpi 
radialis (FCR)) EMG electrodes were positioned on a line from the medial epicondyle of the 
elbow to the FCR tendon at the wrist, 7-9 cm distal to the medial epicondyle (Leis and 
Trapani 2000). The extensor (extensor carpi radialis longus) EMG electrodes were positioned 
on a line from the lateral epicondyle of the elbow to the 2nd metacarpal, 5-7cm distal to the 
lateral epicondyle (Leis & Trapani 2000) (Figure 4.1). Reference electrodes were placed over 
the medial and lateral epicondyles of the elbow. The electrodes were held in firm contact with 
the skin using tape.  EMG signal quality was checked visually in every subject by testing for 
clear evidence of an EMG response to voluntary muscle contractions of flexor and extensor.  
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Positioning of participants:  
The hemiplegic arm of impaired participants was tested, whereas the dominant arm was 
tested for the unimpaired group. This was because it was considered important to measure 
‘best performance’, and thus a more consistent unimpaired reference value was obtained.   
Furthermore, due to the practicalities of the study, it was difficult to match the hemiplegic and 
unimpaired participants in terms of hand dominance. The set-up of the rig can be seen in  
Figure ‎ 4-2 4.2.  The arm to be tested was placed on the armrest and the forearm supports 
were adjusted for the correct height so that the shoulder was relaxed.  With the wrist 
positioned over the pivot point, the forearm was strapped onto the arm rest and the upper arm 
strapped to an elbow restraint positioned behind the elbow so that the arm was held firmly but 
comfortably. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 4-1 Positions of the wrist flexor and extensor EMG electrodes 
 
 
 
 
 
 
 
 
 
Figure ‎ 4-2: The wrist rig with participant positioned ready for testing  
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4.8.  Wrist rig testing procedure 
The following tests were performed in the rig. Further details of how the tests are performed 
are in Appendix C (Rig testing procedural protocol). 
  Active range of movement (AROM):  Three maximal active flexion and extension 
movements from which the active mid-point is also calculated.  
  Passive range of movement (PROM): Three maximal passive flexion and extension 
movements conducted by the assessor. End of passive extension range was defined 
as the point where resistance from tissues increases either to a block or where further 
movement is difficult but remains pain-free. In this research, PROM was measured in 
the hemiplegic wrist only, whereas others have quantified it using the intact side minus 
the hemiplegic side (Ada et al. 2006). Measuring the intact wrist was not considered 
practical in this study bearing in mind the number of other tests that needed to be 
completed within the data collection time. 
  Flexion and extension maximal voluntary isometric contractions (MVC) at the 0˚ and 
20˚ flexion position on the rig.  The 0˚ position is commonly used in research and the 
20˚ position was chosen as it was thought to be within the mid-range of active 
movement where muscle contraction is strongest (Saladin 2004).  Three five second 
contractions were performed into extension and flexion (Canning et al. 1999; Chae et 
al. 2002b; Colebatch et al. 1986). 
  Torque/angle test - slow passive ramp movements from full passive flexion to 
extension (defined from the PROM test) at 5˚/s, and hold at full extension for 5 
seconds, and rest at full flexion for 10 seconds.  
  Stretch response test - fast passive sinusoidal movements with ﾱ20˚ displacement 
around the active mid-point at 1.5 Hz, and ﾱ5˚ at 3.5Hz, to calculate the stretch 
response at a high velocity, and ﾱ20˚ 0.5 Hz to compare passive stretch response with 
muscle activation during the active sine tracking task  
  Active tracking tasks without resistance then with resistance set at a percentage of 
participants’ extension MVC force 
o  sinusoidal tracking 
o  step tracking 
Prior to the final performance, participants practised each tracking task until they 
reached their maximal performance (3 to 6 practice sessions depending on the 
participant’s ability and their rate of learning). 
4.9.  Data Processing 
The EMG signals were amplified and low pass filtered (2
nd order, with a cut-off frequency of 
approximately 500 Hz) and digitized (1608FS, Measurement Computing, Norton, MA, USA) at 
a sampling rate of 2000 Hz.  All the signals were acquired simultaneously to the laptop Methodology    Chapter 4 
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computer which also controlled the target, using the customized software program developed 
in Matlab® (Natick, MA, USA). The angle and flexor and extensor EMG and torque raw data 
were analysed visually to check for subjects’ compliance with the protocol, noise and 
artefacts. All signals were decimated reducing the sampling rate from 2000Hz to 200 Hz 
(following anti-alias filtering with a third order Butterworth filter, applied in forward and reverse 
direction). For the EMG signals a notch filter was applied to remove 50Hz mains noise and its 
harmonics. The flexor and extensor EMG envelope was then extracted by first removing the 
mean from the signals, and then rectification and smoothing (Butterworth low pass filter, 5 Hz 
cut-off, applied in the forward and reverse direction to cancel phase-shift). The cut-off 
frequency was chosen based on visual analysis of the signals, and a best compromise 
between smoothness and time-resolution. 
4.10. Modified Wolf Motor Function Test (mWMFT) procedure 
4.10.1.  Development of testing and scoring manual  
The modified version of the WMFT (Whitall et al. 2006) was chosen for this research because 
it is more valid for use with moderately affected patients than the original.  However, as there 
was no published protocol guidelines of the mWMFT, and as the researcher needed to learn 
how to administer and score the WMFT, a manual with clear testing administration and 
scoring guidelines was developed in collaboration with a research therapist based at the 
University of East Anglia. The authors of the Whitall et al (2006) study were contacted. Their 
study WMFT manual was received and reviewed and further clarity was sought from the 
authors where necessary.  A further manual of the original WMFT that was found on the 
internet (iCSP neurology section) and which was written in 2000 by the Constraint-Induced 
Movement Therapy Research Group, (University of Alabama and Birmingham Veteran’s 
Administration Medical Center, USA) and used in a reliability study (Morris et al. 2001), 
further informed the testing and scoring guidelines.  The following additions to the mWMFT 
manual were made for this study (see Appendix F, WMFT instruction manual):  
  A template was added for precise positioning of objects as well as a list of required 
materials and equipment,  
  Standardisation of table height and chair position to each participant has been included 
with the aim of accommodating all sizes and heights of participants,  
  Practise of each task first with the non-paretic arm was allowed (not included in previous 
guidelines),  
  The instructions have been changed to UK English,  
  Specific guidelines for each task on scoring have been added. Methodology    Chapter 4 
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Lastly, the modified WMFT materials were prepared, and through the process of reviewing 
previous WMFT manuals and forming a new UK-based version, the researcher familiarised 
herself with the test prior to piloting with patients in Pilot Study 3 (Chapter 5, section ‎ 5.4).   
4.11. Data analysis 
4.11.1.  Data management and storage 
The signals recorded during the wrist rig tests were automatically saved as Matlab files on the 
laptop computer.  After checking and pre-processing of the signal data as described in 
Section ‎ 4.9, indices were derived from the signals, as described in ‎ 4.11.2.2, and saved in 
Excel spread sheets on a password protected computer. Access to the data was restricted to 
the researcher, and when necessary for analysis, to the research team. All data on the 
computerised data sheets was coded without using participants’ names to ensure anonymity.  
Data collected on case record forms also was coded to ensure confidentiality, and stored in a 
locked filing cabinet within the Faculty of Health Sciences building. Data from the Excel 
spread sheets were transferred to SPSS for statistical analysis see (Section ‎ 4.11.3.). 
4.11.2.  Derivation of indices 
4.11.2.1. Introduction 
In our previous research the wrist rig and sinusoidal tracking tests were used to develop 
neuromechanical measures of motor control (sinusoidal tracking accuracy), muscle activation 
patterns (flexor modulation index), weakness (MVC force), active range of movement, 
spasticity (neural response to passive stretch), and stiffness (force angle relationship to non-
neural passive stretch). Using this experience, and knowledge from the literature review, 
common post-stroke motor impairments were identified which could be measured using the 
proposed tests conducted in the wrist rig (Table ‎ 4-1). 
For some of these impairments, measurement is straight forward, for example weakness can 
be simply and adequately quantified by measuring force during a maximal voluntary 
contraction (MVC), and active range of movement by recording maximal angle.  
Measurement of other impairments, such as movement tracking performance and altered 
muscle activation, is more complex, as these are derived from angle and EMG signals 
recorded during controlled tasks, which require signal processing and interpretation. The 
tracking tests were undertaken with and without resistance. However, the system for applying 
resistance did not work as well as anticipated - the backlash was too big and the resistance 
was not 100% smooth across full angle (see Table ‎ 5-3 in Pilot Study Chapter 5). The resisted 
tracking data was therefore not included in the analysis.  Methodology    Chapter 4 
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Table ‎ 4-1: The motor impairments that were identified as important to measure in the wrist rig 
Motor 
Impairments  
Impairment 
measurement 
Rig Test  Signals needed for 
measurement or index 
Active range of 
Movement  
AROM  AROM  Wrist movement angle 
Passive Range 
of Movement 
PROM  PROM  Wrist movement angle 
Weakness  Isometric Force   Flexor and extensor 
MVC 
Lever arm torque 
Movement 
tracking 
performance 
Overall tracking accuracy   Sinusoidal / Step 
Tracking  
Target and wrist movement 
angle 
Accuracy at target end 
point 
Step Tracking  Target and wrist movement 
angle 
Corrective overshooting at 
target end point 
Step Tracking  Target and wrist movement 
angle 
Muscle 
activation 
patterns 
Coactivation  Sinusoidal / Step 
Tracking  
EMG;  target and wrist 
movement angle 
Muscle onset timing  Step Tracking  EMG; target and wrist 
movement angle  
Spasticity  Neural response of flexor 
to passive stretch  
Fast passive tracking  Flexor EMG; target and 
wrist movement angle 
Non-neural 
stiffness 
Non-neural resistance to 
passive stretch  
Slow passive tracking  Lever arm torque; wrist 
movement angle 
 
4.11.2.2. Calculation of the indices 
The software to pre-process the data and calculate the indices from the signals was written 
by Dr D. Simpson in Matlab, in accordance with specifications provided by the researcher's 
(RT) review of the literature and clinical knowledge. The researcher then applied this software 
to the wrist rig signal data to extract the impairment indices. All the results were checked in 
accordance with visual inspection of signal plots. Where the analysis of the signals indicated 
the need for modifications in the indices, this was discussed jointly, considering relevant 
aspects of physiology and physiotherapy as well as signal processing, before specifying and 
testing the new indices. The researcher made minor modifications to the software (e.g. to 
provide different plots or change timing parameters) and also wrote part of the Matlab 
programme for calculating muscle onset timing.  
4.11.3.  Data entry 
For all studies, the participant characteristics and measurement data was entered onto the 
SPSS (PASW v18) data sheet by the researcher who carried out all statistical analyses. All 
the data sets were examined using histograms or dot plots to identify any outliers that may 
have occurred due to incorrect data entry. Methodology    Chapter 4 
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4.11.4.  Checking for normal distribution 
All data was checked for normal distribution prior to any further statistical analysis. 
Histograms with normal distribution curves overlaid, as well as the z-score for skewness, 
were examined. Finally the impairment and activity measure was tested for normal 
distribution using the Kolmogorov-Smirnov and Shapiro-Wilks tests. If one or both of the tests 
were found to be significant (p=0.05), then the variables in question were taken as being not-
normally distributed and non-parametric statistics applied.   
4.11.5.  Descriptive statistics 
The demographic and clinical characteristics of participants in the Pilot and Main Studies are 
presented as means, standard deviations (SD) and ranges.  
4.11.6.  Pilot Studies statistical analysis 
All variable data in the Pilot Studies was found to be normally distributed, therefore 
parametric tests were used with the statistical significance level set at p=0.05. The following 
tests were used: 
4.11.6.1. Differences between impaired and unimpaired 
Descriptive statistics (mean SD and range) for each measurement index for the impaired and 
unimpaired groups are presented. Differences between the impaired and unimpaired groups 
were tested using two sample t tests and 95% confidence intervals. 
4.11.6.2. Differences between hand positions 
Differences between hand positions for each of the impairment variables and between 
impaired and non-impaired groups were determined using repeated measures ANOVA. 
Where statistical significance was found a t-test and 95% confidence intervals were 
calculated to determine specifically where the statistical significant difference lay. 
4.11.7.  Main Study statistical analysis 
Some of the impairment measures were found not to be normally distributed in the Main 
Study (see Appendix G Table G-2). It was therefore decided to use non-parametric tests for 
all the impairment measures; a p-value of 0.05 was accepted as statistically significant. The 
following tests were used: 
4.11.7.1. Validity (ability to distinguish between impaired and unimpaired) 
The purpose of evaluating the ability of the impairment indices to distinguish between 
impaired and unimpaired was to confirm the findings in the Pilot Studies with a larger sample 
of older impaired participants in the acute as well as chronic phase post-stroke. Methodology    Chapter 4 
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4.11.7.2. Between-days test-retest reliability (active tests) 
Reliability is commonly assessed using the intraclass correlation (ICC) (Kirkwood and Sterne 
2003), however the ICC is estimated using a one-way analysis of variance and thus is a 
parametric test and assumes normal distribution of data. Bland Altman methods (Bland and 
Altman 1986) were used to evaluate between-days agreement for the impairment 
measurement indices. The 95% limits of agreement, were calculated and examined with 
respect to the within and between-group range of values for each index. The 95% limits of 
agreement are given by the mean difference between the day 1 minus the day 2 readings 
plus or minus twice the SD of the differences. If the differences are normally distributed then 
approximately 95% of the differences lie in this range. Again, this analysis assumes normal 
distribution of data, but no other more appropriate test appears to be recommended in the 
literature.  Bland and Altman plots for each of the differences between the day 1 and day 2 
readings against the mean value for each participant were examined. The repeatability 
coefficient (Bland & Altman 1986) was calculated as      √
∑         
    using the readings 
from day 1 (d1 ) and day 2 (d2), and gives a 95% range about a true change that might be 
expected from measurement error alone. Changes larger than the value of the repeatability 
coefficient can be considered to be due to a real change in underlying values, rather than 
random variations. The repeatability coefficient has thus also been termed the smallest real 
difference, SRD (Beckerman et al. 2001). 
4.11.7.3. Within-test repeatability (active and passive sinusoidal tests) 
Within-test repeatability of the impairment indices was assessed to understand how 
movement tracking, muscle activation patterns, flexor EMG stretch response and isometric 
force may change within the period of the tests concerned. This could be assessed with the 
sine tracking index and coactivation index but not with the step tracking indices because the 
active sine tracking test involved repeated identical cycles whereas the step tracking 
consisted of random movements through the test. Similarly the stretch index could be 
assessed because the passive stretch response test involved repeated identical cycles.  The 
mean torque test also involves five identical cycles, but repeatability could not be assessed 
because in the calculation of the mean torque index only cycles where the extensor and flexor 
activity were below a threshold were accepted, and this was often not the case for all cycles.  
 
For the within-test repeatability, data from each of the tests were divided into three sections of 
equal number of target cycles. The sine tracking test was divided into three sections of eight 
target cycles: beginning (section 1), middle (section 2) and end (section 3), and the mean 
tracking index and coactivation index for those sections were calculated. Similarly the passive 
sine tracking test (stretch response test) at 3.5Hz was divided into three sections of 44 target 
cycles, and at 0.5Hz into three sections of six target cycles. Mean stretch index for each Methodology    Chapter 4 
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section was calculated. Changes were examined between sections one and two, and two and 
three, and tested for statistical significance using the two related samples Wilcoxon test.                                                                       
4.11.7.4. Differences between acute impaired, chronic impaired and unimpaired 
groups 
These results are presented to show how the impairments differ at the acute and chronic 
phases post-stroke compared to unimpaired.  Differences between the three groups were 
determined using a Kruskal Wallis Test, the non-parametric equivalent of a MANOVA, which 
takes account of the number of variables, and thus reduces the risk of a type I error, where 
there is a false claim of statistical significant difference due to the number of tests conducted. 
Post hoc tests are not provided with this test, so in order to determine the chronic vs. 
unimpaired and acute vs. unimpaired differences for each impairment variable, Mann Whitney 
U tests were also used. To show how individuals differ across the three groups, data for each 
participant across the three groups are presented as dot plots. 
4.11.7.5. Association between impairment indices and motor control accuracy 
(tracking performance) 
To determine the contribution of the motor impairments to good and poor motor control 
accuracy (MCA) differences in the motor impairments between high and low motor control 
accuracy (MCA) groups were evaluated. The impaired participants were assigned to high and 
low MCA groups based on their step tracking performance. Visual inspection of step-tracking 
performance indicated a suitable threshold for separating between the groups. To compare 
differences between the three groups (low MCA, high MCA and unimpaired) for all the 
impairment measures, a Kruskal Wallis Test was first conducted followed by Mann Whitney U 
tests to determine where statistical significance lay (see section ‎ 4.11.7.4 for justification of 
these tests). The individual participants who had low MCA and high MCA shown on the dot 
plots of step tracking performance were identified and their values in other impairment dot 
plots were compared. 
4.11.7.6. Inter-relationships between negative, positive and secondary motor 
impairments 
To examine the inter-relationships between all the impairments, separately for the acute and 
chronic groups, Spearman’s correlation was used and statistical significance presented as p-
values. Because of the number of variables tested (12 impairments) a Bonferroni correction 
was added, which although very conservative (Field 2000), highlighted the most important 
relationships within the data. Methodology    Chapter 4 
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4.11.7.7. Relationships between impairment indices and functional activity 
measure   
To examine the relationships between the impairment measures and functional activity 
(mWMFT), separately for the acute and chronic groups, Spearman’s correlation was used, p-
values calculated, and statistical significance assessed with and without Bonferroni correction 
(see Section ‎ 4.11.7.6 for justification).  
To examine the importance of impairment measures in explaining performance of the 
functional activity measure (mWMFT), separately for the acute and chronic groups, a multiple 
linear regression was calculated using SPSS (PASW statistics v18). Statistical analysis of 
linear regression is based on the assumption that the data are normally distributed, and 
because some of the main study data did not fit this assumption, a quantile regression was 
also run using Stata (StataCorp LP) by a Statistician with expertise in Stata (Peter Nicholls) to 
compare and verify the results.  
Not all the impairments could be tested all together, because the number of predictors and 
how they are entered into the regression analysis can have a great impact on the resulting 
regression coefficient values (Field 2000). Selection of predictors for the regression analysis 
was even more important because of the small sample size, which was further reduced as the 
acute and chronic groups were considered separately.  The impairments were therefore 
grouped into negative, positive and secondary features in each patient group, and a series of 
two regression analyses were performed to determine the most important (statistically 
significant) contribution of an individual predictor in each feature group and each patient 
group. Firstly, an individual linear regression of each impairment measure was applied and 
those that were statistically significant were chosen as important predictors for each feature 
impairment group in the next multiple regression analysis, as recommended by Field (Field 
2000). For each impairment feature group, where there were two or more significant 
predictors, these predictors were entered into a forward stepwise analysis, which revealed the 
predictor that accounts for the most variance in mWFMT and made a statistically significant 
contribution to the power of the model. 
 
4.12. Summary  
This Chapter has presented the methodologies used in the Pilot and Main Studies of this 
research programme in order to achieve the research objectives outlined at the end of 
Chapter 2 Literature Review. Further details of methods specific to the Pilot or Main Studies 
are included in those Chapters (Chapter 5 and 6). The following Chapter, Chapter 5, reports 
the Pilot Studies undertaken, the aims of which were to finalise the testing protocols and 
derive the impairment measure indices in preparation for the Main Study.Pilot Studies    Chapter 5 
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5. Pilot studies and derivation of indices 
5.1.  Introduction 
Following the development of the wrist rig described in Chapter 3, the aim of the pilot work 
was to optimise the design of the rig, to test the methodology of data collection proposed for 
the main study and develop and evaluate methods for deriving impairment indices  
Figure ‎ 5-1 5.1.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-1 A flowchart to illustrate how the four pilot studies with the overall objectives follow 
on from the development of the wrist rig described in Chapter three. 
 
Pilot Study 1: Evaluation of preliminary methods to 
derive a coactivation index 
Pilot Study 2: Evaluation of the usability of active 
tracking tests and four hand positions 
Pilot Study 3: Evaluation of all wrist rig tests, two hand 
positions, and methods to derive impairment indices 
Pilot Study 4: Evaluation of passive stretch response 
test and index 
Bench testing 
and 
calibration 
Redesign and 
build of wrist 
rig hardware 
Development of the 
wrist rig 
Development of 
human computer 
interface software 
program 
Development 
of tracking 
tests 
Pilot Studies Pilot Studies    Chapter 5 
    63 
A series of four pilot studies was conducted and, using an iterative process, the following 
overall objectives were addressed: 
1.  Define protocols for conducting the tests in preparation for the main study 
a.  Test parameters – frequency of target tracking movements, range of 
displacement, length of baseline recording and resistance applied during the tests 
b.  Application of the modified Wolf Motor Function Test (WMFT) protocol 
2.  Optimise usability and comfort of the rig from the participants’ perspective in terms of: 
a.  Comfort of the chair and arm in the rig 
b.  Performance of the tracking and strength tasks in terms of speed, rest time 
intervals, range of displacement and visualisation of the target 
3.  Derive impairment indices using existing data from a previous study and data from the 
pilot studies 
a.  Develop and define methods of analysis to generate the most physiologically and 
clinically relevant indices to characterise motor impairments – considering a wide 
range of options. 
b.  Evaluate how the measurement indices differentiate between those impaired from 
stroke and neurologically intact controls 
4.  Determine the optimal hand positioning in the rig in terms of: 
a.  Differences for each of the impairment variables between hand supports  
b.  Differences between impaired and non-impaired groups for each of the 
impairment variables measured using different hand supports  
c.  Usability and comfort of different hand supports 
 
5.2.  Pilot Study 1  
5.2.1.  Introduction 
The aim of this study was to develop and evaluate methods to measure coactivation during 
sinusoidal tracking. Focus was placed on coactivation because this index was needed for 
Pilot Study 2 (see section   5.3) to answer an important question; does different positioning of 
the fingers affect the amount of coactivation recorded?   
The literature review identified seven methods to measure co-activation in stroke and, of 
these, the method that was chosen was correlation of the agonist and antagonist EMG 
(Canning et al. 2000; Hu et al. 2006) because this method can selectively analyse abnormal 
simultaneous activation of the antagonist (flexor) when the agonist (extensor) is activated, by 
measuring the similarity in timing and shape of the agonist and antagonist activation curves. 
The measure provides a correlation coefficient ranging between +1 and -1, with positive 
values indicating simultaneous activation (coactivation) and negative values alternating Pilot Studies    Chapter 5 
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activation (reciprocal inhibition/activation). To investigate correlation, EMG, target and wrist 
angle data was used that had been recorded during a 0.5Hz sinusoidal tracking test from a 
previous wrist rig study (Turk et al. 2008b). To investigate validity of this measure, the 
relationship with wrist tracking accuracy (motor control) and upper limb activity limitation (the 
ARAT described previously in Chapter 2 section   2.11), was evaluated. 
5.2.2.  Methods 
Data from ten participants impaired from stroke and 12 unimpaired participants who had 
taken part in a previous study (Turk et al. 2008b) was used (Table ‎ 5-1). Participants had 
undertaken a sinusoidal tracking test at 0.5 Hz and ± 20º around their active mid-range, and 
performed the ARAT.  
 
Table ‎ 5-1 Demographic characteristics of participants from a previous study (Turk et al. 
2008b) whose data was evaluated in Pilot Study 1  
    Impaired (N=10)  Unimpaired (N=12) 
Age (years)  Mean (SD)  
Min - max 
62.9 (11.6)  
44 - 78 
50.5 (19.5) 
22 - 72 
Gender  Male 
Female 
6 
4 
6 
6 
Time from stroke 
(years) 
Mean (SD) 
Min - max 
5.6 (3.8)                 
1 - 13 
N/A 
Side assessed  Right     
Left 
3 
7 
10 
2 
ARAT score 
(normal value = 57)  
Mean (SD) 
Min - max 
18.8 (11.5)  
3 - 37 
N/R 
N/A = not applicable; N/R = not recorded; ARAT = Action Research Arm Test 
 
The target, wrist angle and EMG data between 5 and 60 seconds were selected for analysis. 
The raw flexor and extensor EMG data were rectified and smoothed using a low pass filter at 
2 Hz to produce an EMG envelope. To aid visual analysis of the data, the peak flexion of the 
wrist angle signal was detected and ensembles of the wrist angle, flexor EMG envelope and 
extensor EMG envelope were made centred on each flexion peak with 2 seconds of data 
before and after the peak (Figure ‎ 5-2).  Coherent averaging was used to calculate an 
average of the ensemble of signals. 
 
For the analysis, the graphical results for each correlation method were visually analysed as 
flexor/extensor EMG plots (Results Section Figure ‎ 5-3). Correlation of the extensor and 
flexor EMG envelopes was then calculated using four different criteria for selecting which 
segments of the flexor and extensor EMG envelope samples to be included in the analysis:  
1.  Correlation of the whole sample (the EMG envelopes during both flexion and extension 
movements) Pilot Studies    Chapter 5 
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2.  Correlation during extension movement only, based on the angle data from peak flexion 
to peak extension.  This can be seen on Figure ‎ 5-2 a) between zero and one seconds. 
3.  Correlation based on the extensor EMG signal when the extensor EMG was increasing 
(Results Section Figure ‎ 5-4). In order to avoid the inclusion of periods with small 
fluctuation in extensor EMG amplitude, only the periods when there was an increase in 
greater than half the standard deviation of extensor EMG (calculated over the duration of 
the task) were included. 
4.  Correlation based on the extensor EMG signal during peak extensor EMG. Segments 
were included when the extensor EMG samples were greater than 50% of the peak 
extensor EMG 
Correlation based on angle data when there was acceleration into extension was also 
considered, but was found to be unsuitable as this would include the flexion phase if the 
movement was in a true sinusoidal pattern.Pilot Studies    Chapter 5 
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a)                   
 
 
 
 
 
 
 
 
 
     
    b)             
 
 
 
 
 
 
 
 
 
c) 
     
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-2: Ensembles (thin lines) and average (bold line) of a) wrist movement, b) flexor 
and c) extensor EMG envelopes from one impaired participant performing a sinusoidal 
tracking test (0.5Hz, ﾱ20˚). The extension phase is shown between 0 and 1 seconds; there is 
clear extensor activation and slight flexor activation during the extension phase. 
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5.2.2.1. Statistical analysis 
The mean was removed from the EMG envelope signals and the simultaneous extensor and 
flexor EMG sample values, according to the four criteria above, were plotted (extensor on the 
x axis and flexor on the y axis) (Results Section Figure ‎ 5-5).  A Pearson’s correlation was 
then applied in MatLab to calculate the coactivation index values. Descriptive statistics 
(mean and SD) were calculated to compare mean differences between impaired and 
unimpaired activation for each coactivation measurement method.  Dot plots were created to 
show individual differences between the impaired and unimpaired values. Interpretation of 
the strength of coactivation was based on recommended values for strength of relationship/ 
associations between variables (Pett 1997); these being:  0.00 to 0.25 no association to 
weak association, 0.26 to 0.50 a low degree of association, 0.51 to 0.75 moderate to strong 
degree of association and 0.76 to 1.00 very strong association. It should be pointed out that 
due to the correlation between successive samples in each signal, the degrees of freedom 
are smaller than the number of samples available, preventing the application of the usual test 
os statistical significance for the correlation coefficient. To investigate the relationship of the 
coactivation measure with motor control accuracy and functional activity, a two-tailed 
Pearson correlation analysis was performed using SPSS (PASW statistics v18) with a 
tracking index (accuracy of tracking a moving sinusoidal target calculated using cross 
correlation) (Notley SV et al. 2007) and with the ARAT performance score.  
 
5.2.3.   Results 
Figure ‎ 5-3 shows two examples of muscle activation patterns seen in this study: an 
unimpaired participant with a classic reciprocal activation / inhibition pattern and good 
tracking performance, and an unimpaired participant with coactivation and poor tracking. 
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a)                b) 
 Figure ‎ 5-3 a and b: Two Individual examples of sinusoidal tracking showing the target 
(black dotted) and wrist movement (blue solid), together with rectified and smoothed flexor 
(red dashed) and extensor (green dashed) EMG. Example a) is an unimpaired participant 
with good tracking performance and reciprocal activation.  Example b) is an impaired 
participant with poor tracking performance and coactivation. 
 
 
a)                      b) 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-4 a & b: Two examples of rectified and smoothed flexor (red) and extensor (blue) 
EMG during sinusoidal tracking showing a) reciprocal activation (unimpaired participant in 
Figure ‎ 5-3a) and b) coactivation (impaired participant in Figure ‎ 5-3b). Sections of bold 
between the dotted lines are the EMG samples included in the correlation analysis based on 
when extensor EMG is increasing (blue bold).  
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a)   
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-5: Individual examples of correlation analysis graphs of extensor and flexor EMG 
samples. Example a) is an unimpaired participant with good tracking performance and 
reciprocal activation (r=-0.64).  Example b) is an impaired participant with poor tracking 
performance and coactivation (r=0.86). 
 
 
The mean and SD of the impaired and unimpaired groups can be seen in Table ‎ 5-2.  The 
mean impaired group values indicate low to no coactivation, though the SD and minimum to 
maximum ranges show the wide variation in the data. 
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Table ‎ 5-2: Mean (SD) of the coactivation measure (correlation coefficient) for the impaired 
and unimpaired groups comparing four different criteria for selection of data (none 
statistically significant P≤0.05) 
Group 
Measure of Coactivation (correlation) Mean (SD) and min to max 
During flexion and 
extension 
movements 
During extension 
movement  
When extensor 
EMG is increasing 
During peak 
extensor EMG 
Impaired (N=10)  -0.08 (0.44) 
-0.51 to 0.88 
0.35 (0.30) 
-0.24 to 0.85 
-0.08 (0.43) 
-0.54 to 0.86 
0.01 (0.38) 
-0.32 to 0.79 
Unimpaired (N= 12)  -0.29 (0.30) 
-0.62 to 0.42 
0.29 (0.24) 
-0.01 to 0.64 
-0.28 (0.35) 
-0.64 to 0.63 
-0.06 (0.22) 
-0.32 to 0.36 
Mean Difference  0.21  0.06  0.20  0.06 
  
Although not reaching statistical significance, greater mean differences between impaired 
and unimpaired were found in two criteria for selection of data:  during the whole test (flexion 
and extension movements) and when extensor EMG was increasing. The other two criteria, 
during movement into extension and during peak extension, tended to have more positive 
correlation coefficients for both groups with only small differences between impaired and 
unimpaired performance. To investigate this, visual analysis of the data showed that for 
some participants in both groups there was some flexor EMG activation towards the end of 
the extension movement, presumably acting as a break (see Figure ‎ 5-2b between zero and 
one seconds for an example from the stroke group). Coactivation analysis during extension 
movement and during peak extension includes this section of the data where both the 
extensor and flexor EMG are activated. This did not reflect abnormal coactivation as when 
the whole pattern was observed it can be seen that the flexor EMG was at low activation 
levels during extension compared to flexion, and there was clearly reciprocal activation. 
Correlation analysis based on when extensor EMG is increasing, however, includes the 
section of data before the movement starts and at the beginning of the movement, resulting 
in better distinction between normal and abnormal coactivation. Two examples illustrating 
this method of analysis can be seen in Figure ‎ 5-4 a) and b).  
 
Specifically correlation of the flexor and extensor envelopes during an increase in extensor 
EMG was selected for further analysis as it most reflected the part of the cycle where 
abnormal coactivation may be detrimental to the action of the extensor to produce extension 
movement.  Comparison of the individual impaired and unimpaired values using this 
measure is shown in the dotplot in Figure   5-6 and the wide spread of values can be seen.  In 
the unimpaired group most correlation coefficient values lie near to zero or are negative 
indicating reciprocal activation/inhibition, except for one outlier with strong coactivation 
(r=0.63) which was also evident from visual analysis of the tracking and EMG plots. In the Pilot Studies    Chapter 5 
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impaired group, the majority of values also lie near to or below zero, also indicating that 
these participants used reciprocal activation/inhibition during tracking movements. However 
one participant showed low coactivation (r=0.43) and another very strong coactivation 
(r=0.86).   
 
For the impaired group a moderate to strong and statistically significant negative correlation 
was found between coactivation and tracking accuracy (r=-0.675, p=0.032) (Figure ‎ 5-7); 
there was a moderate but non-significant correlation with functional ability (r=-0.621, 
p=0.055). The two strongest co-activators also showed the worst performance in the tracking 
test and lowest function scores. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-6 Dotplot of coactivation measurement values for the impaired and unimpaired 
groups using correlation of extensor and flexor EMG when extensor EMG is increasing  
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Figure ‎ 5-7 Scatter plot to show correlation between a coactivation measurement (correlation 
of extensor and flexor EMG when extensor EMG is increasing) and tracking performance 
 
5.2.4.  Discussion and conclusion 
In Pilot Study 1 we have used correlation of the flexor and extensor EMG to quantify 
coactivation during a sinusoidal tracking test.  A limitation of using correlation as a method is 
the assumption that the two variables have a linear relationship, and with flexor and extensor 
EMG this is not the case. However, previous methods used to quantify coactivation have 
been found unsuitable as they neither evaluate the co-activation relationship between the 
antagonist with the agonist, nor attempt to distinguish between abnormal coactivation from 
normal co-activation that stabilises a joint and ensures end-point movement accuracy.   
Coactivation has previously been quantified during a random tracking test at the elbow using 
correlation of EMG through the whole test (flexion and extension movements) (Canning et al. 
2000). In our study four methods of correlation of flexor and extensor EMG envelopes were 
compared.  Two methods of correlation better distinguish normal coactivation from abnormal 
coactivation due to stroke: correlation of EMG through the whole test (flexion and extension 
movements) and when extensor EMG is increasing. The latter method may be more useful 
clinically as it most reflects the part of the cycle where abnormal coactivation may hinder the 
action of the extensor to produce extension movement. Visual analysis of the traces 
suggested this approach was able to exclude more sections of the data where there is 
‘normal’ coactivation to stabilise a joint and ensure end-point movement accuracy. 
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Using this correlation method, coactivation was found in two of the ten patients in this small 
sample suggesting it was not the main cause of disability for the group, but is present in 
some individuals. This is similar to findings of other upper limb studies where coactivation 
during tracking has been evaluated (Canning et al. 2000; Turk et al. 2008b). Coactivation 
was also found in one unimpaired participant showing that even in the unimpaired whose 
tracking performance is excellent a variety of muscle activation strategies can be used.  
Coactivation in this study was found to be associated with poor tracking performance  
(r=-0.675, p=0.032) and (less) with functional performance (r=-0.621, p=0.055). This is unlike 
the findings of our previous study where coactivation was measured using a flexor 
modulation index (ratio of flexor activity as an antagonist and agonist) and no association 
was found with sinusoidal tracking performance (r=0.380, p=0.162) and upper limb functional 
activity using the ARAT (r=0.217, p=0.438) (Burridge et al. 2008). 
   
This initial investigation of coactivation analysis methods would enable further investigation in 
Pilot Study 3 with both sinusoidal and step tracking data. 
 
5.3.  Pilot Study 2  
5.3.1.  Objectives 
The purpose of this study was early evaluation of the modified wrist rig components and 
proposed test variables. The objectives were as follows:  
5.3.1.1. Define tests  
  Evaluate the newly developed step tracking test with varying visual feedback and 
random timing 
  Evaluate sinusoidal and step tracking with resistance set at a fixed % of participants’ 
MVC  
5.3.1.2. Evaluate wrist rig usability and comfort 
  The comfort and usability of the wrist rig from participants’ perspective was evaluated. 
 
5.3.1.3. Evaluate four hand splints  
The importance of hand positioning in the wrist rig has been discussed in the development 
Chapter (Section 3.2). The four different hand splints, designed and built during the 
development phase (see Section   3.2 and Figure   5-8 a-d) were evaluated specifically to: Pilot Studies    Chapter 5 
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  Evaluate the usability of the hand splints when conducting active tests – sinusoidal 
and step tracking and MVC 
  Evaluate the effect of the hand splints on muscle activation (using a coactivation 
index developed in Pilot Study 1 section ‎ 5.2). It was hypothesised that positioning the 
fingers in flexion, for example around a handle during the active tracking tasks may 
increase normal coactivation patterns in the forearm muscles due to the fingers 
gripping the handle, especially in resisted tracking.   
 
a) Handle (the fingers are in flexion)  b) Full hand splint (the fingers are in relaxed                       
extension) 
 
 
 
 
 
 
 
 
c)  Palm Splint (the splint reaches to the  d) Air splint (the fingers are in relaxed  
metacarpophalangeal joints allowing     extension) where the hand is held by an 
flexion of the fingers   air-filled cuff  
             
                                                                                                                                              
 
 
 
 
 
Figure ‎ 5-8 a – d: Four different hand positions tested during Pilot Study 2 
 
5.3.2.  Methods  
5.3.2.1. Participants 
Participants were recruited for this study who were able to tolerate repeated procedures 
without fatigue, had an understanding of the project and were able to give informed 
feedback.  Four unimpaired participants, two female and two male with a mean age of 40 Pilot Studies    Chapter 5 
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years (30 to 57 years), were recruited from staff in the Faculty of Health Sciences ARM 
research programme. 
5.3.2.2. Data collection 
Following set up in the rig as described in Chapter 4 Methodology Section   4.7, the hand was 
initially positioned around the handle with the wrist joint in vertical alignment with the pivot 
joint (Figure   5-8 a) and the following tests were carried out: 
  Participants provided feedback after practicing the following tests:  
o  Sinusoidal tracking at 0.25Hz and 0.5Hz, ﾱ 20˚  
o  Random step tracking with varying rest time intervals and increasing 
displacements.   
o  MVC of wrist flexors and extensors at the 0˚ and 20˚ flexion position on the rig.   
  Resistance at approximately 5% and then 10% of participants’ extensor MVC was trialled 
with : 
o  Sinusoidal tracking at 0.5Hz ﾱ 20˚, for 60 seconds  
o  Step tracking with random 1-4 second rest intervals between movement of the 
target, increasing displacement of the target from 5˚ to 40˚ in 15 second blocks for 
a total of 90 seconds.         
  Resistance was set at 10% of MVC and three further hand supports were tested in the 
following order: full hand splint, palm splint, and air splint (see Figure   5-8 b, c and d).  
Participants performed: 
o  Sinusoidal tracking test as above  
o  Random step tracking test as above  
o  MVC of flexors and extensors 
 
To determine the usability of the rig and active tests, each participant was asked the 
following questions at appropriate times throughout the testing process: 
1. How comfortable did you find the wrist rig when you performed the tasks? a) The forearm 
and elbow support, b) Each hand support, c) The straps that secure the arm and hand 
2.  How easy did you find it to track the lights on the LED display? a) Without resistance, b) 
with resistance 
3.  How easy did you find it to perform a maximal contraction using each hand support? 
Answers were recorded on the participant record form (Appendix H). 
5.3.2.3. Analysis of coactivation  
The flexor and extensor EMG envelopes were visually analysed.  A section from 25 to 60 
seconds of the data from both the step and sine tracking tests was selected for analysis 
because in step tracking only small movements are made prior to 25 seconds and Pilot Studies    Chapter 5 
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coactivation was easier to observe and measure in the larger movements.  In order to select 
the EMG data where there was movement i.e. exclude data during no movement but where 
there is still some EMG activity, a moving standard deviation of the wrist angle in windows of 
0.5 seconds was calculated and only the parts of the data where the standard deviation was 
greater than the median value were selected for analysis.   
 
To calculate coactivation, a correlation coefficient between the flexor and extensor EMG 
envelope during both flexion and extension movements was used.  It was measured during 
both flexion and extension because normal coactivation may occur in both phases of 
movement, so with unimpaired participants it is not so important to measure only during the 
extension phase of movement as is the case for stroke impaired participants.  Due to the 
small sample size, descriptive statistics were used to describe differences in coactivation 
between the hand splints for the two tracking tests.  Interpretation of the strength of 
coactivation was based on recommended values for strength of relationship/ associations 
between variables (Pett 1997) as described in Pilot Study 1 section   5.2.2. 
 
5.3.3.  Results  
5.3.3.1. Usability of wrist rig and tracking tests  
Issues that affected the ability of participants to perform the tracking tasks and modifications 
made are outlined in Table ‎ 5-3. 
 
Table ‎ 5-3 Issues encountered during the pilot testing process with unimpaired participants 
and modifications made 
Subject  Usability issues  Modification 
LED target 
display 
Tracking accuracy was variable 
depending on participant height due to 
a parallax problem  
A pointer was designed and 
attached to the end of the lever 
arm to point close to the LEDs 
The hand supports obscured vision of 
all the  LEDs; LED display board is too 
close to participant’s lap 
Height of LED display board was 
increased; size of the air splint 
was reduced  
Sinusoidal 
tracking 
When tracking at 0.5Hz, there was 
blurring of the LED target (appearance 
of 3 LEDs activated at the same time) 
due to the rapid sequential activation of 
successive LEDs, which makes it 
difficult to be accurate in tracking. 
The software for the task was 
redesigned so that each LED was 
on for a shorter length of time 
(with approximately 20ms gap 
before the next LED was 
activated) which ensured that the 
eye saw only one LED lit at any 
time during the cycle. 
Rest period of 
tracking tests 
Too short rest period (2 seconds) 
before start of  tracking tasks  
Rest period increased to 4 
seconds 
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Subject  Usability issues  Modification 
Step tracking  Different strategies used during step 
tracking: if accuracy is the main focus 
for the participants, movement is slow, 
and when speed of tracking is the main 
focus accuracy is compromised. 
Instructions to participants 
clarified with speed being the 
priority – ‘track the target as 
quickly and accurately as 
possible’ 
Random rest time interval between 
target changes: 1-3 seconds was 
challenging for unimpaired and likely to 
be too difficult for impaired group. Time 
intervals longer than 4 seconds seemed 
very easy and may not be challenging 
enough for some impaired participants 
2-4 seconds was still challenging 
for unimpaired but allows some 
slower times for impaired 
participants. This will be trialled 
with impaired participants in Plot 
Study 3.  
Resistance 
applied using 
the slip clutch 
Challenge of setting resistance as 
accurately as possible to 5% and 10% 
of extensor MVC as speed of moving 
the lever arm altered the torque (Nm) 
recorded at the torque sensor. 
It was important when setting the 
resistance manually to use a 
0.5Hz ±20º sinusoidal tracking 
task, to standardise the speed 
and range of movement of the 
lever arm. When this was used, 
accuracy in setting the level of 
resistance altered between cycles 
by approximately ±0.02Nm   
When resistance was applied at 5% the 
task was too easy; at 10% of MVC the 
resistance was felt but the task was still 
easy to perform. 
Resistance was set at 10% and 
trialled with impaired participants 
in Plot Study 3. 
With resistance applied there was ‘play’ 
in the lever arm due to the backlash 
effect of the slip clutch. This affected 
target end-point tracking accuracy 
during step tracking causing greater 
overshoot and undershoot movements.  
This was a limitation of the slip 
clutch that could not be modified 
at this stage. This issue may be a 
confounding factor when 
investigating target end-point 
accuracy with resisted tracking  
5.3.3.1. Usability of the hand supports 
All the participants found the handle easy to use for the tracking tasks, but found the 
extensor MVC task difficult as all the pressure is applied through the thumb.  The participants 
found the palm and full hand splints insecure especially when force was applied during the 
MVC.  The air splint was easy to use and the hand felt secure and ‘connected’ to the rig. One 
participant found it easier than the handle as the fingers are pointing at the target. In 
summary, the handle with a minor modification and the air splint seemed most usable. 
5.3.3.2. Effect of hand supports on muscle activation patterns   
Correlation coefficients of flexor and extensor EMG envelopes during the two tracking tests 
and for the four hand positions can be seen in Table ‎ 5-4.  For sinusoidal tracking reciprocal 
activation / inhibition was seen in all participants. For step tracking, three participants have 
negative correlations i.e. reciprocal activation / inhibition, and have similar correlation values 
for the hand positions. The reciprocal activation / inhibition could be seen on the tracking and 
EMG plots (see Figure   5-9 for an example). Further observation showed agonist activation 
(AG1) at the start of movement with antagonist activation (ANT1) at the end of the movement Pilot Studies    Chapter 5 
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in order to accurately reach the target or make a correction for overshooting the target with 
further agonist activation to stabilise the position (AG2) (Figure   5-9). One participant (#1) 
showed moderately strong coactivation (r=0.65) when using the handle which was evident 
from the plot (Figure   5-10). The correlation value for this participant reduces with subsequent 
tests to weak coactivation with the full splint (r=0.33), and no appreciable coactivation with 
the palm splint (r=0.28) and air splint (r=0.23).  When comparing the group means for each of 
the different hand support conditions there is little difference between the means for both 
tracking tasks. 
Table ‎ 5-4 Correlation coefficients of flexor and extensor muscle activity during random step 
and sinusoidal tracking tasks with four different hand supports; Positive correlation = more 
coactivation, negative correlation = reciprocal activation. 
Participant  Resistance 
10% Extensor 
MVC (Nm) 
Tracking  Correlation Coefficients 
Handle  Full 
splint 
Palm 
Splint 
Air Splint 
1  0.18 
Step     0.65**    0.33*    0.28    0.23 
Sinusoidal  0.01  0.05  -0.08  -0.22 
2  0.24 
Step  -0.11  -0.24  -0.36  -0.27 
Sinusoidal  -0.76  -0.82  -0.74  -0.61 
3  0.61 
Step  -0.13  -0.11  -0.03  -0.01 
Sinusoidal  -0.63  -0.64  -0.56  -0.53 
4  0.5 
Step  -0.23  -0.28  -0.19  -0.16 
Sinusoidal  -0.71  -0.68  -0.72  -0.62 
Group Mean (SD)   Step  0.05 
(0.41) 
-0.08 
(0.28) 
-0.08 
(0.27) 
-0.05 
(0.22) 
Sinusoidal  -0.52 
(0.36) 
-0.52 
(0.39) 
-0.53 
(0.31) 
-0.50 
(0.19) 
* weak coactivation; ** moderate to strong coactivation 
 
 
 
 
 
 
 
 
Figure ‎ 5-9 Example of unimpaired muscle activation during the step tracking task using the 
air splint showing reciprocal activation – alternating agonist activation of the extensor and 
flexor.  The enlarged section is an extension movement showing a classic triphasic activation 
pattern of agonist (AG1) then antagonist (ANT1), then agonist again (AG2) 
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Figure ‎ 5-10 Example of unimpaired muscle activation during the step tracking task using the 
handle showing some coactivation of the extensor (green) and flexor (red) 
 
5.3.4.  Discussion  
This was the first trial of the step tracking test and feedback from participants allowed 
decisions to be made on the timing parameters of the test - details of the final tests decided 
upon for the Main Study are defined at the end of this Chapter in Section ‎ 5.6 Table ‎ 5-19.   As 
resistance setting was dependent on the speed at which the lever arm was moved, it was 
impossible to be accurate unless a tracking task was used to standardise the speed and 
range of movement when moving the lever arm.  When this was used accuracy in setting the 
level of resistance at the slip clutch was approximately ±0.02Nm, which, although was not 
ideal, was considered suitable for this study as the 10% of extensor MVC mean for these 
unimpaired participants was 0.62 Nm and range 0.43 to 0.89.  Older unimpaired and stroke 
impaired participants are likely to have smaller MVC torques, and this needed further 
investigation in Pilot Study 3. 
5.3.5.  Conclusions 
1.  Following usability testing with unimpaired participants, modifications made to the wrist 
rig system and tests will be further trialled in Pilot Study 3 with impaired and older 
unimpaired participants 
2.  The perspectives of the participants on the usability of the different hand supports 
suggest that the full hand and palm splints are not useable, but that the handle and air 
splint could be used with some modification to the handle to include an extra padded bar 
next to the dorsal surface of the hand against which participants can push when 
performing the extensor MVC. 
3.  There was little difference in mean coactivation values seen between the different hand 
positions during both tracking tasks, though this is limited by the small number of 
participants tested.  Coactivation was seen in one participant during the random step 
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tracking task, though this reduced over time with each hand position tested.  The 
difference seen between hand position conditions, therefore, may be a trend due to a 
learning effect. 
4.  Two of the four hand splints, the handle and air splint will be further tested with patients in 
the next Pilot Study using all the active and passive tests, in order to conclude which 
hand support should be used in the main patient and unimpaired studies. 
 
5.4.  Pilot Study 3  
5.4.1.  Objectives 
The purpose of this Pilot Study was the evaluation of the modified wrist rig components and 
proposed test variables with a small group of impaired participants with chronic stroke who 
were able to tolerate repeated procedures and give feedback, and a group of older 
unimpaired participants. The specific objectives were as follows: 
5.4.1.1. Define tests 
  Evaluate the sinusoidal and step tracking tasks that were modified in Pilot Study 2 
  Evaluate the level of resistance set at a percentage of participants’ extension MVC force 
– 5% or 10% 
  Evaluate the Stretch response test - passive sinusoidal movements of ±20º around the 
mid-point of each participant’s active ROM at 1.5Hz and 0.5Hz. Whereas in a previous 
study the stretch response test was ±30º at 1.5Hz (Turk et al. 2008b), a displacement of 
±20º was chosen because it was the same as the active sinusoidal test and therefore 
results could more easily be compared. 
  Evaluate the speed and number of repetitions needed for the Torque/angle test – six slow 
passive ramp and hold movements at 5º/second (slow enough to exclude stretch reflex 
activation). The greater the number of repetitions, the more likely to get a number of 
cycles without neural activity and the more accurate the measurement. However a 
balance was needed with the length of time to undertake the test. At 5º/second speed the 
test time could be long (four minutes for six repetitions), an important factor to consider 
with older patients with acute stroke who fatigue easily.  
5.4.1.2. Assess usability 
As well as the usability of the tests described above, the comfort of the wrist rig as a whole 
was evaluated from the perspective of patients and older unimpaired adults. Pilot Studies    Chapter 5 
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5.4.1.3. Derive indices 
In Pilot Study 1 methods to derive a coactivation index were considered (see Section   5.2).  In 
Pilot Study 3 methods to derive indices to characterise the following impairments were 
assessed: 
1.  Active ROM 
2.  Passive ROM 
3.  Isometric Force of flexors and extensors 
4.  Wrist movement tracking accuracy – sinusoidal and step tracking 
5.  Coactivation – sinusoidal and step tracking 
6.  Timing of extensor muscle activation – step tracking  
7.  Stretch reflex response of the wrist and finger flexors 
8.  Biomechanical stiffness of the wrist and finger flexors (and other soft tissues)  
Each impairment index was evaluated to determine how they differentiate between those 
impaired from stroke and neurologically intact controls. 
5.4.1.4. Evaluate two hand positions 
The effect of two different hand positions (the handle with fingers in flexion and the air splint 
with the fingers in extension) on the ability to conduct the tests and comfort was evaluated. 
Differences between hand positions for each of the impairment variables and how they 
differentiate between the impaired and non-impaired groups were evaluated 
5.4.2.  Methods  
5.4.2.1. Participants 
Participants with post-stroke hemiplegia (n=7) were recruited as a convenience sample from 
the Faculty of Health Sciences’ Participant Register.  Unimpaired participants (n=9) were 
recruited from a University of the Third Age group. Selection criteria for both groups are 
detailed in the Methodology Chapter 4 Section   4.4. Participant characteristics are shown in 
Table   5-5. 
Table ‎ 5-5 Demographic characteristics of Pilot Study 3 participants 
    Impaired (N=7)  Unimpaired (N=9) 
Age (years)  Mean (SD)  
Min - max 
60.43 (8.02) 
49 – 74 
75.89 (3.44) 
71 – 81 
Gender  Male 
Female 
4 
3 
1 
8 
Time from 
stroke (months) 
Mean (SD) 
Min - max 
79.57 (52.35)                
41 – 192 
N/A 
Side assessed  Right     
Left 
1 
6 
9 
0 
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5.4.2.2. Data collection  
Following set up in the rig as described in the Methodology Chapter 4 Section   4.7, 
participants were tested with their hand positioned around the handle (Figure   5-8a) and in 
the air splint (Figure   5-8d) in a random order.  The following tests were carried out using both 
hand positions in the following order (for justification of tests and detail of how tests were 
conducted see Methodology Chapter 4 Section   4.8 and Appendix C): 
  Active range of movement (AROM). 
  Passive range of movement (PROM). 
  Flexion and extension maximal isometric contractions (MVC) at 0˚ and 20˚ flexion.   
  Torque/angle test: six repetitions of passive ramp movement from full passive flexion to 
full extension at 5˚/s. 
  Stretch response test: passive ﾱ20˚ displacement at 1.5 Hz to measure the stretch 
response at high velocity and 0.5 Hz to compare stretch response with muscle activation 
during the active tracking task.  
  Active tracking tasks, first non-resisted then with resistance set at 5% and 10% MVC 
o  Sinusoidal tracking test at 0.5Hz, ﾱ 20˚, for 60 seconds  
o  Random step tracking task with increasing displacement of the target from 5˚ to 40˚ in 
15 second blocks for 90 seconds and random 2-4 second target rest intervals. 
To determine the usability of the two hand splints and the tests conducted with participants, 
the questions asked previously in Pilot Study 2 (Section   5.3.2.2) were asked at appropriate 
times throughout the testing process. Answers were recorded on the participant record form 
(Appendix H). 
 
Participants’ activity was assessed using the modified WMFT (detailed in Methodology 
Chapter 4, Section   4.10 and instruction manual in Appendix F).  The assessments were 
video-taped, viewed and rescored by the researcher to improve her scoring ability. They 
were also viewed and scored by a moderator, a research therapist at University of East 
Anglia. Where there was scoring inconsistency due to lack of clarity, instructions were added 
to the manual. 
 
5.4.3.  Derivation of impairment indices 
5.4.3.1. Introduction 
From our previous research and knowledge from the literature, common post-stroke motor 
impairments were identified, which could be measured using the proposed tests conducted in 
the wrist rig (see Methodology Chapter 4 Section   4.11.2, Table ‎ 5-6). The following sections 
in this Chapter describe how the indices were derived to characterise motor impairments. Pilot Studies    Chapter 5 
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Table ‎ 5-6: The motor impairments that were measured in the wrist rig 
Motor 
Impairments  
Impairment 
measurement 
Rig Test  Signals needed for 
measurement or index 
Active range of 
Movement  
AROM  AROM  Wrist movement angle 
Passive Range 
of Movement 
PROM  PROM  Wrist movement angle 
Weakness  Isometric Force (IF)  Flexor and extensor 
MVC 
Lever arm torque 
Movement 
tracking 
performance 
Overall tracking accuracy   Sinusoidal / Step 
Tracking  
Target and wrist movement 
angle 
Accuracy at target end 
point 
Step Tracking  Target and wrist movement 
angle 
Corrective overshooting at 
target end point 
Step Tracking  Target and wrist movement 
angle 
Muscle 
activation 
patterns 
Coactivation  Sinusoidal / Step 
Tracking  
EMG;  target and wrist 
movement angle 
Muscle onset timing  Step Tracking  EMG; target and wrist 
movement angle  
Spasticity  Neural response of flexor 
to passive stretch  
Fast passive tracking  Flexor EMG; target and 
wrist movement angle 
Non-neural 
stiffness 
Non-neural resistance to 
passive stretch  
Slow passive tracking  EMG; Lever arm torque; 
wrist movement angle 
5.4.3.1. Range of movement 
Active and passive range of movement was taken as the maximum angle range of flexion 
and extension recorded during the AROM and PROM tests. 
5.4.3.2. Weakness 
Weakness was measured as the maximum flexor and extensor isometric force (IF) (Nm) 
from the three trials of the flexor and extensor MVC tests, as has been used in previous 
studies (Ada et al. 2003; Canning et al. 1999; Colebatch et al. 1986). 
5.4.3.3. Tracking indices (motor control accuracy) 
Tracking indices have been developed to measure accuracy, speed and smoothness of the 
wrist movement compared to the tracking target during the two different tracking tests: 
a)  Step tracking indices (TIstep):  
The step tracking task involved a series of discrete movements from which the accuracy in 
attaining the target, as well as movement control at the target end points can be assessed. 
Sixty seconds of data was included for analysis which included 17 random flexion and 
extension movements. The same sequence was used for all subjects. Step tracking was 
divided into movement phases (movement of the wrist to the target and any corrective sub-
movements that occur within 1.5 seconds of the target change), and target phases (from the 
end of the movement phase until the next target change) (Figure   5-11 and Figure ‎ 5-13). Pilot Studies    Chapter 5 
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Figure ‎ 5-11: Example of step tracking undertaken by an unimpaired participant. The target 
(dotted line) moves in random steps of gradually increasing range of up to 40
o around the 
midpoint of the participant’s active range of movement.  The bold line represents wrist 
movement. The expanded section shows the movement phase (movement to target and 
slight overshoot lasting approximately 1.5 seconds) and target phase (holding target position) 
Visual analysis of impaired tracking data identified in different cases: inaccuracy during the 
movement phase and target phase, and range and number of corrective sub-movements 
(over- and under-shoot) during the target phase (see Figure   5-12 and Figure ‎ 5-13 for 
examples). It was thought important to assess the accuracy and smoothness of tracking for 
the total task (movement and target phases) and specifically to assess the ability to attain the 
target position and control the extent of corrective sub-movements at the target phase.   
 
a)              b) 
             
 
 
 
 
 
 
 
 
 
Figure ‎ 5-12 Examples of step tracking from two impaired participants: a) Participant has the 
ability to attain the target but has poor movement control at the target phase; b) Participant 
has difficulty attaining the target in extension which worsens with bigger amplitudes. 
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The following indices were derived: 
The mean absolute error (MAE) between wrist movement and target was used to assess 
tracking accuracy (Miall et al. 2000; Weir et al. 1989).  
               
 
 ∑ |       |    
            (Equation 1  
where wi is the wrist angle at sample i, ti the corresponding target and the sum is taken over 
N samples in the recording selected for analysis. This index may be considered as 
measuring the area between the target and wrist, normalized by the duration of the recording 
selected for analysis. This is similar to the root mean square error (RMSE) used in other 
studies (Patten et al. 2003), but less sensitive to large errors, which are exaggerated by 
squaring. Two indices using MAE were derived:  
1)  MAE was calculated during the whole task i.e. all movement and target phases 
(TIstep(totalMAE)). This index is a gross overall measure of tracking performance and does 
not quantify specific subtle differences between individuals in movement control such as 
speed of response, ability to attain the target and amount of over- and under-shoot at the 
target phases (corrective sub-movements).  
2)  MAE was calculated only at the target phase (TIstep(targetMAE)). This index measures 
specifically the ability to attain and maintain the target position. 
 
Other indices were derived to characterise the amount of corrective sub-movements (over- 
and under-shoot) specifically at the target phases (Figure ‎ 5-13): 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-13 An example of impaired control during step tracking showing the target phase 
sections (bold green) during which the path lengths and standard deviation of the wrist angle 
are calculated then summed and averaged (greater over- and undershoot indicates larger 
path length and standard deviation). 
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3)  The total variability of the wrist position during each end target position was measured 
using the path length of the angle data (i.e. the more over-and under-shoot from the 
target position, the longer the path length and the higher the variability). Path length has 
been used in previous motor control research using step tracking (Feys et al. 2006) and 
in this research was defined as the total distance of travel by the wrist, normalized by the 
length of the target phase recording: 
            
 
     ∑ |      - |    
          (Equation 2  
The path length was measured in units of degrees per sample (using the decimated 
sampling rate of 200 Hz) and the sum was taken over all the samples in the target phase. 
This index does not depend on how well subjects attain the target, but rather the extent of 
sub-movements at the target phase and is sensitive to the smoothness of fluctuations. 
4)  The range of variance at each end target position was calculated using the standard 
deviation (SD) of the wrist angle (i.e. the larger the range of over-and under-shoot 
displacement, the greater the standard deviation), as follows: 
                     √
∑       ̅  
          (Equation 3) 
b)  Sinusoidal tracking index (TIsin): 
Examples of unimpaired and impaired sinusoidal tracking performance can be seen in 
Figure   5-14.  Prior to analysis the signals were visually analysed and the initial eight seconds 
of each test were removed to exclude the resting baseline and first two cycles which often 
showed poor tracking due to the need for initial adjustment to the test and were therefore 
unrepresentative of overall performance. In previous work (Notley SV et al. 2007) on sine 
tracking, we found that the RMS error did not correlate well with functional performance 
(Action Research Arm Test) and is therefore not reconsidered in this current work. Instead, 
our previous recommendation has been followed by using correlation: 
T sin      {
 
 ∑ wit〈i  〉    
    }       (Equation 4   
where   is a delay, which varies over a range of ±1.2 s (i.e. a little over half a cycle for the 0.5 
Hz sinusoidal target). The maximum value of the correlation is used in order to disregard 
delay or target anticipation the subjects may show in tracking the periodically moving target. 
The mean value of w and t are removed prior to this analysis to disregard any offset in 
tracking. One can regard this parameter as a correlation coefficient between target and wrist 
movement, which has not been normalized to the range ±1, and is thus sensitive to the 
amplitude of wrist movement, as well as the shape of the movement. Normalized correlation 
is unsuitable since it only quantifies the similarity in signal shape of target and wrist 
movements, regardless of the amplitude of wrist deflections; the amplitude is clearly 
important in the assessment of patients’ wrist control. Pilot Studies    Chapter 5 
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a) Unimpaired tracking               b)  Impaired tracking 
 
Figure ‎ 5-14 Examples of unimpaired and impaired sinusoidal tracking performance at 0.5 Hz 
20
o around the midpoint of the participant’s active range of movement, showing target and 
wrist movement. The impaired tracking shows difficulty with extension movement which 
becomes progressively worse over time.  
5.4.3.4. Coactivation index during both sine and step tracking 
Following the initial evaluation of methods to measure coactivation during sinusoidal tracking 
in Pilot Study 1 (Section   5.2), further investigation of correlation analysis methods for the 
coactivation index was undertaken using both sinusoidal and step tracking data from Pilot 
Study 3.  Sinusoidal tracking (5 to 55 seconds into the recording) and step tracking (5 to 65 
seconds) data were selected. Three correlation analyses each related to the extensor phase 
were performed: 
  CI (extmovt) - Correlation during extension movement only, based on the angle data from 
peak flexion to peak extension. 
  CI (incext) - Correlation based on the extensor EMG signal when the extensor EMG was 
increasing. 
  CI (peakext) - Correlation based on the extensor EMG signal during peak extensor EMG. 
Correlation of the whole sample (the EMG envelopes during both flexion and extension 
movements) that was evaluated in Pilot Study 1 and 2 was not included because it did not 
quantify coactivation specifically during the extension phase, and this is what is most 
problematic to stroke patients. The graphical results for each of the three methods were 
visually analysed (for examples see Figure   5-22 and Figure   5-23 in the Results 
Section   5.4.4.2) and descriptive statistics were calculated and compared. 
5.4.3.5. Extensor muscle onset time  
Extensor muscle onset timing was calculated across all 11 discrete extension movements to 
attain the target in step tracking (Figure ‎ 5-15); it was not investigated during sine-tracking 
because movement was continuous and graded.  Extensor muscle timing was chosen 
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because activating the extensors is commonly more problematic than the flexors in the upper 
limb for patients after stroke. In the literature review, computer-based methods to determine 
muscle onset timing have been discussed (Chapter 2, Section ‎ 2.8).  Rather than using recent 
advanced techniques in this study which are computationally intense, beyond the scope of 
this project and too complex for a clinically-based measurement tool, muscle onset was 
detected by comparing the EMG  envelope with a threshold based on the envelope during a 
baseline period (Hodges & Bui 1996). This method has an advantage in that it requires 
relatively uncomplicated processing algorithms, but is criticized for not being based directly 
on the raw (i.e. physiological origin) of the signal. Furthermore if a time delay is introduced by 
the filtering a methodological bias will result; however in this study the filtering method used 
corrects for this. All previous studies using this method have used a global resting baseline 
(typically before the start of the task) but differing processing parameter, such as the degree 
of smoothing the EMG signal (the frequency of the low pass filter (LPF)), the width of the 
sample window (in ms) for a moving average filter (MAF), and the magnitude of the deviation 
from the baseline selected as the threshold to define the beginning of muscle activation 
(number of standard deviations (SD)). Others have suggested that local analysis of the 
signal, where muscle onset is measured with respect to baseline EMG values taken from just 
before each individual movement starts, may lead to greater accuracy (Khalil & Duchene 
2000). 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-15: An example of the step tracking task conducted by an unimpaired participant 
and showing the extensor EMG envelope. Note the peaks of extensor activity in phase with 
each step movement into extension, and occasional smaller peaks during flexion, 
corresponding to corrective sub-movements. 
 
The parameters for the muscle onset timing algorithm were chosen by methods used 
previously (Hodges & Bui 1996) where visually determined onsets of the rectified raw signal 
were compared with those from the algorithm.  The global baseline method was compared 
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against the local baseline method. With the global baseline, the LPF/SD/MAF parameter 
combinations of 50Hz/3 SD/25ms and 50 Hz/1 SD/50 ms respectively were tested because 
in a previous study computer determination using these parameters did not significantly vary 
from visually derived EMG onsets (Hodges & Bui 1996). The 50Hz/3 SD/no MAF 
combination was also assessed in order to evaluate the usefulness of the using the MAF as 
well as the LPF.  As no previous studies have used thresholds based on local baselines to 
determine EMG onset, the LPF in this analysis was chosen to be 50Hz as in the global 
conditions. Two, three and four SD from the baseline was trialed and it was found from visual 
evaluation of plots that the 4SD threshold level was nearest to visually derived onsets.  For 
the final data analysis six different parameter combinations were compared, as seen in 
Table ‎ 5-7. The global baseline was given by the extensor EMG envelope during a three 
second window prior to the first target step.  The local baseline was given by the extensor 
EMG envelope during a one second window prior to each movement of the target in the 
direction of extension. 
 
These tests were carried out on data from four participants (two impaired and two 
unimpaired) purposefully selected from the study sample because they covered the full range 
of step tracking performances and amount of background EMG activity (SNR).  Extensor 
muscle onset timing was calculated as the time-lag between the target moving and the 
detected EMG activation onset. For the six computer analysis conditions, each of the 11 
muscle onset timings and the overall mean timing were recorded. To compare methods the 
mean timings, and differences between the mean computer-based timings and the mean 
visually determined onset timings, are presented.  To compare the methods Bland Altman 
95% limits of agreement, given by the mean difference between the visual minus each of the 
computer-based readings plus or minus twice the SD of the differences, were calculated. 
Table ‎ 5-7: The six low pass filter / standard deviation / moving average filter parameter 
combinations for the computer-based analysis, three using a global baseline and three using 
local baselines 
Baseline 
condition  LPF  SD  MAF 
Global 1  50Hz   3SD  none 
Global 2  50Hz   1SD  100 samples / 50ms 
Global 3  50Hz   3SD  50 samples / 25ms 
Local 1  50Hz   4SD  none 
Local 2  50Hz   4SD  50 samples / 25 ms 
Local 3  50Hz   4SD  20 samples / 10 ms 
LPF – low pass filter; SD – standard deviation from the mean baseline for the threshold; MAF – moving average filter Pilot Studies    Chapter 5 
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5.4.3.6. Stretch index 
The stretch index characterises the flexor EMG stretch response (SR) to passive movement. 
The target, angle and flexor EMG data from the 1.5Hz speed ±20˚ displacement test 
conducted in Pilot Study 3 were edited then analysed.   
a)  Method of editing data 
The signals from each file were plotted and visually checked for any artefacts.  As the 
passive tracking was undertaken manually, it was important to ensure that the data used for 
analysis corresponded to periods where the passive tracking was most accurate to the set 
target. Data were included from four to 40 seconds (36 seconds, corresponding to 54 cycles 
of data for analysis) of the task. Extension cycles (from maximum flexion to maximum 
extension) were excluded where displacement was more than ﾱ5˚ of the target extension 
peak and/or more than ﾱ10˚ of the target flexion peak.  Greater accuracy was deemed 
necessary at the extension peak as the peak stretch response lies between zero crossing 
and peak extension.  Less accuracy at full flexion was accepted due to physical restrictions 
of the rig and participant comfort (size of abdomen).  
b)  Method of analysis 
The flexor EMG envelope in the section of each extension cycle was detected for analysis. 
Where a stretch response was seen it started approximately at the start of wrist extension, or 
just after (see Figure 5-16 and Figure 5-17).  
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-16 Passive sinusoidal tracking at 1.5 Hz showing target (black), wrist movement 
(blue) and flexor EMG envelope (red). This is an example of an impaired participant with a 
flexor stretch response during the extension phase. 
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Figure ‎ 5-17 Plot to illustrate the method used to calculate stretch response showing data 
from an impaired participant with a stretch reflex response. The index was calculated as the 
area under the flexor EMG envelope curve normalised by the length of the extension phase 
for each cycle, minus the resting baseline. 
 
To quantify flexor response the stretch index was calculated (Figure 5-17), as follows: 
                
 
 ∑ (                ̅̅̅̅̅̅̅̅          )                                        (Equation 5) 
where          is the flexor EMG envelope at sample i, and the sum is calculated over all 
samples from maximum flexion to maximum extension, for each of the M cycles, and 
      ̅̅̅̅̅̅̅̅           is the average value of the flexor EMG envelope during the baseline period. 
This might thus be considered as the average area (per cycle) of the EMG above baseline. 
For the calculation of the baseline a moving average filter with one second window was 
applied from zero to four seconds of data (the period of rest before the start of the passive 
tracking). The baseline flexor EMG level was taken as the minimum of the moving average 
windows. Although this method does not involve normalisation of the EMG, it was 
appropriate for the purposes of this study to compare the stretch response within participants 
using two hand positions. Visual analysis of unimpaired stretch tests, however, showed that 
some participants, despite clear instructions and encouragement, appeared to be unable to 
avoid flexor activity during the extensor stretch Figure   5-18.  This voluntary activity looked 
very similar to the stretch reflex response seen in some patients, but its presence was more 
variable, whereas if the stretch response was present it appeared in every cycle. 
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b)                                                                           c) 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-18 a-c: An example of unimpaired passive sinusoidal tracking at 1.5 Hz showing 
voluntary flexor activity from mid to end of the extension phase possibly as protection from 
the stretch. This activity was variable between cycles (compare section b and section c). 
 
 
The stretch index calculation was therefore modified in an attempt to exclude the flexor 
activity in the unimpaired group. The area under the flexor EMG envelope curve minus the 
resting baseline EMG was determined during a -5º and 18º window of the extension phase 
for each cycle (rather than the full extension phase -20º to +20º), and the mean across cycles 
was then calculated (Figure   5-19). This window was where most stretch reflex response 
peaks occurred, whereas most unimpaired flexor activity peaks occurred after 18º. 
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Figure ‎ 5-19 Plot to illustrate the modified stretch response calculation showing data from an 
impaired participant with a stretch reflex response. The area under the flexor EMG envelope 
minus the resting baseline EMG for each cycle was taken during a -5º to 18º window. The 
start and end points of the window varies slightly for each cycle because the timing of the 
manual tracking is slightly different. 
5.4.3.7. Torque/angle index 
Secondary, non-neural mechanical changes in the muscle and soft tissue may restrict 
voluntary movement. In deciding upon an intervention and measuring response, it is 
important for a therapist to know whether the stiffness experienced by the patient, or 
detected on passive movement, is of neural or non-neural origin. By measuring both the 
stretch response (neural) and the resistance to movement in the absence of EMG activity 
(non-neural) the relative importance of each can be examined. Passive non-neural stiffness 
was characterised by quantifying the torque around the wrist applied by soft tissues during 
the passive ramp and hold stretch tests at 10˚/s and 5˚/s speed. Target and wrist angle, 
flexor and extensor EMG, and torque data were used for this analysis.  
c)  Editing of data 
This is a measure of non-neural passive stiffness and thus EMG activity during the passive 
stretch will affect the calculation. Flexor activity (voluntary or stretch reflex) may increase 
flexor stiffness and extensor activity (participant assisting the movement) may reduce 
stiffness. Prior to calculation of the torque the first cycle was automatically excluded in order 
to minimise initial thixotrophic effects and to allow participants time to relax and minimise 
EMG activation. However, inspection of EMG during the other cycles showed that, in spite of 
clear instructions and encouragement, some impaired and unimpaired participants appeared 
to be unable to consistently avoid flexor and extensor muscle activation in phase with 
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passive wrist movement.  The data were therefore edited to exclude any cycles with flexor 
and/ or extensor EMG envelope amplitudes above a set threshold (Figure   5-20). Baseline 
flexor and extensor EMG values were calculated by applying a moving average filter with a 
one second window during an initial five second rest period and taking the mean value of the 
minimum window. When the flexor and extensor EMG envelope increased more than three 
standard deviations from the baseline, the muscles were considered to be active and the 
cycles automatically excluded (Figure   5-20). This threshold level has been used in other 
spasticity measurement research (Pisano et al. 2000).  
 
 
Figure ‎ 5-20 An example of torque-angle test data from an impaired participant.  The top 
graph shows the wrist and target angle data, with six ramp and hold extension movements.  
The sections between the red and green dotted vertical lines represent the 50º period of data 
that was used for analysis. The middle graph is the torque which increases in magnitude with 
extension. The bottom graph is the flexor EMG with a resting baseline flexor EMG level (blue 
dotted) and a threshold 3SD above the baseline (black dotted).  The two cycles that are 
included for the torque analysis (bold black) are those where the flexor EMG (and extensor, 
but not shown here) does not exceed the threshold. 
d)  Methods of analysis 
For each cycle included for analysis, the torque angle curve was determined over 50˚ at the 
end of the passive extension range, ending 10˚ from the maximal extension angle to avoid a 
change in speed due to deceleration. Firstly an index that characterises the changes in 
torque with increasing extension angle was determined. The torque angle index (TAI) was 
calculated as the gradient of the torque angle curves for all cycles, as illustrated in 
Figure   5-21.  
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The torque-angle index assumes that stiffness linearly increases with increasing extension 
angle.  However, on visualisation of the data it could be seen that a linear fit is only a rough 
approximation and furthermore for some patients the gradient of their torque angle curve was 
quite flat i.e. although their stiffness was high it did not alter much with changing angle. A 
second index was derived that simply measures the mean torque without taking into account 
changing angle. The mean torque index (MTI) was the centre torque value of the 50˚ 
regression line i.e. the mean torque, which is also the torque at the mean angle. 
 
  
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-21 A line graph showing the two torque-angle curves over a 50º period included in 
the torque-angle analysis from the example in Figure   5-20. The red bold line is a regression 
line, and the torque-angle index is calculated as the slope of this line, whereas the mean 
torque index corresponds to the centre torque value of that distribution.  
 
5.4.3.8. Statistical Analysis 
  To evaluate how the measurement indices derived from the tests data differentiate 
between those impaired from stroke and neurologically intact controls descriptive 
statistics for each index for the impaired and unimpaired groups were calculated. 
Differences between the impaired and unimpaired groups were evaluated using two 
sample t tests with the statistical significance level set at p<0.05.  
  To assess the effect of two different hand positions on the test results, descriptive 
statistics of a selected number of impairment indices were calculated. The impairment 
indices were selected depending on how well they differentiated between impaired and 
unimpaired. Differences between hand positions for each of the impairment variables 
and between impaired and non-impaired groups were determined using repeated 
measures ANOVA.  
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5.4.4.  Results 
Of the 16 participants recruited for Pilot Study 3, data was missing from one impaired 
participant for the tests using the handle because his high level of spasticity and contractures 
meant that he was not able to complete any of the tests (see Results Section   5.4.4.3).  Due 
to technical problems data was missing for two unimpaired participants for the resisted 
tracking tests i.e. sine and step tracking and coactivation indices for handle and air splint 
positions.  
5.4.4.1. Defining the tests 
  The sinusoidal and step tracking tasks that were modified in Pilot Study 2 worked well 
with the participants in Pilot Study 3 and no further modifications were made 
  When setting the level of resistance for the tracking tasks at a percentage of participants’ 
extension MVC force, it quickly became obvious after testing the first few participants 
using 5% and 10%, that 5% MVC resistance was not challenging enough.  The 
resistance was set at 10% for all further participants. 
  Visual analysis of stretch response test data (passive sinusoidal movements of ±20º at 
1.5Hz) showed that a number of unimpaired participants, despite encouragement, were 
unable to prevent voluntary activation of their flexors (as described in Section   5.4.3.6). As 
such their stretch index was almost as high as those patients with stretch reflex activity 
and it was difficult to distinguish between those with spasticity and those without – see 
Section   5.4.4.2 for data.   
  Visual analysis of the Torque/angle test (passive ramp and hold movements at 
5º/second) showed that six repetitions were needed to ensure that for most participants 
at least one cycle without neural activity could be included in the analysis. However, 
following editing of the data to remove cycles with neural activity, one impaired 
participant’s data could not be included because a flexor reflex response was present at 
each stretch cycle; two unimpaired participants’ data were excluded because despite 
encouragement they were unable to prevent extensor activity at each stretch cycle. 
5.4.4.1. General Usability 
All participants found the rig comfortable; skin contact with the straps, elbow stop and air 
splint caused minimal reddening which disappeared within 30 minutes. 
5.4.4.2. Derivation of indices 
A summary of the data for the derived impairment indices for both impaired and unimpaired 
groups, with between group mean differences, 95% confidence intervals and P values 
(where appropriate) are shown in Table   5-8 (ROM and isometric force), Table   5-9 (tracking Pilot Studies    Chapter 5 
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accuracy), Table   5-10 (coactivation), Table ‎ 5-11 and Table ‎ 5-12 (extensor onset timing) and 
Table   5-13 (stretch response and torque).  
Range of movement and isometric force: Although flexion, extension and total ROM was 
recorded, only extension was presented (Table   5-8) as this is the direction of interest and 
flexion ROM was often not accurate due to the physical restrictions of the rig and size of the 
participant’s abdomen. There were statistically significant differences between impaired and 
unimpaired participants in active ROM, but not passive ROM. Weakness was quantified by 
isometric force. With this sample of participants there was a statistically significant difference 
between impaired and unimpaired in extension IF, not flexion IF (Table   5-8).   
Table ‎ 5-8 Differences in values for extension range of movement and isometric muscle force 
in the impaired (N=7) and unimpaired (N=9) groups. Statistically significant P values are in 
bold.  
Test  Range of Movement 
(ROM) 
Isometric Force (IF)     
Impaired  
Mean (SD) 
Min-max 
Unimpaired  
Mean (SD)   
Min-max 
Mean 
difference 
[95% CI] 
P 
Active 
ROM 
AROM extension  
(degrees) 
-0.63 (48.36) 
-58.3 - 64.1 
57.41 (9.96) 
41.5 – 70.9 
58 04 
[13.25, 102.83] 
0.019 
Passive 
ROM 
PROM extension  
(degrees) 
54.06 (20.79) 
23.1 - 79 
66.89 (9.62) 
43.5 – 74.4 
12.83 
[-32.40, 6.74] 
0.169 
MVC 
IF Extension  
(Nm) 
1.91 (2.19) 
0 - 5.51 
4.95 (2.60) 
1.84 – 10.05 
3.04 
[0.41, 5.67]  
0.027 
 
IF Flexion  
(Nm) 
7.16 (4.42) 
0.94 – 12.25 
6.66 (3.49) 
2.09 – 13.04 
0.51 
[-3.73, 4.74] 
0.801  
 
Tracking accuracy: For tracking accuracy (Table   5-9) all the derived indices reach statistical 
significance between the groups, except TI (target MAE) which did not quite reach the 
P<0.05 significance level. 
 
Table ‎ 5-9 Differences in values for tracking accuracy indices in the impaired (N=7) and 
unimpaired (N=9) groups. Statistically significant P values are in bold. 
Test  Tracking accuracy 
Indices (TI) 
Impaired  
Mean (SD) 
Min-max 
Unimpaired  
Mean (SD)   
Min-max 
Mean 
difference 
[95% CI] 
P 
Sine 
tracking 
TI (CC)  (degrees
2)  112.99 (85.70) 
3.81-205.60 
226.14 (18.45) 
203.96-258.65 
113.15 
[33.78, 192.52] 
0.012 
Step 
tracking 
TI (total MAE) (degrees)   8.07 (4.07) 
3.89-12.94 
3.81 (0.54) 
3.14-4.65 
4.27 
[0.50, 8.03] 
0.032 
TI (target MAE) (degrees)  5.41 (5.58) 
0.31-12.53 
0.30 (0.08) 
0.19-0.45 
5.11 
[-0.06, 10.27] 
0.052 
TI (path length) 
(degrees/sample) 
0.015 (0.002) 
0.012-0.017 
0.007 (0.001) 
0.005-0.009 
0.008 
[0.006, 0.009] 
<0.001 
TI (SD) (degrees)  0.69 (0.44) 
0.15-1.36 
0.06 (0.02) 
0.02-0.09 
0.63 
[0.21, 1.04] 
0.009 Pilot Studies    Chapter 5 
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Coactivation: Mean values for the different methods of calculating the coactivation indices 
are shown in Table   5-10.  There was no statistically significant difference for any of the 
methods, though correlation when extensor EMG is increasing showed the greatest mean 
difference between impaired and unimpaired. Visual analysis of individual sine and step 
tracking and EMG plots confirmed the findings in Pilot Study 1 that the correlation methods 
based on extension movement and during peak extensor EMG included normal antagonist 
activation which often occurred towards the end of the movement phase acting as a brake, 
whereas correlation when extensor EMG is increasing included the phase of agonist activity 
before the movement starts, resulting in better distinction between normal and abnormal 
coactivation (see Figure   5-22 and Figure   5-23).  
 
Table ‎ 5-10 Differences in values for coactivation indices in the impaired (N=7) and 
unimpaired (N=9) groups. P value not shown as none reached statistical significance. 
Test  Methods of Coactivation 
Indices (CI) (correlation 
coefficient) 
Impaired (N=7) 
Mean (SD) 
Min-max 
Unimpaired (N=9) 
Mean (SD)   
Min-max 
Mean 
difference 
[95% CI] 
Sine  CI (increase extensor EMG)   0.14 (0.43) 
-0.43 – 0.73 
-0.19 (0.31) 
-0.53 – 0.45 
0.32 
[-0.10, 0.75] 
 
CI (extension movement)  0.24 (0.31) 
-0.12 – 0.65 
0.12 (0.19) 
-0.09 – 0.52 
0.12 
[-0.15, 0.39] 
 
CI (peak extensor EMG)  0.16 (0.21) 
-0.11 – 0.47 
0.05 (0.16) 
-0.11 – 0.32 
0.11 
[-0.09, 0.31] 
Step  CI (increase extensor EMG)   0.09 (0.34) 
-0.26 – 0.60 
-0.08 (0.22) 
-0.53 – 0.45 
0.17 
[-0.13, 0.47] 
 
CI (extension movement)  0.16 (0.43) 
-0.53 – 0.58 
0.20 (0.41) 
-0.53 – 0.72 
-0.05 
[-0.50, 0.40] 
 
CI (peak extensor EMG)  0.11 (0.36) 
-0.43 – 0.52 
0.02 (0.21) 
-0.19 – 0.52 
0.09 
[-0.21, 0.40] 
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a) bold sections: extensor EMG increasing            b) bold sections: wrist extension 
 
Figure ‎ 5-22 Example of unimpaired step tracking showing wrist movement (blue), extensor 
EMG (green) and flexor EMG (red). Lines in bold are sections of data included in the 
coactivation calculation based on: a) extensor EMG increasing; b) during wrist extension. 
This example shows the agonist extensor EMG increasing before and during extension to 
initiate and propel the movement, and the antagonist flexor EMG increasing towards the end 
of extension to act as a brake, while both muscles modulate with corrective sub-movements 
at the target position. The bold EMG curves in a) are graphically dissimilar and the resulting 
correlation coefficient, using this method, was r=-0.03 (no coactivation).  The bold EMG 
curves in b) are similar and using this method the resulting correlation coefficient was r=0.72 
(strong coactivation).  This illustrates the ability of method a) to detect and exclude normal 
coactivation. Plots are displayed in arbitrary units in the vertical axis to facilitate visualization. 
  
a) bold sections: extensor EMG increasing      b) bold sections: wrist extension 
Figure ‎ 5-23 Example of impaired step tracking: bold lines are the sections of data included in 
the coactivation analysis based on: a) extensor EMG increasing; b) during wrist extension. In 
both a) and b) the EMG curves increase simultaneously (abnormal coactivation) and for each 
method the resulting correlation coefficients are similar (r=0.60, r=0.57 respectively). 
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Because no significant difference was seen between impaired and unimpaired groups, sine 
and step coactivation index values from the correlation during increase in extensor EMG 
method were further investigated at an individual level and can be seen in the dot plots in 
Figure   5-24 a & b. Values greater than two standard deviations from the unimpaired mean 
were taken as being beyond the normative range. For both coactivation indices there is much 
overlap between the groups though three impaired participants clearly lie outside the 
normative range. In particular it is interesting to note that there is an outlier in the unimpaired 
group in sine tracking with a coactivation index value as high as 0.45; visual analysis of the 
EMG traces confirmed their coactivation. 
 
 
a)                b)  
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-24: Dot plots for a) sine coactivation index and b) step coactivation index values 
based on when extensor EMG is increasing. Differences between participants in the impaired 
and unimpaired groups are shown. The horizontal line is the mean of the unimpaired group 
and the dashed line is the mean +2SD. Participants with values above this line are 
considered to have abnormal coactivation  
 
 
Muscle onset timing: The mean differences and 95% limits of agreement between visually 
determined onsets (V) and the six computer based methods (G1-3 and L1-3) for each of the 
four participants and the group mean difference are shown in Table ‎ 5-11. The group mean 
difference between the visual determination and computer-based methods shows that the 
local baseline methods generally were more similar to the visual onsets than the global 
methods. The least difference was seen for method local 3 (LPF 50Hz / 4SD / MAF 10 ms). Pilot Studies    Chapter 5 
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Table ‎ 5-11: Mean differences and 95% limits of agreement between visually determined 
onsets (V) and the six computer based methods (G1-3 and L1-3) for each of the four 
participants and the group mean difference 
 
Participant 
ID 
053MB  057FR   016RO   021VS 
Group Mean 
Difference 
(ms) 
V vs. G1 
Mean 
difference  168  -271  -57  23  -34.1 
 
Limits of 
agreement  (-266, 218)  (-274, 525)  (-113, 477)  (-136, 71)   
V vs. G2 
Mean 
difference  115  -373  -62  -38  -89.4 
 
Limits of 
agreement  (-185, 332)  (-197, 596)  (-68, 475)  (-90, 105)   
V vs. G3 
Mean 
difference  169  -236  -21  121  8 
 
Limits of 
agreement  (-267, 217  (-332, 404)  (130, 473)  (-367, 188)   
V vs. L1 
Mean 
difference  91  -45  -52  25  4.9 
 
Limits of 
agreement  (-206, 163)  (-120, 276)  (-195, 133)  (-64, 40)   
V vs. L2 
Mean 
difference  62  -57  -104  171  17.8 
 
Limits of 
agreement  (-449, 203)  (-184, 279)  (-539, 253)  (-300, 202)   
V vs. L3 
Mean 
difference  116  -36  -90  24  3.7 
 
Limits of 
agreement  -(221, 152)  -(118, 264)  (-235, 142)  (-62, 41)   
 
 
The extensor muscle onset results, using the local baseline method 3 (LPF 50Hz / 4SD / 
MAF 10 ms) and applied to the seven impaired and nine unimpaired participant data, can be 
seen in Table ‎ 5-12. A difference between impaired and unimpaired onset timing can be seen, 
but that did not reach significance (p=0.09) in this small sample. Examples of impaired and 
unimpaired step tracking with the extensor EMG envelope can be seen in Figure ‎ 5-25, 
showing the points of activation onset as determined using local baseline method 3.  
  
Table ‎ 5-12: Differences in values extensor muscle onset timing in the impaired (N=7) and 
unimpaired (N=9) groups 
  Impaired 
Mean (SD) 
Min-max 
Unimpaired  
Mean (SD) 
Min-max 
Mean 
difference 
[95% CI] 
P  
Extensor muscle onset 
timing (seconds) 
0.58 (0.36) 
0.02 - 1.16 
0.31 (0.06) 
-0.12 - 0.23 
0.27 
[-0.06, 0.60] 
0.090 
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a) Unimpaired step tracking 
b) Impaired step tracking 
Figure ‎ 5-25: Step tracking and simultaneous extensor EMG activation from a) an unimpaired 
participant and b) an impaired participant. The dashed vertical line is where the target moved 
into extension and the red stars show the points at which muscle onset was calculated to 
occur, which was somewhat delayed in the impaired participant. In these examples, muscle 
onset was defined as the time at which the extensor EMG envelope exceeds the mean of the 
local baseline EMG plus four times its standard deviation (local baseline method 3).  The 
local baseline was given by the extensor EMG envelope during a one second window, prior 
to movement of the target in the direction of extension. 
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Stretch response: The stretch index group results can be seen in Table   5-13. This shows a 
difference between impaired and unimpaired that did not quite reach significance (p=0.052). 
The stretch index calculation chosen was dependent not only on the area of flexor EMG 
activation, but also on a global resting baseline level.  This was found to be problematic 
because visual analysis of flexor EMG data from the 1.5Hz and 0.5Hz stretch response tests 
and sine and step tracking tests showed that the amplitude of the global resting baseline 
within participants was often very variable; thus was likely to affect the accuracy and 
repeatability of the stretch response measure. 
     
Table ‎ 5-13 Differences in values for stretch and torque indices in the impaired (N=7)* and 
unimpaired (N=9)* groups 
Passive 
Tests 
Stretch (SI) and Torque 
Indices  
Impaired 
Mean (SD) 
Min-max 
Unimpaired  
Mean (SD) 
Min-max 
Mean 
difference 
[95% CI] 
P  
Stretch  Stretch index (mean area-BL) 
(mV·s) 
0.35 (0.39) 
0.02 - 1.16 
0.05 (0.12) 
-0.12 - 0.23 
0.29 
[-0.002, 0.59] 
0.052 
Torque  Torque-angle Index
 a 
(Nm) 
0.023 (0.016) 
 
0.007 - 0.048 
0.015 (0.005) 
0.009 - 0.023 
0.008 
[-0.009, 0.024] 
0.284 
 
Mean Torque Index
 a 
(Nm/degree) 
0.86 (0.39)
  
0.44 - 1.52 
0.46 (0.11) 
0.34 - 0.65 
0.40 
[-0.02, 0.81] 
0.057 
*Unless stated otherwise; 
 a Impaired group N = 6, Unimpaired group N=7 
 
Torque: Editing the data and detailed inspection of the EMG showed that, in spite of clear 
instructions and encouragement, three participants were unable to entirely avoid any flexor 
and extensor activation during all cycles of passive wrist extension and were excluded from 
the analysis. This included two unimpaired participants with voluntary extensor activity and 
one impaired participant with increasing flexor activity in phase with passive wrist extension 
(see Figure ‎ 5-26). This patient was one of three in the group who had spasticity, though this 
was not tested formally. The torque indices can be seen in Table   5-13. The mean torque 
index showed a greater difference between impaired and unimpaired that almost reached 
statistical significance (p=0.057) and less overlap of values between the groups than the 
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Figure ‎ 5-26: Data from the torque angle test showing top - target and wrist movement (black 
and blue), middle – flexor EMG (red), and bottom – extensor EMG (green).  The EMG plots 
show the mean resting baseline (blue dashed) and the 3SD threshold level (green dotted). 
The data analysed for this test is between the two vertical lines (black dotted) at each 
movement cycle. In this impaired participant, increasing flexor EMG activity can be seen in 
phase with the passive extension that is above the 3SD threshold. This participant was 
excluded from the non-neural torque analysis because of this evident neural activity.  
 
5.4.4.3. Differences between hand positions 
In terms of participant preference, twelve participants (5 stroke and 7 unimpaired) thought 
the handle was more comfortable and they felt more in control during the tracking tasks, 
whereas five participants (3 stroke and 2 unimpaired) thought the air splint was more 
supportive and effective, especially for the extensor MVC test. A deciding factor was that one 
participant was unable to perform any of the tasks using the handle because it was not 
supportive enough, even with extra straps around the fingers. This participant had spasticity 
with contractures that made positioning his arm in the mid-prone position difficult, which is a 
common problem for those patients with higher levels of spasticity.  The air splint with the 
forearm supports and straps were supportive enough to maintain his arm in this position so 
that he could isolate some movement at the wrist.  
 
Means and standard deviations of a select number of measurement indices for each of the 
hand positions and a comparison between impaired and unimpaired groups are shown in 
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Table ‎ 5-14 and Table ‎ 5-15. The repeated measures ANOVA showed statistical significance 
for extensor isometric force for hand position as a factor (p=0.028) and for the step tracking 
correlation index when both hand position and group factors were considered (p=0.026). A 
post hoc paired sample t-test showed that in the impaired group there was statistically 
significant greater extension force using the air splint than the handle (p=0.023). A post hoc 
independent samples t-test comparing the impaired and unimpaired group step coactivation 
index using the handle and air splint showed a statistically significant difference between the 
groups only for the air splint (p=0.030). There was more coactivation in the impaired group 
and more reciprocal activation/inhibition in the unimpaired group using the air splint. 
      
 
Table ‎ 5-14 Differences in impairment indices from the active tests for the two hand positions and 
between the impaired and unimpaired groups 
Active Tests  Impaired group N=6  Unimpaired group N=9  Between group  
difference  
Test  Indices  Handle
 
Mean 
(SD) 
Air 
Splint 
Mean 
(SD) 
Mean 
Difference 
Handle 
Mean 
(SD) 
Air 
Splint 
Mean 
(SD) 
Mean 
Difference 
Handle  Air 
splint 
Sine  Tracking Index(CC) 
(degrees
2) 
 
143.65 
(86.56) 
124.78 
(76.09) 
18.88  221.57 
(12.34) 
216.19 
(15.59) 
5.38  -77.91  -108.22 
Coactivation Index 
(correlation increase 
ext EMG) 
  
-0.02 
(0.49) 
0.07 
(0.46) 
-0.09  -0.47 
(0.21) 
-0.49 
(0.17) 
0.01  0.46  0.60 
Step  Tracking 
Index(totalMAE) 
(degrees) 
 
5.63 
(2.25) 
5.21 
(2.16) 
0.42  3.45 
(0.51) 
3.71 
(0.51) 
-0.26  2.18  1.82 
Tracking Index(PL) 
(degrees/sample) 
 
0.014 
(0.005) 
0.015 
(0.004) 
-0.001  0.009 
(0.001) 
0.010 
(0.004) 
-0.001  0.005  0.005 
Coactivation Index 
(correlation increase 
ext  
EMG) 
 
0.09 
(0.49) 
0.26 
(0.47) 
-0.16  -0.02 
(0.18) 
-0.18 
(0.16) 
0.16  0.12  0.42* 
  Extensor onset  
time (seconds) 
 
0.41 
(0.14) 
0.35 
(0.16) 
0.06  0.25 
(0.10) 
0.25 
(0.04) 
-0.001  0.16  0.15 
MVC IF Extension (Nm)  1.98 
(1.58) 
2.94 
(2.25) 
-0.96*  3.55 
(1.19) 
4.50 
(2.51) 
-0.95*  -1.57  -1.98 
*statistically significant difference between groups (p=0.030)  
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Table ‎ 5-15 Differences in impairment indices values from the passive tests for the two hand 
positions and between the impaired and unimpaired groups 
Passive Tests  Impaired group N=6  Unimpaired group N=9  Between 
group  
difference 
Test Indices  Handle
 
Mean 
(SD) 
Air 
Splint 
Mean 
(SD) 
Mean 
Difference 
Handle 
Mean 
(SD) 
Air 
Splint 
Mean 
(SD) 
Mean 
Difference 
Handle  Air 
splint 
Stretch 
Index(area-BL) 
(mV·s) 
  
0.52 
(0.92) 
0.32 
(0.48) 
192  0.02 
(0.09) 
0.05 
(0.12) 
-0.03  0.49  0.27 
Mean Torque 
Index (Nm) 
0.65 
(0.14) 
0.71 
(0.25) 
-0.06  0.30 
(0.13) 
0.42 
(0.10) 
-0.12  0.35  0.33 
 
 
5.4.5.  Discussion  
5.4.5.1. Defining the tests 
In this research both sine and step tracking were chosen as ways in which motor control 
could be assessed. Although sine tracking is potentially more reliable, because it generates 
multiple cycles of data that can be averaged, random step tracking, which involves complex 
acceleration and deceleration, demands cognitive control for which higher-level planning 
areas of the cortex are recruited (Schaal et al. 2004). This is probably more related to the 
requirements of day-to-day functional activities involving the wrist than repetitive movements. 
The step tracking test has also provided additional insights into tracking accuracy (path 
length at the end-point target position) and muscle activation patterns (extensor muscle 
onset timing).  The step tracking test was carefully designed to be random in terms of timing 
and displacement of step changes, but also to have graduated amount of displacement so 
that most patients, even with only small amounts of wrist movement, could complete some of 
the test. The parameters for timing and displacement that were defined in Pilot Study 2 with 
unimpaired participants were then tested for the first time with patients in this Pilot Study. 
These have worked well with this sample of impaired participants with a wide range of 
movement abilities. 
The stretch test was problematic because the 1.5Hz speed at which the test was undertaken 
was not fast enough over 40º ROM to exclude voluntary flexor activation by some unimpaired 
participants.  These test parameters were used because we had used similar parameters 
(±30º at 1.5Hz) in a previous study (Turk et al. 2008b) without any issues with voluntary 
flexor activation by unimpaired participants.  The displacement was reduced to ±20º for this 
study so it was the same as the active sinusoidal test and therefore could more easily be Pilot Studies    Chapter 5 
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compared. On re-reviewing the literature on this issue, it was found that others have tested 
sinusoidal passive displacements using a smaller range of 10 º displacements and found that 
speeds of at least 3 Hz needed to be used to prevent voluntary tracking activity (Ada et al. 
2006; Neilson 1972; O'Dwyer et al. 1996). It was therefore decided that a re-evaluation of the 
stretch test with varying velocities and range of displacement was needed and this was 
carried out in Pilot Study 4 (Section   5.5).   
The torque angle test was not entirely acceptable because one of the seven impaired 
participants and two of the nine unimpaired participants had neural activity during the test 
and therefore could not be included in the torque index analysis, as it aims to measure non-
neural stiffness.  The unimpaired participants had voluntary extensor activity which may 
further reduce the torque around the wrist joint. The impaired participant had increasing 
flexor activity in phase with passive extension (Figure ‎ 5-26), which may have increased the 
flexor torque around the wrist joint. Others who measured non-neural wrist stiffness during 
50˚ passive extension displacements in a torque motor controlled rig using constant velocity 
movements at 10˚/second (Pisano et al. 2000), also found that 29 of the 48 impaired subjects 
could not be included in the analysis as they also exhibited flexor EMG activity during the 
test. With the current study the test was purposely undertaken at a slower speed 5˚/second, 
which may have reduced the presence of flexor reflex activity, but not fully. An alternative 
method that claims to separate neural from non-neural stiffness measures very small 
perturbations at joints together with a complex mathematical model, described as a parallel-
cascade non-linear system (Kearney et al. 1997; Mirbagheri et al. 2001; Mirbagheri et al. 
2007). However, because if its complexity, the model described by Kearney and Mirbagheri 
was not considered practical for this study which aims to use measures that could be applied 
easily in a clinical setting. Therefore, although the method tested in this Pilot Study is not 
ideal it was decided to further evaluate it with a larger group of participants in the main study. 
Furthermore, as the impaired participant who was excluded from the analysis also had 
spasticity, it was decided to test spasticity formally with the participants in the main study 
using a standardised clinical test, the modified Tardieu scale (Boyd and Ada 2001; Morris 
2002) (see Methodology Chapter 4, Section ‎ 4.6.2).  
 
5.4.5.2. Derivation of Indices 
A number of different methods of deriving indices to quantify various motor impairments have 
been evaluated in this Pilot Study. It was important to exclude indices that were not useful in 
order to limit the number of measurement variables used in the statistical analysis of the final 
main study. These indices, with reasons for exclusion, are detailed in Table ‎ 5-16 
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Table ‎ 5-16: Indices excluded from the main study analysis and reasons for their exclusion 
Indices excluded from the 
main study 
Reason 
Step tracking index (target 
MAE) 
Similar to Step tracking index (total MAE) but is not as 
good at distinguishing impaired from unimpaired. This only 
measures the ability to attain the target; its poor 
performance suggests that delay in movement may also 
be an important feature of the impairment   
Step tracking index – standard 
deviation (SD) 
Similar to path length but path length is sensitive to 
smoothness of fluctuations whereas standard deviation is 
only sensitive to overall range of dispersion of wrist 
position during the target phase. 
Coactivation indices based on 
  Extension movement 
  Peak extensor EMG 
These methods generated smaller differences between 
abnormal and normal coactivation. Visual analysis of EMG 
plots suggested that these approaches included more 
sections of the data where there is ‘normal’ coactivation 
such as antagonist activation occurring towards the end of 
the movement phase and simultaneous relaxation of both 
agonist and antagonist muscles at the end of the extension 
(see Figure   5-22 and Figure   5-23). This would contribute 
to a positive correlation coefficient between extensor and 
flexor activity, but does not necessarily reflect ‘abnormal’ 
coactivation. 
Stretch Index (area-BL)  This measure has a disadvantage in that it needs to be 
normalised so that comparisons can be made across 
participants.  The global resting baseline within 
participants was found to be variable which was likely to 
affect the accuracy and repeatability of the stretch 
response measure 
Torque angle index  This measure is sensitive to the change of resistance with 
increasing extension angle, rather than resistance itself 
and is less able to distinguish abnormal stiffness than the 
mean torque calculation. 
 Pilot Studies    Chapter 5 
    109 
  The indices that characterise motor impairments and best distinguish between 
impaired and unimpaired participants are summarised in a table at the end of this 
Chapter (Table ‎ 5-19, Section   5.6), and are discussed further here: 
Accuracy of movement tracking: The indices that characterise motor control in both step and 
sine tracking clearly distinguish between impaired and unimpaired, confirming what was 
evident from visual analysis of the wrist movement plots. This extends results seen 
previously in sine tracking (Notley et al. 2007; Turk et al. 2008b), now showing differences in 
performance during step-tracking, especially for total tracking accuracy using MAE and 
accuracy at target end point using path length. 
Coactivation: A novel method to quantify coactivation has been employed using a correlation 
analysis of the agonist (extensor) and antagonist (flexor) EMG calculated only over the time-
periods where the agonist EMG is increasing, in accordance with the definition of 
coactivation (simultaneous activation of both muscles (Sheean 2002)). This coactivation 
index method was first tested in Pilot Study 1 using sinusoidal tracking data of impaired and 
unimpaired participants from a previous wrist rig study (Turk et al. 2008b) and showed that it 
better distinguished abnormal coactivation from that used normally to stabilise a joint and 
ensure end-point movement accuracy than other methods based on extension movement or 
peak extensor EMG. Visual analysis of the traces of both sinusoidal and step tracking in Pilot 
Study 3 suggested that, again, this approach was able to exclude more sections of the data 
where there is ‘normal’ coactivation, which provides a major improvement over indices 
previously used in terms of improved compliance with the usual definition of co-activation.  
The wide and rather similar distribution of values for coactivation found in both groups in this 
study highlights the variety of muscle activation strategies used by both impaired and 
unimpaired participants, which was evident from visual inspection of the flexor and extensor 
EMG on the tracking plots. Even in the unimpaired groups whose tracking performance was 
excellent there were a variety of strategies used. Some appeared to use reciprocal 
inhibition/activation as described by Sherrington (Sherrington 1906). For others there was 
overlapping activity of AG1, ANT1 and AG2 in triphasic activity, often with additional bursts of 
AG and ANT activity as described by others (Brown and Cooke 1990). One unimpaired 
participant in the sine tracking task used coactivation and achieved good tracking 
performance. One consideration is that this individual found the task challenging and 
coactivation has been shown to increase with task difficulty and reduce with learning (Osu et 
al. 2002). This was not likely to be the case in this study as all participants were allowed to 
practice the test before data was recorded. If further changes in coactivation might have 
occurred with longer training is unclear, however, such a requirement is unrealistic for routine 
clinical use. Although the majority of impaired participants did not have coactivation at levels 
beyond the normal range during sine and step tracking movements, there are clearly some Pilot Studies    Chapter 5 
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individuals who did coactivate.  Further investigation of the relationship of coactivation and 
other impairments with level of tracking performance and functional activity was carried out 
with more participants in the main study to explore if coactivation affects motor performance. 
Extensor muscle onset timing: A method using a local baseline threshold, which best 
compared with visual analysis of the rectified raw extensor EMG activation pattern, was 
evaluated in this study.  The results using this method showed a trend towards a delay in 
extensor muscle onset in the impaired group is similar to findings in previous studies (Chae 
et al. 2002a; Hughes et al. 2010a; Wagner et al. 2007). This did not reach significance 
possibly due to the small sample size in this Pilot Study, and further investigation of this 
measure was carried out in the main study. 
   
Stiffness: Despite the fact that not all participants data could be used in the analysis due to 
presence of neural activity (see Section   5.4.4.1) the mean torque index showed a greater 
difference between impaired and unimpaired that almost reached statistical significance 
(p=0.057) than the torque angle index. The mean torque index simply represents the mean 
non-neural resistance or stiffness around the wrist joint during slow passive wrist extension, 
and unlike the torque angle index is not sensitive to change over the range of angles tested. 
From these preliminary findings it can be cautiously suggested that patients with stroke, 
compared to unimpaired participants, may have more problems with increased stiffness 
through range rather than stiffness increasing with extension angle.  
5.4.5.3. Hand position 
Although participant preferences were mainly for the handle, described as having ‘better 
control’ during the tracking tasks, there were no statistically significant differences in tracking 
performance between the groups. The air splint was thought to be supportive and one 
impaired participant with spasticity and contractures could only use the air splint for this 
reason. Some found the air splint easier to use during the extensor MVC test and evidence 
for this was seen as the isometric extension force with the air splint was significantly greater 
for the impaired group than with the handle. Furthermore when comparing the impaired and 
unimpaired step coactivation index using the handle and air splint, a statistically significant 
difference between the groups was shown only for the air splint (p=0.030) (Table ‎ 5-14), due 
to more coactivation in the impaired group and more reciprocal activation/inhibition in the 
unimpaired group. With the handle there was more coactivation in the unimpaired group and 
less in the impaired group, compared to the air splint. This partially supports our hypothesis 
that when using the handle, participants (unimpaired in particular) may use ‘normal’ 
coactivation because of the flexed gripping position of the fingers around the handle.   
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5.4.6.   Conclusions  
1.  The air splint was more appropriate for use in the main study as it provided support for 
the upper limb across all the range of impairments, and was better able to distinguish 
between impaired and unimpaired coactivation than the handle.  
2.  The sine and step tracking test parameters worked well and the indices derived from 
them distinguished between impaired and unimpaired performance. Of the four derived 
step tracking indices evaluated in this Pilot Study, two best differentiate between impaired 
and unimpaired and were chosen for the main study analysis – total tracking accuracy 
using MAE and accuracy at target end point using path length.  
3.  For the step and sine tracking tests, the method of correlation of extensor and flexor 
EMG when extensor EMG is increasing was better at distinguishing between impaired 
from unimpaired coactivation than correlation methods based on extension movement or 
peak extensor EMG.  
4.  The torque angle test was able to distinguish between neural and non-neural stiffness for 
most but not all participants. Other methods cited in the literature were considered to be 
too complex for this clinically-focussed study. It was therefore decided to include this test 
and its derived index in the main study to further evaluate it with a larger group of 
participants.  
5.  Before the main study was undertaken, the stretch test and derivation of the stretch index 
needed further evaluation with more impaired and unimpaired participants using a range 
of tests with different velocities and range of displacements – this was the focus of Pilot 
Study 4. 
 
 
5.5.  Pilot Study 4 
5.5.1.  Objectives 
In Pilot Study 3 the stretch test was problematic because of the presence of voluntary flexor 
activity in the unimpaired group that was related to the speed of the test. The objectives of 
this study were firstly to define a fast passive stretch test for the main study which enables 
calculation of the flexor stretch reflex response (when spasticity is present) but prevents 
voluntary tracking activity.  Secondly, it aimed to derive a stretch index that is not necessarily 
dependent on a global resting baseline and best distinguishes impaired from unimpaired 
stretch response. Thirdly, the stretch test at 0.5 Hz ﾱ20˚ was to be evaluated in order to 
investigate the presence of a stretch response at the same frequency used for the active 
tracking task, so that the relationship between spasticity measured during passive movement 
and coactivation during activation could be assessed. Pilot Studies    Chapter 5 
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5.5.2.  Participants 
Five participants with hemiplegia in the chronic phase post-stroke who were recruited from 
the Faculty of Health Sciences participant database were included in this study. Five older 
unimpaired adults (age 65 and over) were recruited from a local church community and five 
unimpaired staff members (under age 65) were recruited from the Faculty of Health Sciences 
ARM research programme. The selection criteria remained the same as those detailed in the 
Methodology Chapter Section   4.4. Participant characteristics can be seen in Table ‎ 5-17. 
Table ‎ 5-17: Demographic characteristics for Pilot Study 4 participants   
    Impaired (N=5)  Older unimpaired 
(N=5) 
Younger 
unimpaired (N=5) 
Age (years)  Mean (SD)  
Min - max 
64.2 (6.6) 
56 – 74 
69 (4.5) 
65 – 76 
34.4 (6.0) 
30 - 41 
Gender  Male 
Female 
5 
0 
3 
2 
2 
3 
Time from 
stroke (months) 
Mean (SD) 
Min - max 
67.4 (18.3)                
48 – 91 
N/A  N/A 
Side assessed  Right     
Left 
2 
3 
4 
1 
4 
1 
 
5.5.3.  Data collection 
To compare stretch tests with different velocities and ranges of displacement, participants 
were set up in the rig (see Methodology Chapter Section   4.7) with their hand positioned in 
the air splint (Figure   5-8d). Four 40 second passive tests were carried out: 1.5Hz and 0.5 Hz 
with ﾱ20˚ displacement around the active midpoint (as used in Pilot Study 3), and 3Hz and 
3.5Hz with ﾱ5˚ displacement as used in previous studies (Ada et al. 2006; Neilson 1972; 
O'Dwyer et al. 1996) without voluntary tracking activity. Higher speeds than 3.5Hz were 
considered but it was found that passive manual tracking was impossible to carry out. The 
order of testing was randomised using a Latin square.  
5.5.4.  Derivation of indices 
The signals from each file were plotted and visually checked for any abnormalities.  For each 
of the tests, 40 seconds of data were analysed. As in Pilot Study 3 the data were edited to 
ensure that the data used for analysis were those where the passive tracking was most 
accurate to the set target (see Section   5.4.3.6.a). For the 1.5Hz and 0.5Hz tests extension 
cycles were excluded where the error in tracking was more than ﾱ5˚ off the target extension 
peak and/or more than ﾱ10˚ off the target flexion peak - as also used in Pilot Study 3.  For 
the 3Hz and 3.5Hz tests, extension cycles were excluded where the displacement was ﾱ2˚off 
the target flexion and/or extension peak.  
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5.5.4.1. Methods of analysis 
Two methods of analysis were compared: 
a)  The stretch index was calculated as in Pilot Study 3. This was taken as the mean of the 
area under the flexor EMG curve normalised by the length of the extension phase (i.e. 
the average amplitude) for each cycle minus a global resting baseline EMG:  
                
 
 ∑ (                ̅̅̅̅̅̅̅̅          )                                        (Equation 6) 
For the 1.5Hz and 0.5Hz tests the resting baseline EMG was calculated by applying a 
moving average filter with one second window from zero to five seconds of data (the period 
of rest before the start of the passive tracking). For the 3Hz and 3.5Hz tests a moving 
average filter was applied with a five second window from zero to 15 seconds into the 
recording. The baseline flexor EMG level was taken as the minimum value from all of the 
moving average windows. The method, however, proved not to be satisfactory, firstly 
because there is no normalisation and although it can be evaluated within participants within 
one session when the electrodes are not removed, cannot be evaluated within participants 
over time or across participants. Secondly the global baseline was often found to be variable 
and because this method was dependant on the baseline, this variability was likely to affect 
the accuracy and repeatability of the stretch response measure.  
b)  A second method was evaluated that used a local baseline rather than the global resting 
baseline, thus the baseline values vary within the recording but are related to each of the 
cycles which may improve the accuracy of the algorithm (Khalil & Duchene 2000).  This 
was taken as the median of a ratio of the stretch response area normalised by the length 
of the extension movement (as in (a)) to the local baseline for each cycle (Figure   5-27): 
                                                                          ⁄                (Equation 7) 
Where              is the mean EMG area of the flexor over an interval of 0.1s prior to 
extension on the m
th cycle (i.e. the local baseline), and                is the equivalent 
during that extension.  
The advantage of this method is that it is normalized, and thus the value of the index can 
easily be interpreted – which is more difficult for SI(area-BL) in units of mV.s. Thus if the 
ratio is 1.0, the stretch response average amplitude is the same as the local baseline, 
and if the ratio is higher than 1.0, the stretch response average amplitude is greater than 
the local baseline. 
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Figure ‎ 5-27 Plot to illustrate the second method used to calculate stretch response: the 
median of a ratio of the stretch response area normalised by the length of the extension 
phase to the local baseline for each cycle.  
   
5.5.5.  Results 
A summary of the stretch index data comparing the two stretch index methods and different 
test parameters for both impaired and unimpaired groups are shown in Table   5-18. Between 
group mean differences, 95% confidence intervals and P values are presented. Although 
none were statistically significant between impaired and unimpaired, the 3.5Hz, ﾱ5˚ test data 
with the ratio of stretch response to local baseline index was clearly the nearest to reaching 
statistical significance (p=0.058). Dot plots (Figure   5-28) with all the impaired and unimpaired 
values for the 3.5 Hz test using the two different methods show for the global baseline 
method one impaired participant lies outside the normal (unimpaired) range, and for the local 
baseline method there are three.  
To evaluate the two stretch index methods with the 0.5 Hz with ﾱ20˚ displacement test, data 
were pooled from Pilot Study 3 and Pilot Study 4. Dot plots showing the impaired and 
unimpaired values for the two different stretch index methods are shown in Figure 5-29. 
Using the global baseline method one participant (#13) has a stretch response outside the 
normal range. It is interesting to note that for this participant in the 0.5Hz ﾱ20˚ displacement 
test the stretch index is almost ten times as big as in the 3.5Hz, ﾱ5˚ test. With the slower 
0.5Hz test both methods show unimpaired outliers with greater flexor activity.  
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Table ‎ 5-18 Differences in values for two stretch index methods using different test 
parameters in the impaired (N=5) and unimpaired (N=10) groups 
Stretch 
response 
Test 
Indices  Impaired N=5 
Mean (SD) 
Unimpaired N=10 
Mean (SD) 
Mean Difference 
[95% CI] 
P 
1.5Hz, ﾱ20˚  SI (area – GBL) 
(mV.S)  
0.66 (1.08)  0.001 (0.24)  0.66 
[-0.66, 1.99] 
0.243 
SI (ratio area : LBL)  1.46 (0.55)  1.02 (0.06)  0.44 
[-0.24, 1.12] 
0.152 
3Hz, ﾱ5˚  SI (area – GBL)  
(mV.S) 
0.37 (0.46)  0.04 (0.07)  0.33 
[-0.80, 1.45] 
0.343 
SI (ratio area : LBL)  1.18 (0.27)  1.05 (0.16)  0.13 
[-0.14, 0.41] 
0.307 
3.5Hz, ﾱ5˚  SI (area – GBL)  
(mV.S) 
0.10 (0.17)  0.04 (0.08)  0.06 
[-0.15, 0.27] 
0.362 
SI (ratio area : LBL)  1.25 (0.21)  1.00 (0.09)  0.24 
[-0.01, 0.50] 
0.058 
 
 
 
a)                    b) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 5-28 Impaired and unimpaired values from the 3.5Hz stretch response test for a) 
mean areas minus global baseline (GBL) and b) ratio of area to local baseline (LBL). This 
shows that using method a) only one participant (#13) had a stretch response outside the 
normal range, whereas using method b) three participants lie outside the normal range. 
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a)                b)  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure ‎ 5-29 Impaired and unimpaired values from the 0.5Hz stretch response test for all 
participants in Pilot Study 3 & Pilot Study 4 showing a) mean areas minus global baseline 
(GBL) and b) ratio of area to local baseline (LBL). In a) one impaired participant (#13 who is 
the same as in Figure   5-28) and b) two impaired participants lie outside the normative range. 
 
5.5.6.  Discussion and conclusions 
The results have shown that the stretch index method using a ratio of the mean area to local 
baseline and with data from the 3.5Hz ﾱ5˚ test distinguishes best between impaired and 
unimpaired. The advantage of using a ratio is that there is no need for normalisation, plus it 
provides meaningful values (values above 1 indicate a stretch response) rather than units of 
mV.S. The dot plots of stretch index values from the 3.5Hz test (Figure   5-28) illustrate that 
using the local baseline method two more participants have stretch indices outside the 
normative range than with the global baseline method.  A reason for this, confirmed by visual 
analysis of the passive tracking and EMG traces, was that their local baselines during the 
test were lower in amplitude than the initial ‘resting’ global baseline. This may be because of 
initial activation in the muscle created by anticipation of the test, but may also be the effect of 
the passive extension stretches reducing flexor activity in the flexed position at which point 
the local baseline is calculated. 
 
The dot plots in Figure 5-29 with the values for the two methods for the 0.5Hz ﾱ20˚ 
displacement test show a similar pattern with a greater number of impaired participants 
identified to have a stretch response using the local baseline than the global baseline Pilot Studies    Chapter 5 
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method. There were also a number of unimpaired outliers with higher flexor activity; it is 
hypothesized that with the slower tracking speed participants are not able to prevent 
voluntary activity. Case #13 has the highest stretch response values throughout all the tests 
and methods used, with values much higher than other impaired participants in tests with 
larger displacements – i.e. 0.5 Hz and 1.5Hz with ﾱ20˚ displacement.  This suggests that his 
stretch reflex response has a considerable length dependant component which may be 
explained by group II afferents as well as velocity dependence (see Chapter 2, Section ‎ 2.6.2, 
the physiology of stretch reflexes).  
 
To conclude, one fast passive tracking test needed to be chosen for the main study, and the 
3.5Hz ﾱ5˚ test was better than the 1.5 Hz ﾱ20˚ test at distinguishing between impaired and 
unimpaired because there was less voluntary tracking activity by unimpaired participants.  
The 0.5Hz ﾱ20˚ test was also included as a comparison to the active tracking test at the 
same frequency and displacement, and to give information on the behaviour of the stretch 
response over a larger angle of displacement. Lastly, the ratio method of stretch response 
area to local baseline was chosen for used in the main study as it was more accurate in 
determining the presence of a stretch response than using a global baseline.  
 
5.6.  Summary of objectives achieved in the Pilot Studies:  
1.  Define the testing protocol for the main study: 
  The wrist rig tests and their parameters have been defined (Table ‎ 5-19) 
  Resistance during active tracking was set at 10% of each participant’s MVC. 
  The stretch response test will be conducted at 3.5Hz ﾱ5˚  
  The torque angle test will be performed at 5º/second  
  More detailed instructions and scoring guidance for the modified Wolf Motor Function 
Test protocol has enabled better agreement between two assessors. 
2.  Optimise usability and comfort of the rig from the participants’ perspective: 
  With some minor modifications to the usability of the LED tracking display, the rig has 
been made ready for use with participants in the main study.  
3.  Derive impairment indices 
  Methods of analysis have been identified to generate indices that characterise motor 
impairments following stroke and best differentiate between stroke impaired and 
neurologically intact participants (Table ‎ 5-19).  
4.  Determine the optimal hand positioning in the rig 
  The air splint will be used in the main study as it provides the best support for most 
participants, and differentiates better between abnormal and normal coactivation. 
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Table ‎ 5-19: The measurement indices that were found to characterise motor impairments 
following stroke and best differentiate between impaired and unimpaired that are included in 
the main study analysis 
Wrist rig tests and their 
parameters chosen for the 
main study 
Indices included in the main 
study analysis 
(measurement unit)  
(Section where method is 
detailed) 
Motor impairment 
Active range of movement 
(AROM) 
Extensor AROM (degrees) 
(Section   5.4.3.1) 
Active ROM into extension 
Passive range of movement 
(PROM) 
Extensor PROM (degrees) 
(Section   5.4.3.1)  
Passive ROM into 
extension 
 
Maximal voluntary contraction 
(MVC) 
Extensor IF (Nm) 
(Section   5.4.3.2) 
Extensor muscle 
weakness 
 
Active sinusoidal tracking – 
0.5 Hz ±20º displacement 
around the midpoint of active 
ROM. Tracking is first 
unresisted and then resisted 
at 10% of extensor IF. 
Sine tracking index (cross 
correlation) (degrees
2) 
(Section   5.4.3.3   b) 
Total motor control 
accuracy during rhythmic 
movements 
Sine coactivation index 
(correlation when extensor EMG 
increases) (correlation coefficient) 
(Section   5.4.3.4)  
Coactivation of extensors 
(agonist) and flexors 
(antagonist) during 
rhythmic movements 
Active step tracking - steps of 
increasing displacement of the 
target from 5˚ to 40˚ in 15 
second blocks for a total of 90 
seconds with random 2-4 
second rest intervals between 
movements of the target. 
Tracking is first unresisted and 
then at 10% of extensor IF. 
Step tracking index (total Mean 
Absolute Error) (degrees) 
(Section   5.4.3.3  a) 
Total motor control 
accuracy during discrete 
movements, specifically 
including timing of 
movement, attainment of 
target and control at target 
end point. 
Step tracking index (path length) 
(degrees/sample) 
(Section   5.4.3.3  a) 
Motor control accuracy at 
the target end point, 
specifically amount of 
corrective sub-movements  
Step coactivation index 
(correlation when extensor EMG 
increases) (correlation coefficient) 
(Section   5.4.3.4) 
Coactivation of extensors 
(agonist) and flexors 
(antagonist) during 
discrete movements 
Stretch response test  - Fast 
passive sinusoidal tracking at 
3.5Hz, ﾱ5˚ displacement 
around the midpoint of active 
ROM, and 0.5Hz, ±20˚ 
displacement  
Stretch index (area of flexor 
stretch response: local baseline 
flexor EMG 
(Section   5.5.4.1) 
Spasticity (stretch 
response) in flexors 
Torque/angle test  - Slow 
passive ramp and hold 
tracking at 5º/second over full 
passive range of movement 
Mean torque index (Nm) 
(Section   5.4.3.7) 
Non-neural stiffness 
around the wrist Main Study    Chapter 6 
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6. Main Study 
6.1.  Introduction 
This Chapter describes the main study. The primary aim was to evaluate the inter-
relationships between wrist motor impairments and their association with motor control and 
functional activity early and late post-stroke. Secondary aims were to confirm the validity of 
the impairment indices to distinguish between impaired and unimpaired and to undertake a 
preliminary evaluation of their repeatability. Figure   6-1 shows a flowchart of the main study. 
Specific objectives: 
1.  Evaluate differences in motor impairments between impaired (acute and chronic), and 
unimpaired groups 
2.  Evaluate between-days test-retest reliability (active tests) and within-test repeatability 
(sinusoidal tests) 
3.  Evaluate associations between motor impairments and motor control accuracy 
4.  Evaluate inter-relationships between negative, positive and secondary motor impairments  
5.  Evaluate relationships between motor impairments and functional activity (modified Wolf 
Motor Function Test (mWMFT)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 6-1 Flowchart showing the main study following on and interrelating with the pilot 
studies 
Pilot Studies 
Design and 
evaluate the 
testing protocol for 
the main study 
Develop and evaluate 
methods to derive 
impairment indices for 
the main study 
Evaluate different 
hand positioning 
in the rig 
Evaluate usability 
and comfort of 
the rig 
Main Study 
Acute stroke group 
(< 4 months) n=13 
Reliability sub-group 
(n=9) 
Chronic stroke group 
(> 1 year) n=13 
Reliability sub-group 
(n=9) 
Unimpaired group 
n=14 
Data analysis to evaluate a) differences between acute, chronic and 
unimpaired groups, b) test-retest and within-test repeatability and c) 
relationships between impairments, motor control and functional activity 
Perform wrist rig tests and mWMFT Main Study    Chapter 6 
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6.2.  Methods  
6.2.1.  Recruitment of Participants 
Patients for the acute and chronic groups were identified and selected for participation if they 
satisfied the inclusion and exclusion criteria as follows: 
Inclusion criteria  
1.  Diagnosis (MRI/CT scan) of first stroke 
2.  Between 2 and 17 weeks (four months) post-stroke (acute group) or over one year post-
stroke (chronic group)  
3.  Aged 60 or over   
4.  Upper limb movement deficit: at least, some perceivable activity in the wrist (at least 5˚ 
flexion/extension movement in the rig), at most, some remaining gross movement deficit 
i.e. those with only hand dexterity problems were excluded  
5.  Able to transfer to a chair with the assistance of one therapist; and  
6.  Informed written consent.  
Exclusion criteria  
1.  Upper limb movement deficits attributable to non-stroke pathology;  
2.  Unilateral visuo-spatial neglect (star cancellation test score less than 51 (Wilson et al. 
1987)) or other, non-corrected, visual deficits likely to compromise ability to attend to the 
tracking target;  
3.  Skin allergy to alcohol wipes and sticky tape;  
4.  Medical, psychological, language or cognitive impairment that, in the opinion of the 
treating therapist and/or researcher would compromise ability to undertake the testing 
protocol. 
 
For the acute group, a consecutive sample of older adults with hemiplegia following stroke 
who were receiving rehabilitation from stroke services based at the three hospital sites in 
Southampton and South-west Surrey (see Methodology Chapter, Section 4.4.2 for details) 
were identified by therapy staff as being suitable for the study.  Potential participants were 
invited by their therapist to take part and given a participation information sheet (see 
Appendix I).  For the chronic group, older adults with hemiplegia who had received 
rehabilitation from the stroke services as above and were identified by therapy staff through 
their patient records and were sent an invitation and information sheet by letter from the lead 
therapist of the stroke service. Those who expressed an interest in participating to their 
therapist or the researcher were recruited following an interview with the researcher (either in 
person or over the phone) with an explanation of the study and the opportunity to ask 
questions.  If patients had a history of unilateral neglect, a screening test, the star Main Study    Chapter 6 
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cancellation test (Appendix E), was performed to ensure that this would not be a confounding 
factor in the results. Informed consent was obtained and documented (Appendix J) for each 
recruit.   
 
The data collected from the participants with stroke was compared with the data collected 
from a convenience sample of older (aged 60 or over) unimpaired participants recruited for 
the Pilot Studies from a local church and University of the Third Age (U3A) group. The 
characteristics of all participants are shown in the Results Section   6.3.1, Table ‎ 6-1. 
6.2.2.  The Testing Procedure 
Assessment of participants involved performance of the wrist rig tests and the modified 
WMFT. Prior to data collection in the rig, participants were assessed using clinical scales of 
spasticity: Tardieu scale (Morris 2002); and wrist joint proprioception: proprioception test in 
the Nottingham Sensory Assessment (Stolk-Hornsveld et al. 2006) as described in the 
Methodology Chapter Section   4.6.3, Appendix E.  Participants were set up in the rig as 
described in the Methodology Chapter Section   4.7 and with their hand positioned in the air 
splint (Figure   6-2).  The dominant arm of unimpaired participants and the hemiplegic arm of 
impaired participants were tested. The wrist rig tests and the order they are undertaken were 
as described in the Methodology Chapter Section   4.8, and Appendix C) and are summarised 
here: 
  Active range of movement (AROM) 
  Passive range of movement (PROM) 
  Maximal voluntary flexion and extension isometric contractions (MVC) at the 0˚ and 20˚ 
flexion positions.   
  Torque/angle test - six repetitions of passive ramp and hold at 5˚/s through full passive 
ROM. 
  Stretch response tests with displacement around the active mid-point: 
o  3.5 Hz ﾱ5˚ to calculate the stretch response at a high velocity  
o  0.5 Hz ﾱ20˚, to compare passive stretch response with the active sine tracking task  
  Active tracking tasks, first non-resisted then with resistance set at 10% extensor MVC: 
o  Sinusoidal tracking test at 0.5Hz, ﾱ 20˚, for 60 seconds  
o  Random step tracking task with increasing displacement of the target from 5˚ to 40˚ 
for 90 seconds and random 2-4 second rest intervals between movements of the 
target. 
 
Most participants were tested over two days either at their hospital site or at the University 
laboratory by the researcher (RT). This was considered necessary for most participants Main Study    Chapter 6 
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because the testing process, including learning the tests, was quite lengthy and fatigue is a 
common problem especially early after a stroke. The first session was therefore primarily a 
practice session and allowed participants to learn and perform the active rig tests and the 
mWMFT. On the second day participants completed the full protocol of wrist rig tests 
(passive and active) and performed the mWMFT.  For some participants, however, fatigue 
was not a problem; they quickly learnt the active tasks and were able to complete the full-
testing protocol in one day session. For the convenience of these participants, testing was 
therefore only conducted on one day. Seventeen participants who completed two day 
sessions of testing and successfully performed the active tests on both days (nine acute and 
eight chronic participants) were allocated to a reliability sub-group for analysis.  
  
 
Figure ‎ 6-2 Participant set-up in the wrist rig 
 
6.2.3.  Data Processing 
The processing of signal data was as described in the Methodology Chapter 4, Section   4.9.  
6.2.4.  Derivation of indices 
The impairment indices that were used for the main study and their method of calculation 
were as described at the end of the Pilot Study Chapter 5, Table ‎ 5-19.  One change was 
made to the process of deriving muscle onset timing. Visual analysis of the main study 
participant data showed that in a few individuals with very poor movement, extensor EMG 
activation could often not be detected. It was therefore decided that if muscle onset was 
detected less than four times out of the total of 11 target jumps, the participant would be 
excluded from the analysis. Additionally, the maximum torque applied during the extension 
sEMG 
electrodes 
Air splint to 
support the 
hand Main Study    Chapter 6 
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PROM test was calculated and recorded, so that the amount of force applied by the assessor 
to gain end of passive range could be verified across the three groups. 
6.2.5.  Statistical analysis 
The statistical tests used in this study analysis are those that were described and justified in 
the Methodology Chapter, Section 4.11, and are summarized here. Because some of the 
impairment indices were not normally distributed (see Appendix G), non-parametric tests 
have been used with all the impairment variables. 
6.2.5.1. Validity and repeatability of impairment indices  
The results for validity (defined here as ability to distinguish between impaired and 
unimpaired) and repeatability are presented in three groups of impairment indices according 
to the negative, positive and secondary features of the upper motor neurone syndrome. 
a)  Validity (ability to distinguish between impaired and unimpaired)  
Differences between the impaired and unimpaired groups were determined using the two 
independent samples Mann Whitney U test.  
b)  Between-days test-retest reliability (active tests)  
To measure between-days level of agreement of the active test indices Bland Altman 
methods have been used (Bland & Altman 1986). The Bland and Altman plot of the 
differences between the day 1 and day 2 readings against the mean value for each 
participant were examined. The 95% limits of agreement were examined with respect to the 
within and between-group range of values for each index. A repeatability coefficient (Bland & 
Altman 1986) for each of the indices was also calculated, and gives a 95% range about a 
true change that might be expected from measurement error alone. Changes larger than the 
value of the repeatability coefficient can be considered to be due to a real change in 
underlying values, rather than random variations. 
c)  Within-test repeatability (active and passive sinusoidal tests) 
Data from each of the tests were divided into three sections of equal number of target cycles. 
Mean tracking index, coactivation index and stretch index for each section was calculated. 
Changes were examined between sections one and two, and two and three, and tested for 
statistical significance (p<0.05) using the two related samples Wilcoxon test.  
d)  Differences between acute impaired, chronic impaired, and unimpaired groups 
Differences between the three groups were determined using a Kruskal Wallis Test.  Mann 
Whitney U test was used to determine the chronic vs. unimpaired and acute vs. unimpaired Main Study    Chapter 6 
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differences for each impairment variable. Data for each participant across the three groups 
are presented as dot plots which were used to visually examine differences.                      
6.2.5.2. Association between impairment indices and motor control accuracy  
Preliminary observation of individual step tracking data showed that stroke participants fell 
into distinct low motor control accuracy (MCA) and high MCA groups (see step tracking 
values in Results, Section ‎ 6.3.2). To compare differences between the low MCA group, the 
high MCA group and the unimpaired group for all the impairment indices, analysis was 
undertaken using a Kruskal Wallis test and Mann Whitney U tests. 
6.2.5.3. Inter-relationships between negative, positive and secondary motor 
impairments  
Relationships between all the impairment indices are presented separately for the acute and 
chronic groups using Spearman’s correlation coefficients and p values. A Bonferroni 
correction was added, after which the statistical significance level was P≤0.004. Strength of 
relationship/ associations between variables were based on recommended values (Pett 
1997); these being:  0.00 to 0.25 no association to weak association, 0.26 to 0.50 a low 
degree of association, 0.51 to 0.75 moderate to strong degree of association and 0.76 to 
1.00 very strong association.  
6.2.5.4. Relationships between motor impairments and functional activity 
(mWMFT) 
To examine the importance of impairment indices in explaining performance of the functional 
activity measure (mWMFT), separately for the acute and chronic groups, a multiple linear 
regression was calculated using SPSS (PASW statistics v18). A non-parametric quantile 
regression was also run to compare and verify the results.  
The impairments were grouped into negative, positive and secondary features in each 
patient group, and a series of two regression analyses were performed to determine the most 
important (statistically significant) contribution of an individual predictor of mWMFT in each 
feature group and each patient group.  
  
6.3.  Results 
The results of the main study are presented in three sections.  Firstly the characteristics of 
participants are presented, and missing data explained. The second section relates to the 
validity (here defined as the ability to distinguish between impaired and unimpaired) and 
repeatability (between-days test-retest and within-test) of the impairment measurement Main Study    Chapter 6 
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indices, and lastly the differences between the acute impaired, chronic impaired and 
unimpaired groups, showing differences in individuals in each group.  In the third section, 
relationships between impairment indices, motor control accuracy and functional activity are 
examined. 
6.3.1.  Participants 
Time for recruitment to the Main Study was limited due to prior unforeseen problems with the 
development of the wrist rig and the detail of analysis required to derive impairment indices 
from the Pilot Study data. Additionally recruitment was affected at times by the Southampton 
Stroke Unit being closed for infection control. The final number recruited for the Main Study 
was 26 impaired participants (13 each in the acute and chronic groups), whose data was 
compared with fourteen unimpaired participants. Participant characteristics can be seen in 
Table ‎ 6-1.  
Table ‎ 6-1: Characteristics of study participants 
    Impaired  Unimpaired 
    Acute 
(N=13) 
Chronic 
(N=13) 
Total   
(N=26) 
(N=14) 
Age (years)  Mean (SD) 
Min – max 
74.6 (10.4)   
60 – 94 
65.6 (5.3)    
60 – 74 
70.1 (9.3)  
60 – 94 
73.4 (5.0)   
65 – 81 
Gender  M : F  5:8  10:3                    15:11  4:10 
Side assessed  R : L  7:6  6:7  13:13  13:1 
Hand dominance  R : L  12:1  13:0  25:1  14:1 
Time from stroke 
(months) 
Mean (SD) 
Min – max 
2.2 (1.0)      
0.7 – 4 
40.6 (27.2)              
12 – 91 
21.3 (27.2)  
0.7 – 91 
N/A 
Spasticity
a               
(0–4) 
Mean (SD) 
Min – max 
0.6 (1.0)         
0 – 3 
1.6 (1.2)        
0 – 3 
1.1 (1.2)      
0 – 3 
N/A 
Spasticity 
medication
b 
No : Yes  13:0  9:4  22:4  N/A 
Propriception
c         
(0-3) 
Mean (SD) 
Min - max 
1.2 (1.1)     
0 - 3 
1.7 (0.6)     
0 - 3 
1.5 (0.9)     
0 - 3 
N/A 
UL activity
d               
(0 – 92) 
Mean (SD) 
Min - max 
29 (17)           
2 - 64 
43 (27)          
2 - 75 
36 (23)         
2 - 75 
92 
a Tardieu scale fast movement score (Morris 2002): 0 - No resistance; 1- Slight resistance, no clear catch; 2- 
Clear catch at an angle and release; 3- Fatigable clonus (<10 seconds) at a precise angle; 4- Infatigable clonus 
(>10 seconds) at a precise angle; 
b Anti-spasticity medication – Baclofen or Tizanidine; 
c Wrist proprioception, 
Nottingham Sensory Assessment (Stolk-Hornsveld et al. 2006) : 2– normal, 1– impaired, 0– absent; 
d modified 
Wolf Motor Function Test, total function score (Whitall et al. 2006).  
 
All 26 impaired participants completed all the tests except one acute stroke participant who 
withdrew from the study after the first day practice session as she found the testing process Main Study    Chapter 6 
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too tiring. This participant consented for her session one data (the active rig tests and 
modified WMFT) to be included in the data analysis, but passive test data (stretch index and 
mean torque) was missing for this participant. Stretch index data is missing for one 
participant (chronic group) for technical reasons related to data quality. For the mean torque 
index, data were excluded from the analysis because of flexor EMG activity for two impaired 
participants (one acute and one chronic) and extensor EMG activity for one impaired (acute) 
and two unimpaired participants. Data for the analysis of step tracking coactivation from one 
participant (chronic) and for extensor onset timing from two participants (chronic) could not 
be included due to either very poor tracking or very low EMG signals. Of the 17 participants 
allocated to the reliability sub-group, data for one participant (acute) for the sine tracking 
index, four (one chronic and three acute) for the sine and step coactivation indices, and three 
(1 chronic and 2 acute) for extensor onset timing was missing from the day 1 session for 
technical reasons related primarily to data quality. 
 
6.3.2.  Validity and repeatability of impairment indices 
In this section the validity (here defined as the ability to distinguish between impaired and 
unimpaired), the test-retest and within-test repeatability, and differences between the acute 
impaired, chronic impaired and unimpaired are presented. The results are presented in three 
groups of impairment indices according to the negative, positive and secondary features of 
the upper motor neurone syndrome. Important results are presented in tables in this Chapter, 
with the full tables of data analysis in Appendix G. 
6.3.2.1. Negative impairments: Sine and step tracking indices, Extension active 
range of movement, Extensor isometric force and Extensor onset 
timing 
All the negative impairments showed a statistically significantly difference between impaired 
and unimpaired participants at a P level of <0.001 or for extensor onset timing P=0.006 
(Table ‎ 6-2). For between-days test-retest reliability, the Bland and Altman between-days 
limits of agreement and repeatability coefficients for each of these impairments, expressed in 
the same units as the impairment measure itself, are reported in Table ‎ 6-3. The Bland and 
Altman Plots (see Appendix G) showed no evidence for a trend in the difference between 
assessments other than a greater extension active range of movement mean value for the 
second day recording that was statistically significant (see mean difference and confidence 
intervals in Table ‎ 6-3). However, the mean difference was four degrees, which is small 
compared to the range of values (-52.3º to 51.2º). Main Study    Chapter 6 
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Table ‎ 6-2: Median (Interquartile range) and P values for negative impairment indices 
comparing the impaired and unimpaired groups. Statistical significance was tested using the 
non-parametric Mann Whitney U test. Statistically significant between group differences 
(p<0.05) are in bold. 
  Impairment Indices  Group median (IQR)  P values 
Impaired 
(N=26) 
Unimpaired 
(N=14) 
Unimpaired - 
Impaired 
Negative 
Impairments  
 
 
Sine tracking index 
(degrees
2) 
118.2  
(31.7, 193.5) 
222.3  
(213.8, 236) 
<0.001 
Step tracking index 
(degrees)  
6.36 
(5.57, 11.28) 
3.97    
(3.52, 4.23) 
<0.001 
Path length 
(degrees/sample) 
0.022  
(0.016, 0.025) 
0.009  
(0.007, 0.010) 
<0.001 
Active ROM extension 
(degrees) 
22.1  
(-15, 36) 
57.8  
(53, 65) 
<0.001 
Extensor IF 
 
(Nm) 
1.18 
(0.2, 2.6) 
4.95  
(3.1, 6.8) 
<0.001 
Extensor onset 
a  
(seconds) 
0.41  
(0.31, 0.56) 
0.29  
(0.26, 0.34) 
0.006 
ROM – Range of movement; IF – isometric force; 
a Impaired group n=24; 
 
Table ‎ 6-3: Between-days repeatability for the negative impairment indices for 17 impaired 
participants* (9 acute, 8 chronic) showing the range of values for this group, mean day 2 – 
day 1 difference and 95% confidence intervals, Bland and Altman limits of agreement and 
coefficient of repeatability. 
  Impairment 
Indices 
Range of 
values  
(min – max) 
Between-days repeatability 
Mean 
difference  
(day 2 – day 1) 
Limits of 
agreement 
Coefficient 
of 
repeatability 
Negative 
Impairments  
 
 
Sine tracking 
index 
a (degrees
2) 
2.0 - 229.6  3.13                
[-6.6, 12.9] 
(-33.5, 39.8)  ±35.32 
Step tracking 
index (degrees)  
4 - 16.42  -0.21               
[-0.7, 0.29] 
(-2.14, 1.72)  ±1.88 
Path length 
(degrees/sample) 
0.012 - 
0.050 
-0.002              
[-0.006, 0.002] 
(-0.016, 
0.013) 
±0.014 
Extension AROM 
(degrees) 
-52.3 - 51.2  4.4             
[1.4, 7.4]  
(-7.3, 16.1)  ±14.1 
Extensor IF 
 
(Nm) 
0 - 4.8  0.1                  
[-0.1, 0.4] 
(-0.9, 1.2)  ±1.1 
Extensor onset 
b 
(seconds) 
0.22 - 1.28  -0.008 
[-0.12, 0.11] 
(-0.39, 0.38)  ±0.37 
*Unless stated otherwise; 
a N=16; 
b N = 13; Data was missing due to technical reasons on one day assessment. 
AROM – active range of movement; IF – isometric force; 
 
Within-test repeatability for the sine tracking index for the impaired (acute and chronic) and 
unimpaired groups is illustrated graphically in Figure ‎ 6-3. A statistically significant difference Main Study    Chapter 6 
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was found in the acute group between the first and second, and second and third sections, 
which might reflect fatigue or loss of concentration. 
 
 
       
   
 
 
 
 
 
Figure ‎ 6-3: Line chart showing the mean and SD (vertical error bars) values for a) sine 
tracking index in TIsine 1 (beginning section), TIsine 2 (middle section) and TIsine 3 (end 
section), comparing the impaired (acute and chronic) and unimpaired groups.  
a Statistically significant difference between sections (p<0.05). 
 
Differences between the three participant groups are presented as median and interquartile 
ranges (IQR) and P values in Table ‎ 6-4, and individual differences illustrated graphically in 
Figure ‎ 6-4. There were statistically significant differences between the unimpaired and both 
the acute and chronic groups for all the negative impairments.  
 
Table ‎ 6-4: Median (Interquartile range) and P values for negative impairment indices 
comparing the acute and chronic groups with the unimpaired group. Statistical significance 
was tested using a Mann Whitney U test. Statistically significant between group differences 
(p<0.05) are in bold. (AROM – active range of movement; IF – isometric force;
 a Chronic group n=11) 
Negative 
Impairment 
Indices 
Group median (IQR)  Kruskal 
Wallis Test 
P values 
Mann Whitney U test       P 
values 
Acute 
(N=13) 
Chronic 
(N=13) 
Unimpaired 
(N=14) 
Unimpaired 
- Acute 
Unimpaired 
- Chronic 
Sine tracking 
index (degrees
2) 
107.8 
(41.3, 174.7) 
178.8  
(6.8, 201.1) 
222.3  
(213.8, 236) 
<0.001  <0.001  <0.001 
Step tracking 
index (degrees)  
6.51 
(6, 10.8) 
5.90  
(4.8, 12.0) 
3.97    
(3.52, 4.23) 
<0.001  <0.001  <0.001 
Path length 
(degrees/sample) 
0.024  
(0.022, 0.029) 
0.017  
(0.015, 0.022) 
0.009  
(0.007, 0.010) 
<0.001  <0.001  <0.001 
Extension AROM 
(degrees) 
19.5  
(0.6, 34) 
28.8  
(-41, 37) 
57.8  
(53, 65) 
<0.001  <0.001  <0.001 
Extensor IF  (Nm)  0.51  
(0.23, 1.38) 
1.98 
(0.17, 3.71) 
4.95  
(3.1, 6.78) 
<0.001  <0.001  0.002 
Extensor onset 
a 
(seconds) 
0.5  
(0.32, 0.64) 
0.4  
(0.30, 0.50) 
0.29  
(0.26, 0.34) 
0.018  0.008  0.043 
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Figure ‎ 6-4 (a-f): Dot plots for the negative impairment indices illustrating differences 
between participants in the chronic and acute impaired and unimpaired groups.  The dashed 
line is 2SD from the mean (solid line) of the unimpaired group. Values above the 2SD line 
(below for sine tracking index and extensor isometric force) are considered to be ‘impaired’. 
 
For most indices there was a greater variability (IQR) across the impaired group compared 
with the unimpaired group, except for extensor isometric force. In this index the unimpaired 
group had greater variability, illustrated as the spread of individual values in Figure ‎ 6-4 f). 
a)               b)                      c) 
d)               e)                      f) Main Study    Chapter 6 
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This spread of values can be partly explained by gender differences in unimpaired strength, 
as is illustrated in Figure ‎ 6-5 a) and b). Taking +/- 2SD from the unimpaired mean as a 
normal range, a clear difference between impaired and unimpaired participants can be seen 
in all three tracking indices and extensor AROM (Figure ‎ 6-4 a – d). For extensor onset timing 
there is greater overlap between all three groups (Figure ‎ 6-4 f), and an overlap between the 
unimpaired and chronic group for extensor isometric force can be seen (Figure ‎ 6-4 e). For 
the extensor isometric force, however, when the groups are divided into male and female, 
the overlap between the chronic and unimpaired groups is removed except for one case of 
each gender (Figure ‎ 6-5 a and b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 6-5 a) and b): Dot plots of extensor isometric force for a) male and b) female 
participants, indicating some gender differences in strength in the unimpaired group which 
partly contributes to the variability across the unimpaired group strength. 
  
 
6.3.2.2. Positive Impairments: Stretch Index (spasticity) and Coactivation Indices 
(sine and step tracking) 
The sine tracking coactivation index and stretch index at 3.5 Hz were able to statistically 
significantly distinguish between impaired and unimpaired participants (P=0.024 and 
P<0.001 respectively) (see Table ‎ 6-5). The step tracking coactivation index did not show a 
statistically significant difference (P=0.558). 
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Table ‎ 6-5: Median (Interquartile range) and P values for positive impairment indices 
comparing the impaired and unimpaired groups. Statistically significant between group 
differences (p<0.05 in bold) were tested using the non-parametric Mann Whitney U test.   
  Impairment Indices  Group median (IQR)  P values 
Impaired 
(N=26) 
Unimpaired 
(N=14) 
Unimpaired - 
Impaired 
Positive 
impairments 
Coactivation  
(sine tracking) 
(correlation coefficient) 
0.11 
(-0.30, 0.30) 
-0.34  
(-0.45, -0.20) 
0.024 
Coactivation  
(step tracking) 
a 
(correlation coefficient)  
-0.05  
(-0.27, 0.17) 
-0.12 
(-0.28, 0.05) 
0.558 
Stretch index 
b (3.5Hz) 
(ratio SR area: LBL 
1.24  
(1.05, 1.76) 
1.00 
0.98, 1.02 
<0.001 
SR – stretch response; LBL – local baseline;
 a Impaired group n=25; 
b Impaired group n=24 
 
Between-days reliability is not presented for the stretch index as it was derived from a 
passive tracking test which was only assessed during one day session. For the sine tracking 
coactivation index, there is no trace of a trend in the mean between-days difference, however 
the step tracking coactivation index showed a statistically significant trend towards less 
coactivation on day 2 (Table ‎ 6-6). For both the coactivation indices the limits of agreement 
and repeatability coefficients are wide compared to the range of values, especially for the 
sine tracking coactivation index.  Observation of the Bland Altman plot for this index 
(Appendix G) showed an outlier who went from -0.68 (strong reciprocal inhibition) on day 1 to 
0.14 (weak coactivation) on day 2. Despite this change in activation pattern (confirmed by 
visual inspection of the traces), his good tracking performance (within the unimpaired range) 
did not change from day 1 to day 2, and underlines the large within subject variability that 
presents one of the main challenges in the field. 
Table ‎ 6-6: Between-days repeatability for the coactivation indices from the sine and step 
tracking tests for 13 participants from the impaired group showing the range of values for this 
group, mean day 2 – day 1 difference and 95% confidence intervals, Bland and Altman limits 
of agreement and coefficient of repeatability 
Impairment Indices  Range of 
values  
(min – max) 
Between-days repeatability 
Mean 
difference  
[95% CI] 
Limits of 
agreement 
Coefficient of 
repeatability 
Coactivation  
(sine tracking) 
(correlation coefficient) 
-0.54 - 0.73  0.05                  
[-0.15, 0.24] 
 
(-0.60, 0.69)  ±0.61 
Coactivation  
(step tracking) 
(correlation coefficient)  
-0.50 - 0.71  -0.10 
[-0.19, -0.01] 
(-0.40, 0.21)  ±0.34 
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Within-test repeatability for the stretch index and the sine tracking coactivation index is 
illustrated in Figure ‎ 6-6. No statistically significant differences between sections 1, 2 and 3 
were found. The sine tracking coactivation index shows a trend to reduce in the middle 
section in all groups, and mostly in the acute group.   
a) Stretch index (0.35Hz)            b) Sine Coactivation Index 
 
 
 
 
 
 
 
 
 
Figure ‎ 6-6 a) and b): Line charts showing the mean and SD (vertical error bars) values for 
a) stretch index in SI 1 (beginning section), SI 2 (middle section) and SI 3 (end section), and 
b) the equivalent sections for the sine tracking coactivation index (CIsine1, CIsine2, CIsine3), 
comparing the impaired (acute and chronic) and unimpaired groups.  
 
Differences between the acute, chronic and unimpaired groups are shown in Table ‎ 6-7 and 
individual differences are illustrated in the dot plots in Figure ‎ 6-7. Statistically significant 
differences are seen for the stretch index between both the acute and chronic groups and the 
unimpaired group, and between the chronic and unimpaired groups for the sine tracking 
index. There was a greater difference for the step tracking coactivation index between the 
chronic and unimpaired groups but not statistically significant.   
 
Table ‎ 6-7: Median (Interquartile range) and P values for positive impairment indices 
comparing the acute and chronic groups with the unimpaired group. Statistically significant 
group differences (Mann Whitney U test, p<0.05) are in bold. 
Positive Impairment 
Indices 
Group median (IQR)  Kruskal 
Wallis Test 
P values 
P values 
Acute 
(N=13) 
Chronic 
(N=13) 
Unimpaired 
(N=14) 
Unimpaired 
- Acute 
Unimpaired 
- Chronic 
Coactivation (sine tracking) 
(correlation coefficient) 
-0.2  
(-0.45, 0.07) 
0.14 
(-0.19, 0.42) 
-0.34  
(-0.45, -0.20) 
0.014  0.356  0.003 
Coactivation (step tracking) 
a 
(correlation coefficient)  
-0.09  
(-0.33, 0.12) 
0.04  
(-0.20, 0.31) 
-0.12 
(-0.28, 0.05) 
0.459  0.884  0.237 
Stretch index 
b (ratio SR:LBL)  1.15  
(1.05, 1.76) 
1.34  
(1.04, 1.93) 
1.00 
0.98, 1.02 
<0.001  <0.001  <0.001 
a Chronic
 group n=12; 
b Acute and chronic group n=12; SR – stretch response; LBL – local baseline 
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In both coactivation indices there was wide variation across the unimpaired group. Taking +/- 
2SD from the unimpaired mean as a normal range, clear differences were seen in the stretch 
index, whereas in both coactivation indices there was greater overlap between the groups. 
Six individuals for sine tracking and three for step tracking had coactivation values outside 
the normal range, more in the chronic group than acute. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 6-7 a)-c): Dot plots for the positive impairment indices illustrating differences between 
participants in the three groups.  The dashed line is 2SD from the mean (solid line) of the 
unimpaired group. Values above the 2SD line are considered to be ‘impaired’. 
6.3.2.3. Secondary impairments: Extension passive range of movement and 
Mean torque index (non-neural stiffness)  
There was a statistically significantly difference between impaired and unimpaired 
participants for extension passive range of movement (PROM) (P<0.001) but not for mean 
torque (P= 0.109) (see Table ‎ 6-8).  
Table ‎ 6-8: Median (Interquartile range) and P values for secondary impairment indices 
comparing the impaired and unimpaired groups. Statistically significant between group 
differences, tested using the non-parametric Mann Whitney U test, (p<0.05) are in bold. 
  Impairment Indices  Group median (IQR)  P values 
Impaired 
(N=26) 
Unimpaired 
(N=14) 
Unimpaired - 
Impaired 
Secondary 
impairments 
Passive ROM extension 
(degrees) 
60.1  
(42.4, 65.7) 
70.09  
(65.5, 73.9) 
<0.001 
Mean torque 
a  
(Nm) 
0.49  
(0.33, 0.87) 
0.45  
(0.39, 0.65) 
0.109 
a Impaired group n=22, unimpaired n=11  
a)                   b)                c) Main Study    Chapter 6 
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Between-days reliability is not presented for mean torque as it was derived from a passive 
tracking test which was only assessed during one day session. The between-days reliability 
data for extension PROM can be seen in Table ‎ 6-9. There was no trend in the mean 
between-days difference. The limits of agreement and coefficient of repeatability values are 
similar to the extension AROM values, though the extension PROM range is smaller. 
Observation of the Bland Altman plot showed that there was an outlier with a between-days 
difference of 18º, whereas most other between-days values were grouped between ±10º 
(Appendix G).  
Table ‎ 6-9: Between-days repeatability for extension passive range of movement for 13 
participants from the impaired group showing the range of values for this group, mean day 2 
– day 1 difference and 95% confidence intervals, Bland and Altman limits of agreement and 
coefficient of repeatability 
Secondary 
Impairment  
Range of values  
(min – max) 
Between-days repeatability 
Mean difference  
[95% CI] 
Limits of 
agreement 
Coefficient of 
repeatability 
Extension PROM 
(degrees) 
21 - 69.8  2.3                     
[-1.1, 5.7] 
(-10.9, 15.5)  ±13.4 
 
Differences between the acute, chronic and unimpaired groups are shown in Table ‎ 6-10 and 
individual differences are illustrated in Figure ‎ 6-8. Extension PROM was statistically 
significantly lower in the acute and chronic groups compared to the unimpaired group, and 
the differences can be clearly seen in the dot plot (Figure ‎ 6-8a). To verify that the force 
applied by the assessor to gain end of passive range of movement was comparable across 
the different groups, a Kruskal Wallis test comparing the maximum torque applied during the 
PROM test across the three groups was used. The results showed that there was no 
significant difference between the groups (p=0.874). The acute group had statistically 
significantly lower mean torque compared to the unimpaired group, whereas there was no 
statistically significant difference between the chronic and unimpaired groups. 
Table ‎ 6-10: Median (Interquartile range) and P values for secondary impairment indices 
comparing the acute and chronic groups with the unimpaired group. Statistical significance 
was tested using a Mann Whitney U test. Statistically significant between group differences 
(P<0.05) are in bold.  
Impairment 
Indices 
Group median (IQR)  Kruskal 
Wallis Test 
P values 
P values 
Acute 
(N=13) 
Chronic 
(N=13) 
Unimpaired 
(N=14) 
Unimpaired 
- Acute 
Unimpaired 
- Chronic 
Ext PROM 
(degrees) 
48.9  
(31.2, 55.8) 
60.1  
(42.4, 65.7) 
70.09  
(65.5, 73.9) 
<0.001  <0.001  0.007 
 
Mean torque 
a 
(Nm) 
0.18  
(0.07, 0.27) 
0.49  
(0.33, 0.87) 
0.45  
(0.39, 0.65) 
0.002  0.002  0.853 
PROM – passive range of movement;
 a Acute group n=10, chronic n=12, unimpaired n=11 Main Study    Chapter 6 
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Figure ‎ 6-8b) shows the overlap of values between all the groups for mean torque. Like active 
ROM, gender was found to have an effect on non-neural stiffness. Male unimpaired 
participants had higher mean torque than female, and when the groups were divided by 
gender, the overlap of values between the groups reduced (Figure ‎ 6-8 c and d). These dot 
plots showed that in the chronic group some participants had lower mean torque values than 
the normal range, but two outliers (one male, one female) had much higher torque values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎ 6-8 a) - d): Dot plots for the secondary impairment indices (a) and (b) illustrating 
differences between participants in the chronic, acute and unimpaired groups.  Values for the 
mean torque index have been divided to show differences between male (c) and female (d). 
The dashed line is 2SD from the mean (solid line) of the unimpaired group. Values above (or 
below) the 2SD line are considered to be ‘impaired’.  
a)                      b) 
c)                   d) Main Study    Chapter 6 
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6.3.3.  Association between impairment indices and motor control 
accuracy (MCA) 
When the individual step tracking data was plotted on dot plots, it could be seen that the 
impaired stroke participants were separated into two clear groupings, those with an error up 
to 7.5º (high MCA), and those with an error of between 10.5º and 16.5º (low MCA) (see step 
tracking values in Section ‎ 6.3.2 Figure ‎ 6-4 b).   
 
The values for all impairment indices in the low and high motor control accuracy (MCA) 
groups and unimpaired group are shown in Appendix G, Table G-6. The Kruskal Wallis Test 
showed that most impairments indices were statistically significant across the three groups, 
except for the mean torque index. The impairments that showed statistically significant 
difference between low and high MCA (Mann Whitney U tests) were extension AROM 
(p=<0.001), extensor isometric force (p=0.001), extensor onset time (p=0.022), coactivation 
sine tracking (p=0.001) and step tracking (p=0.003), and extension passive range of 
movement (p=0.022). No statistically significant difference was seen for stretch index and 
mean torque index.  
 
The low MCA group was statistically significantly different from the unimpaired group in all 
impairment indices except mean torque index. The high MCA group was statistically 
significantly different from the unimpaired group in extension AROM (p=<0.001), extensor 
isometric force (p=0.001), stretch index (p=<0.001), extension PROM (p=0.002) and mean 
torque index (p=0.021). Most impairment measures in both the low and high MCA groups 
had either lower or higher values than the unimpaired group. However, the mean torque was 
lower in the high MCA group than unimpaired and non-significantly higher in the low MCA 
group. 
 
When observing the dot plot of step tracking performance, in particular the individuals who 
had low MCA and high MCA, and comparing their values in other impairment dot plots, some 
clear patterns have emerged (Figure ‎ 6-9). Patients with low MCA in the acute group were 
also those with the weakest wrist extensors, and those with low MCA in the chronic group 
had the most coactivation and weakest wrist extensors. Patients with higher MCA also were 
those with nearest normal wrist extensor strength. 
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  Low MCA, with coactivation and weakness 
  Low MCA with weakness 
High MCA with moderate weakness 
Figure ‎ 6-9: Dot plots with sub-groups showing impaired participants with low motor control 
accuracy (MCA) who also had weakness (acute group), or had both coactivation and 
weakness (chronic group), and those with higher MCA also had moderate weakness (both 
groups).  The numbers next to the dots refer to individuals. Main Study    Chapter 6 
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6.3.4.  Inter-relationships between negative, positive and secondary 
motor impairments 
Acute and Chronic group correlation coefficients (Spearman’s) for all the impairments are 
presented in Appendix G, Table G-7 and Table G-8. For the negative impairments  
, in the acute group the tracking indices statistically significantly correlated with each other 
and extensor onset timing, and extensor isometric force correlated with extensor active range 
of movement.  In the chronic group, all the negative impairment inter-relationships were 
significant with the exception of extension AROM with extensor onset time, and path length 
which showed no to weak correlation with all other impairment variables.  
 
Table ‎ 6-11: Statistically significant (p<0.05) Spearman’s correlation coefficients between 
negative impairments for acute group (N=13) and chronic group (N=13). Shaded cells are 
statistically significant values following Bonferroni correction (p<0.004)  
Group  Impairment indices  Correlation  Group  Impairment indices  Correlation 
Acute  Sine TI with Step TI   -0.912 
(P<0.001) 
Chronic  Sine TI with Step TI  -0.863 
(P<0.001) 
Sine TI with Ext onset  -0.619 
(P=0.024) 
Sine TI with Ext onset  -0.661 
(P=0.027) 
Step TI with Ext onset  -0.619 
(P=0.024) 
Step TI with Ext onset  0.638 
(P=0.035) 
IF ext with AROM ext  0.775 
(P=0.002) 
IF ext with AROM ext  0.725 
(P=0.005) 
    Sine TI with AROM ext  0.681 
(P=0.010) 
    Step TI with AROM ext  -0.676 
(P=0.011) 
    Sine TI with IF ext  0.846 
(P<0.001) 
    Sine TI with IF ext  -0.780 
(P=0.002) 
 
    IF ext with Ext onset  -0.651 
(P=0.030) 
TI: Tracking Index; Ext: extension; IF: Isometric force; AROM: active range of movement 
 
For the positive impairments (Table ‎ 6-12), the coactivation indices significantly correlated 
with each other in both patient groups. In the acute group there was a moderate correlation 
of the step tracking coactivation index with the stretch index at 0.5Hz that approached 
significance (r=0.573, p=0.051). In the chronic group there was a moderate non-significant 
correlation of stretch index at 3.5Hz with sine tracking coactivation (r=0.531, p=0.075). The 
sine tracking coactivation index significantly correlated with the tracking indices in both 
groups and with extensor onset in the acute group, and extension AROM in the chronic 
group. The step tracking coactivation index significantly correlated with the sine tracking 
index. The stretch index at 3.5Hz was only weakly correlated with all other impairments in the Main Study    Chapter 6 
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acute group, and weak to moderately correlated in the chronic group; none of these reached 
statistical significance.  
 
Table ‎ 6-12: Statistically significant (p=0.05) Spearman’s correlation coefficients between 
positive and negative impairments for acute group (N=13) and chronic group (N=13). Shaded 
cells are statistically significant values following Bonferroni correction (p<0.004) 
Group  Impairment indices  Correlation  Group  Impairment indices  Correlation 
Acute  CI Sine with CI Step   0.748 
(P=0.003) 
Chronic  CI Sine with CI Step  0.592 
(P=0.043) 
CI Sine with Sine TI   -0.878 
(P<0.001) 
CI Sine with Sine TI   -0.725 
(P=0.005) 
CI Sine with Step TI   0.880 
(P<0.001) 
CI Sine with Step TI   0.615 
(P=0.025) 
CI Sine with Ext onset  0.763 
(P=0.002) 
CI Sine with AROM ext  -0.692 
(P=0.009) 
CI Step with Sine TI  -0.571 
(P=0.041) 
CI Sine with IF ext  -0.698 
(P=0.008) 
CI Step with SI (0.5Hz)  0.573 
(P=0.051) 
CI Step with Sine TI  -0.669 
(P=0.017) 
    CI Step with Step TI  0.795 
(P=0.002) 
    CI Step with IF ext  -0.834 
(P=0.001) 
 
    SI (3.5Hz) with SI (.5Hz)  0.776 
(P=0.003) 
CI: coactivation index; TI: Tracking Index; Ext: extension; SI: stretch index; IF: Isometric force  
 
For the secondary impairments (Table ‎ 6-13), extension PROM significantly correlated with 
extension AROM and extensor isometric force in both groups. The mean torque index was 
not significantly correlated with any impairment in either group.  
 
Table ‎ 6-13: Statistically significant (p=0.05) Spearman’s correlation coefficients between 
secondary and negative impairments for acute group (N=13) and chronic group (N=13). 
Shaded cells are statistically significant values following Bonferroni correction (p<0.004) 
Group  Impairment indices  Correlation  Group  Impairment indices  Correlation 
Acute  PROM ext with AROM ext   0.758 
(P=0.003) 
Chronic  PROM ext with AROM ext  0.720 
(P=0.006) 
PROM ext with IF ext  0.555 
(P=0.049) 
PROM ext with IF ext  0.566 
(P=0.044) 
 
6.3.5.   Relationships between motor impairments and functional activity 
(mWMFT)  
Correlation coefficients (Spearman’s) for all the impairments and functional activity measure 
(mWMFT total function score) are presented in Appendix G, Table G-7 and Table G-8 and Main Study    Chapter 6 
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indicate differences in impairment and activity relationships in the acute and chronic groups.  
Statistically significant correlation coefficients are presented in Table ‎ 6-14. In the acute 
group, very strong and strong (Pett 1997) statistically significant associations were found 
between mWMFT and two negative impairments: extension AROM and extensor isometric 
force and a moderate association with one secondary impairment: extension PROM.  The 
correlation coefficient of one other negative impairment indicated a moderate degree of 
association which approached statistical significance: sine tracking (r=0.539, p=0.057). In the 
chronic group, more statistically significant relationships were found. Strong to very strong 
associations were found between mWMFT and negative impairments: sine and step tracking, 
extension AROM, extensor isometric force, extensor onset timing; and positive: sine tracking 
coactivation index, step tracking coactivation index; and stretch index. MWMFT was not 
significantly correlated to path length or mean torque index in either groups, and the 
correlation coefficients indicated a weak to low degree of association (Pett 1997).  
Table ‎ 6-14 Statistically significant (p=0.05) Spearman’s correlation coefficients between 
impairments and functional activity (mWMFT) for acute group (N=13) and chronic group 
(N=13). Shaded cells are statistically significant values following Bonferroni correction 
(p<0.004) 
Group  Impairment 
indices 
Correlation 
with mWMFT 
Group  Impairment 
indices 
Correlation 
with mWMFT 
Acute  AROM ext  0.787 
(P=0.001) 
Chronic  Sine TI   0.863 
(p<0.001) 
IF ext  0.707 
(P=0.007) 
Step TI  -0.835 
(p<0.001) 
PROM ext  0.624 
(P=0.023) 
Ext onset  -0.647 
(P=0.031) 
    AROM  0.791 
(P=0.001) 
    IF ext  0.758 
(P<0.003) 
    CI (sine)  -0.786 
(P=0.001) 
    CI (Step)  -0.697 
(P=0.012) 
    SI (3.5Hz)  -0.720 
(P=0.008) 
 
Linear regression was used to examine the importance of the impairment measures in 
explaining performance of the functional activity measure (mWMFT) and the results verified 
using quantile regression. In stage one of this process, each impairment was entered 
separately into a linear regression and a quantile regression analysis with mWMFT, to 
examine which were statistically significant predictors in each of the negative, positive and 
secondary feature groups (Appendix G Table G-9). The impairment variables which uniformly Main Study    Chapter 6 
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failed to reach significance in both patient groups using both forms of analysis, were path 
length (negative feature), stretch index (positive feature), and mean torque index (secondary 
feature), and were removed from further regression analysis. Other variables remained in the 
analysis because in one or other group, or in one or other form of analysis, they reached, or 
at least approached, statistical significance. 
Because there were two or more remaining impairment variables in the negative and positive 
feature groups, in the second stage of regression analysis, these impairments were entered 
into a forward stepwise regression with mWMFT to determine the most important one. In the 
acute group, for the negative impairments, there was no significant effect of sine tracking 
index (p=0.498), step tracking index (p=0.450), extensor AROM (p=0.162) and extensor 
onset timing (p=0.068) whereas extensor isometric force was significant (p<0.001) (quantile 
regression: p=0.003). For the positive impairments neither coactivation indices were 
statistically significant (sine p=0.795, step p=0.116). This left extensor isometric force 
(negative) and extension PROM (secondary) as the most important predictors of mWMFT for 
this patient group (Table ‎ 6-15). In the chronic group, for the negative impairments there was 
no significant effect of extensor isometric force (p=0.905), step tracking index (p=0.621), 
extensor AROM (p=0.327) and extensor onset timing (p=0.810) whereas the sine tracking 
index was significant (p<0.001) (quantile regression: p=0.001). For the positive impairments, 
there was no significant effect of step tracking coactivation index (p=0.063) whereas sine 
tracking coactivation index was significant (p=0.001) (quantile regression: 0.050). Thus the 
sine tracking index (negative), sine tracking coactivation index (positive), and extension 
PROM (secondary), were the most important predictors of mWMFT for this patient group 
(Table ‎ 6-15).   
Table ‎ 6-15: Linear regression of mWMFT on negative, positive and secondary impairments 
Acute Group  Impairment variable  R
2  95 %CI  P value 
Negative  Isometric Force     68.9%  7.1, 18.5  <0.001 
Secondary  Extension PROM  37.1%  0.10, 1.32  0.027 
Chronic Group  Impairment variable  R
2  95 %CI  P value 
Negative  Tracking Index (sine)     88.5%  0.21, 0.36  <0.001 
Positive  Coactivation Index (sine)          66.4%  -79.1, -26.3  0.001 
Secondary  Extension PROM  37.7%  0.15, 1.92  0.026 
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6.4.  Summary of findings 
Presented here is a summary of the main findings in this Chapter.  Discussion of these 
points, and how they relate to previous research findings and to clinical practice, follows in 
Chapter 7. 
6.4.1.  Validity and repeatability of indices: 
  With all the impairment participants grouped together, all the negative impairments (sine  1.
and step tracking indices, extension AROM, extensor isometric force and extensor onset 
timing), the sine tracking coactivation index and stretch index (positive), and extension 
PROM (secondary) distinguished between impaired and unimpaired. The step tracking 
coactivation index (positive) and mean torque index (secondary) did not. 
  For between-days test-retest repeatability in the active tests, the impairment indices  2.
derived from EMG signals – extensor onset timing and coactivation indices – showed 
wide 95% limits of agreement and coefficients of repeatability. 
  Within-test repeatability of indices showed a statistically significant deterioration of the  3.
sine tracking index was seen, only in the acute impaired group. Other indexes tested 
(isometric force, sine tracking coactivation index and stretch index) did not show this, 
  With the impaired participants in acute and chronic subgroups, all the negative  4.
impairments, the stretch index and extension PROM were statistically significantly 
different compared to the unimpaired group. In the acute group, both the coactivation 
indices did not significantly differ from unimpaired. In the chronic group the sine tracking 
coactivation index was statistically significantly different, whereas the step tracking 
coactivation index was not. 
  For most indices a greater interquartile range was observed for impaired participants than  5.
for unimpaired. However for some impairment measures (extensor isometric force, mean 
torque index and the coactivation indices) the unimpaired range was almost as wide, if 
not wider (in extensor isometric force), than the impaired groups. Gender differences 
were found to contribute to the variability in the unimpaired group in extensor isometric 
force and mean torque index. The variability in coactivation indices indicates the breadth 
of muscle activation strategies used in normal movement.   
6.4.2.  Association between impairment indices and motor control 
accuracy (MCA) 
  The factors that distinguished low MCA from high MCA were smaller extension AROM  6.
and PROM, reduced extensor isometric force, delayed extensor onset timing and 
coactivation (sine and step tracking). There was no statistically significant difference for 
spasticity (stretch index) and non-neural stiffness (mean torque index). Main Study    Chapter 6 
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  Sub-groups of impaired participants were identified which related to the level of MCA.  7.
Those patients with low MCA in the acute group were also those with the most extensor 
weakness, and those with low MCA in the chronic group also had the most coactivation 
and extensor weakness. Those patients with higher MCA also were those with extensor 
strength nearer the normal range. 
6.4.3.  Inter-relationships between impairment indices  
  There were more statistically significant inter-relationships in the chronic than acute  8.
group. 
  Most of the negative impairments in the chronic group were significantly correlated,  9.
except for path length which did not correlate with any other impairment measure. In the 
acute group the tracking indices and extensor onset timing were significantly correlated, 
as well as extension AROM with extensor weakness. 
 Within the positive group there was a moderate correlation between coactivation (step  10.
tracking at 0.5 Hz) and spasticity (stretch index at 0.5Hz) in the acute group that almost 
reached statistical significance (p=0.051). 
 None of the positive impairments (coactivation and spasticity) statistically significantly  11.
correlated with the secondary impairments - non-neural stiffness (MTI) and contracture 
(extension PROM). MTI did not significantly correlate with any other impairment measure. 
 Extension PROM significantly correlated with extension AROM and extensor weakness.  12.
6.4.4.  Relationships of impairment indices with functional activity  
 Using Spearman’s correlation, the impairments that were related to functional activity  13.
(mWFMT) in the acute group were extensor weakness, extension AROM and PROM.  
 In the chronic group, there were many more impairments that were associated with  14.
functional activity.  As well as weakness and loss of AROM, other negative impairments 
included sine and step tracking accuracy and delayed extensor muscle onset. The 
positive impairments also had a strong influence, as the stretch index and both 
coactivation indices were significantly correlated with the mWFMT. The secondary 
impairments were only weakly correlated. 
 Regression analysis showed that the most important negative impairment contributor to  15.
functional activity in the acute group was extensor weakness, and in the chronic group 
was the sine tracking index. The most important positive impairment contributor, in the 
chronic group only, was sine tracking coactivation.  Extension PROM was the most 
important secondary impairment contributor in both groups.Discussion    Chapter 7 
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7. Discussion  
The aim of this thesis was to advance understanding of the neuromechanical mechanisms 
associated with normal and impaired functional activity and recovery and the relationship 
between motor impairments and loss of activity in the upper limb of older adults, early and 
late post-stroke. This has clinical importance, because currently there is a lack of objective 
impairment measures and therefore the choice of treatments are not well informed. This 
study has used a comprehensive approach to the evaluation of motor impairments. A 
previous study at the metacarpophalangeal joints (Kamper et al. 2006b), and our preliminary 
research at the wrist (Burridge JH et al. 2005; Turk et al. 2008b), have also evaluated a wide 
range of motor impairments and assessed their relationship with functional activity, but this is 
the first study to compare impairments at the acute and chronic phases post-stroke. 
Furthermore novel methods have been developed and evaluated to quantify motor control 
accuracy during discrete movements, coactivation, muscle onset timing and spasticity and 
stiffness. 
 
A neuromechanical tool (the wrist rig) and tests to measure a wide range of motor 
impairments have been developed. In Pilot Studies (Chapter 5) the testing protocol was 
optimised and physiologically and clinically relevant motor impairment indices were derived 
from the neuromechanical signals, and then evaluated. In the Main Study (Chapter 6) the 
wrist rig tests and a test of upper limb functional activity were applied to a sample of older 
impaired participants in the acute and chronic stages post-stroke, and the results were 
compared with a sample of unimpaired participants. A preliminary analysis quantified test-
retest and within test repeatability of the impairment indices.  Relationships between 
impairments and between impairments and functional activity have been quantified. In this 
Chapter, the most clinically important and novel findings from Chapters 5 and 6 are 
examined and discussed in the context of previous published research. The implications for 
clinical practice and the limitations of the study are discussed, and plans for future research 
presented. 
 
In the Sections that follow, the results are discussed in the context of the negative, positive 
and secondary impairment features of the upper motor neurone syndrome. 
 
7.1.  Negative Impairments 
Previous research has repeatedly identified that the negative impairments associated with 
the UMN syndrome are critical to function and our findings support this (Ada et al. 2006; Discussion    Chapter 7 
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Bohannon et al. 1991; Burridge et al. 2008; Canning et al. 2004; Chae et al. 2002b; Kamper 
et al. 2006b; Mercier and Bourbonnais 2004; Wagner et al. 2006; Zackowski et al. 2004). 
Most importantly we have identified valid and reliable tests to quantify a range of negative 
impairments that have the potential to be adapted for clinical use to inform choice of 
treatment and monitor progress. We have also identified the relationships between negative 
impairments and function and how they differ between sub-acute and chronic populations. 
The negative impairments discussed below are: accuracy of motor control, measured in the 
tracking tasks; wrist extensor weakness; reduced range of active movement and wrist 
extensor muscle onset time. 
7.1.1.  Motor control accuracy - Sinusoidal and Step tracking 
Finding suitable parameters to assess motor control presents methodological challenges. 
There are multiple ways in which movement control can be assessed. In this work the 
analysis has been restricted to measures from movement tracking tasks at the wrist, which 
are of interest for stroke rehabilitation, based on published research, seminal literature on 
motor control and pathophysiology.  
 
Using our chosen methods of measuring motor control from movement tracking tasks, we 
were able to statistically significantly distinguish between the unimpaired and impaired group, 
both when the acute and chronic groups were analysed together and separately, confirming 
what was evident from visual analysis of the wrist movement plots.  
 
Tracking ability or skill is complex and can be measured in a variety of different ways (Ada et 
al. 1996; Dietz et al. 1991; Feys et al. 2006; Halaney & Carey 1989). In this study a 
sinusoidal tracking test (Turk et al. 2008b) was used to represent rhythmic movements of the 
wrist, and a novel step tracking test was developed to represent discrete movements. 
Although sine tracking is potentially more reliable, because it generates multiple cycles of 
data that can be averaged, random step tracking, which involves complex acceleration and 
deceleration, demands cognitive control for which higher-level planning areas of the cortex 
are recruited (Schaal et al. 2004). This is probably closer to the requirements of day-to-day 
activities involving the wrist than repetitive movements and therefore possibly more related to 
function. The step tracking test has also provided additional insights into tracking accuracy 
(path length at the end-point target position) and muscle activation patterns (extensor onset 
timing). 
 
The sine tracking index using cross-correlation has been used previously to characterise 
overall tracking accuracy during the sinusoidal tracking task (Notley et al. 2007) and has 
been shown as a valid method to distinguish unimpaired motor control accuracy from Discussion    Chapter 7 
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impaired in the chronic phase post-stroke (Turk et al. 2008b). The step tracking 
measurement methods chosen for the Main Study assessed accuracy during the total task 
using mean absolute error (MAE), and path length at the end-point target position. This was 
chosen because in Pilot Study 3, with a small number of impaired participants in the chronic 
phase, these methods distinguished best between impaired and unimpaired compared to two 
other similar measurement methods (MAE and standard deviation at the end-point target 
position).  The results of both these studies were corroborated in the Main Study of this 
research with a larger sample.  
 
Repeatability between day 1 and day 2 assessments was evaluated using Bland Altman 
statistics – the mean difference, 95% levels of agreement and the repeatability coefficient. 
The mean difference between repeated measurements was evaluated for any statistically 
significant systematic trend, which was not present for the sine and step tracking and path 
length indices. The 95% levels of agreement are more difficult to interpret; the decision as to 
what level of discrepancy between assessments is indicative of lack of agreement needs to 
be made on clinical rather than purely statistical grounds.  This is difficult to decide at this 
stage because these measurements are new, and have not been used during rehabilitation 
studies. It may be useful to compare the 95% levels of agreement to the range of values for 
impairment indices, and it can be said that for both tracking indices they were relatively 
narrow, but for path length were relatively wide (-0.016, 0.013 deg/sample) compared to the 
range of values (0.012 - 0.050 deg/sample). The repeatability coefficients obtained in this 
study are benchmark values that can be used in future studies in which the wrist rig tests are 
used to measure change in an individual’s stroke condition following an intervention. The 
sine tracking index has previously been assessed for test-retest repeatability within one 
session (Turk et al. 2008b) and the repeatability coefficient was ±58 degrees
2, whereas in 
this study evaluating between-days repeatability, the repeatability coefficient was smaller at 
±35 degrees
2.  The difference between these repeatability coefficient values is likely to be 
due to the studies having different patient samples, but may also be due to having a different 
target display for the sinusoidal tracking task. The first study used a moving target on a 
screen at eye-level, whereas for this study the target was an LED display placed close to the 
hand being tested. Thus the target and wrist movement can be viewed simultaneously, which 
may reduce the visuo-perceptual demands of the task, improving the repeatability of results.  
 
Evaluation of sine tracking within-test repeatability showed that the performance in both 
impaired groups tended to deteriorate during the test, and in the acute group this was 
statistically significant. Considering the nature of this task which is to maintain repeated 
flexion and extension movements of 40º for one minute, it is probable that the cause of the Discussion    Chapter 7 
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reduction of tracking performance is neuromuscular fatigue. This is a clinically recognised 
problem for those with stroke especially during the acute and sub-acute phases, and has 
been identified in research during MVC tasks (Knorr et al. 2011; Riley and Bilodeau 2002), 
but has not previously been identified in research involving tracking tasks. 
Relationships of tracking performance with other impairments and with function will be 
discussed in Sections ‎ 7.4 and ‎ 7.5. 
7.1.2.  Extensor weakness (isometric force) and active extension range of 
movement    
Extensor weakness and limited active extension range of movement are important negative 
impairments that are commonly measured during the assessment of a stroke patient, though 
often not objectively. Weakness and active range of movement are simple to measure, 
requiring no signal processing of multiple signals.  
 
The findings from both the Pilot and Main Studies confirm the important presence of both 
these impairments in the impaired group. Similar observations have been made by numerous 
others (Bohannon et al. 1991; Bourbonnais & Vanden 1989; Meskers et al. 2009). The acute 
group had statistically significantly more weakness and loss of range of movement, than the 
chronic group and unimpaired group, and the chronic group also was statistically significant 
different to the unimpaired group. 
  
The repeatability analysis revealed that for the isometric force measurement there was no 
evidence of a trend in between-days measurement, and the repeatability coefficient was 
small (±1 Nm) compared to the range of values (0 to 5 Nm), which confirms the findings of 
other studies using strength testing equipment more suited to clinical use (Bertrand et al. 
2007; Riddle et al. 1989). For extension active range of movement a greater mean value for 
the second day recording (4º) that was statistically significant, however, this is small 
compared to the range of values (-52.3º to 51.2º). Test-retest reliability of the assessment 
active range of movement in stroke patients using simple clinical equipment such as a 
goniometer has not been published up to now, though a scale such as the Fugl Myer which 
contains a range of movement testing within it, has been shown to have excellent reliability 
(Platz et al. 2005). 
 
There is a clear clinical perception that extensor weakness is closely related to loss of 
extensor ROM, and Spearman correlations in this present research study show a very strong 
and statistically significant association between these impairments in both the acute and 
chronic groups, thus corroborating that perception. Correlation between weakness and range Discussion    Chapter 7 
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of movement at the finger has been shown previously (Cruz et al. 2005). However, strong to 
very strong relationships were also found between the coactivation indices and both 
weakness and AROM, which will be explored further in Section ‎ 7.2.1 on coactivation. 
 
7.1.3.  Extensor onset timing 
This study has used a new method of calculating muscle onset timing that may directly relate 
to reduced motor drive and explain a reduction in isometric force. The method involved a 
simple comparison of the EMG  envelope with a threshold based on the envelope during a 
baseline period (Hodges & Bui 1996), but unlike previous research, used a local (i.e. 
immediately prior to the muscle activation) rather than global (i.e. before the start of the task) 
baseline.  Consistent with previous studies (Chae et al. 2002a; Hammond et al. 1988b; 
Hughes et al. 2010b; Wagner et al. 2007) a statistically significant delayed onset of the 
extensor muscles was found during discrete movements (step tracking) in the impaired group 
compared to the unimpaired controls. The delay was statistically significant in both impaired 
groups compared to unimpaired, but more so in the acute than the chronic group. These 
findings corroborate previous studies where delayed muscle onset has been found in 
participants with chronic stroke during isometric contractions at the hemiplegic wrist 
compared to the non-hemiplegic side (Chae et al. 2002a; Hammond et al. 1988b), and during 
supported reaching movements at the elbow (Hughes et al. 2010b). In a study with an acute 
group of post-stroke participants, delayed onset of wrist, elbow and shoulder muscles during 
unsupported reaching improved to within normal limits from the acute to sub-acute phase 
(Wagner et al. 2007).  
 
The discrete movement task can be broken down into three components: signal detection 
(visual detection of target LED change in position), signal processing and selection of motor 
strategy, and task execution (extensor contraction to move to target position), all of which 
could be impaired by a stroke lesion (Chae et al. 2002a). It is not possible to establish from 
this study where the cause of delayed muscle activation lies, but it has been suggested that 
motor processing may cause a large proportion of the delay shown in a previous study (Chae 
et al. 2002a). 
 
For between-days repeatability of extensor onset timing, the limits of agreement and 
repeatability coefficient were wide compared to the range of values. It is not possible to 
establish from this study whether the variability is due to variability inherent in measurement 
from the random signal that is the surface EMG or due to day-to-day change in muscle 
activation patterns in participants. Discussion    Chapter 7 
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Extensor onset timing was moderate to strongly associated with weakness in the chronic but 
not acute groups. This finding is similar to a previous study which found that slowness to 
generate force in the upper limb post-stroke significantly contributes to weakness. It makes 
clinical sense that patients who are weak, also are slow to activate their muscles and 
generate force. There was also a very strong association between extensor onset timing and 
coactivation during sine tracking, which will be explored further in Section ‎ 7.2.1. 
 
7.2.  Positive Impairments 
In general, there is a consensus in recent literature that positive impairments are not as 
important to functional activity as negative impairments (Ada et al. 2006; Burridge et al. 2008; 
Canning et al. 2000; Katz et al. 1992).  Positive impairments are clinically perceived to be 
associated with secondary impairments such as contracture, and there is some evidence that 
corroborates this (Ada et al. 2006). The positive impairments discussed below are co-
activation and spasticity measured as a response to rapid passive stretch. 
7.2.1.  Coactivation during sinusoidal and step tracking 
In this study a new method has been developed and tested to quantify coactivation, and in 
particular to distinguish abnormal coactivation from that used normally to stabilise a joint and 
ensure end-point movement accuracy. To do this we have measured coactivation during a 
dynamic movement which we also consider to be much more clinically relevant than the 
more commonly used (and easier) method of measurement during an isometric contraction. 
We have used a correlation analysis of the agonist (extensor) and antagonist (flexor) EMG 
calculated only over the time-periods where the agonist EMG is increasing, in accordance 
with the usual definition of coactivation (simultaneous activation of both muscles (Sheean 
2002)).  
 
This coactivation measurement method provides a major improvement over indices 
previously used for a number of reasons: 
  Other methods have calculated coactivation during isometric contraction (Chae et al. 
2002b; Hammond et al. 1988a; Kamper et al. 2006b), whereas our method measures 
during movement, which is more related to functional activity, and addresses the 
important question ‘What is the clinical relevance of inappropriate coactivation during 
activity?’ 
  Our method includes both the agonist and antagonist EMG in the calculation, and thus 
complies with the strict definition of coactivation (simultaneous activation of both muscles 
(Sheean 2002)). Others have focussed their calculation on the flexor EMG by either Discussion    Chapter 7 
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comparing with the unimpaired limb or unimpaired controls (Gowland et al. 1992; Kamper 
& Rymer 2001), or by a ratio of flexor EMG during extension and flexion (Turk et al. 
2008b).  
  Other methods have calculated the area of agonist and antagonist EMG overlap (Hu et 
al. 2007) but validity in distinguishing impaired and unimpaired subjects was not 
demonstrated. This is important as some tasks require more ‘normal’ coactivation than 
others, as demonstrated in the differences between the muscle activations patterns seen 
during sine and step tracking in the unimpaired group in this study. The measurement 
method used in this study, for the first time in the literature, targets the exclusion of 
sections of the data where there is ‘normal’ coactivation, thus focussing more on the 
sections where abnormal coactivation may occur.  
  Previously coactivation has been measured using cross-correlation of the flexor and 
extensor EMG and the presence of coactivation was said to occur using an arbitrary 
threshold based on proportion of variance of the antagonist EMG and the phase of the 
two opposing muscle activation bursts (Canning et al. 2000). Thus coactivation was 
deemed to be either present or it was not.  The coactivation index used in the current 
research provides a correlation coefficient ranging between +1 and -1 with positive 
values indicating simultaneous activation (coactivation) and negative values alternating 
activation (reciprocal inhibition/activation), providing a graded scale which is easily 
interpreted. Thus the values represent not just the extent to which the opposing muscle 
groups are activating simultaneously, but also reciprocally, and both of these factors may 
contribute to the strong association of this measure with motor control accuracy. 
 
In Pilot Study 3, visual analysis of the traces suggested that this approach was able to 
exclude more sections of the data where there is ‘normal’ coactivation, compared to other 
methods based on time-periods during peak extensor EMG or during extension movement. 
Statistical analysis showed greater differences between unimpaired and impaired 
coactivation for this method in both sine and step tracking, but none reached statistical 
significance.  In the Main Study with a larger sample, a statistically significant difference was 
found between the impaired and unimpaired groups for coactivation during sine tracking 
(p=0.024) measured using our method. When the impaired group was separated into chronic 
and acute, the analysis revealed that it was in the chronic group where the statistically 
significant difference lay (p=0.003); the acute group did not show a statistical significant 
difference. This contrasts with the findings of our previous study of chronic stroke patients, 
where the difference between impaired and unimpaired coactivation during the same wrist 
sine tracking test (with on-screen, rather than LED targets), was measured using a flexor 
modulation index (ratio of flexor activity as an antagonist and agonist) which showed a non-Discussion    Chapter 7 
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significant trend (p=0.07) (Turk et al. 2008b). This result is unlikely to be influenced by 
sample size as the first study calculation was based on 10 participants in each group 
compared to 13 chronic impaired and 14 unimpaired in this study.   
 
In contrast to sine tracking, the step tracking coactivation index did not show a statistically 
significant difference between impaired and unimpaired. The reason for this is not that the 
mean impaired coactivation index was any less, but that the mean unimpaired group 
coactivation index was less negative suggesting a tendency towards less reciprocal 
activation and more coactivation in the step tracking task. This suggests that the triphasic 
activity during fast discrete movements tends towards more coactivation while rhythmic 
movements use more reciprocal activation. This confirms the findings from an elbow study of 
unimpaired fast discrete extension movements which showed that the reciprocal activation of 
the agonist and then antagonist bursts was always followed by coactivation of both muscles 
(Yamazaki et al. 1995). 
The wide distribution of values for coactivation found in all groups in the Main Study 
confirmed the initial findings from Pilot Study 3. This highlights the variety of muscle 
activation strategies used by both the impaired and unimpaired participants, which was 
evident from visual inspection of the flexor and extensor EMG on the tracking plots. Even in 
the unimpaired groups whose tracking performance was excellent there were a variety of 
strategies used. Some appeared to use reciprocal inhibition/activation as described by 
Sherrington (Sherrington 1906). For others there was overlapping activity of AG1, ANT1 and 
AG2 in triphasic activity, often with additional bursts of AG and ANT activity as described by 
others (Brown & Cooke 1990). Although the majority of impaired participants did not have 
coactivation at levels beyond the normal range during sine and step tracking movements, 
there are clearly some individuals who did coactivate, and more so in sine than step tracking.   
 
In the main study, a small but statistically significant reduction in step tracking coactivation 
index from day 1 to day 2 was found, suggesting that patients may coactivate less (or use 
more reciprocal activation) with repeated day-to-day assessments; such a trend can be 
expected as a result of ‘training’ which tends to lead to more energy-efficient movement 
strategies (Osu et al. 2002). The limits of agreement and repeatability coefficients for both 
coactivation indices were wide, in sine tracking almost as wide as the spread of values in the 
sample (-0.60 to 0.69 and ± 0.61 respectively compared to minimum to maximum range of      
-0.54 to 0.73), indicating a large amount of variability between day 1 and day 2. This is partly 
due to the outlier in the chronic group whose activation patterns changed dramatically from 
clear reciprocal inhibition on day 1 to slight coactivation on day 2, which was evident from 
visual analysis of the sine tracking and EMG plot for this participant. With this outlier Discussion    Chapter 7 
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removed, the group sine coactivation index limits of agreement and repeatability coefficient 
are less wide (-0.46 to 0.43 and ±0.42 respectively) and similar to step tracking results. The 
effect of this outlier is exaggerated because of the small sample size which is a limitation of 
this study. The other reasons for variability may be that muscle activation patterns do vary 
from day-to-day in patients, or it may be due to variability inherent in surface EMG 
measurement. Visual inspection of traces did show a clear change in coactivation between 
these repeated measurements.  Furthermore, in some cases (in both the impaired and 
unimpaired groups) even within the same recording, clear changes in coactivation were 
observed, suggesting that the level of coactivation can sometimes be modulated by voluntary 
or other factors. This within-session variability for the sine coactivation index is evident in 
Figure ‎ 6-3, Chapter 6 Main Study, although was not statistically significant. 
 
Coactivation is associated with the negative features of the UMN syndrome. A statistically 
significantly correlation was found between the tracking indices (see Section ‎ 7.4 for further 
discussion), extensor onset timing in the acute group, and extensor muscle weakness and 
AROM in the chronic group. The relationship between delayed extensor onset timing and 
coactivation have not been evaluated previously in the literature, although a study involving 
tracking training combined with FES in a two dimensional robot, found that both delayed 
onset timing and coactivation improved post treatment (Hughes et al. 2010b).  The 
relationship between coactivation, weakness and AROM is a key finding in this study, and 
relates to the close association with tracking performance (see Section ‎ 7.4 for detailed 
discussion). 
 
A key question that this study was hoping to address was whether there was a relationship 
between coactivation and spasticity. In the acute group there was a moderate correlation 
which approached statistical significance (r=0.573, p=0.051) between coactivation measured 
during the sine tracking test, and spasticity measured during a passive sinusoidal test using 
the same timing and displacement parameters, but no correlation in the chronic group. 
Additionally there was a moderate and less statistically significant relationship (r=0.531, 
p=0.075) between sine coactivation and spasticity measured using the 3.5 Hz test.  These 
findings suggest that the association of coactivation and spasticity is still unresolved.  
      
7.2.2.  Spasticity – Stretch index 
The stretch indices were calculated from two different tests – a fast test at 3.5Hz with 10º 
displacement, and a slower test at 0.5 Hz with 40º (± 20 º ) displacement.  The latter was 
used to compare the stretch response in passive tracking with coactivation in active tracking Discussion    Chapter 7 
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using a test with the same parameters. A new method of calculating the stretch index has 
been used. In previous studies the area of the flexor EMG activity in response to stretch was 
calculated as the increase with respect to the mean global resting baseline (Sorinola et al. 
2009; Turk et al. 2008b), or the mean plus 3 SD of a global baseline (Pisano et al. 2000).  
Because the global resting baseline was found to be variable, a local baseline was used 
instead.  The use of a ratio of the SR area to the local baseline meant that the measure was 
normalised without having to use other methods such as %MVC, and the value of the index 
can easily be interpreted. Thus if the ratio is 1.0, the stretch response average amplitude is 
the same as the local baseline, and if the ratio is higher than 1.0, the stretch response 
average amplitude is greater than the local baseline. The results from Pilot Study 4 
confirmed that this method of measuring the index, with the 3.5Hz ± 10º displacement test, 
showed the greatest difference between impaired and unimpaired, though it did not quite 
reach statistical significance. 
 
In the Main Study with a larger sample, and consistent with prior studies (Pisano et al. 2000; 
Turk et al. 2008b), there was a statistically significant difference in the stretch index between 
impaired and unimpaired (p<0.001), and this was shown in both the acute and chronic 
groups when analysed separately (p<0.001).  Observation of individual data on the dot plots 
Figure ‎ 6-7) confirmed these findings. The unimpaired values were mainly narrowly grouped 
at 1.0, and although some impaired participants also had stretch index values at or near to 
1.0 (more in the acute group than chronic), there were clearly some individuals who have 
much higher levels of stretch response. 
 
Although spasticity tested at 3.5Hz distinguished impaired from unimpaired, no statistically 
significant associations were found between spasticity and other impairment variables. 
Moderate non-significant associations (r=0.531, p=0.075) were found between spasticity and 
sine tracking performance, AROM and sine coactivation indices only in the chronic group, 
which, with a larger sample size, may reach statistical significance. 
  
7.3.  Secondary impairments 
Secondary impairments are biomechanical changes to soft issues and joints that occur as a 
result of the primary (negative and positive) impairments.  The secondary impairments 
discussed below are contracture or loss of extension passive range of joint movement, and 
non-neural stiffness of muscles and joints.   Discussion    Chapter 7 
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7.3.1.  Contracture - Extension passive range of movement 
Loss of extension passive range of movement (PROM) indicates contracture, a secondary 
impairment seen after stroke (Ada et al. 2006).  Judgement of the end of passive range of 
movement can be subjective. In this study a clear definition was used to identify end of 
passive range (the point where resistance from tissues increases either to a block or where 
further movement is difficult but remains pain-free). Additionally the maximum force applied 
by the assessor was recorded, and no statistical difference in this value was found across 
the three participant groups.  
 
In Pilot Study 3, the difference in extension PROM between impaired and unimpaired did not 
reach statistical significance, whereas in the main study it did, with more difference in the 
acute group (p<0.001) than the chronic group (p<0.007).  
 
A key finding in this study is that contracture is strongly associated with extension AROM, 
and moderately associated with extensor isometric force, but only very weakly associated 
with positive impairments such as spasticity.  The correlations used in these analyses cannot 
be used to infer causal connections between these variables. A longitudinal study, which 
evaluated the causal relationship between spasticity and weakness and the development of 
contracture at the elbow, found that spasticity made a significant contribution to contracture 
within the first four months post-stroke, and that weakness made a significant contribution to 
contracture later on at six to nine months post-stroke (Ada et al. 2006).  
 
7.3.2.  Non-neural stiffness – mean torque index 
The mean torque index was designed to measure non-neural resistance to passive 
movement (stiffness) towards the end of passive extension range. The index was based on 
the method used in a previous measurement of spasticity study (Pisano et al. 2000), though 
slower speed of movement (5º/second compared to 10º/second) was used during the test in 
an attempt to minimise the presence of neural activity, which in the previous study was 
present in 39 of the 58 patients. In Pilot Study 3, three participants were unable to entirely 
avoid any flexor and extensor activation: two unimpaired participants with voluntary extensor 
activity (in spite of instructions to the contrary) and one impaired participant with increasing 
flexor activity in phase with passive wrist extension. In the Main Study, flexor EMG activity 
was present for two impaired participants (one acute and one chronic) and extensor EMG 
activity for one impaired (acute) and two unimpaired participants. The impaired participant 
with flexor activity in the Pilot Study was considered to have spasticity, although this was not 
formally measured using a clinical scale. This raised the possibility that those with higher Discussion    Chapter 7 
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levels of spasticity may not be able to be measured using this stiffness index.  However, for 
the two impaired participants with flexor activity in the Main Study, one had moderate 
spasticity (score 2 on the Tardieu scale), whereas the other had none, and there were three 
other participants with a score of 3 on the Tardieu scale who did not have flexor activity and 
therefore were included in this part of the analysis. 
  
In the Pilot Study, the mean torque values in the chronic impaired group were higher and 
almost reached statistical significance compared to the unimpaired group. Contrary to these 
findings, in the Main Study, the mean chronic group values were only slightly higher than the 
unimpaired, and nowhere near statistically significant. In fact, the mean values of the acute 
group were statistically significantly lower than unimpaired. Observation of the dot plots 
explained these findings. Most of the acute group values were below the normal stiffness 
range, which fits with the clinical picture in the acute phase where low muscle tone and 
weakness predominate. Only two impaired participants in the chronic group were above the 
normal stiffness range (one male and one female) with most within the normal stiffness range 
of even below it. Furthermore stiffness did not contribute to poor motor control accuracy, and 
no relationships were found between this stiffness and any other impairment measure or with 
the mWMFT. It is clear that of the two secondary impairments, loss of PROM or contracture 
is a more important measure than stiffness measured using the mean torque index. 
 
7.4.  Association between impairment indices and motor control accuracy 
(MCA) 
Participants with poor tracking performance, whether they were in the acute or chronic group, 
were compared against those with better performance and the unimpaired. This was to 
evaluate which impairments underlie the inability to perform a) simple flexion / extension 
movements in the rig and b) accurately track the target. The impairments that distinguished 
low MCA from high MCA were smaller extension AROM and PROM, reduced extensor 
isometric force, delayed extensor onset timing and coactivation (sine and step tracking). 
There was no statistically significant difference for spasticity (stretch index) but both the low 
and high MCA group were distinguished from the unimpaired group suggesting that spasticity 
may be present within the impaired group but does not determine the relative level of motor 
control within the patient group. Coactivation also was statistically significant between the low 
MCA and unimpaired group and not the high MCA group, suggesting that this is a major 
contribution to poor motor control.  
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Further observation of sub-groups revealed that it was the chronic patients with coactivation 
who had the low MCA.  They also were the sub-group with the most weakness, though it is 
not possible to know whether their weakness was due to poor activation of the extensors, or 
coactivation where the flexors counteract the effect of the extensors. Further evidence for 
this relationship is that coactivation was shown to be strongly correlated with weakness and 
AROM in the chronic group. In the acute group, those with low MCA were also the sub-group 
with the most weakness, though there was one participant (#17) who also had coactivation.  
The finding that those participants with moderate weakness problems and no coactivation 
were those in the high MCA group, further strengthens the argument that weakness and 
coactivation strongly relate to motor control.  Further evidence for this was found in the 
correlation between the sine and step tracking indices, isometric force and coactivation 
indices. There was a moderate to very strong association between the coactivation indices 
and tracking indices in both the acute and chronic groups. Weakness was very strongly 
associated to tracking performance in the chronic group, but had only a low association in 
the acute group, where extensor onset timing was the impairment that was most strongly 
associated (Section ‎ 7.1.3).   
 
7.5.  Relationships between impairment indices and functional activity  
Relationship between impairments and functional activity (mWMFT) was evaluated in this 
study using correlation to assess individual associations without taking into account other 
impairments, and multiple regression analysis to evaluate best prediction of mWMFT among 
the negative, positive and secondary impairment groups.   n the acute group the Spearman’s 
correlation showed that extensor weakness, AROM and contracture were related to 
functional activity, and similarly the regression analysis showed that the most important 
negative impairment contributor to functional activity was extensor weakness (R
2=70%), and 
extension PROM was the most important secondary impairment contributor (R
2=37%). In the 
chronic group all the negative impairments were strongly or very strongly associated with 
functional activity except for path length. This may be because this measure relates more to 
delicate precision tasks, which the mWMFT does not address.  The most important negative 
impairment contributor to functional activity was sine tracking accuracy (R
2=89%), the most 
important positive impairment contributor was sine tracking coactivation, and again, 
extension PROM was the most important secondary impairment contributor (R
2=37%).    
 
Thus, consistent with the findings of other studies (Ada et al. 2006; Bohannon et al. 1991; 
Burridge et al. 2008; Canning et al. 2004; Chae et al. 2002b; Kamper et al. 2006b; Mercier & 
Bourbonnais 2004; Wagner et al. 2006; Zackowski et al. 2004), negative impairments, in Discussion    Chapter 7 
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particular weakness, AROM and motor control accuracy, have been found to most relate to 
functional activity post-stroke.  This study is the first to evaluate both the acute and chronic 
phases, and determine that weakness is most important in the acute phase, and motor 
control accuracy is the most important in the chronic phase. Another study found weakness 
to be more important than motor control accuracy (termed dexterity), but they evaluated 
stroke patients in a longitudinal study only in the acute to sub-acute phase (up to 27 weeks). 
In our previous study with patients in the chronic phase (> 1 year post-stroke) sine tracking 
was found to be the impairment that contributed the most (R
2 = 56%) to the variance in the 
Action Research Arm test (ARAT) score, whereas extensor isometric force showed less 
contribution (R
2 = 33%). 
 
It is important to point out that, unlike sine tracking, step tracking did not show a statistically 
significant association to function in the regression analysis, and although in the correlation 
analysis it was very strongly associated with functional activity in the chronic group, showed 
only a low non-significant association in the acute group. One hypothesis of this study was 
that step tracking would be more related to functional activity because of the nature of 
discrete movements being closer to day-to-day activities of the upper limb than rhythmic 
movements. However these findings suggest that sine tracking is more related to functional 
activity. One possible reason for this is that while step tracking involved discrete movements 
and rest periods, sine tracking involves constant movement over a one minute period. It is 
likely that impaired participants found this tiring, as shown in the statistically significant 
reduction in sine tracking performance over the test period. This cannot be assessed with the 
step tracking test as the task becomes more difficult over time. Fatigue, a common symptom 
seen clinically following stroke, can also limit patients’ ability to carry out functional activities. 
In the mWMFT, the first tasks involved simple single movements from one position to 
another. However, the later more functional tasks, such as turning over three cards, or 
stacking three chequers, involved a series of complex movements, which are likely to induce 
fatigue. Another difference between step and sine tracking is at the cortical level it involves. 
Rhythmic movements at the wrist were found to involve the cerebrum on the contralateral 
side of the moving limb, whereas discrete movements involved widespread areas of the 
ipsilateral cerebrum, and specific areas in the contralateral cerebrum (Schaal et al. 2004). 
Considering a stroke lesion damages the contralateral cerebrum, it is possible that those with 
hemiplegia may find rhythmic movements more challenging, whereas discrete movements 
such as step tracking, which use the intact side of the brain as well as the side of the lesion, 
may be easier to undertake.   
 Discussion    Chapter 7 
      158 
 
Unlike the findings of some studies of isotonic contractions (Canning et al. 2000; Gowland et 
al. 1992; Kamper et al. 2006b; Wagner et al. 2007) and similar to others using isometric 
contractions (Chae et al. 2002b), the positive impairment coactivation (measured during sine 
coactivation) also seems important to functional activity but more in the later stages post-
stroke. It is possible that the more careful method of measuring coactivation used in this 
study may contribute to this finding. This method is different to any used previously, 
evaluates the correlation between the antagonist and agonist curves excluding some time-
periods when ‘normal’ coactivation occurs, and measures the extent of reciprocal activation 
as well as coactivation.  
 
Contracture has also been found to be important contributor in both the acute and chronic 
phases, though lower than that of the negative impairment weakness in the acute and 
chronic group and positive impairment coactivation in the chronic group. Contracture has 
previously been found to be an important impairment after stroke (O'Dwyer et al. 1996; 
Pandyan et al. 2003a; Vattanasilp et al. 2000). The previously mentioned longitudinal study 
(Ada et al. 2006) however, found that contracture never made a major contribution to 
functional activity loss up to a year post-stroke, and only statistically significantly contributed 
at the six week period post-stroke.   
 
7.6.  Summary of acceptance of the hypotheses  
The five null (H0) and alternative (H1) hypotheses were listed in Chapter 2, Section ‎ 2.15. 
Here the hypotheses are discussed in relation to whether they have been found to be 
accepted by the findings of the study: 
1.  The alternative hypothesis is accepted: Negative impairments will relate more to loss of 
functional activity than positive and secondary impairments, especially in acute 
participants.  
In general, the negative impairments have been found to relate more to functional activity 
than the positive and secondary impairments, in particular extensor weakness and active 
range of movement in the acute group, and loss of motor control accuracy in the chronic 
group.  However, coactivation (positive impairment) was also found to relate to functional 
activity in the chronic group, and contracture (secondary impairment) related to functional 
activity in both groups. 
2.  The alternative hypothesis is accepted: Positive and secondary impairments will relate to 
loss of functional activity in some individuals, especially in the chronic group. 
Abnormal coactivation was found to be present in some individuals, more in the chronic 
group, and those tended to have the worst functional activity, and motor control accuracy Discussion    Chapter 7 
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scores. As has been indicated above, coactivation (chronic group) and contracture (acute 
and chronic groups) were found to relate to functional activity. Spasticity was present in the 
impaired group (shown by the statistically significant difference between impaired and 
unimpaired), but did not relate to functional activity. Stiffness was lower in the acute group, 
and also did not relate to functional activity. 
3.  The null hypothesis is accepted: Motor control accuracy and coactivation measures from 
step tracking (discrete movements) will not relate more to upper limb functional activity 
than the same measures from sinusoidal (rhythmic) tracking. 
The findings show that sine tracking accuracy and coactivation during sine tracking are more 
related to functional activity than the step tracking measures. This was discussed further in 
Section ‎ 7.5 above. 
4.  The alternative hypothesis is accepted: Negative impairments will relate more with each 
other rather than with positive and secondary impairments 
In general, the negative impairments did strongly relate with each other, particularly the sine 
and step tracking indices, extensor weakness, extension AROM and extensor onset timing.  
The step tracking path length measure did not relate to any other impairments.  
5.  The null hypothesis is accepted: Positive impairments will not relate more with each other 
and with secondary impairments  
Coactivation (positive impairment) was found to strongly relate more to the negative 
impairments – sine and step tracking indices, extensor onset timing in the acute group, and 
extensor muscle weakness and AROM in the chronic group. Only a moderate non-significant 
relationship was found between coactivation and spasticity in the acute group. Spasticity was 
not found to relate to secondary or negative impairments. Contracture (secondary 
impairment) was found to strongly relate to the negative impairments extensor muscle 
weakness and AROM. Stiffness did not relate to any other impairments. 
7.7.  Implications for clinical practice 
  In the acute group, the impairments that were found to be important to functional activity 
were extension ROM and extensor isometric force, therefore therapy should be focussed 
on techniques to increase muscle activity, range of movement and strength. 
  Contracture (loss of PROM) was found important to functional activity in both the acute 
and chronic phase, but was found to be more related to weakness and loss of active 
range of movement than the positive impairments of coactivation or spasticity. This 
suggests that techniques which encourage activity and strengthening as well as 
stretching joints at the same time would be beneficial. These include technologies such 
as FES or active splinting e.g. SaeboFlex (Saebo, Inc.). Discussion    Chapter 7 
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  When present (more likely in the chronic phase) positive impairments such as 
coactivation and spasticity should be addressed.  Specific treatment for the problem of 
coactivation is not clear; however, a recent study of botulinum toxin therapy suggested a 
reduction in coactivation measured using EMG (Gracies et al. 2009). Other studies have 
shown a reduction in coactivation using less direct techniques such as FES and robot 
training (Burridge & McLellan 2000; Hu et al. 2007). 
  A fundamental message arising from this research is the need to measure impairments 
more objectively in clinical practice so that treatment could be better targeted. Some 
impairments that have been found to be very important to functional activity such as 
strength and active range of movement are relatively simple and easy to measure using 
off-the shelf devices.  Other impairments such as tracking performance, coactivation and 
spasticity are also important but are more complex to measure.  Clinically relevant 
devices need to be developed and the problem of variability in EMG measurement 
remains a challenge.  
7.8.  Limitations of the study 
The results from this study need to be interpreted whilst acknowledging the limitations of the 
study. Limitations in the methodology have been minimised where possible, or where this 
was not possible are addressed here, and identified to be addressed in future research. 
7.8.1.  Sample size 
The relatively small number of participants recruited for the Main Study was regarded as a 
convenience sample, and has resulted in limited strength of the statistical findings.  A power 
calculation was performed earlier in the research project based on pilot data from 10 
participants with chronic stroke. The data consisted of 9 impairment variables; wrist flexor 
and extensor strength, active range of movement, 2 motor control indices (sinusoidal and 
step tracking performance), 2 coactivation indices (from sinusoidal and step tracking EMG), 
spasticity index, and stiffness index – and a measure of arm activity, the Wolf Motor Function 
Test (WMFT). The calculation was based on regression analysis i.e. the effect sizes were 
based on R-squared values - the percentage of variation in the arm activity score that is 
explained by the predictor (impairment) variable(s).  A regression analysis using the existing 
data showed that the first eight variables (all except the stiffness index) were individually 
strongly associated with the WMFT - all produced a large R
2 and therefore a large effect size. 
However a regression based on the final variable (stiffness index) had a lower R
2 - a medium 
rather than large effect. The calculation at 80% power found that the joint predictive value of 
the 8 best-predicting variables could be adequately described with 54 cases but, with the 
final variable included, more cases are needed to have the same level of confidence.  A 
sample size of 70 (35 in each impairment group) was therefore proposed. This calculation Discussion    Chapter 7 
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was limited by using data from only a small number of participants, and would need to be 
repeated using the full data set for a subsequent suitably-powered trial, however, it gives an 
indication of how this study is under-powered.  
7.8.1.  Number of impairment variables 
The purpose of this research was to evaluate a considerable number of impairment variables 
so that the heterogeneity of stroke participants could be assessed. The disadvantage of this, 
however, is that it reduces the strength of the statistical findings. In this study multiple 
comparison procedures have been performed, and to control the type I error a Bonferroni 
correction has been used. However, this is a conservative test so that the probability of 
rejecting an effect that does actually exist is increased (type II error).   
7.8.2.  Impairments only been measured at the wrist 
Impairments have only been measured using simple flexion-extension movements at the 
wrist, whereas functional activity involves multi-joint, multi-directional movements. Despite 
this, some strong correlations have been found. Further research to determine impairments 
and their relationship with functional activity at other joints is warranted. 
7.8.3.  Acute and chronic group participants 
Comparisons have been made between acute and chronic impaired participants, but these 
are not the same individuals, therefore the question of how impairments and functional 
activity change over time has not been fully addressed. A future follow-up study is planned 
where the acute group in this study will be reassessed when they are in the chronic phase 
(see Future research, Section‎ 7.9 ). 
7.8.4.  Analysis of test-retest reliability 
Preliminary test-retest reliability analysis was carried out in this study. This only included the 
active tests, as on a practical level it was not feasible to conduct the passive tests at both 
day1 and day 2 sessions. Also not all participants were included in the reliability sub-group. 
Some participants who were able to complete the full testing protocol on day 1 were not 
included. Generally they were those who had travelled from further away, they had less 
problems with fatigue and tended to be the more physically able. The smaller numbers in the 
reliability sub-group reduced the power of the statistical results.  
7.8.5.  Hand dominance 
For practical reasons and to identify ‘best performance’ the unimpaired participants were all 
tested using their dominant arms. It seems likely that in unimpaired tracking performance, the 
dominant side performs better than the non-dominant, however this is not known warrants Discussion    Chapter 7 
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further investigation. However, the impaired participants were tested using their hemiplegic 
arm, which for 14 of them was their dominant arm, and for 12 was their non-dominant arm.  
Thus any effect of hand dominance has not been controlled for in this study. However, the 
relevance of dominance is questionable as when a person has a stroke, their non-hemiplegic 
side immediately becomes their dominant side which tends to over-ride any pre-morbid hand 
dominance.  
7.8.6.  Gender matching 
For practical reasons it was difficult to match the impaired and unimpaired groups in terms of 
gender.  This was because the unimpaired group were recruited first, and because of the 
larger older female population compared to male, there were more female volunteers for the 
study. Gender has been shown to have an effect on some impairments, especially muscle 
strength and stiffness, and the fact that gender was not controlled for may have reduced the 
strength of the statistical results. 
 
7.9.  Recommendations for future research 
The following studies are proposed for future research, the first two of which are already in 
the planning stages, one with MSc students, and one other involving a team of researchers 
working across multiple sites in the UK. 
  A follow-up study of the acute participants sample from the Main Study, who will be re-
tested when they are over a year post-stroke i.e. in the chronic phase, using the same 
testing protocol. The purpose of this is to evaluate changes in motor impairments and 
functional activity from the acute to the chronic phase to enhance understanding of 
natural recovery and the changing relationship between impairments and functional 
activity. 
  To use the wrist rig neuromechanical impairment measures, along-side biomechanical 
assessment of upper limb movements (motion analysis), and measures of cortical activity 
(e.g. TMS), in a longitudinal trial to understand underlying mechanisms and determine 
the nature of the course of upper limb recovery post-stroke. 
  To use the neuromechanical impairment measures derived from this study as impairment 
level outcome measures in a clinical trial to evaluate the underlying mechanisms of 
therapy-induced recovery e.g. functional strength training or botulinum toxin therapy. 
  To apply the wrist measurement and analysis methods to another joint such as the 
elbow, to compare differences between the wrist and elbow motor impairments and their 
relationship with functional activity.  Discussion    Chapter 7 
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  To evaluate test-retest reliability with all the wrist rig measures with a larger sample 
population as this study has only provided a preliminary test-retest reliability analysis.  
  To evaluate impairment problems in sub-acute patients undergoing rehabilitation using 
the wrist rig measures and compare decision making regarding treatment based on the 
neuromechanical measures, with those based on current therapists’ clinical assessment. 
This would be to identify the differences between a therapy plan based on quantitative 
neuromechanical assessment compared to that based on a subjective clinical 
assessment.   
  To develop more clinically suitable assessments tools, especially for the measurement of 
spasticity and coactivation, or evaluate current off-the-shelf tools to use in clinical 
assessment.  The lab-based wrist rig measures would be used in the validation of these 
tools. 
  Further evaluation of the relationship between coactivation, weakness and active range 
of movement, to identify whether coactivation or reduced muscle activation is the cause 
of weakness and loss of active movement. 
 
7.10. Summary 
This Chapter has discussed the findings of this study which provide answers to the original 
study objectives and questions. Differences between impaired and unimpaired groups have 
confirmed the validity of the impairment indices derived from the wrist rig tests, and 
preliminary evaluation of repeatability highlighted the challenge of repeated assessment 
using EMG. Important relationships between impairments, motor control accuracy and 
functional activity have been discussed in reference to the literature and the relevance to 
clinical practice.  Limitations of the study have been discussed, and plans for future research 
presented.  The following Chapter of this thesis summarises the main conclusions from this 
research. 
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8. Conclusions 
This study has been the first to provide a comprehensive evaluation of motor impairments 
measured at the wrist, using neuromechanical methods, with a sample of participants with 
hemiplegia in both the acute and chronic stages post-stroke and with unimpaired controls. 
Previously developed indices have been used to describe motor control during a rhythmic, 
extensor muscle weakness, and active and passive extension range of movement. Novel 
methods have been developed and evaluated to quantify motor control accuracy during 
discrete movements, coactivation, muscle onset timing and spasticity and stiffness. Results 
from the study confirmed the validity of most impairments to distinguish between impaired 
and unimpaired except coactivation (step tracking) and stiffness. Most impairments 
distinguished between acute, chronic and unimpaired groups except both coactivation 
indices in the acute group, and step tracking coactivation and stiffness in the chronic group. 
Repeatability coefficients for the active test indices have been presented as benchmark 
values for use in future trials. The muscle activation indices showed lower repeatability and 
therefore their use to measure change over time is limited. It is not clear how much the 
between-days variability is due to genuine variability within patients or the random nature of 
EMG measurements. 
 
The impairments that distinguished between poor and good motor control accuracy were 
reduced extensor weakness, delayed extensor onset timing, coactivation and smaller 
extension AROM and PROM, suggesting that these are important impairments to consider in 
deciding upon intervention and to measure progress. Somewhat surprisingly, coactivation 
was more strongly associated with motor control accuracy than with spasticity or stiffness.  
 
The main contributor to functional activity in the acute phase was extensor weakness as well 
as loss of active and passive range of movement. In the chronic phase, there were many 
more impairments that were associated with functional activity.  In general the negative 
impairments, especially motor control accuracy (sine tracking) were found to have more 
influence on functional activity than the positive impairments.  However, unlike the findings of 
previous studies (Burridge et al. 2008; Canning et al. 2000) in this study coactivation (sine 
tracking) showed a strong and statistically significant relationship with functional activity. 
Contracture also significantly contributed to functional activity in both phases, though was 
strongly associated with the negative impairments weakness and loss of active range of 
movement rather than spasticity or stiffness. 
The findings in general support the notion that rehabilitation strategies should focus on 
increasing muscle strength and prevention of contracture. However, assessment of more Conclusions    Chapter 8 
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complex impairments like motor control accuracy and coactivation may be crucial to better 
target therapy, especially in the later phases post-stroke. References    Chapter 9 
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Appendix B - Bench testing and Calibration 
In order to test the system and its outputs and calibrate the measurements, bench tests on the 
rig components were carried out by the researcher and Dr Simpson with the assistance of ISVR 
technicians.  This process involved iterative testing, (modification and retesting) to ensure that 
the rig system and output data were valid and reliable.  The following section details the bench 
testing and calibration processes undertaken following the rebuild of the wrist rig. The calibration 
coefficients for each output (angle, torque, EMG) were calculated and inserted into a customised 
Excel spread sheet (Table B-1). This Excel spread sheet was read by the specially designed 
Matlab® wrist rig software when processing signals and representing signals on graphs in 
appropriate units of measurement (degrees; Nm; mV). 
Potentiometer (angle) 
The resistance of the potentiometer is converted to a voltage in the appropriate electronic 
circuits, which needs scaling so the angle of the wrist joint can be calculated. The potentiometer 
output was tested initially to investigate noise levels and adequate resolution (< 1 degree). 
Calibration of angles was undertaken by making marks on the LED display board which 
represented actual angle values.  The zero degrees point (where the wrist is in line with the 
forearm) was already determined on the wrist rig, and angles to the left were positive angles, 
and to the right were negative angles. The lever arm was moved to different angles (in steps of 
10 degrees) according to the marks on the LED display and voltage values from the 
potentiometer were recorded (see Table B-1). Linear regression was performed between the 
known angles and measured voltages and the gradient and offset values calculated. The 
resultant calibration coefficients were entered into the Excel spread sheet (Table B-1). 
LEDs on the target tracking display 
Each LED is activated over a distinct, narrow range of voltages, and in order to light each LED 
individually, which is important for the tracking task, knowledge of the correct voltage for each 
was needed. Testing was therefore undertaken to find the voltage relating to each LED that 
related to an angle every 2º between -79º to 79º. These voltages (showing approximately linear 
spacing) were recorded in a lookup table (see Table B-1), and used to determine the output 
voltage driving the LEDs at each instant in time.   
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Pivot strain gauge 
The initial plan was to use the pivot strain gauge (mounted in the shaft between the slip-clutch 
and the wrist) to measure the torque when resistance was applied at the slip clutch; however it 
was found that the pivot strain gauge measurements showed a slow drift over time and zero 
torque did not give a constant voltage over all angles.  This we thought was due to the position 
of the axle in the pivot joint being slightly off vertical, and possibly due to the material (Perspex) 
used, which may display ‘creep’.  As the resistance applied by the slip clutch could be measured 
by the lever arm strain gauge (with the subject’s wrist removed), it was decided not to use the 
pivot strain gauge. 
Lever arm strain gauge 
Initial testing was undertaken to investigate noise levels, gain and drift of the lever arm strain 
gauge. The gain on the amplifier was modified so that it was sufficient to measure both 
resistance to passive movement (very low levels of torque) and maximum voluntary contraction 
(higher levels of torque). The signals were found to remain stable, with no drift over time in gain 
and offset, so it was decided to use the lever arm strain gauge to measure both passive 
resistance to movement of the limb, and the resistance set in the rig at the slip clutch. 
 
Calibration of lever arm strain gauge was undertaken as follows. Weights between 0-150g at 
20g or 50g intervals were hung freely from the end of the lever arm on a string over a freely 
running pulley system, with a 90˚ angle (perpendicular) to the lever arm and the weights pulling 
both to the left (+ve direction) and to the right (-ve direction).  Measurements were carried out 
with the lever arm set at 0˚ (in line with the arm support) and at a 30˚ angle.  An example of true 
and measured torque (after calibration) is shown in Figure B-1, where all measured points lie 
very close to the desired line of equality. The calibration coefficients are shown in Table B-1. 
 
To further check the lever torque calibration, 0 – 2Kg weights were hung at a point 15 cm from 
the centre of the pivot joint and at 11 cm position from the pivot joint.  Later in the study, during 
the use of the system and on repeated recalibration and further assessment of the lever torque, 
an offset was seen in the range of 0.05v-0.1v.  The strain gauge wiring was checked and a 
problem was found causing a short circuit which was thought to be the source of the offset. The 
system was rewired and further assessment showed stability. 
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Figure B-1 Results from calibration of lever torque.  The horizontal axis shows the true torque 
(given by the weights and the distance along the lever arm), and the vertical axis shows the 
measured torque, after applying the calibration coefficients to the voltage output.  
 
However, the lever torque was regularly calibrated, and the calibration coefficients were found to 
have changed following the pilot study.  As these had remained stable through repeated 
assessments during the bench testing and calibration process, and changes to the pivot joint 
and electronics were also made following the pilot study, the source of the change was not clear.  
Because the accuracy of the calibration of this sensor was very important, it was decided to 
recalibrate before and after each testing session in the main study. As it became clear that the 
calibration coefficients were remaining stable, recalibration then occurred after every second 
testing session for the remainder of the data collection. 
EMG 
Shielded and unshielded EMG leads were tested for signal quality and, on visual analysis, less 
noise was found in the signal with the shielded leads which were then used throughout the 
study.  Initial testing of EMG showed very large signal to noise ratio so that the output from 
muscles was not detected. Rewiring of connections and change of the power supply was 
needed to reduce the noise.  Some 50 Hz and harmonics (mains noise) remained but this was 
successfully removed using a notch filter during processing of the raw signal (see Methodology 
Chapter 4, Section ‎ 4.9). Calibration of both EMG outputs was undertaken using calibrated 
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voltage levels at the input to the EMG amplifier and linear regression (see calibration coefficients 
in Table B-1). 
Testing the performance of the slip clutch in setting resistance 
When the slip clutch was completely turned ‘off’ the lever arm moved freely with very little friction 
detected, when the slip clutch was gradually tightened (to increase the resistance) the lever arm 
torque remained approximately constant through all angles of the movement. With increasing 
resistance, however, a ‘backlash’ was felt at the beginning and end of movement. This feature 
meant that there was a small angle over which no resistance was exerted and it made it difficult 
to move and place the lever arm precisely. It was found that this inherent problem of the 
commercial slip-clutch, caused by ‘play’ in the mounting, has limited the usefulness of applying 
resistance during movement.  Other methods to apply constant resistance with smoother 
movement were considered but were found to be costly in terms of time and money and thus 
beyond the scope of this project. 
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Table B-1: Calibration coefficients for wrist rig outputs, and voltages to drive the LEDs for each 
angle, from -79 to 79 degrees.  
Outputs  gain  added  offset 
Angle  -67.2318  200.9842 
EMG1  0.66667  0.63158 
EMG2  0.70778  1.0348 
Lever torque  1.7415  -1.2771 
Volts for measured angles  Angles  Volts 
 
-79  0.096  1  2.0776 
 
-77  0.1562  3  2.1275 
 
-75  0.2063  5  2.1875 
 
-73  0.2565  7  2.2379 
 
-71  0.3066  9  2.2881 
 
-69  0.3567  11  2.3381 
 
-67  0.4069  13  2.3884 
 
-65  0.4569  15  2.4381 
 
-63  0.497  17  2.4883 
 
-61  0.5569  19  2.5384 
 
-59  0.5968  21  2.5883 
 
-57  0.6467  23  2.6385 
 
-55  0.6969  25  2.6984 
 
-53  0.7469  27  2.7483 
 
-51  0.807  29  2.7987 
 
-49  0.8569  31  2.8487 
 
-47  0.9069  33  2.8983 
 
-45  0.9468  35  2.948 
 
-43  0.987  37  2.9986 
 
-41  1.0366  39  3.0483 
 
-39  1.0867  41  3.0885 
 
-37  1.1467  43  3.1487 
 
-35  1.1869  45  3.1989 
 
-33  1.237  47  3.2489 
 
-31  1.2871  49  3.2988 
 
-29  1.3374  51  3.349 
 
-27  1.3871  53  3.3991 
 
-25  1.4371  55  3.4492 
 
-23  1.4869  57  3.4992 
 
-21  1.537  59  3.5491 
 
-19  1.5871  61  3.599 
 
-17  1.6371  63  3.6489 
 
-15  1.6874  65  3.6994 
 
-13  1.7375  67  3.7393 
 
-11  1.7775  69  3.7892 
 
-9  1.8375  71  3.8392 
  -7  1.8778  73  3.8892 
  -5  1.9275  75  3.9394 
  -3  1.9873  77  3.9893 
  -1  2.0275  79  4.049  
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Appendix C – Wrist Rig Testing Protocol 
 
Methods 
 
Signals recorded during each test 
EMG – wrist flex/ext 
Target angle (set by data file) 
Movement angle (potentiometer) 
Lever arm force - Passive Movement / Isometric Force (strain gauge on lever arm) 
Hinge Force -  sokinetic Movement (force applied on sensor by subjects’ activity) / Rig 
Resistance (resistance to movement applied by the braking mechanism set at each test for 
individual subject)  
 
General Points 
  All signals will be displayed during the tests in real time 
  All signals will be displayed on graphs at the end of the recording; a single graph can be 
displayed by clicking on the graph. 
  Files will be saved automatically and default names will be given but can be changed in the 
spread sheet file.  
  Extension angle is upwards on the graph and +ve, flexion angle is downwards and –ve. 
 
1.  Initial Set up 
  Register subject details: initials/ number / date / side tested / assessor / assessment no. 
  Save participant file 
  Test outputs 
 
2.  Active Range of movement (AROM) 
  Start AROM Test  
  Ask subject to move wrist to their maximum range of extension and flexion  
  Press AROM button to exit 
  There is a semi-automatic recording of maximum and minimum values.  Peak maximum and 
minimum default values are selected but values can also be selected manually.  
Automatic online calculation  
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  Mid-range for each subject is calculated as the mid-point between maximum and minimum. 
This is calculated at the initial assessment only. 
 
3.  Passive Range of Movement (PROM) 
  Start PROM Test  
  Assessor holds the buttons a the end of the lever arm and moves wrist to their maximum 
range of extension and flexion  
  Press PROM button to exit 
  There is a semi-automatic recording of maximum and minimum values.  Peak maximum and 
minimum default values are selected but values can also be selected manually. 
Automatic online calculation 
  Passive mid-range for each subject is calculated as the mid-point between maximum and 
minimum. This is calculated at the initial assessment only. 
 
4.  Isometric Force (IF) / Maximum Voluntary contraction (MVC) 
   mmobilise rig at zero˚ for wrist  
  Select MVC button and press ‘extension’ to start test 
  Ask the subject to push as hard as possible into extension against the pin for 5 seconds until 
asked to stop and give standard verbal encouragement throughout. Then rest (for 10 
seconds), then repeat the maximal contractions twice more (seconds each with 10 seconds 
rest).   
  The force into extension is recorded; the 3 peak maximum values of force are selected 
automatically but can be adjusted manually. 
  Select ‘flexion’.   
  Ask the subject to push as hard as possible into flexion against the pin for 5 seconds until 
asked to stop and give standard verbal encouragement throughout. Then rest (for 10 
seconds), then repeat the maximal contractions twice more (seconds each with 10 seconds 
rest).   
  The force into flexion is recorded; the 3 peak maximum values of force are selected 
manually. 
Automatic online calculation 
  Flexor / Extensor MVCforce is derived from maximum peak force of 3 tests.   
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5.  Active Tracking 
a)  Sinusoidal tracking 
  Ensure no resistance is applied. 
  Click tracking tab and select data file of sinusiodal tracking with desired test range through 
which the test is conducted (e.g. +/- 20˚ about mid-range of subject’s active range of 
movement) and desired target oscillation rate (e.g.0.5 HZ)   
  Explain the tracking test to the subject and instruct them to follow the lit LEDs as accurately 
and smoothly as possible. 
  Start the tracking test and LEDs to switch on at mid-point (initial rest period to record a 
baseline EMG signal with no voluntary activity (15 secs). 
  Target starts to move at the set frequency in sinusiodal pattern.  Encourage subject in a 
standard way. Data plots automatically appear on screen on line.  Check data represents 
subject’s performance. 
  Wait for total set time or press exit to stop 
  All signals are recorded and saved automatically 
Repeat as necessary 
 
b)  Step tracking 
  Ensure no resistance is applied. 
  Click tracking tab and select data file of square wave pattern with pre-determined 
frequencies, amplitudes and timing in a random order with the desired range (amplitude) 
through which the test is conducted (e.g. increasing range from +/- 5˚ to +/- 40˚ about mid-
range of subject’s active range of movement 
  Explain the tracking test to the subject and ask them to move to LED that is switched on as 
quickly and accurately as possible and to hold the position until another LED lights up. 
  Start the tracking test and LEDs to switch on at mid-point (initial rest period to record a 
baseline EMG signal with no voluntary activity (15 secs). 
  Target starts to move at the set square wave pattern.  Encourage subject in a standard way. 
Data plots automatically appear on screen on line.  Check data represents subject’s 
performance. 
  Wait for total set time or press exit to stop 
  All signals are recorded and saved automatically 
Repeat as necessary using other selected data files 
 
  
  189 
c)  Tracking with resistance 
  Set resistance at hinge joint – unstrap subject’s arm from the arm support and ask them to 
lift their arm away from the rig. Twist the slip clutch to increase resistance. Start the 0.5Hz 
sinusoidal tracking test and push lever arm back and forth holding onto the end stop whilst 
tracking the target. Read off force levels online and by adjusting the slip clutch set 
appropriate resistance level – percentage of participants extensor MVC. 
  Place and secure subject’s arm onto armrest and conduct tracking tests a) and b) as above. 
 
6.  Stretch Response Test 
  Ensure resistance clutch is fully released 
  Click Stretch test tab to select data file of sinusoidal wave pattern with desired range and 
target oscillation rate  
  Explain the tracking test to the subject and ask them to close their eyes, relax their arm and 
try not to help the movement during the test.  
  Start tracking target.  For the initial 5 seconds of the test LEDs light up at passive/active 
mid-range and the rig should remain still so a baseline EMG is recorded.  
  LEDs light up in sinusoidal wave.  The assessor then starts moving lever arm by holding 
the end of the rig at the set position so that the lever arm lines up with the lit LEDs  
  Wait for total time or press exit to stop 
  Data plots automatically appear on screen.  Check data. 
Repeat using other selected data files 
 
7.  Force/angle Test 
  Click browse to select data file of triangular wave pattern with desired target speed. 
  The subject is asked to relax , close their eyes and encouraged not to help the movement 
  Start the test, the LEDs will one by one light up at a constant rate  
  The assessor will move the subject’s wrist passively following the moving target (lit LEDs) 
by holding a fixed position at the end of the lever arm and hold the position of last lit LED 
for 5 secs. 
  Lit LED returns to full passive flexion range, assessor returns lever arm to the same 
position and allows a rest period of 10 seconds.  
  The target LEDs light up as before and the movement is repeated six times. 
  Wait for total time or press exit to stop. 
  Data plots automatically appear on screen.  Check EMG data to check for stretch response 
and any voluntary activity.   
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Appendix D – Ethical and Research Governance approval 
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Appendix E – Clinical Measurement Protocols 
The star Cancellation Test 
 
Figure A-1  The star Cancellation Test (SCT) from the Behavioural Inattention Test (Wilson et 
al. 1987). In the SCT, the patient is required to cross out 54 small stars (two on the midline and 
are crossed out by the health professional for the purposes of instruction) 27 on the left and 27 
on the right.  The small stars are randomly distributed among non-verbal and verbal distractors 
(52 larger stars, 13 letters and 10 short words) (Fig 2).  The cut-off score that indicates neglect is 
recommended as 51.  
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Table E-1: The Tardieu scale protocol and soring used in this study and based on the protocol 
by Morris et al (Morris 2002)  
Position  Participant in a sitting position, elbow flexed by 90° 
Specified velocity of extension 
stretch movement 
V3: As fast as possible (faster that the rate of the natural drop 
of the limb segment under gravity) 
Quality of muscle reaction (X):  0: No resistance throughout the course of the passive 
movement 
1: Slight resistance throughout the course of the passive 
movement, with no clear catch at a precise angle 
2: Clear catch at a precise angle, interrupting the passive 
movement, followed by release 
3: Fatigable clonus (<10 seconds when maintaining pressure) 
occurring at a precise angle 
4: Infatigable clonus (>10 seconds when maintaining pressure) 
occurring at a precise angle 
Angle of muscle reaction (catch) 
felt during extension stretch (Y): 
Measured in degrees flexion or extension relative to the zero 
position (hand in a straight line with forearm) 
 
Table E-2: Specific starting positions, movements and hand grips for testing proprioception used 
in this study, based on a revised version of the Nottingham Sensory Assessment (Stolk-
Hornsveld et al. 2006). 
Starting position  Participant in a sitting position, elbow flexed by 90° 
Movement and instruction  Three passive flexion and extension of the wrist throughout the full 
available range of movement, the patient was asked: 'Is your hand 
moving upwards or downwards?' 
Assessor hand grips  Distal (moving) hand: place the thumb on the lateral aspect and the 
index finger on the medial aspect of the hand. 
Proximal (fixing) hand: fix the distal end of the forearm. 
Scoring  0 – Absent: Patient does not detect the movement taking place. 
1 – Impaired: Patient detects the movement taking place but the 
direction is not correct on all three occasions. 
2 – Normal: Patient correctly detects the direction of the movement 
taking place on all three occasions. 
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Appendix F - Wolf Motor Function Test Instruction Manual 
 
Rebecca Stuck (University of East Anglia) and Ruth Turk (University of Southampton)  
September 2009 
 
The original version of the WMFT was by Dr. Steven Wolf (1989), Emory University, and 
later modification of this was based on observations during a visit of three persons from 
UAB (Edward Taub, Paul Blanton, and Karen McCulloch).  A further version of the test 
was written by David Morris, M.S.P.T, Jean Crago, M.S.P.T and Edward Taub, PhD 
(2001).  Additional modifications were made by Sandy McCombe Waller and Jill Whitall, 
(University of Maryland Baltimore) to collect data on subjects with mild and moderate 
hemiparesis (Whitall et al. Arch Phys Med Rehabil, 2006).  
 
This instruction manual for the WMFT is based on the protocol from Morris et al, 2001, 
but incorporates the scoring scale and additional sub-tasks from Whitall et al (2006) as it 
is more suitable for both mild and moderate severity of hemiparesis. In this version, 
however, the standardisation of the table height as well as the chair position to each 
subject has been included with the aim of accommodating all sizes and heights of 
subjects. Subjects will be allowed to practice each task first with their nonparetic arm 
whereas previous guidelines have not included this suggestion.  A template has been 
added for precise positioning of objects as well as a list of required materials and 
equipment, and the instructions have been changed to UK English.  Also in this version 
(September 2009) task numbers 8 and 14 have been removed as the weighted object 
tasks will not be required for the current study. 
 
 
General Instructions 
 
1.  The final time score will be median (and/or mean) time required for all timed tasks 
executed.  One hundred twenty seconds is the maximum time allowed for each task 
attempted.  Since medians will be used, all scores above the median (whether, e.g., 
62 sec or 120 +) have the same weight.  Thus, if the examiner feels that the subject 
cannot possibly complete the task, they can terminate in order to prevent excessive 
subject discouragement. The time to be recorded would be 120 +. 
 
2.  Functional Ability is scored using a 5-point scale (page 3). Specific guidance is also 
given for each task in the manual. For the Functional Ability score the total and mean 
score can be used.  
 
3.  In order to assure a standard placement of test objects, a template should be taped 
to the desk so that its front edge is flush with the front edge of the desk.  The outline 
of each test objects should be traced on the template in the position in which it 
should be placed. 
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4.  The position and setup of the table and chair are different in this version of the 
WMFT. The table height is adjusted to reflect the height of the subject and the 
position of chair is set up to accommodate the subjects arm length as all tasks 
require some form of reaching. The starting position should be optimal for the task 
performance (e.g. desk does not block/restrict movement, subject can reach 
objects). Final chair positioning should be established using the less-affected upper 
extremity and recorded on the recording form so that the position can be replicated in 
later tests. The height of the table should also be recorded. If testing both arms the 
same chair position should be used.  For more detailed guidance see Subject 
Positioning section on page 4. 
 
5.  The non-paretic limb is not generally tested, but can be tested in order to compare 
what is ‘normal’ when scoring for the paretic limb  
 
6.  Subjects wearing long sleeves should roll the sleeve up on the affected arm before 
beginning the test.  
 
7.  Starting point: The point at which timing begins (i.e. when the examiner says, “Go.”) 
 
8.  For all timed tasks, subjects should be encouraged to perform the tasks as quickly as 
possible. 
 
9.  Timing is carried out using a stopwatch.  (It was felt this was adequate since test 
subjects are primarily subjects with motor deficits who give large performance times.) 
 
10. Verbal encouragement may be given to subjects during the task attempts to maintain 
motivation or attention. The phrase “good effort, keep going, don’t give up” should be 
repeated in a calm, confident voice. The phrase should be repeated approximately 
12 times over the 2 minute period (i.e. once every 10 seconds).  
 
11. Each task should be described and demonstrated two times at the time the 
instructions are given.  Note: subjects may practice the task with their non-paretic arm 
but not with the paretic arm before being tested. 
 
12. If objects are dropped on the floor during a task attempt, the tester should quickly 
return the object to the starting position without interrupting the timing process. It 
may be useful to have back-up items (i.e. extra paper clip, pencil etc.) so that the 
item can be replaced quickly if dropped. If it takes longer than 5 seconds to replace 
an item the task should be repeated.  
 
13. The purpose of the examination is not to test cognitive ability. Therefore if a subject 
appears confused about or misunderstands the task on the first attempt, the task 
should be repeated. Entire verbal instructions and demonstration can be repeated 1 
time per task and subjects may practice the task again with their non-paretic arm. If 
the subject performs the task incorrectly the second time, a 120+ is assigned for the 
time score.  
14. Some tasks have several subtasks.  At each testing point have the subject attempt 
all subtasks in the specified order and record the time and functional ability score for 
each subtask.  
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15. Pre-post comparisons for timing and function score must compare like strategies. 
 
16. Filming is optional but maybe advantageous for non-blinded raters and to prevent 
other forms of bias 
 
 
Instructions to the subject: These instructions should be given to each subject as an 
introduction each time the WMFT is administered: 
 
“Today I am going to see how well you can use you arm. 
There are 15 tasks that I will ask you to do as quickly as you can. 
Before each task I will read you the instructions and demonstrate the task 2 times. 
You may practice the tasks with your unaffected arm while I am demonstrating, but not 
with your affected arm, I can explain again if you do not understand.  Please try and do 
each part of the test even if you do not think that you can do it. The tasks will be timed, 
you can work on each task for up to two minutes, but if it is obvious that you are unable 
to carry out a task then we will stop and move on to the next task.  Do you have any 
questions?” 
 
 
 
Functional Ability Scoring Scale: 
 
0 =   Does not / unable to attempt with the involved arm 
1 =   Involved arm does not participate functionally and the task is not achieved; 
however an attempt is made to use the arm 
2 =   Arm does participate and the task is achieved, but movement is influenced to 
some degree by compensatory movements and/or abnormal movement patterns 
or performed slowly and/or with effort  
3 =   Arm does participate and the task is achieved in one attempt; movement is close 
to normal but slightly slower; may lack precision, fine co-ordination, or fluidity 
4 =  Arm does participate; movement appears to be normal, timely (pay attention to 
expected normal times) and controlled.  
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Scoring guidance for each specific task is given throughout the manual 
 
 
Positioning of the Subject 
 
  The subject must be seated in an upright position with their legs in front of the 
chair, and feet in contact with floor throughout testing.  The assessor may provide 
foam padding to the back of the chair to ensure that an upright position is 
maintained.(Yozbatiran, 2008) 
  The height of testing-table should be approximate to the subject’s midabdomen, 
with the difference in chair-table height of 20-30 cm considered optimal. 
Shoulders should be in neutral elevation/depression when forearms pronated on 
the testing-table. Chair to table height should be recorded on baseline and 
replicated for all reassessments 
  Position of the chair will be determined by the length of their upper limb. Use the 
grid on page 4 to determine position of chair in relation to table. Record the 
placement of the chair on the Wolf cover sheet.   
  Pay careful attention to subject’s body and arm position for each task.  Make sure 
effort for tasks is coming from the arm and not from trunk movement. The head is 
held in a neutral upright position.   
 
Positioning of Subjects – task specific instructions: 
 
In previous versions of the WMFT the chair is placed at 8.5cm away from the table 
assuming that subjects’ average height is 5’8”. Where subjects are substantially taller or 
shorter than 5’8” the chair position is adjusted so that patients can reach the items on 
the template (Morris, Crago and Taub 2001), though this adjustment is not standardised.   
 
In order to standardise the tasks to the size of each individual, in this version, the 
assessors determine the distance of the chair from the table by measuring the subjects 
arm length. This is done using the following procedure and grid:  
 
Measure each subject’s non-paretic arm from acromion to tip of thumb when their arm is 
relaxed down by side in sitting.  Use the grid below to determine chair placement in 
terms of distance from table. Once positioned, ensure the subject can reach the 40cm 
line with non-paretic thumb; the chair can be moved closer if required as long as it is 
recorded on the score sheet. 
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Subject Positioning Table 
Length of subject arm 
from acromion to tip of 
thumb 
Tasks 1-4  
Chair facing sideways  
Distance from table to 
side of seat 
Tasks 5-6 and 9-17 
Chair facing forwards 
Distance from table to front 
of seat 
60cm (or less)  Side of seat next to table  Front of seat next to table 
65cm  Approx 4cm  Approx 4cm 
70cm   Approx 8cm  Approx 8cm 
<70cm  Up to 12cm  Up to 12cm 
 
Filming Instructions 
 
Although a study has suggested that videotaping is not required to generate accurate 
scores (Whitall, 2006), it may be advantageous to videotape examinations for later 
rating by a panel of blinded clinicians to the pre-post treatment status of the subject or to 
other considerations that might bias ratings.  Camera height and position should allow a 
view that included maximal clarity of the task end position on the template.  
 
 
Guidance for filming positions: 
 
Filming position side: tasks 1-6, 8 17 (gross tasks) 
View of the whole body while the subject’s side being tested is placed next to desk. The 
edge of the camera tripod should be placed approx 3 feet to the side of the desk and 
directly in line with the back edge of the desk. The camera should be facing the subject 
and the view should include the subject’s entire body.  
 
Filming position side-close: tasks 9-13, 15-16 (fine motor tasks)  
Profile of Expanded View of Limb being tested: The camera tripod remains in the same 
position at the side position. The camera view should be zoomed in to focus on the fine 
motor skills. The view should include the patient’s entire upper extremity.  
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Materials, equipment and template 
 
Materials and Equipment  
 
 
 
 
                  Box Dimensions   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Template dimensions and Lines  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Specific Task Instructions 
 
 Height adjustable table to fit template (137 x 76cm) 
 A standard upright chair / wheelchair with firm back 
and without armrests         
 A laminated template (with object positioning, 
placement and target lines)  
 Stopwatch 
 A box (23cm H / 35 cm L / 26 cm W) 
 Weights – 1lb wrist weight with Velcro strap; 3 lb 
weight 
 12oz unopened soft drink can 
 7 inch pencil 
 2 inch paper clip 
 3X5 inch playing cards 
 3x checkers size:  
 Standard Yale Key and lock mounted at 16cm height 
on a board, tumblers of the lock set to allow 180
0 arc, 
with 90
0 of that arc on either side of midline 
 Small dish towel – approx size: 57cm x 41 cm 
 Shopping basket with handle 
 Adjustable height, rolling bedside table – set at 15” 
above testing- table 
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1.   Forearm to table (side) 
 
SET UP 
 
Starting position: 
  Position chair 
according to 
guidance above 
and record on 
scoring sheet 
  Hips against chair 
back 
  Both feet on floor or 
supported with 
footplates at 90º 
 
  Filming position 
(side) 
TASK 
 
Task description: 
  Subject attempts to place 
forearm on the table (adjacent 
and parallel to front edge) by 
abduction at the shoulder.  
(Some shoulder flexion will 
probably also be necessary to 
get arm past the edge of table.)  
“Forearm” is defined as the 
wrist and elbow.  The palmar 
surface of the hand need not be 
flat.  Timing ends when both 
the forearm and hand touch the 
table. 
 
Timing procedure: 
  Start on word “Go” and ends 
when subject’s forearm and 
hand touch the table in the 
required position. 
 
Measure: 
  The time elapsed from the 
starting point to the moment the 
forearm and hand touch the 
table in the required fashion. 
 
VERBAL INSTRUCTIONS 
 
Verbal Instructions: 
 
“When   say “Go” Place your 
forearm on the table as 
quickly as you can like this 
(examiner demonstrates).   
 
Make sure you place your 
arm and hand completely on 
the top of the table  
Ready, Go.” 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
Score 0= 
No voluntary movement seen at involved joints. 
I.e. if movement seen only in hand and there is 
no reaching movement then subject scores a 0  
Score 1= 
Movement seen at involved joints  
  
  205 
2.  Forearm to box (side) 
 
SET UP 
 
Starting position: 
  Subject seated in chair, as 
position 1. 
  Hips against chair back 
  Hand not being tested placed 
on thighs 
  Shoulder of tested arm 
abducted with forearm 
pronated and placed flat on 
the table with radial edge 
adjacent to front edge of table; 
elbow at line 14 cm from edge 
of end of table (with the 
shoulder joint not flexed or 
extended).  Palmar surface of 
hand need not be flat.  If final 
position of arm on previous 
task is not 14 cm from side 
edge of table, move subject’s 
arm into correct position 
before beginning this task. 
  Box is placed at 14cm from 
the side edge of the table, and 
at 8cm from the front edge  
  Box should be stabilised by 
someone during the trial 
 
  Filming position (side). 
TASK 
 
Task description: 
  Subject attempts to place 
forearm (as defined above- 
from wrist to elbow) on the 
box by further abduction at 
the shoulder.  (Again some 
shoulder flexion may be 
necessary to clear edge of 
box.)  At the end, the 
forearm should be flat on the 
box with the hand drooping 
over side edge of box.  The 
wrist must be beyond the line 
2 cm from the front edge of 
box and the elbow must be 
beyond the front edge of the 
box.  
 
Timing procedure: 
  Starts on word “Go” and 
ends when subject’s forearm 
is flat on box with the hand 
drooping over the edge of 
the box. 
 
Measure: 
  The time elapsed from the 
starting point to the moment 
the forearm touches the top 
of the box in the required 
fashion with the hand 
drooping over the edge of 
the box.   
 
VERBAL 
INSTRUCTIONS 
 
Verbal Instructions: 
 
 “When   say “Go” 
place your forearm on 
the box as quickly as 
you can like this 
(examiner 
demonstrates).   
 
Place you arm so that 
your hand is drooping 
over the edge of the 
box and your wrist is 
past the line. 
Ready, Go.” 
 
 
 
Task specific scoring guidance 
Score 0= 
No voluntary movement seen at involved 
joints. 
I.e. if movement seen only in hand and 
there is no reaching movement then subject 
scores a 0   
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3.  Extend elbow (to the side) 
 
SET UP 
 
Starting position: 
  Subject seated in chair as 
position 1. 
  Hips against chair back. 
  Hand not being tested on 
thighs 
  Shoulder of tested arm 
abducted with forearm 
resting flat on table in a 
pronated position.  Palmar 
surface of hand need not 
be flat on table 
  Forearm being tested 
adjacent to front edge of 
table; elbow at line 14 cm 
from side edge of table 
(with the shoulder joint not 
flexed or extended) 
 
TASK 
 
Task position: 
  Subject attempts to reach 
across the 40 cm line on 
template (drawn from the 
front edge of the table) by 
extending the elbow (to the 
side).  Elbow can be lifted 
off the table during the task.  
This may be the only way 
shorter subjects can reach 
40 cm line.  Shoulders 
should be kept level to 
prevent leaning with the 
trunk.  Some external 
rotation at the shoulder is 
necessary to carry out this 
movement, but the 
examiner should prevent 
too much of this movement. 
 
Timing procedure: 
  Starts on the word “Go” and 
ends when the subject’s 
thumb passes the line. 
 
Measure: 
  The time elapsed from the 
starting point to the time the 
thumb crosses the line. 
 
VERBAL INSTRUCTIONS 
 
  “When   say “Go” slide 
your hand across the 
table by straightening 
your elbow so that your 
thumb reaches over 
this line like this 
  Your elbow is allowed 
to rise off the table.   
   Keep your body as still 
as you can.  
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
Note: the subject should 
slide their hand across the 
table.  Repeat the task if 
they lift their hand off of the 
table. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
Score 0= No voluntary movement seen at involved joints. 
I.e. if movement seen only in hand and there is no reaching movement then subject 
scores a 0  
Score 1= Movement seen at involved joints but does not achieve task 
Score 2= Achieves task but with excessive compensation at the trunk (rotation or 
leaning) 
Score 3= Achieves task with minor trunk compensation and loss of elbow extension 
Score 4 = Must demonstrate full range of elbow extension (in comparison to non-
paretic arm).  Hand must remain in contact with the table  
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4.  Extend elbow (to the side) – with 1 lb weight 
 
SET UP 
 
Starting position: 
 
  Subject seated in chair as 
position 1. 
  Hips against chair back 
  Hand not being tested on 
thighs 
  Shoulder of tested arm 
abducted with forearm 
resting flat on table in 
pronated position exactly 
as in last task. 
  Forearm of arm to be 
tested adjacent to front 
edge of table; elbow at 
line 14 cm from side edge 
of table (with the shoulder 
joint not flexed or 
extended); palmar surface 
of hand need not be flat. 
  1 lb weight (sandbag) 
placed at ulnar edge of 
wrist; bottom edge of 
weight aligned with ulnar 
styloid process. 
 
  Filming position (side) 
TASK 
 
Task description: 
 
  Subject attempts to push the 
sandbag across 40 cm line 
(drawn from front edge of 
table) by extending the elbow 
and to a lesser extent 
externally rotating the 
shoulder.  Elbow should be 
kept on the table throughout 
the task (different from 
previous task) and shoulders 
should be kept level to 
prevent leaning with the trunk.  
Again, the examiner needs to 
be aware of subject’s trunk 
leaning and/or excessive 
external rotation at the 
shoulder to perform task 
(especially true for taller men) 
 
Timing procedure: 
  Starts on the word “Go” and 
ends when the leading edge 
of sandbag crosses line. 
 
Measure: 
  The time elapsed from the 
starting point to the time the 
leading edge of the sandbag 
initially crosses the line. 
 
VERBAL INSTRUCTIONS 
 
Verbal instructions: 
 
  “When   say “Go” push 
the weight across the 
line by straightening 
your elbow as quickly 
as you can like this  
  This time keep your 
elbow on the table.   
  Keep you arm in 
contact  the weight until 
you have finished 
  Try to keep your body 
as still as possible 
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
Note: If the elbow is lifted, 
allow a 2
nd attempt.  
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
Score 0= No voluntary movement seen at involved joints. 
I.e. if movement seen only in hand and there is no reaching movement then subject scores a 0  
Score 1= Movement seen at involved joints  
Score 2= Accomplished with excessive compensatory trunk movement and/or very limited 
elbow extension 
Completes task but hand does not remain in contact with the weight  
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5. Hand to table (front) 
 
SET UP 
 
Starting position: 
  Position chair 
facing the table 
according to 
guidance above. 
Record position on 
scoring sheet) 
  Both hands on 
thighs 
  Hips against chair 
back 
 
  Filming position 
(side) 
 
 
TASK 
 
Task description: 
  Subject attempts to place involved hand on 
the table.  The heel of the hand must rest 
beyond taped line 2 cm from front edge of 
table.  The palmar surface of the hand 
need not be flat (Place most of the hand in 
the circle.) 
 
Timing procedure: 
  Starts on the word “Go” and ends when the 
heel of the hand and fingers touch table 
beyond the taped 2 cm line. 
 
Measure: 
  The time elapsed from starting point to 
moment the heel of the hand and fingers 
touch table beyond the taped 2 cm line 
 
VERBAL 
INSTRUCTION 
 
Verbal instructions: 
  “When   say 
“Go” place your 
hand in the 
circle on the 
table as quickly 
as you can like 
this (examiner 
demonstrates)   
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
Score 0= 
No voluntary movement seen at involved joints. 
I.e. if movement seen only in hand and there is 
no reaching movement then subject scores a 0  
Score 1= 
Movement seen at involved joints  
Note: The final posture of the hand and fingers 
does not influence scoring as long as the heel of 
the hand is in contact with the table  
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6. Hand to box (front) 
 
SET UP 
 
Starting position: 
  Subject seated in chair 
facing table; chair centred 
on template as for task 5. 
  Hand not being tested on 
thighs. 
  Hand to be tested placed on 
table, heel of hand just 
beyond the line 2 cm from 
front edge of table (i.e. just 
past taped line, in circle – as 
in final position on last task). 
  Box centred on table; front 
edge aligned with 20 cm 
line. 
  Box should be stabilised by 
someone during the trial 
 
  Filming position (side) 
 
TASK 
 
Task description: 
  Subject attempts to place 
hand on the box.  The heel of 
the hand must be placed past 
the front edge of the box.  The 
palmar surface of the hand 
need not be flat. 
 
Timing Procedure: 
  Starts on the word “Go” and 
ends when the heel of the 
hand and fingers touch the 
box past the edge of the box. 
 
Measure: 
  The time elapsed from starting 
point to moment the heel of 
the hand and fingers touch 
box past the edge of the box. 
 
VERBAL 
INSTRUCTIONS 
 
Verbal Instructions: 
  “When   say “Go” lift 
your hand from the 
table and place it on 
the box as quickly as 
you can, like this 
(examiner 
demonstrates).   
  Make sure your hand 
goes all the way onto 
the top of the box  
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
Score 0= 
No voluntary movement seen at involved joints. 
I.e. if movement seen only in hand and there is 
no reaching movement then subject scores a 0  
Score 1= 
Movement seen at involved joints  
Note: The final posture of the hand and fingers  
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8. Reach and Retrieve 
 
SET UP  
 
Starting position: 
  Move chair closer to the table 
so that front legs of chair are 
approximately 11 cm further in 
than front edge of table. Check 
the position by asking the 
Subject to reach to the 40 cm 
line with their non-paretic arm 
and check their fingers cross 
the line (if not move the chair in 
closer or further away) (record 
chair position on scoring 
sheet). 
  1 lb weight centred on table 
and positioned just beyond 40 
cm line 
  Hand not being tested on 
thighs 
  Arm to be tested: elbow 
extended with palm of hand in 
contact with weight and 
forearm positioned in midrange 
between pronation and 
supination.  
  Hips against chair back 
  Subject must be able to 
maintain starting position while 
the tester states “Ready, Go” 
  Filming position (side) 
 
TASK 
 
Task description: 
  Subject attempts to 
pull 1 lb weight 
across the 8 cm line.    
Task object is a cuff 
weight folded in half 
and kept in place 
with a Velcro 
fastener. 
 
Timing procedure: 
  Start on the word 
“Go.”  End when the 
leading edge of the 
weight crosses the 8 
cm line. 
 
Measure: 
  The amount of time 
elapsed from the 
starting point to the 
moment the leading 
edge of the weight 
crosses the 8 cm 
line. 
 
VERBAL INSTRUCTIONS 
 
Verbal Instructions: 
  “When   say “Go” slide the 
weight across the table so 
it passes this line as 
quickly as you can.  Do 
the task by bending your 
elbow like this (examiner 
demonstrates). The weight 
should remain in contact 
with your hand until it 
crosses the line. 
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Specific Scoring guidance 
For this task the examiner is allowed to assist the subject in achieving the starting position  
Score 0 = No voluntary movement /no active control of elbow joint (flexion) observed 
Unable maintain starting position without physical assistance 
Score 1 = Starting position achieved through compensatory movement, i.e. excessive trunk flexion or 
restricted range of elbow extension / shoulder flexion.  
Score 2 = Subject loses contact with weight or pronates forearm or excessive upper arm or hand 
movements (i.e., swatting the weight with the hand) to achieve task 
Score 3 = Minimal compensation movements of the trunk, upper arm or hand and / or lacks fluidity  
Note: Some subjects may need to reach forward in order to reach 40cm line. Allow for appropriate trunk 
flexion but not if subject uses this as compensation for limited elbow extension / shoulder flexion.   
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9. Lift Can 
 
SET UP 
 
Starting position: 
  Subject seated in 
chair facing 
table; chair 
centred on 
template. 
  Chair returned to 
earlier position – 
tasks 5 & 6 
  Hands on thighs 
  Unopened 12 oz 
soft drink can 
placed on table 
at subjects 
midline with front 
edge of can just 
beyond 20 cm 
line 
 
  Filming position 
(side-close) 
TASK 
 
Task description: 
  Sub task 9a: subject to lift the can 
and bring it close to lips with a 
cylindrical grasp 
  Subtask 9b: subject to lift the can 
and bring it close to lips with disc 
grip 
  Subtask 9c: subject to lift the can 
and bring it close to lips with a 
cylindrical grasp, unaffected hand 
to stabilize can. 
  Subtask 9d: subject to lift the can 
and bring it close to lips with disc 
grip, unaffected hand to stabilize 
can. 
 
Timing procedure: 
  Start on the word “go.”  End when 
can is within approximately one 
inch of subject’s mouth. 
 
Measure: 
The time elapsed from starting point to 
the moment the can comes within 
approximately one inch of the subject’s 
mouth. 
VERBAL INSTRUCTIONS 
 
Verbal instructions: 
 
  “You may be asked to do 
this task four different 
ways.   
 
Subtasks a & b 
  When   say “Go” lift the can 
to your mouth without 
touching your lips, like this 
(demonstrate).  Do this as 
quickly as you can.   
Ready, Go.” 
 
 
Subtasks c & d 
  When   say “Go” lift the can 
to your mouth without 
touching your lips, you 
may support the can with 
your other hand like this 
(demonstrate).  Do this as 
quickly as you can.   
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
For all tasks requiring hand function, i.e. grasping, lifting 
and manipulation of objects, there must be some 
movement of the fingers / thumb to score a 1. 
Score 0 = No movement at fingers / thumb   
Score 1 = Movement must be initiated at hand / fingers. 
Unable to use specific grip given in instructions to 
complete the task  
Score 2 = Achieves task using correct grip but with 
abnormal movement pattern (e.g. poor opening of the 
hand, lifting and trajectory control) moving of the object 
around the table, and/or more than 1 attempt to 
complete task 
Score 3 = Achieves task but with minor difficulty 
opening hand / lifting the object, or slightly slower than 
normal  
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10. Lift Pencil 
 
SET UP 
 
Starting position: 
  Subject seated 
in chair facing 
table; chair 
centred on 
template 
  Hands on 
thighs 
  Hips against 
chair back 
  7 inch pencil 
placed parallel 
to front edge of 
table, centred 
on subject’s 
midline and 
with front edge 
of pencil at 20 
cm. line 
 
  Filming position 
(side-close) 
TASK 
 
Task Description: 
  Subtasks 10a: subject attempts to 
pick up the pencil using 3-jaw 
chuck prehension (thumb and first 
two fingers). 
  Subtask 10b: subject attempts to 
pick up the pencil using 3-jaw 
chuck prehension with unaffected 
hand stabilizing the pencil 
Note: The pencil should be picked up 
off the table and not over the edge of 
the table. If the patient performs the 
task by lifting the pencil over the edge 
of the table once, repeat the task one 
more time. Assign a 120+ if the task 
cannot be accomplished in the 
correct manner 
  Subtask 10c: subject attempts to 
pick up the pencil by sliding it to 
the edge of the table and then 
using a palmar grasp 
 
Timing Procedure: 
Starts on word “Go” and ends when 
entire pencil (all surfaces) is raised 
from the table by at least an inch 
VERBAL INSTRUCTIONS 
 
Verbal instructions: 
   “You may be asked to do 
this task 3 different ways 
 
Subtask  a  
  When   say “Go” pick up the 
pencil like this (examiner 
demonstrates).  The pencil 
should be picked up on the 
table and not over the edge 
of the table. Do this as 
quickly as possible.  
Ready, Go.” 
Subtask b 
  When   say “Go” pick up the 
pencil like this (examiner 
demonstrates). You may use 
the other hand to support the 
pencil Do this as quickly as 
possible.  
Ready, Go.” 
Subtask b 
When   say “Go” pick up the 
pencil like this (examiner 
demonstrates). 
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
For all tasks requiring hand function, i.e. grasping, lifting 
and manipulation of objects, there must be some 
movement of the fingers / thumb to score a 1. 
Score 0 = No movement at fingers / thumb   
Score 1 = Movement must be initiated at hand / fingers 
Unable to use specific grip and/or pick up the pencil in 
the correct manner given in instructions (assign 120+) 
Score 2 = Achieves task using correct grip but with 
abnormal movement pattern (e.g. poor opening of the 
hand and lifting control) moving of the object around the 
table, and/or more than 1 attempt to complete task 
Score 3 = Achieves task but with minor difficulty opening 
hand / lifting the object, or slightly slower than normal 
Note: take in to account control of clasp.   
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11. Pick up paper clip 
SET UP 
 
Starting position: 
  Subject seated in chair 
facing table; chair 
centred on template.  
  Hands on thighs 
  Hips against chair back 
  2 in paper clip placed 
parallel to the edge of 
the table, centred on 
subject’s midline, and 
with front edge of clip at 
20 cm line; the wider 
end of the paper clip 
should be facing 
towards the side to be 
tested. 
 
  Filming position (side-
close) 
TASK 
 
Task description: 
  Subtask 11a: Subject attempts to 
pick up the paper clip using a 
pincer grasp (pads of thumb and 
index finger opposed). 
  Subtasks 11b: Subject attempts 
to pick up the paper clip using a 
pincer grasp with unaffected 
stabilizing the paper clip 
Note - The paper clip should be 
picked up on the table and not over 
the edge of the table. If the patient 
performs the task by lifting the paper 
clip over the edge of the table once, 
repeat the task one more time. 
Assign a 120+ if the task cannot be 
accomplished in the correct manner. 
 
Timing procedure: 
  Start on the word “go.”  End 
when entire paper clip is off the 
table. 
Measure: 
  The time elapsed from the 
starting point to the moment the 
entire clip is raised from the table 
surface. 
VERBAL INSTRUCTIONS 
 
Verbal instructions: 
Subtask a: 
  When   say “Go” pick up the 
paper clip like this as quickly 
as you can (examiner 
demonstrates). The paper clip 
should be picked up on the 
table and not over the edge of 
the table.    
Ready, Go.” 
Subtask b: 
  When   say “Go” pick up the 
paper clip like this as quickly 
as you can (examiner 
demonstrates). You can use 
your other hand to support the 
paper clip. The paper clip 
should be picked up on the 
table and not over the edge of 
the table. 
Ready, Go.” 
Special Consideration: 
Fingernail length can significantly 
affect performance; therefore, 
patient should be instructed when 
making test arrangements to not 
clip fingernails for at least three 
days before test session. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12. Stack Checkers 
 
 
 
Task specific scoring guidance 
For all tasks requiring hand function, i.e. grasping, lifting and 
manipulation of objects, there must be some movement of the 
fingers / thumb to score a 1. 
Score 0 = No movement at fingers / thumb   
Score 1= Movement must be initiated at hand / fingers.  Unable 
to use specific grip given in instructions to complete the task 
(120+ sec given) 
Score 2 = Achieves task using correct grip but with abnormal 
movement pattern (e.g. poor opening of the hand and lifting 
control) moving of the object around the table, and/or more than 
1 attempt to complete task 
 Score 3 = Achieves task but with minor difficulty opening hand / 
lifting the object, or slightly slower than normal  
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12. Stack Checkers 
SET UP 
 
Starting position: 
  Subject seated in 
chair facing table; 
chair centred on 
template 
  Hands on thighs 
  Three checkers are 
placed in a line 
parallel to front edge 
of table with front 
edge of each checker 
just beyond 20 cm 
line.  Checkers 
spaced 4.5 cm apart 
with middle checker at 
subject’s midline. 
 
  Filming position (side-
close) 
 
TASK 
 
Task description: 
  Subject attempts to stack the 
two end checkers onto the 
centre checker.  The task can 
be executed by picking up 
either checker first. 
 
Timing procedure: 
  Start on the word “Go.”  End 
when subject has placed the 
third checker in prescribed 
position. 
 
Measure: 
  The time elapsed from the 
starting point to the moment the 
third checker is in place. 
 
VERBAL INSTRUCTIONS 
 
Verbal instructions: 
  “When   say “Go” stack 
the two checkers on the 
end onto the middle 
checker like this 
(examiner 
demonstrates).  Do this 
as quickly as you can.   
Ready, Go.” 
 
 
Note: Checkers may be out 
of alignment, but, in order 
for the task to be considered 
completed, the top two 
checkers may not be 
touching the table surface. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
For all tasks requiring hand function, i.e. 
grasping, lifting and manipulation of objects, 
there must be some movement of the fingers / 
thumb to score a 1. 
Score 0 = No movement at fingers / thumb   
Score 1= Movement must be initiated at hand / 
fingers 
Score 2 = Achieves task but poor control in 
clasping checkers, drops checkers etc 
Score 3 = Achieves task but with minor difficulty 
with precision or fluidity, or slightly slower than 
normal 
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13. Flip cards 
 
SET UP 
 
Starting position: 
  Subject seated on 
chair; chair centred 
on template 
  Hands on thighs 
  Hips against chair 
back 
  3, 3 X 5 in index 
cards placed in a 
line parallel to front 
edge of table, with 
short edge of card 
closest to subject 
just beyond 20 cm 
line.  Cards spaced 
3 cm apart with 
middle card at 
subject’s midline. 
 
TASK 
 
Task description: 
  Subtasks 13a: Using a pincer grasp on the 
near edge of the cards, subject attempts to 
flip each of the cards over.  This task 
should be done by sliding the front edge of 
the card just past the front edge of the table 
with some or all of the fingers and then 
grasping the card edge protruding past the 
table edge between the palmar surfaces of 
thumb and index finger.  Cards should be 
flipped over from side to side (for 
supination, rather than from front to back).  
The cards do not have to be straightened or 
adjusted after they have been turner over.  
The subject should first flip over the card on 
the side being tested, then the centre card 
and then the card on the opposite side.  
Subject should be prevented from wetting 
fingers by licking. 
 
  Subtask13b: Slide the cards towards the 
body and then flip them, end over end, with 
the dorsum of the hand. 
 
VERBAL INSTRUCTIONS 
 
Verbal description: 
Subtask a: 
  “When   say “Go” flip 
over each card from side 
to side. Start with the 
card on your (state side 
being tested) side, then 
the middle card, and then 
the card on your (state 
opposite side) side.   
  Watch me first (examiner 
demonstrates). Do this 
as quickly as you can.  
Ready, Go.” 
 
Subtask b: 
  “This time you will flip the 
cards from end to end 
like this (examiner 
demonstrates).   
  Do not lick your fingers 
and do the task as 
quickly as you can when 
I say Go 
 Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
For all tasks requiring hand function, i.e. grasping, lifting 
and manipulation of objects, there must be some 
movement of the fingers / thumb to score a 1. 
Score 0 = No movement at fingers / thumb   
Score 1= Movement must be initiated at hand / fingers 
Unable to use specific grip given in instructions to 
complete the task (120+ given) 
Score 2 = Achieves task using correct grip but with 
poor dexterity of the fingers, and excessive 
compensation of the trunk or upper arm and/or more 
than 1 attempt to flip any card 
Score 3 = Achieves task but with minor difficulty with 
fluidity and precision, or slightly slower than normal 
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15. Turning Key in Lock 
SET UP 
 
Starting position: 
  Subject is seated in 
chair facing table; chair 
centred on template. 
  Chair returned to 
original position 
  Hands placed on thighs. 
  Hips against chair back 
  Examiner holds lock 
and key board, 
preventing board from 
moving when used by 
subject; board held 
parallel to front edge of 
table, just beyond 8 cm 
line and centred on 
subject’s midline. 
 
  Filming position (side-
close) 
TASK 
 
Task description: 
  Using a lateral pincer grasp, 
subject attempts to move the 
key in the lock from the vertical 
position first to the side being 
tested, then to the opposite side 
and finally back to the vertical 
starting position.  Tumblers of 
the lock are set so that the key 
moves through a 180 degree arc 
(only), with 90 degrees of that 
arc on either side of the midline 
 
Timing procedure: 
  Start on the word “Go.”  End 
when the key is in the starting 
position again. 
 
Measure: 
  The time elapsed from the 
starting point to the moment the 
key is returned to the starting 
position. 
VERBAL INSTRUCTION 
 
Verbal instructions: 
  “When   say “Go” Grasp 
the key between your 
thumb and your first 
finger (examiner 
demonstrates)  
  Then turn the key, first to 
the (state side being 
tested) until the key is 
horizontal then to the 
(state the opposite side) 
until the key is horizontal 
and finally return the key 
to the original vertical 
position. 
  Do this as quickly as you 
can.   
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
For all tasks requiring hand function, i.e. grasping, 
lifting and manipulation of objects, there must be 
some movement of the fingers / thumb to score a 1. 
Score 0 = No movement at fingers / thumb   
Score 1= Movement must be initiated at hand / 
fingers 
Score 2 = Achieves task using a grasp other than 
pincer. Incorrect sequence used for turning key 
Score 3 = Achieves task but with minor difficulty with 
fluidity and precision, or slightly slower than normal 
Note: Take into account the extent of pronation and 
supination observed at forearm to achieve task  
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16. Fold Towel 
 
SET UP 
 
Starting position: 
  Subject is seated in 
chair facing table; chair 
centred on template. 
  Chair returned to 
original position 
  Hips against chair back 
  Hand towel is placed 
flat on table centred on 
subject with short edge 
of towel at 8 cm line. 
  Start with both hands 
gripping the closest 
corners of the towel 
between the thumb and 
index finger. 
 
 
  Filming position (side-
close) 
Ensure trunk and both 
upper limbs in view  
TASK 
 
Task description: 
  Subject folds the towel in half 
lengthwise on the table.  Using 
the affected hand the towel is 
pulled closer to the subject and 
then folded in half in the other 
direction, from the affected side to 
the unaffected side.  The folding 
does not need to be exact, but 
ends of the towel need to be 
approximately aligned (within 1.5 
inches). 
 
Timing procedure: 
  Start on the word “Go.”  End when 
the towel is completely folded on 
the table. 
 
Measure: 
  The time elapsed from the starting 
point to the moment the towel is 
completely folded on the table. 
 
 
VERBAL 
INSTRUCTIONS 
 
Verbal instructions: 
  “When   say “Go” 
Fold this towel in half 
length wise and then 
in half again, like this 
(examiner 
demonstrates).  Do 
this task as rapidly 
as possible.   
Ready, Go.” 
 
 
 
 
 
 
 
 
 
 
 
 
Task specific scoring guidance 
Score 0= 
No attempt / unable to grip towel, i.e. no movement seen in 
fingers / thumb 
Score 1= Movement seen in fingers but unable to grip and/or 
release towel 
Assisted to position towel in fingers prior to starting task 
Score 2=Towel may be poorly folded or need smoothing / 
straightening out.  Over use of non-paretic hand in the first fold. 
Excessive use of trunk flexion to compensate for reduced 
elbow extension. Abnormal grip to fold towel. 
Score 3 = Achieves task but with minor difficulty with fluidity 
and precision, or slightly slower than normal 
NB allow trunk flexion to reach towel as long as it is not 
compensating for reduced elbow extension / shoulder flexion.  
If towel is pulled towards subject in a normal functional manner 
during first fold do not penalize subject.   
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Task specific scoring guidance 
Score 0= Unable to stand 
No movement at hand to grasp basket (subtask a) 
Score 1= Hand movement seen but unable to grasp 
basket handle (subtask a) 
Score 2= Achieves task but hits basket on side or 
bangs it onto shelf in uncontrolled manner or abnormal 
grasp on basket.  Movement out of original foot 
position or use of non-paretic hand to maintain 
balance.  Over compensation from significant extent of 
trunk rotation to complete task 
Score 3= Lacks precision when placing basket on 
shelf 
Slight loss of balance when achieving task (but no use 
of non-paretic hand or foot movement for support) 
17. Lift Basket 
 
SET UP 
 
Starting position: 
  Subject standing and 
facing table. 
  Rolling bedside table 
(15” higher than table) 
placed over the desk on 
subject’s side to be 
tested.  The rolling 
bedside table extends 
across the length of the 
desk from the edge 
nearest the subject to the 
edge farthest from the 
subject 
  Basket at 8 cm line on 
the test table template, 
leading edge 14 cm from 
side edge of table of side 
to be tested, handles 
(taped together) lined up 
with centre of body. 
  Three pound weight 
placed in basket. 
  Filming position (side or 
front) 
 
TASK 
 
Task description: 
  Subtask 17a: Subject to pick up basket 
by grasping handle (from underneath the 
handle) and placing the basket on far 
edge of the rolling bedside table.  The far 
edge of the basket should touch the far 
edge of the table. 
  Subtask 17b: Subject to pick up basket 
by hooking forearm under the handle 
and placing the basket on far edge of the 
rolling bedside table.  The far edge of the 
basket should touch the far edge of the 
table. 
 
Timing procedure: 
  Start on the word “Go.”  End when any 
portion of the base of the basket extends 
beyond the far edge of the bedside table. 
 
Measure: 
  The time elapsed from the starting point 
to the moment the basket has been 
placed on the cart in the required 
position.  (Note: release of the basket is 
not included in the time measure). 
 
VERBAL 
INSTRUCTIONS 
 
Verbal Instructions: 
  “When   say 
“Go” Pick up 
the basket with 
your (state the 
side being 
tested) hand 
and place the 
basket on the 
rolling table.  
The far edge of 
the basket 
should touch 
the far edge of 
the bedside 
table (examiner 
demonstrates). 
Try not to move 
your feet while 
you do this 
task.  Do this 
as quickly as 
possible.  
Ready, Go.”  
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Distance between top of table 
and chair seat  (with table 
positioned at mid abdomen 
height) 
                                                           
 
          
      cm                                                  
Scoring scale 
0 =   Does not / unable to attempt with the involved arm 
1 =   Involved arm does not participate functionally and the task 
is not achieved; however an attempt is made to use the arm 
2 =   Arm does participate and the task is achieved, but 
movement is influenced to some degree by compensatory 
movements and/or abnormal movement patterns or performed 
slowly and/or with effort  
3 =   Arm does participate and the task is achieved in one 
attempt; movement is close to normal but slightly slower; may lack 
precision, fine co-ordination, or fluidity 
4 =  Arm does participate; movement appears to be normal, 
timely (pay attention to expected normal times) and controlled.  
 
 
Chair position sideways      
(items 1 - 4) 
 
 
 
               
cm         
 
Chair position facing table  
(items 5, 6, 9-13, 15, 16)     
 
            
    
      cm                                                       
 
Chair position facing table  (item 
8) 
 
          
      cm                                  
 
 
Item 
 
Time (0 – 120 s) 
Functional 
ability score 
 
Notes: 
 
1. Forearm to table (side) 
 
    
  0  1   2   3  4   
 
 
2. Forearm to box (side)  
 
     
  0  1   2   3  4   
 
 
3. Extend elbow (side) 
 
   
0  1   2   3  4     
 
 
4. Extend elbow to side with 
weight 
     
  0  1   2   3  4   
 
 
5. Hand to table (front) 
 
     
0  1   2   3  4   
 
 
6. Hand to box (front 
 
     
 0  1   2   3  4    
 
 
8. Reach and Retrieve 
 
   
0  1   2   3  4    
 
 
9a. Lift Can subtask 1 
 
     
0  1   2   3  4   
 
 
9b. Lift Can subtask 2 
 
    
 0  1   2   3  4   
 
WMFT scoring sheet 
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9c. Lift Can  subtask 3 
 
     
0  1   2   3  4     
 
 
9d. Lift Can  subtask 4 
 
     
 0  1   2   3  4    
 
 
10a. Lift Pencil  subtask 1 
 
     
 0  1   2   3  4    
 
 
10b. Lift Pencil  subtask 2   
 
     
 0  1   2   3  4   
 
 
10c. Lift Pencil  subtask 3 
 
    
 0  1   2   3  4   
 
 
11a. Lift Paperclip  subtask 1 
 
     
0  1   2   3  4     
 
 
11b. Left Paperclip  subtask 2 
 
     
0  1   2   3  4     
 
 
12. Stack Checkers 
 
    
 0  1   2   3  4     
 
 
13a. Flip Cards  subtask 1 
 
     
0  1   2   3  4     
 
 
13b. Flip Cards  subtask 2 
 
     
0  1   2   3  4     
 
 
15. Turning Key in Lock 
 
     
0  1   2   3  4     
 
 
16. Fold Towel 
 
     
 0  1   2   3  4    
 
 
17a. Lift Basket  subtask 1 
   
    
0  1   2   3  4     
 
 
17b. Lift Basket subtask 2 
 
   
0  1   2   3  4   
 
 
Total Score 
     
 
Mean of total score       
 
Median of total score 
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Appendix G - Main Study Statistical Results  
Table G- 1: The list of motor impairment indices included in the main study analysis 
Indices included in the main study analysis 
(measurement unit)  
Wrist rig tests  
Extensor AROM (degrees)  Active range of movement 
 
Extensor PROM (degrees) 
 
Passive range of movement 
 
Extensor IF (Nm)  Maximal voluntary contraction 
 
Sine tracking index (cross correlation) 
(degrees
2) 
 
Active sinusoidal tracking  
Sine coactivation index (correlation coefficient) 
 
Step tracking index (total Mean Absolute Error) 
(degrees) 
 
Active step tracking  
Path length (degrees/sample) 
 
Step coactivation index (correlation coefficient) 
 
Extensor onset timing  
(seconds) 
Stretch index (3.5Hz)   
 
Fast passive sinusoidal tracking 
(stretch response test)  - 3.5Hz  
Stretch index (0.5Hz)  Fast passive sinusoidal tracking 
(stretch response test)  - 0.5Hz 
Mean torque index (Nm) 
 
Slow passive ramp and hold tracking 
(torque test)  
       
Table G- 2: Impairment measures that were found not to be normally distributed in the 
different patient groups of the main study 
Group  Impairment measures which were not normally 
distributed 
Impaired n=26  TI step, Ext onset, SI 3.5, SI 0.5 
Unimpaired n=14  CI sine, Ext onset, SI 0.35, SI 0.5 
   
Acute n=13  TI step, Ext onset, SI 3.5, SI 0.5 
Chronic n=13  TI step, Ext onset, AROM ext, SI 0.5 
   
Low MCA n=6  IF ext, SI 0.5 
High MCA n=13  SI 3.5, SI 0.5 
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Table G- 3: Median (Interquartile range) values for all impairment indices and P values 
comparing the impaired and unimpaired groups. Statistical significance was tested using the 
non-parametric Mann Whitney U test. Statistically significant between group differences 
(p<0.05) are in bold. 
  Impairment Indices  Group  P values 
Impaired 
(N=26) 
Unimpaired 
(N=14) 
Unimpaired - 
Impaired 
Negative 
Impairments  
 
 
Sine tracking index 
(degrees
2) 
118.2  
(31.7, 193.5) 
222.3  
(213.8, 236) 
<0.001 
Step tracking index 
(degrees)  
6.36 
(5.57, 11.28) 
3.97    
(3.52, 4.23) 
<0.001 
Path length 
(degrees/sample) 
0.022  
(0.016, 0.025) 
0.009  
(0.007, 0.010) 
<0.001 
Active ROM extension 
(degrees) 
22.1  
(-15, 36) 
57.8  
(53, 65) 
<0.001 
Extensor IF 
 
(Nm) 
1.18 
(0.2, 2.6) 
4.95  
(3.1, 6.8) 
<0.001 
Extensor onset 
a  
(seconds) 
0.41  
(0.31, 0.56) 
0.29  
(0.26, 0.34) 
0.006 
       
Positive 
impairments 
Coactivation  
(sine tracking) 
(correlation coefficient) 
0.11 
(-0.30, 0.30) 
-0.34  
(-0.45, -0.20) 
0.024 
Coactivation  
(step tracking) 
b 
(correlation coefficient)  
-0.05  
(-0.27, 0.17) 
-0.12 
(-0.28, 0.05) 
0.558 
Stretch index 
c (3.5Hz) 
(ratio SR area: LBL 
1.24  
(1.05, 1.76) 
1.00 
0.98, 1.02 
<0.001 
         
Secondary 
impairments 
Passive ROM extension 
(degrees) 
60.1  
(42.4, 65.7) 
70.09  
(65.5, 73.9) 
<0.001 
Mean torque 
d  
(Nm) 
0.49  
(0.33, 0.87) 
0.45  
(0.39, 0.65) 
0.109 
ROM – Range of movement; IF – isometric force; SR – stretch response; LBL – local baseline            
 a 
Impaired group n=24; 
b Impaired group n=25; 
c Impaired group n=24; 
d Impaired group n=22, 
unimpaired n=11   
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Table G- 4: Between-days repeatability for the measurement indices from the active tests for 
17 participants* from the impaired group (9 acute, 8 chronic) showing the range of values for 
this group, mean day 2 – day 1 difference, Bland and Altman limits of agreement and 
coefficient of repeatability 
  Impairment Indices  Range of 
values  
(min – max) 
Between-days repeatability 
Mean 
difference  
[95% CI] 
Limits of 
agreement 
Coefficient of 
repeatability 
Negative 
Impairments  
 
 
Sine tracking index 
a 
(degrees
2) 
2.0 - 229.6  3.13                
[-6.6, 12.9] 
 
(-33.5, 39.8)  ±35.32 
Step tracking index 
(degrees)  
4 - 16.42  -0.21               
[-0.7, 0.29] 
 
(-2.14, 1.72)  ±1.88 
Path length 
(degrees/sample) 
0.012 - 0.050  -0.002              
[-0.006, 0.002] 
 
(-0.016, 0.013)  ±0.014 
Active ROM extension 
(degrees) 
-52.3 - 51.2  4.4             
[1.4, 7.4]  
 
(-7.3, 16.1)  ±14.1 
Extensor IF 
 
(Nm) 
0 - 4.8  0.1                  
[-0.1, 0.4] 
 
(-0.9, 1.2)  ±1.1 
Extensor onset 
b 
(seconds) 
0.22 - 1.28  -0.008 
[-0.12, 0.11] 
(-0.39, 0.38)  ±0.37 
         
Positive 
impairments 
Coactivation  
(sine tracking) 
b 
(correlation coefficient) 
-0.54 - 0.73  0.05                  
[-0.15, 0.24] 
 
(-0.60, 0.69)  ±0.61 
Coactivation  
(step tracking) 
b 
(correlation coefficient)  
-0.50 - 0.71  -0.10 
[-0.19, -0.01] 
(-0.40, 0.21)  ±0.34 
         
Secondary 
impairments 
Passive ROM 
extension (degrees) 
21 - 69.8  2.3                  
[-1.1, 5.7] 
 
(-10.9, 15.5)  ±13.4 
*Unless stated otherwise; 
a N=16; 
b N = 13; Data was missing due to technical reasons on one day 
assessment;  
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Figure G- 1: Bland Altman Plots for between-days test retest reliability for 17 impaired 
participants in the reliability sub-group, showing mean difference (bold line) and 95% limits of 
agreement (dashed): negative impairments – Sine (N=16) and step tracking indices, path 
length, active range of movement extension, extensor isometric force and extensor onset 
timing (N=13) 
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Figure G- 2: Bland Altman Plots for between-days test retest reliability impaired participants 
in the reliability sub-group, showing mean difference (bold line) and 95% limits of agreement 
(dashed): positive impairments – coactivation indices (sine and step tracking), N=13. 
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Table G- 5: Median (Interquartile range) values for all impairment indices and P values 
comparing the acute and chronic groups with the unimpaired group. Statistical significance 
was tested using a Mann Whitney U test. Statistically significant between group differences 
(p<0.05) are in bold 
  Impairment 
Indices 
Group  P values 
Acute 
(N=13) 
Chronic 
(N=13) 
Unimpaired 
(N=14) 
Unimpaired 
- Acute 
Unimpaired 
- Chronic 
Negative 
Impairments  
 
 
Sine tracking 
index (degrees
2) 
107.8 
(41.3, 174.7) 
178.8  
(6.8, 201.1) 
222.3  
(213.8, 236) 
<0.001  <0.001 
Step tracking 
index (degrees)  
6.51 
(6, 10.8) 
5.90  
(4.8, 12.0) 
3.97    
(3.52, 4.23) 
<0.001  <0.001 
Path length 
(degrees/sample) 
0.024  
(0.022, 0.029) 
0.017  
(0.015, 0.022) 
0.009  
(0.007, 0.010) 
<0.001  <0.001 
AROM extension 
(degrees) 
19.5  
(0.6, 34) 
28.8  
(-41, 37) 
57.8  
(53, 65) 
<0.001  <0.001 
Extensor IF  
(Nm) 
0.51  
(0.23, 1.38) 
1.98 
(0.17, 3.71) 
4.95  
(3.1, 6.78) 
<0.001  0.002 
Extensor onset 
a 
(seconds) 
0.5  
(0.32, 0.64) 
0.4  
(0.30, 0.50) 
0.29  
(0.26, 0.34) 
0.008  0.043 
           
Positive 
impairments 
Coactivation 
(sine tracking) 
(correlation 
coefficient) 
-0.2  
(-0.45, 0.07) 
0.14 
(-0.19, 0.42) 
-0.34  
(-0.45, -0.20) 
0.356  0.003 
Coactivation 
(step tracking) 
b 
(correlation 
coefficient)  
-0.09  
(-0.33, 0.12) 
0.04  
(-0.20, 0.31) 
-0.12 
(-0.28, 0.05) 
0.884  0.237 
Stretch index 
c 
(3.5Hz) 
1.15  
(1.05, 1.76) 
1.34  
(1.04, 1.93) 
1.00 
0.98, 1.02 
<0.001  <0.001 
             
Secondary 
impairments 
PROM extension 
(degrees) 
48.9  
(31.2, 55.8) 
60.1  
(42.4, 65.7) 
70.09  
(65.5, 73.9) 
<0.001  0.007 
 
Mean torque 
d 
(Nm) 
0.18  
(0.07, 0.27) 
0.49  
(0.33, 0.87) 
0.45  
(0.39, 0.65) 
0.002  0.853 
AROM – active range of movement; IF – isometric force; PROM – passive range of movement;          
 a 
Chronic group n=11; 
b Chronic
 group n=12; 
c Acute and chronic group n=12; 
d Acute group n=10, 
chronic n=12, unimpaired n=11;   
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Table G- 6: Median (Interquartile range) values for impairment indices and P values 
comparing the low and high MCA and unimpaired groups. Statistical significance was tested 
using a Kruskal Wallis Test and Mann Whitney U test. Statistically significant between group 
differences (p<0.05) are in bold. 
Impairment 
Indices 
Group median (IQR)  Kruskal 
Wallis Test 
P values 
Mann Whitney U test P values 
High MCA 
(N=17) 
Low MCA 
(N=9) 
Unimpaired 
(N=14) 
High – 
Low MCA 
Unimpaired 
– High MCA 
Unimpaired 
– Low MCA 
Negative Impairments             
Extension AROM 
(degrees) 
31.0 
(21.7, 42.8) 
-55 
(-29, 1) 
57.8 
(53, 65) 
<0.001  <0.001  <0.001  <0.001 
Extensor IF 
(Nm) 
1.67 
(0.81, 3.71) 
0.06 
(0.01, 0.58) 
4.95 
(3.1, 6.78) 
<0.001  0.001  0.001  <0.001 
Extensor onset 
a 
(seconds) 
0.4 
(0.29, 0.50) 
0.75 
(0.35, 1.28) 
0.29 
(0.26, 0.34) 
0.002  0.022  0.052  0.002 
Positive Impairments             
Coactivation 
(sine) (correlation 
coefficient) 
-0.22 
(-0.45, -0.08) 
0.28 
(0.07, 0.59) 
-0.34 
(-0.45, -0.20) 
0.001  0.001  0.311  0.001 
Coactivation 
(step)
b (correlation 
coefficient) 
-0.13 
(-0.36, 0.09) 
0.30 
(0.01, 0.58) 
-0.12 
(-0.28, 0.05) 
0.010  0.003  0.551  0.017 
Stretch index 
c  
(ratio SR:LBL) 
1.15 
(1.03, 1.48) 
1.38 
(1.13, 2.21) 
1.00 
0.98, 1.02 
<0.001  0.178  <0.001  <0.001 
Secondary Impairments             
Extension PROM 
(degrees) 
60.1 
(44.4, 65.5) 
60.1 
(42.4, 65.7) 
70.09 
(65.5, 73.9) 
<0.001  0.022  0.002  <0.001 
Mean torque 
d 
(Nm) 
0.23 
(0.15, 0.46) 
0.52 
(0.26, 0.84) 
0.45 
(0.39, 0.65) 
0.067  0.142  0.021  1.00 
AROM – active range of movement; IF – isometric force; PROM – passive range of movement; SR – stretch 
response; LBL – local baseline;
 a Low MCA group n=7; 
b Low MCA group n=8; 
c Low MCA group N=8 and high 
MCA group n=16; 
d High MCA group n=14, unimpaired n=11  
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Table G - 7: Spearman’s correlation coefficients between all the variables for acute stroke group (N=13), statistically significant values in bold (p<0.05) 
  Variable  Sine TI  Step TI  Path 
length 
Ext  
onset 
AROM 
ext 
IF ext  CI (sine)  CI (Step)  SI (3.5Hz)  SI (0.5Hz)  PROM 
ext 
MTI 
Negative 
impairment 
Step TI  -0.912 
(p<0.001) 
                     
Path 
length 
-0.011 
(P=0.971) 
-0.011 
(P=0.971) 
                   
Ext onset  -0.619 
(P=0.024) 
-0.619 
(P=0.024) 
-0.071 
(P=0.818) 
                 
AROM ext  0.368 
(P=0.216) 
-0.291 
(P=0.334) 
0.537 
(P=0.058) 
-0.110 
(P=0.720) 
               
IF ext  0.368 
(P=0.216) 
-0.286 
(P=0.344) 
-0.147 
(P=0.632) 
-0.085 
(P=0.782) 
0.775 
(P=0.002) 
             
                           
Positive 
impairment 
CI (sine)  -0.878 
(P<0.001) 
0.880 
(P<0.001) 
0.097 
(P=0.752) 
0.763 
(P=0.002) 
-0.242 
(P=0.426) 
-0.206 
(P=0.4.99) 
           
CI (Step)  -0.571 
(P=0.041) 
0.538 
(P=0.058) 
-0.117 
(P=0.562) 
0.495 
(P=0.085) 
-0.473 
(P=0.103) 
-0.225 
(P=0.459) 
0.748 
(P=0.003) 
         
SI (3.5Hz)  0.042 
(P=0.897) 
-0.105 
(P=0.746) 
0.382 
(P=0.221) 
0.245 
(P=0.442) 
0.063 
(P=0.846) 
0.182 
(P=0.572) 
0.144 
(P=0.656) 
0.245 
(P=0.442) 
       
SI (0.5Hz)  -0.067 
(P=0.854) 
0.310 
(P=0.383) 
0.233 
(P=0.536) 
0.032 
(P=0.923) 
-0.077 
(P=0.812) 
-0.217 
(P=0.499) 
0.361 
(0.249) 
0.573 
(P=0.051) 
0.182 
(P=0.572) 
     
                           
Secondary 
impairment 
PROM ext  0.253 
(P=0.405) 
-0.022 
(P=0.943) 
0.507 
(P=0.077) 
0.127 
(P=0.680) 
0.758 
(P=0.003) 
0.555 
(P=0.049) 
0.055 
(P=0.858) 
-0.225 
(P=0.459) 
0.182 
(P=0.572) 
-0.098 
(P=0.762) 
   
MTI  -0.067 
(P=0.854) 
0.310 
(P=0.383) 
0.223 
(P=0.536) 
-0.177 
(P=0.625) 
0.188  
(P=0.602) 
0.274 
(P=0.444) 
0.146 
(P=0.688) 
-0.012 
(P=0.973) 
-0.213 
(P=0.555) 
-0.118 
(P=0.960) 
0.298 
(P=0.403) 
 
                           
Activity  mWMFT  0.539 
(P=0.057) 
-0.371 
(P=0.212) 
0.214 
(P=0.483) 
-0. 273 
(P=0.367) 
0.787 
(P=0.001) 
0.707 
(P=0.007) 
-0.347 
(P=0.245) 
-0.476 
(P=0.100) 
-0.056 
(P=0.863) 
-0.035 
(P=0.914) 
0.624 
(P=0.023) 
0.541 
(P=0.106) 
Statistically significant correlation - Bold shaded cells (P≤0.004 level), bold un-shaded cells (P≤0.05 level); TI: Tracking Index; Ext: extension; AROM: active range of movement; IF: 
Isometric force; CI: coactivation index; SI: stretch index; PROM: passive range of movement; MTI: mean torque index; mWMFT: modified wolf motor function test  
    229 
Table G- 8 Spearman’s correlation coefficients between all the variables for chronic stroke group (N=13), statistically significant values in bold (p<0.05) 
  Variable  Sine TI  Step TI  Path 
length 
Ext onset  AROM 
ext 
IF ext  CI (sine)  CI (Step)  SI (3.5Hz)  SI (0.5Hz)  PROM 
ext 
MTI 
Negative 
impairment 
Step TI  -0.863 
(p<0.001) 
                     
Path length  0.213 
(P=0.484) 
-0.169 
(P=0.581) 
                   
Ext onset  -0.661 
(P=0.027) 
0.638 
(P=0.035) 
-0.074 
(P=0.829) 
                 
AROM  0.681 
(p=0.010) 
-0.676 
(p=0.011) 
0.319 
(P=0.289) 
-0.369 
(P=0.264) 
               
IF ext  0.846 
(p<0.001) 
-0.780 
(p=0.002) 
0.141 
(P=0.645) 
-0.651 
(P=0.030) 
0.725 
(p=0.005) 
             
                           
Positive 
impairment 
CI (sine)  -0.725 
(P=0.005) 
0.615 
(P=0.025) 
-0.061 
(P=0.843) 
0.487 
(P=0.128) 
-0.692 
(P=0.009) 
-0.698 
(P=0.008) 
           
CI (Step)  -0.669 
(P=0.017) 
0.795 
(P=0.002) 
-0.069 
(P=0.831) 
0.555 
(P=0.076) 
-0.490 
(P=0.106) 
-0.834 
(P=0.001) 
0.592 
(P=0.043) 
         
SI (3.5Hz)  -0.531 
(P=0.075) 
0.336 
(P=0.286) 
0.177 
(P=0.583) 
0.382 
(P=0.276) 
-0.531 
(P=0.075) 
-0.420 
(P=0.175) 
0.531 
(P=0.075) 
0.218 
(P=0.519) 
       
SI (0.5Hz)  -0.275 
(P=0.364) 
0.132 
(P=0.668) 
-0.125 
(P=0.685) 
0.241 
(P=0.474) 
-0.412 
(P=0.162) 
-0.275 
(P=0.364) 
0.170 
(P=0.578) 
0.042 
(P=0.897) 
0.776 
(P=0.003) 
     
                           
Secondary 
impairment 
PROM ext  0.552 
(P=0.067) 
-0.456 
(P=0.117) 
0.191 
(P=0.532) 
0.077 
(P=0.821) 
0.720 
(P=0.006) 
0.566 
(P=0.044) 
-0.467 
(P=0.108) 
-0.396 
(P=0.203) 
-0.168 
(P=0.602) 
-0.121 
(P=0.694) 
   
MTI  -0.021 
(P=0.948) 
0.210 
(P=0.513) 
-0.470 
(P=0.123) 
-0.127 
(P=0.726) 
-0.441  
(P=0.152) 
0.056 
(P=0.863) 
0.189 
(P=0.557) 
0.055 
(P=0.873) 
0.209 
(P=0.537) 
0.301 
(P=0.342) 
-0.287 
(P=0.366) 
 
                           
Activity  mWMFT  0.863 
(p<0.001) 
-0.835 
(p<0.001) 
0.263 
(P=0.385) 
-0.647 
(P=0.031) 
0.791 
(P=0.001) 
0.758 
(P<0.003) 
-0.786 
(P=0.001) 
-0.697 
(P=0.012) 
-0.720 
(P=0.008) 
-0.527 
(P=0.064) 
0.445 
(P=0.128) 
-0.266 
(P=0.404) 
                           
Statistically significant correlation - bold shaded cells (P<0.004 level), bold un-shaded cells (P<0.05 level); TI: Tracking Index; Ext: extension; AROM: active range of 
movement; IF: Isometric force; CI: coactivation index; SI: stretch index; PROM: passive range of movement; MTI: mean torque index; mWMFT: modified wolf motor function test 
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Table G- 9: P values for each impairment variable entered individually into a linear 
regression and quantile regression with the mWMFT function score. 
  Impairment 
variables  
Acute group  Chronic group 
Linear regression          
P value 
Quantile regression 
P value 
Negative 
impairments 
TI Sine   0.067  0.221  <0.001  <0.001 
TI Step  0.066  0.123  <0.001  <0.001 
Path length  0.458  0.343  0.239  0.825 
Ext onset  0.075  0.187  0.015  <0.001 
Ext AROM  0.016  0.063  <0.001  <0.024 
Ext IF   <0.001  0.003  <0.001  0.145 
Positive 
impairments 
SI (3.5Hz)  0.295  0.691  0.114  0.060 
CI Sine  0.116  0.635  0.002  0.057 
CI Step  0.530  0.388  0.003  0.037 
Secondary 
impairments 
Ext PROM  0.027  0.144  0.026  0.155 
MTI  0.273  0.222  0.351  0.086 
 
  
    231 
Appendix H - Wrist rig participant record form 
 
Study 
  
 
Session 1 date:        Session 2 date: 
Participant file number 1:      Participant file number 2: 
Participant 
details 
DOB:          R  /  L  sided hemiplegia 
Time from Stroke: 
Clinical 
details 
Hx of Unilateral neglect:      Result of star cancellation test: 
Medication: 
Observation of wrist activity: 
Able to extend wrist and fingers 
>20˚  
Mild severity high functioning 
 
Able to extend wrist thumb 
and 2 digits > 10˚ 
Mild severity low functioning 
 
Able to extend wrist 5˚ when 
supported in wrist rig 
Moderate severity 
MAS score 
= 
0 =  No increase in muscle tone 
1 =  Slight increase in muscle tone, resulting in a “catch” and a “release” (brief 
increase in resistance) at the end of the range of motion 
2 =  Slight increase in muscle tone, resulting in a “catch”, (increased resistance) 
followed by minimal resistance throughout the remainder (less than half) of the 
range of motion  
3 =  A more marked increase in muscle tone throughout most of the range of motion, 
however affected part can be easily moved 
4 =  Marked increase of muscle tone, passive movement difficult 
5 =  The affected part cannot be moved 
Tardieu 
Scale  
V1 X= 
V1 Y= 
V3 X= 
V3 Y= 
0: No resistance throughout the course of the passive movt. 
1: Slight resistance throughout the course of the passive 
movement, with no clear catch at a precise angle. 
2: Clear catch at a precise angle, interrupting the passive 
movement, followed by release.  
3: Fatigable clonus (<10 seconds when maintaining pressure) 
occurring at a precise angle.  
4: Infatigable clonus (>10 seconds when maintaining pressure) 
occurring at a precise angle. 
V1 – slow movt 
V3 – fast movt 
X – quality of 
muscle reaction 
Y – angle of 
muscle reaction 
(V1 end of 
passive range; V2 
angle of catch) 
 
Joint 
position 
sense 
Score: 
0 – Absent: Patient does not detect the movement taking place. 
1 – Impaired: Patient detects the movement taking place but the direction is not 
correct on all three occasions. 
2 – Normal: Patient correctly detects the direction of the movement taking place on all 
three occasions. 
Test  Files recorded/ comments/ problems 
Session 1 
    
Session 2  
1.  AROM      
2.  PROM 
 
 
   
3.  MVC  Ext:  Flex:  Ext:  Flex: 
0˚ 
 
       
20˚ 
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4.  Passive 
tracking 
Session 1  Session 2 
Force/angle test  
5˚/s full PROM 
 
 
 
   
Stretch response 
3.5Hz +/-5˚ 
(sin35_5_stretch) 
 
0.5Hz +/-20˚ 
(sin_5_stretch) 
 
 
 
 
5.   Active 
tracking 
Comments/ problems/ results 
Session 1 
 
Session 2 
Sinusoidal 
without resistance 
0.5Hz +/-20˚ 
(sin5_track) 
 
   
Random step 
without resistance 
(jump_c_track) 
 
 
   
Setting resistance 
files 
 
 
 
Sinusoidal  
with resistance 
(sin5_track)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Random step 
with resistance 
(jump_c_track) 
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Appendix I - Participant Information Sheet 
Project Title:  Arm movement problems and how they relate to arm function post-stroke 
Ethics Submission 
No: 
09/H0504/21 
 
Introduction 
You are being invited to take part in a research study.  Before you decide, it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you wish.  (Part 1 tells 
you the purpose of this study and what will happen to you if you take part. Part 2 gives you 
more detailed information about the conduct of the study). 
Ask us if there is anything that is not clear or if you would like more information.  Take time to 
decide whether or not you wish to take part. Thank you for reading this. 
Part one 
1.1  What is the purpose of the study? 
This study is being undertaken by Ruth Turk, an experienced Physiotherapist, as part of a 
PhD. Muscle weakness, tightness (known as spasticity) and loss of control of movement are 
common problems among people who have had a stroke.  There is a need for better 
objective measures of movement problems to improve research of arm rehabilitation after a 
stroke. A better understanding of the underlying reason for improvement in arm activity after 
a stroke will enable better diagnosis of movement problems and more targeted therapy.  The 
purpose of this study is to measure movement problems of the arm of older adults who have 
suffered a stroke, to understand how these movement problems are related to an 
individual’s ability to perform activities such as reach and grasp, and understand how this 
relationship changes over time after a stroke.   
1.2  Why have I been invited? 
You have been chosen to take part in this study because you had a stroke either within the 
last four months or more than one year ago and you are over the age of 60.  You are 
currently having treatment, or have had treatment in the past, from Physiotherapists or 
Occupational Therapists at one of the following hospitals: Western Community Hospital 
(Southampton), Farnham Hospital or Milford Hospital (Surrey); or you are registered on the 
School of Health Sciences research participant database.  From your stroke you have some 
movement problems with your affected arm. If you decide to take part you will be one of up to 
40 participants.   
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1.3  Do I have to take part? 
It is up to you to decide. If you are interested please let the Therapy team who contacted you 
know by phone or by returning the reply slip in the stamped addressed envelope.  The 
researcher will then contact you and will describe the study and go through this information 
sheet, which you are asked to keep. If you are still interested, you will be asked to sign a 
consent form to show you have agreed to take part and that you understand what is involved. 
You are free to withdraw at any time, without giving a reason. This would not affect the 
standard of care you receive. 
1.4  What will happen to me if I take part? 
You will be asked to take part in two assessment sessions which will take place at the 
Western Hospital, Southampton, or at Farnham or Milford Hospital, Surrey, depending where 
you are receiving or have received your care, or at the School of Health Sciences laboratory, 
University of Southampton.  The tests will be conducted by the researcher and the sessions 
will last approximately one and a half hour with regular breaks (see schedule below). If you 
feel too tired to complete the session, the test of arm function can be undertaken at another 
time within a few days of the session.  The researcher can assist you with any personal 
needs during that time but you may also like to be accompanied by a carer to assist with any 
needs. 
Testing schedule for participants  
Session 1 
Total time 
= 1 ½ 
hours  
Complete neglect 
and spasticity tests, 
test movement in 
the rig (15 minutes) 
Break 
(5 mins) 
Set up and 
practice the rig 
tests, with two 5 
min breaks                
(40 minutes) 
Break 
(10 
mins) 
Test of arm 
function  
(20 minutes) 
Session 2 
Total time 
= 1 ½ 
hours 
Set up and 
complete the rig 
tests with one 5 min 
break                (60 
minutes) 
Break  
(10 
mins) 
Test of arm 
function    (20 
minutes) 
   
  
    235 
Small light 
tracking 
display 
EMG 
electrodes 
and leads 
A wrist rig (see figure 1) designed to measure how the arm moves and how the muscles are 
working. This comprises: 
  A chair with  an arm-rest and a series of 
very  small  lights  (LEDs)  on  a  display 
placed in front.  Your wrist joint is aligned 
with a pivot point to allow horizontal wrist 
movement.   
  Electromyography (EMG) measurement 
(the electric signals from the muscles that 
move your wrist).   
  An  instrument  in  the  arm  rest  that 
measures  your  wrist  angle  and  an 
instrument that measures the strength you 
use to move your wrist.   
  A Laptop computer that: 
-  Records  your  movement  data  from 
each measurement session 
-  Generates  a  moving  target  that  you 
have to try and track with your movements 
-  Analyses the information. 
 
At the first session the researcher will initially conduct two tests with you to ensure you fit the 
criteria for the study.  Firstly you will be asked to cross out stars on a page in order to assess 
your ability to identify objects on both your right and left side.  Then you will be asked to sit 
on the wrist rig chair with your arm placed on the rig armrest and secured with straps.  The 
rig allows free movement of the wrist joint and you will be asked to move your hand towards 
you and away from you to ensure that you have enough strength to move in the rig.  If you fit 
these two criteria, you will be asked to continue with the study. For the rest of the first 
session you will practise the wrist rig tests and then get to know a test of your ability to use 
your arm in a series of 15 tasks such as lifting and placing your arm on a table and on a 
shelf, lifting a drink can to the mouth, stacking some checkers, folding a towel and turning a 
key in a lock.  At the second session firstly the assessor will move your wrist to assess your 
level of spasticity (muscle tightness), then you will be asked to perform the wrist rig tests 
followed by the test of arm function (see schedule). 
To perform the wrist rig tests you will be sitting in the chair with your arm placed on the rig 
armrest and a series of very small lights (LEDs) on a display will be placed in front of the arm 
rest.  You will be required to wear a loose short sleeved top, or one that can be rolled up to 
the elbow, so that your skin on your forearm can be cleaned with alcohol wipes and gel 
electrodes to measure your muscle activity can be placed on your arm.  The researcher will 
again help you to place your arm in the rig in the correct position, and your arm will be 
secured with straps. 
During the testing process you will be first asked to move your wrist towards you and away 
from you as far as you can.  The researcher will then move your wrist through its full range.  
Figure 1 The wrist rig  
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You will then be asked to move your wrist to follow the LEDs as they light up in different 
sequences for a few minutes.  These movements will be without, and then with, a small 
resistance.  You will then be asked to push and then pull your hand against a resistance for 
five seconds.  Lastly the assessor will move your wrist to follow a series of lights on an LED 
display while you relax your arm.   
A recording of video information for the purposes of assessment, teaching and presentation 
of results, may be taken during the testing process.  This will only happen if you agree to it 
and your face and other identifying marks will not be included or will be blurred. 
If you take part in this study in the early stages after your stroke, you may be approached for 
a second follow-up stage of the project 8 to 12 months later. 
1.5  Expenses 
If you travel to the hospital where the testing will take place, your travelling expenses will be 
paid. 
1.6  What are the possible risks of taking part? 
There is a very slight risk of reddening of the skin on the hand and arm while it is held in the 
rig by Velcro straps; care will therefore be taken to ensure that the supports are not fastened 
too tightly and if you are undergoing tests for longer than 20 minutes the arm will be released 
and the skin checked for reddening at 20 minute intervals. If you become uncomfortable 
while in the rig, your arm will be released from the rig until any discomfort has eased.   
1.8  What are the possible benefits of taking part? 
There is no direct benefit to you from taking part.  The information we get from this study may 
help us to improve the measurement of movement problems for future patients with stroke. 
1.9  What if something goes wrong?  
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed. The detailed information on this is given in Part 2.  
1.10  Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled in 
confidence. The details are included in Part 2.  
If the information in Part 1 has interested you and you are considering participation, 
please read the additional information in Part 2 before making any decision. 
Part 2 
2.1  What will happen if I don’t want to carry on with the study?  
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If you wish to withdraw from the study, you may stop the testing at any time without giving 
reason.  If you agree, we will use any data we have collected up until the point of withdrawing 
from the study. 
What if there is a problem? 
If you have a concern or a complaint about this study you should contact Susan Rogers, 
Head of Research & Enterprise Services, at the School of Health Sciences (Address: 
University of Southampton, Building 67, Highfield, Southampton, SO17 1BJ ; Tel: +44 (0)23 
8059 7942; Email: S.J.S.Rogers@soton.ac.uk).   If you remain unhappy and wish to 
complain formally Susan Rogers can provide you with details of the University of 
Southampton Complaints Procedure. In the event that something does go wrong and you are 
harmed during the research and this is due to someone’s negligence then you may have 
grounds for a legal action for compensation against the University of Southampton, 
Southampton City Primary Care NHS Trust, or Surrey Primary Care NHS Trust, but you may 
have to pay your legal costs. The normal National Health Service complaints mechanisms 
will still be available to you (if appropriate). 
2.3   Will my taking part in this study be kept confidential?  
All information which is collected about you during the course of the research will be kept 
strictly confidential.  Any information about you on report forms will have your name and 
address removed so that you cannot be recognised from it.  You will be identified by unique 
number that connects your data to you. Your personal details will be kept separately from the 
research records.  The data recorded, for the purpose of the research project, will be held on 
a password protected computer or as paper records kept in a locked filing cabinet. 
2.4   Involvement of the Consultant  
If you are currently under the care of a stroke Consultant in hospital, they have been 
informed that this research is taking place.    
2.5  What will happen to the results of the research study? 
The results of the study will be compiled in reports and published or presented at scientific 
conferences. If you participate in this study, you will not be identified in any report, 
presentation or publication.  You will be sent a summary of the main findings. 
2.6  Who is organising and funding the research? 
The study is being organised through the University of Southampton and is funded by a 
Dunhill Trust Research Fellowship.  
2.7  Who has reviewed the study? 
The Southampton and South West Hampshire Research Ethics Committee have reviewed 
this study.  
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2.8  Contact for Further Information 
Ruth Turk, PhD Student, 023 8059 8928, re@soton.ac.uk 
Jane Burridge, Professor of Restorative Neuroscience, 023 8059 8885, jhb1@soton.ac.uk 
Thank you for considering taking part in this study. You will be given a copy of the 
information sheet and a signed consent form to keep.  
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Appendix J – Consent form 
 
 
Project Title:   Arm movement problems and how they relate to arm function post-
stroke 
Ethics Submission No: 
Participant ID No: 
Principal Investigator:   Ruth Turk  Tel: 023 8059 8928 
       
 
              Please initial box 
1.  I confirm that I have read and understand the information sheet dated...7/9/09.................  
  (version....5........) for the above study. I have had the opportunity to consider the    
  information, ask questions and have had these answered satisfactorily.        
    
2.  I understand that my participation is voluntary and that I am free to withdraw at any time,  
  without giving any reason, without my medical care or legal rights being affected.     
 
 
3.  I understand that relevant sections of my medical notes and data collected during the  
  study may be looked at by individuals from the University of Southampton and from the  
  NHS Trust, where it is relevant to my taking part in this research. I give permission for  
  these individuals to have access to my records.   
   
4.  I agree to a recording of video information for the purposes of assessment, teaching and   
  presentation of results, although my face and other identifying marks will be blurred    
 
5.  I agree to take part in the above study.       
 
 
 
________________________  ________________  ____________________ 
Name of Participant    Date  Signature 
 
 
 
_________________________  ________________  ____________________ 
Researcher      Date    Signature 
 
1 for participant; 1 for researcher; 1 in medical notes 